1 00:00:05,600 --> 00:00:08,080 WELCOME. 2 00:00:08,080 --> 00:00:10,680 I WILL NOW OFFICIALLY CALL 3 00:00:10,680 --> 00:00:16,040 THE -- I'M LAUGHING, SORRY. 4 00:00:16,040 --> 00:00:18,560 THE 111th MEETING OF THE NIAMS 5 00:00:18,560 --> 00:00:19,200 COUNCIL TO ORDER. 6 00:00:19,200 --> 00:00:21,200 ALL COUNCIL MEETINGS ARE OPEN TO 7 00:00:21,200 --> 00:00:24,600 THE PUBLIC AS REQUIRED BY LAW 8 00:00:24,600 --> 00:00:27,040 EXCEPT FOR REVIEW, DISCUSSION, 9 00:00:27,040 --> 00:00:29,240 EVALUATION OF GRANT APPLICATIONS 10 00:00:29,240 --> 00:00:30,280 AND RELATED INFORMATION WHICH 11 00:00:30,280 --> 00:00:36,080 WILL WE'LL BE ADDRESSING IN 12 00:00:36,080 --> 00:00:37,040 CLOSED SESSION THIS AFTERNOON. 13 00:00:37,040 --> 00:00:39,480 BEFORE WE GET STARTED WE'LL DO 14 00:00:39,480 --> 00:00:40,120 INTRODUCTIONS. 15 00:00:40,120 --> 00:00:42,120 WE'LL START WITH BOB CARTER, 16 00:00:42,120 --> 00:00:43,480 DEPUTY DIRECTOR, AND WE'LL GO 17 00:00:43,480 --> 00:00:46,160 AROUND THE TABLE HERE AND THEN 18 00:00:46,160 --> 00:00:49,680 WE'LL GO TO A COUPLE FOLKS 19 00:00:49,680 --> 00:00:50,080 JOINING VIRTUALLY. 20 00:00:50,080 --> 00:00:50,640 BOB, KICK THINGS OFF. 21 00:00:50,640 --> 00:00:51,760 >> THIS IS A TEST OF WHETHER 22 00:00:51,760 --> 00:00:54,320 YOU CAN TURN ON YOUR MICROPHONE. 23 00:00:54,320 --> 00:00:56,920 GOOD MORNING, BOB CARTER, DEPUTY 24 00:00:56,920 --> 00:00:57,200 DIRECTOR. 25 00:00:57,200 --> 00:01:01,240 WELCOME AND SO FUN TO BE HERE 26 00:01:01,240 --> 00:01:08,320 WITH ALL OF YOU. 27 00:01:08,320 --> 00:01:08,800 >> ANN? 28 00:01:08,800 --> 00:01:10,240 >> ANN ELDERKIN, AFFILIATED 29 00:01:10,240 --> 00:01:13,120 WITH AMERICAN SOCIETY FOR BONE 30 00:01:13,120 --> 00:01:18,040 AND MINERAL RESEARCH, FORMER 31 00:01:18,040 --> 00:01:19,120 EXECUTIVE DIRECTOR. 32 00:01:19,120 --> 00:01:21,160 >> DAVID BECK, 33 00:01:21,160 --> 00:01:21,760 PHYSICIAN-SCIENTIST, ASSISTANT 34 00:01:21,760 --> 00:01:24,720 PROFESSOR AT NYU SCHOOL OF 35 00:01:24,720 --> 00:01:24,960 MEDICINE. 36 00:01:24,960 --> 00:01:27,760 >> MARY BUCKSTEIN, PROFESSOR OF 37 00:01:27,760 --> 00:01:32,320 ORTHOPEDIC SURGERY HARVARD 38 00:01:32,320 --> 00:01:32,920 MEDICAL SCHOOL. 39 00:01:32,920 --> 00:01:34,480 >> GOOD MORNING, PROFESSOR AT 40 00:01:34,480 --> 00:01:36,120 UNIVERSITY OF TEXAS M.D. 41 00:01:36,120 --> 00:01:37,240 ANDERSON CANCER CENTER. 42 00:01:37,240 --> 00:01:40,920 >> GOOD MORNING, I'M BETH 43 00:01:40,920 --> 00:01:44,480 McNALLY, PROFESSOR AT 44 00:01:44,480 --> 00:01:46,040 NORTHWESTERN IN CHICAGO. 45 00:01:46,040 --> 00:01:49,080 >> ELLEN GRAPHLISI, GRAPH OF 46 00:01:49,080 --> 00:01:50,000 RHEUMATOLOGY INFORMATION BRIGHAM 47 00:01:50,000 --> 00:01:51,720 AND WOMEN'S HOSPITAL, PROFESSOR 48 00:01:51,720 --> 00:01:53,880 OF MEDICINE AT HARVARD MEDICAL 49 00:01:53,880 --> 00:01:54,120 SCHOOL. 50 00:01:54,120 --> 00:01:56,160 >> GOOD MORNING, STAR BOOKER, 51 00:01:56,160 --> 00:01:57,160 ASSISTANT PROFESSOR AT THE 52 00:01:57,160 --> 00:01:58,480 UNIVERSITY OF FLORIDA, COLLEGE 53 00:01:58,480 --> 00:02:04,680 OF NURSING, ALSO AN ESI. 54 00:02:04,680 --> 00:02:08,040 >> GOOD MORNING, SUE SHRANT, A 55 00:02:08,040 --> 00:02:10,520 RHEUMATOLOGY PATIENT AND PATIENT 56 00:02:10,520 --> 00:02:11,240 ENGAGEMENT ENTHUSIAST, THAT'S 57 00:02:11,240 --> 00:02:14,320 WHAT I DO FOR A LIVING IS BUILD 58 00:02:14,320 --> 00:02:16,840 PATIENT ENGAGEMENT SOLUTIONS. 59 00:02:16,840 --> 00:02:17,080 THANK YOU. 60 00:02:17,080 --> 00:02:24,080 >> GAIL LESTER, DIRECTOR OF 61 00:02:24,080 --> 00:02:26,280 EXTRAMURAL RESEARCH NIAMS. 62 00:02:26,280 --> 00:02:32,720 >> GOOD MORNING, DARREN 63 00:02:32,720 --> 00:02:33,120 SLEDJESKI, NIAMS. 64 00:02:33,120 --> 00:02:36,240 >> TWO COUNCIL MEMBERS JOINING 65 00:02:36,240 --> 00:02:36,920 VIRTUALLY, STEWART? 66 00:02:36,920 --> 00:02:40,040 >>GOOD MORNING, PROFESSOR OF 67 00:02:40,040 --> 00:02:42,720 ORTHOPEDIC SURGERY, 68 00:02:42,720 --> 00:02:47,400 BIOENGINEERING, STANFORD 69 00:02:47,400 --> 00:02:47,680 UNIVERSITY. 70 00:02:47,680 --> 00:02:48,280 >> AND ANDREW? 71 00:02:48,280 --> 00:02:50,240 >> EARLY STAGE INVESTIGATOR, 72 00:02:50,240 --> 00:02:51,320 NEUROLOGIST, WASHINGTON 73 00:02:51,320 --> 00:02:54,920 UNIVERSITY IN ST. LOUIS, 74 00:02:54,920 --> 00:02:59,640 INTERESTED IN MUSCLE DISEASE. 75 00:02:59,640 --> 00:03:01,520 >> OKAY. 76 00:03:01,520 --> 00:03:02,840 THIS ISN'T WORKING. 77 00:03:02,840 --> 00:03:04,120 ALL RIGHT. 78 00:03:04,120 --> 00:03:05,720 SO, BEFORE WE BEGIN, I'M 79 00:03:05,720 --> 00:03:08,440 DELIGHTED TO INTRODUCE AS YOU 80 00:03:08,440 --> 00:03:10,720 JUST HEARD DR. DARREN SLEDJESKI, 81 00:03:10,720 --> 00:03:12,360 WHO STARTED AS NIAMS' NEW 82 00:03:12,360 --> 00:03:14,360 DIVISION DIRECTOR OF THE 83 00:03:14,360 --> 00:03:16,200 DIVISION OF EXTRAMURAL 84 00:03:16,200 --> 00:03:17,720 ACTIVITIES, DEA, IN MARCH. 85 00:03:17,720 --> 00:03:19,800 DARREN ALSO SERVES AS COUNCIL'S 86 00:03:19,800 --> 00:03:21,240 NEW EXECUTIVE SECRETARY AND WILL 87 00:03:21,240 --> 00:03:23,640 MAKE BRIEF ANNOUNCEMENTS IN JUST 88 00:03:23,640 --> 00:03:26,920 A FEW MOMENTS. 89 00:03:26,920 --> 00:03:28,880 AS NIAMS DEA DIRECTOR HE LEADS 90 00:03:28,880 --> 00:03:30,640 INTEGRATION OF SCIENCE AND BIG 91 00:03:30,640 --> 00:03:32,520 ASPECTS OF THE EXTRAMURAL 92 00:03:32,520 --> 00:03:34,360 PROGRAM, ADVISES NIAMS SENIOR 93 00:03:34,360 --> 00:03:37,840 LEADERS ON NIH-WIDE EXTRAMURAL 94 00:03:37,840 --> 00:03:38,880 RESEARCH POLICY, REPRESENTS 95 00:03:38,880 --> 00:03:41,680 NIAMS ON OVERALL NIH EXTRAMURAL 96 00:03:41,680 --> 00:03:44,400 AND COLLABORATIVE PROGRAM POLICY 97 00:03:44,400 --> 00:03:45,280 COMMITTEES, AND COUNSELS 98 00:03:45,280 --> 00:03:49,120 LEADERSHIP ON DEVELOPING AND 99 00:03:49,120 --> 00:03:50,840 IMPLEMENTING NIAMS-SPECIFIC 100 00:03:50,840 --> 00:03:51,520 EXTRAMURAL RESEARCH GRANTS, 101 00:03:51,520 --> 00:03:55,640 CONTRACTS, AND TRAINING PROGRAM 102 00:03:55,640 --> 00:03:55,880 POLICIES. 103 00:03:55,880 --> 00:03:58,400 MOST RECENTLY HE SERVED AS THE 104 00:03:58,400 --> 00:04:00,280 DEPUTY DIRECTOR OF THE DEA AT 105 00:04:00,280 --> 00:04:03,120 THE NATIONAL INSTITUTE FOR 106 00:04:03,120 --> 00:04:04,120 GENERAL MEDICAL SCIENCES, NIGMS, 107 00:04:04,120 --> 00:04:07,200 WHERE HE HELPED LEAD ALL 108 00:04:07,200 --> 00:04:08,160 GRANT-RELATED ACTIVITIES. 109 00:04:08,160 --> 00:04:10,560 PREVIOUSLY, HE WAS CHIEF OF THE 110 00:04:10,560 --> 00:04:11,920 GENETIC MECHANISMS BRANCH 111 00:04:11,920 --> 00:04:14,200 DIVISION OF GENETICS AND 112 00:04:14,200 --> 00:04:17,400 MOLECULAR CELLULAR AND 113 00:04:17,400 --> 00:04:19,000 DEVELOPMENTAL BIOLOGY, NIGMS, 114 00:04:19,000 --> 00:04:21,880 ALSO WORKED AS SCIENTIFIC 115 00:04:21,880 --> 00:04:24,200 INITIATIVE MANAGER AND REVIEW 116 00:04:24,200 --> 00:04:26,240 OFFICER AT NIAID, NATIONAL 117 00:04:26,240 --> 00:04:28,120 INSTITUTE OF ALLERGY AND 118 00:04:28,120 --> 00:04:28,560 INFECTIOUS DISEASES. 119 00:04:28,560 --> 00:04:31,280 BEFORE HIS TENURE IN THE FEDERAL 120 00:04:31,280 --> 00:04:32,600 GOVERNMENT, HE WORKED AT THE 121 00:04:32,600 --> 00:04:34,840 UNIVERSITY OF TOLEDO MEDICAL 122 00:04:34,840 --> 00:04:37,640 CENTER, BOTH AN ASSISTANT AND 123 00:04:37,640 --> 00:04:39,320 ASSOCIATE PROFESSOR IN 124 00:04:39,320 --> 00:04:43,160 DEPARTMENT OF MICROBIOLOGY AND 125 00:04:43,160 --> 00:04:44,200 IMMUNOLOGY. 126 00:04:44,200 --> 00:04:45,760 AND HE EARNED A BACHELOR OF 127 00:04:45,760 --> 00:04:48,480 SCIENCE IN BIOLOGY FROM COLLEGE 128 00:04:48,480 --> 00:04:50,440 OF WILLIAM AND MARY, Ph.D. IN 129 00:04:50,440 --> 00:04:52,200 MICROBIOLOGY FROM UNIVERSITY OF 130 00:04:52,200 --> 00:04:54,640 MARYLAND COLLEGE PARK. 131 00:04:54,640 --> 00:04:59,840 HE CONDUCTED POSTDOCTORAL 132 00:04:59,840 --> 00:05:02,080 RESEARCH IN NCI EXTRAMURAL 133 00:05:02,080 --> 00:05:02,880 RESEARCH PROGRAM. 134 00:05:02,880 --> 00:05:06,000 IMPORTANTLY, I'D LIKE TO THANK 135 00:05:06,000 --> 00:05:07,440 ERIC EDGERTON FOR HIS 136 00:05:07,440 --> 00:05:12,840 OUTSTANDING JOB AS ACTING DEA 137 00:05:12,840 --> 00:05:14,560 SINCE APRIL OF 2022 AND WOULD 138 00:05:14,560 --> 00:05:17,360 LIKE TO RECOGNIZE DR. KATHY 139 00:05:17,360 --> 00:05:25,080 SALIDA FOR FOR EFFORTS IN 140 00:05:25,080 --> 00:05:26,160 OVERSEEING COUNCIL MEETINGS AND 141 00:05:26,160 --> 00:05:28,120 GRANTS MANAGER SINCE APRIL OF 142 00:05:28,120 --> 00:05:30,840 2022. 143 00:05:30,840 --> 00:05:35,880 JOIN ME IN GIVING DR. SLEDJESKI 144 00:05:35,880 --> 00:05:39,160 A VERY WARM WELCOME. 145 00:05:39,160 --> 00:05:39,440 [APPLAUSE] 146 00:05:39,440 --> 00:05:43,240 DARREN, THE FLOOR IS YOURS. 147 00:05:43,240 --> 00:05:45,040 >> BEFORE THE BUSINESS ASPECTS 148 00:05:45,040 --> 00:05:47,040 I WANT TO SAY I'M HAPPY TO BE 149 00:05:47,040 --> 00:05:48,560 HERE AT NIAMS, HOW EXCITED I AM 150 00:05:48,560 --> 00:05:49,680 TO BE HERE. 151 00:05:49,680 --> 00:05:50,680 IT'S A GREAT GROUP. 152 00:05:50,680 --> 00:05:52,840 I'VE ONLY BEEN HERE A COUPLE 153 00:05:52,840 --> 00:05:57,680 MONTHS, I WANT TO GIVE A SHOUT 154 00:05:57,680 --> 00:05:59,200 OUT TO MELINDA, SARAH NEIL AND 155 00:05:59,200 --> 00:06:01,160 KATHY WHO PUT TOGETHER PREVIOUS 156 00:06:01,160 --> 00:06:04,240 COUNCIL ALSO MY FIRST COUNCIL AT 157 00:06:04,240 --> 00:06:04,760 NIAMS. 158 00:06:04,760 --> 00:06:06,040 IT WOULD HAVE BEEN IMPOSSIBLE 159 00:06:06,040 --> 00:06:06,960 WITHOUT THEIR HELP AND GUIDANCE 160 00:06:06,960 --> 00:06:08,240 ON HOW TO DO THIS. 161 00:06:08,240 --> 00:06:10,800 SO THANKS TO ALL OF THOSE FOLKS. 162 00:06:10,800 --> 00:06:12,080 I HATE TO GO OFF MY SCRIPT 163 00:06:12,080 --> 00:06:13,960 BECAUSE IT MAKES THE STAFF 164 00:06:13,960 --> 00:06:15,520 NERVOUS PROBABLY BUT I'M GOING 165 00:06:15,520 --> 00:06:17,040 TO DO THAT ANYWAY. 166 00:06:17,040 --> 00:06:19,040 SO, THIS IS OUR FIRST IN-PERSON 167 00:06:19,040 --> 00:06:20,240 COUNCIL MEETING SINCE THE 168 00:06:20,240 --> 00:06:20,520 PANDEMIC. 169 00:06:20,520 --> 00:06:23,640 AND WE'VE SET IT UP AS A HYBRID 170 00:06:23,640 --> 00:06:25,680 MEETING, TWO COUNCIL MEMBERS 171 00:06:25,680 --> 00:06:27,440 ATTENDING VIA ZOOM. 172 00:06:27,440 --> 00:06:28,840 WE HAVE STAFF ATTENDING VIA ZOOM 173 00:06:28,840 --> 00:06:31,080 AS WELL AS HERE IN PERSON. 174 00:06:31,080 --> 00:06:33,280 ALSO MEMBERS OF THE PUBLIC CAN 175 00:06:33,280 --> 00:06:36,640 BE WATCHING VIA THE NIH 176 00:06:36,640 --> 00:06:37,640 VIDEOCAST STREAMING SYSTEM. 177 00:06:37,640 --> 00:06:40,120 IF ANY STAFF MEMBERS WATCHING ON 178 00:06:40,120 --> 00:06:42,880 THE VIDEOCAST HAVE AN URGENT 179 00:06:42,880 --> 00:06:48,280 COMMENT OR QUESTION E-MAIL NEIL 180 00:06:48,280 --> 00:06:48,920 ROBERTS. 181 00:06:48,920 --> 00:06:50,920 IF YOU HAVE ANY ISSUES, NEIL IS 182 00:06:50,920 --> 00:06:53,320 HERE OR YOU CAN E-MAIL HIM. 183 00:06:53,320 --> 00:06:55,040 WE ENCOURAGE VIEWERS TO SUBMIT 184 00:06:55,040 --> 00:06:56,520 COMMENTS IN WRITING UP TO 15 185 00:06:56,520 --> 00:06:57,760 DAYS FOLLOWING THE MEETING. 186 00:06:57,760 --> 00:07:00,840 WE HAVE A SPECIAL E-MAIL BOX TO 187 00:07:00,840 --> 00:07:09,520 RECEIVE YOUR COMMENTS, SENT TO 188 00:07:09,520 --> 00:07:10,160 NIAMSCOUNCILMAIL@NIAMS.NIH.GOV. 189 00:07:10,160 --> 00:07:11,840 ANYONE ON THE ZOOM CALL MAY 190 00:07:11,840 --> 00:07:13,320 SPEAK BUT PLEASE MAKE SURE TO 191 00:07:13,320 --> 00:07:15,680 MUTE THE LINE WHEN YOU'RE NOT 192 00:07:15,680 --> 00:07:16,280 SPEAKING. 193 00:07:16,280 --> 00:07:18,280 YOU CAN ALSO RAISE YOUR HAND AND 194 00:07:18,280 --> 00:07:20,000 WE CAN CALL ON YOU. 195 00:07:20,000 --> 00:07:22,840 NEIL WILL HELP WITH THE MUTING 196 00:07:22,840 --> 00:07:23,920 AND UNMUTING AS NECESSARY. 197 00:07:23,920 --> 00:07:25,720 WHICH WILL BE MORE IMPORTANT AS 198 00:07:25,720 --> 00:07:27,680 WE TAKE SOME VOTES. 199 00:07:27,680 --> 00:07:31,360 IF YOU NEED COMPUTER SUPPORT, 200 00:07:31,360 --> 00:07:32,560 THROUGH ELECTRONIC COUNCIL BOOK, 201 00:07:32,560 --> 00:07:33,160 GO TO NEIL. 202 00:07:33,160 --> 00:07:34,760 IF YOU HAVE ANY QUESTIONS. 203 00:07:34,760 --> 00:07:36,520 GO TO NEIL. 204 00:07:36,520 --> 00:07:37,960 MAYBE NEIL SHOULD BE AT THE 205 00:07:37,960 --> 00:07:41,360 FRONT DESK HERE WITH ME. 206 00:07:41,360 --> 00:07:46,840 A NOTICE WAS PUBLISHED IN THE 207 00:07:46,840 --> 00:07:48,000 FEDERAL REGISTER, COUNCIL 208 00:07:48,000 --> 00:07:49,000 MEMBERS ABSENT THEMSELVES IF 209 00:07:49,000 --> 00:07:56,040 THEIR PRESENCE COULD CONSTITUTE 210 00:07:56,040 --> 00:08:02,040 CONFLICT OF INTEREST, MAY NOT 211 00:08:02,040 --> 00:08:04,320 ENGAGE IN LOBBYING ACTIVITIES. 212 00:08:04,320 --> 00:08:07,400 UPCOMING CONFLICT OF INTEREST 213 00:08:07,400 --> 00:08:09,000 REPORTING DATES, YOU'LL BE ASKED 214 00:08:09,000 --> 00:08:11,200 TO RENEW YOUR CONFLICT OF 215 00:08:11,200 --> 00:08:13,040 INTEREST REPORTING IN JUNE, 216 00:08:13,040 --> 00:08:15,240 OCTOBER, AND FEBRUARY. 217 00:08:15,240 --> 00:08:17,440 WHEN YOU RECEIVE THE REQUEST 218 00:08:17,440 --> 00:08:19,480 RESPOND PROMPTLY SO WE CAN MAKE 219 00:08:19,480 --> 00:08:21,920 SURE YOU CAN PARTICIPATE IN 220 00:08:21,920 --> 00:08:24,120 OTHER COUNCIL-RELATED 221 00:08:24,120 --> 00:08:25,040 ACTIVITIES. 222 00:08:25,040 --> 00:08:25,760 FOR FURTHER INFORMATION 223 00:08:25,760 --> 00:08:27,720 REGARDING REGULATIONS WE POSTED 224 00:08:27,720 --> 00:08:28,920 INFORMATION ON THE ELECTRONIC 225 00:08:28,920 --> 00:08:30,280 COUNCIL BOOK AND IF HAVE YOU 226 00:08:30,280 --> 00:08:31,440 QUESTIONS YOU CAN E-MAIL ME. 227 00:08:31,440 --> 00:08:33,280 NOW I WANT TO GO TO THE 228 00:08:33,280 --> 00:08:34,840 CONSIDERATION OF THE PRESIDENT 229 00:08:34,840 --> 00:08:35,400 CLINTONS FROM LAST COUNCIL 230 00:08:35,400 --> 00:08:42,800 MEETING OF THE -- AND WE'LL TAA 231 00:08:42,800 --> 00:08:45,840 VOTE, RAISE YOUR HAND OR UNMUTE 232 00:08:45,840 --> 00:08:50,240 AND SAY YAY OR NAY. 233 00:08:50,240 --> 00:08:51,320 MINUTES FOR JANUARY 31, 2023 234 00:08:51,320 --> 00:08:54,400 COUNCIL, WERE POSTED ON THE 235 00:08:54,400 --> 00:08:55,480 ELECTRONIC COUNCIL BOOK. 236 00:08:55,480 --> 00:08:58,680 LET ME ASK IF ANYONE HAS 237 00:08:58,680 --> 00:08:59,960 COMMENTS OR CORRECTIONS. 238 00:08:59,960 --> 00:09:00,200 NO? 239 00:09:00,200 --> 00:09:02,360 HEARING NONE, I'M GOING TO MOVE 240 00:09:02,360 --> 00:09:04,600 THAT WE APPROVE THE COUNCIL 241 00:09:04,600 --> 00:09:04,880 MINUTES. 242 00:09:04,880 --> 00:09:05,920 DO I HAVE A SECOND? 243 00:09:05,920 --> 00:09:07,120 THANK YOU. 244 00:09:07,120 --> 00:09:08,080 WE HAVE A SECOND. 245 00:09:08,080 --> 00:09:09,720 INSTEAD OF ASKING FOR ALL THOSE 246 00:09:09,720 --> 00:09:11,040 IN FAVOR I'LL SAY IS THERE 247 00:09:11,040 --> 00:09:15,400 ANYBODY WHO IS NOT IN FAVOR OF 248 00:09:15,400 --> 00:09:16,600 APPROVING THIS MOTION? 249 00:09:16,600 --> 00:09:19,360 HEARING NONE, THEN WE'LL SAY 250 00:09:19,360 --> 00:09:20,200 THIS WAS UNANIMOUSLY APPROVED, 251 00:09:20,200 --> 00:09:21,000 THE MOTION PASSES. 252 00:09:21,000 --> 00:09:22,840 THANK YOU. 253 00:09:22,840 --> 00:09:23,440 MINUTES ARE APPROVED. 254 00:09:23,440 --> 00:09:24,440 NOW I'D LIKE TO REMIND YOU ABOUT 255 00:09:24,440 --> 00:09:26,640 THE DATES OF OUR FUTURE COUNCIL 256 00:09:26,640 --> 00:09:27,120 MEETINGS. 257 00:09:27,120 --> 00:09:29,880 THESE ARE POSTED IN THE ECB, AND 258 00:09:29,880 --> 00:09:31,720 ON OUR WEBSITE. 259 00:09:31,720 --> 00:09:35,760 NEXT MEETING IS AUGUST 29, 2023. 260 00:09:35,760 --> 00:09:37,400 WE HAVE NOT DECIDED WHETHER IT 261 00:09:37,400 --> 00:09:39,320 WILL BE IN PERSON, HYBRID, OR 262 00:09:39,320 --> 00:09:39,520 VIRTUAL. 263 00:09:39,520 --> 00:09:41,360 WE'LL SEE HOW THIS MEETING RUNS, 264 00:09:41,360 --> 00:09:42,800 HOW IT WORKS FOR EVERYBODY, BUT 265 00:09:42,800 --> 00:09:44,680 WE'LL LET YOU KNOW AS SOON AS WE 266 00:09:44,680 --> 00:09:45,800 MAKE THAT DECISION. 267 00:09:45,800 --> 00:09:47,600 GOING FORWARD WE DO PLAN ON 268 00:09:47,600 --> 00:09:49,200 HOLDING THE WINTER MEETING AS 269 00:09:49,200 --> 00:09:50,800 VIRTUAL ALL THE TIME SO THAT 270 00:09:50,800 --> 00:09:53,640 WILL BE THE JANUARY 30 MEETING. 271 00:09:53,640 --> 00:09:57,720 AND OF COURSE WE ALWAYS 272 00:09:57,720 --> 00:10:00,240 APPRECIATE YOUR PARTICIPATION SO 273 00:10:00,240 --> 00:10:01,280 PLEASE MAKE SURE THE DATES ARE 274 00:10:01,280 --> 00:10:03,040 ON YOUR CALENDAR. 275 00:10:03,040 --> 00:10:05,160 NEXT IS AUGUST 29, THEN JANUARY 276 00:10:05,160 --> 00:10:06,080 30, MAY 29. 277 00:10:06,080 --> 00:10:08,920 THESE ARE ALWAYS POSTED ON OUR 278 00:10:08,920 --> 00:10:09,320 PUBLIC WEBSITE. 279 00:10:09,320 --> 00:10:12,320 SO IF THERE ARE ANY QUESTIONS 280 00:10:12,320 --> 00:10:13,760 ABOUT FUTURE MEETINGS OR DATES 281 00:10:13,760 --> 00:10:15,360 OR ANYTHING I'VE BEEN OVER? 282 00:10:15,360 --> 00:10:15,800 NO? 283 00:10:15,800 --> 00:10:18,120 THEN I'M GOING TO TURN THIS BACK 284 00:10:18,120 --> 00:10:22,160 TO DR. CRISWELL TO HEAR HER 285 00:10:22,160 --> 00:10:23,520 DIRECTOR'S REPORT. 286 00:10:23,520 --> 00:10:24,040 >> OKAY. 287 00:10:24,040 --> 00:10:25,680 SO, THANK YOU, DARREN. 288 00:10:25,680 --> 00:10:26,760 WELCOME, EVERYBODY, AGAIN. 289 00:10:26,760 --> 00:10:29,280 IT'S NICE TO HAVE YOU HERE. 290 00:10:29,280 --> 00:10:30,680 WHEN WE MET IN JANUARY, I 291 00:10:30,680 --> 00:10:32,240 MENTIONED A NEW NIAMS PROGRAM TO 292 00:10:32,240 --> 00:10:34,680 HAVE RECIPIENTS OF THE MENTORED 293 00:10:34,680 --> 00:10:36,160 CAREER DEVELOPMENT AWARDS 294 00:10:36,160 --> 00:10:38,080 PARTICIPATE INOME SESSION OF 295 00:10:38,080 --> 00:10:40,640 COUNCIL AS AD HOC MEMBERS. 296 00:10:40,640 --> 00:10:42,400 SUSTAINEDEES WERE SELECTED FROM 297 00:10:42,400 --> 00:10:45,120 THE POOL OF K01, K08, K23 298 00:10:45,120 --> 00:10:54,720 AWARDEES WITH CLINICAL AND 299 00:10:54,720 --> 00:10:55,720 NON-CLINICAL INVESTIGATORS 300 00:10:55,720 --> 00:10:57,160 ELIGIBLE FOR SELECTION TO ALLOW 301 00:10:57,160 --> 00:10:58,160 INPUT FROM INVESTIGATORS AT 302 00:10:58,160 --> 00:11:00,640 EARLIER CAREER STAGE THAN FULL 303 00:11:00,640 --> 00:11:02,920 COUNCIL MEMBERS TYPICALLY ARE. 304 00:11:02,920 --> 00:11:06,640 I'M VERY DELIGHTED TO WELCOME 305 00:11:06,640 --> 00:11:10,200 THE FIRST THREE AD HOC MEMBERS 306 00:11:10,200 --> 00:11:13,800 UNDER THIS PROGRAM, DR. DAVID 307 00:11:13,800 --> 00:11:14,680 BECK IS ASSISTANT PROFESSOR IN 308 00:11:14,680 --> 00:11:17,520 DEPARTMENT OF MEDICINE AND 309 00:11:17,520 --> 00:11:19,520 BIOCHEMISTRY AND MOLECULAR 310 00:11:19,520 --> 00:11:20,160 PHARMACOLOGY, NEW YORK 311 00:11:20,160 --> 00:11:21,480 UNIVERSITY SCHOOL OF MEDICINE, 312 00:11:21,480 --> 00:11:23,400 INTERESTED IN UNDERSTANDING THE 313 00:11:23,400 --> 00:11:26,280 GENETIC DETERMINANTS OF DISEASE, 314 00:11:26,280 --> 00:11:28,960 UTILIZING THIS INFORMATION TO 315 00:11:28,960 --> 00:11:29,600 DEFINE MECHANISMS UNDERLYING 316 00:11:29,600 --> 00:11:32,520 PATHOLOGIC PROCESSES WITH MAJOR 317 00:11:32,520 --> 00:11:33,360 FOCUS ON AUTO-INFLAMMATORY 318 00:11:33,360 --> 00:11:33,760 DISEASES. 319 00:11:33,760 --> 00:11:37,560 YOU MAY HAVE READ ABOUT HIS 320 00:11:37,560 --> 00:11:40,120 INTERESTING WORK RELATED TO THE 321 00:11:40,120 --> 00:11:41,280 SYNDROME VEXAS. 322 00:11:41,280 --> 00:11:44,040 B.A. FROM BROWN UNIVERSITY IN 323 00:11:44,040 --> 00:11:46,440 HISTORY AND BIOLOGY, M.D. AND 324 00:11:46,440 --> 00:11:48,120 Ph.D. DEGREES FROM NYU, 325 00:11:48,120 --> 00:11:56,520 LABORATORY OF DR. DANNY 326 00:11:56,520 --> 00:11:58,960 RYANBERG, CONTINUED IN INTERNAL 327 00:11:58,960 --> 00:12:01,200 MEDICINE AT COLUMBIA UNIVERSITY, 328 00:12:01,200 --> 00:12:02,960 THEN COMPLETED CLINICAL GENETICS 329 00:12:02,960 --> 00:12:06,120 TRAINING AT NIH AND JOHNS 330 00:12:06,120 --> 00:12:08,040 HOPKINS COMBINED PROGRAM. 331 00:12:08,040 --> 00:12:10,200 DR. BECK PERFORMED POSTDOCTORAL 332 00:12:10,200 --> 00:12:12,920 RESEARCH WITH DR. DAN KASTNER AT 333 00:12:12,920 --> 00:12:17,080 THE NIH. 334 00:12:17,080 --> 00:12:22,360 NEXT UP DR. STAR BOOKER, NURSING 335 00:12:22,360 --> 00:12:24,720 SCIENCE, UNIVERSITY OF FLORIDA, 336 00:12:24,720 --> 00:12:26,720 RESEARCH ON UNDERSTANDING 337 00:12:26,720 --> 00:12:27,760 CHRONIC OSTEOARTHRITIS AND 338 00:12:27,760 --> 00:12:29,680 MOVEMENT EVOKED PAIN IN OLDER 339 00:12:29,680 --> 00:12:32,160 ADULTS AS WELL AS DEVELOPING 340 00:12:32,160 --> 00:12:33,480 SMART TECHNOLOGIES FOR 341 00:12:33,480 --> 00:12:35,200 SELF-ASSESSMENT AND INTERVENTION 342 00:12:35,200 --> 00:12:37,000 DELIVERY TO REDUCE JOINT PAIN. 343 00:12:37,000 --> 00:12:47,520 DR. BOOKER RECEIVED HER BS IN 344 00:12:48,360 --> 00:12:49,360 NURSING FROM GRAMBLING, Ph.D. 345 00:12:49,360 --> 00:12:59,720 UNIVERSITY OF IOWA. 346 00:13:00,160 --> 00:13:07,440 DR. ANDREW FINDLEY, WASHINGTON 347 00:13:07,440 --> 00:13:10,080 UNIVERSITY OF ST. LOUIS 348 00:13:10,080 --> 00:13:10,840 INTERESTED IN TRANSLATING 349 00:13:10,840 --> 00:13:13,440 PATHOMECHANISMS INTO STRATEGIES 350 00:13:13,440 --> 00:13:15,320 FOR HEREDITARY MUSCLE DISORDERS 351 00:13:15,320 --> 00:13:19,240 SUCH AS MUSCULAR DYSTROPHY AND 352 00:13:19,240 --> 00:13:20,840 AGE-ASSOCIATED MUSCLE DISORDER 353 00:13:20,840 --> 00:13:24,040 SUCH AS SARCOPENIA, B.S. IN 354 00:13:24,040 --> 00:13:26,480 BIOCHEMISTRY FROM U.C. SANTA 355 00:13:26,480 --> 00:13:31,160 BARBARA, MEDICAL DEGREE FROM 356 00:13:31,160 --> 00:13:32,520 UC-IRVINE, BOTH NEUROLOGY 357 00:13:32,520 --> 00:13:34,040 RESIDENCY AND FELLOWSHIP 358 00:13:34,040 --> 00:13:35,680 TRAINING IN NEUROMUSCULAR 359 00:13:35,680 --> 00:13:36,560 MEDICINE AT WASHINGTON 360 00:13:36,560 --> 00:13:38,760 UNIVERSITY SCHOOL OF MEDICINE IN 361 00:13:38,760 --> 00:13:39,000 ST. LOUIS. 362 00:13:39,000 --> 00:13:41,080 SO WE LOOK FORWARD TO HEARING 363 00:13:41,080 --> 00:13:43,200 FROM NEW PARTICIPANTS AS WELL AS 364 00:13:43,200 --> 00:13:44,880 SENIOR COUNCIL MEMBERS TODAY AND 365 00:13:44,880 --> 00:13:55,440 WELCOME FEEDBACK FROM YOU AS THE 366 00:13:56,200 --> 00:13:56,880 PROGRAM IS IMPLEMENTED. 367 00:13:56,880 --> 00:14:00,840 I'LL COVER THE NIH AND NIAMS 368 00:14:00,840 --> 00:14:02,920 BUDGETS FIRST FOR 2023, THE 369 00:14:02,920 --> 00:14:04,360 CURRENT YEAR, AND 2024, AND 370 00:14:04,360 --> 00:14:07,840 PROVIDE AN OVERVIEW OF OUR 371 00:14:07,840 --> 00:14:09,920 FISCAL YEAR 2022 INVESTMENTS. 372 00:14:09,920 --> 00:14:12,560 THEN I'LL HIGHLIGHT PERSONNEL 373 00:14:12,560 --> 00:14:14,280 CHANGES AT NIH AND NIAMS AND 374 00:14:14,280 --> 00:14:17,360 MOVE TO NIH AND NIAMS ACTIVITIES 375 00:14:17,360 --> 00:14:20,240 AND PLANS THAT WILL BE OF 376 00:14:20,240 --> 00:14:21,440 INTEREST TO YOU. 377 00:14:21,440 --> 00:14:23,480 SO WHEN WE SPOKE IN JANUARY, 378 00:14:23,480 --> 00:14:25,240 NIAMS WAS HAVING INTERNAL 379 00:14:25,240 --> 00:14:25,960 DISCUSSIONS ABOUT WHAT OUR 380 00:14:25,960 --> 00:14:29,280 FUNDING PLAN SHOULD BE BASED ON 381 00:14:29,280 --> 00:14:30,600 OUR FISCAL YEAR 2023 BUDGET. 382 00:14:30,600 --> 00:14:32,160 A NUMBER OF MONTHS AGO WE POSTED 383 00:14:32,160 --> 00:14:34,640 FUNDING PLAN ON THE NIAMS 384 00:14:34,640 --> 00:14:37,640 WEBSITE AND SET THE R01 PAYLINE 385 00:14:37,640 --> 00:14:39,920 FOR MOST INVESTIGATORS AT THE 386 00:14:39,920 --> 00:14:41,560 10th PERCENTILE. 387 00:14:41,560 --> 00:14:42,640 THIS SLIGHTLY LOWER PAYLINE 388 00:14:42,640 --> 00:14:44,920 DOESN'T MEAN WE'LL BE PAYING 389 00:14:44,920 --> 00:14:46,560 FEWER R01 GRANTS BUT RATHER IT 390 00:14:46,560 --> 00:14:49,200 REFLECTS THE FACT WE'RE 391 00:14:49,200 --> 00:14:50,800 EMPOWERING OUR PROGRAM DIRECTORS 392 00:14:50,800 --> 00:14:54,720 TO LOOK CRITICALLY AT ALL 393 00:14:54,720 --> 00:14:59,480 APPLICATIONS ABOVE 10th PER 394 00:14:59,480 --> 00:15:00,200 PERCENTILE FOR FUNDING. 395 00:15:00,200 --> 00:15:04,080 WE HAVE A MORE GENEROUS PAYLINE 396 00:15:04,080 --> 00:15:04,960 FOR R01 APPLICATIONS FROM 397 00:15:04,960 --> 00:15:05,760 EARLY-STAGE INVESTIGATORS, WHICH 398 00:15:05,760 --> 00:15:12,840 WE SET AT THE 15th PERCENTILE. 399 00:15:12,840 --> 00:15:15,400 ON MARCH 9 PRESIDENT BIDEN 400 00:15:15,400 --> 00:15:16,160 RELEASED FISCAL YEAR 2024 BUDGET 401 00:15:16,160 --> 00:15:18,240 REQUEST TO THE CONGRESS. 402 00:15:18,240 --> 00:15:26,000 THE AMOUNT REQUESTED FOR NIH 403 00:15:26,000 --> 00:15:28,920 $51.01 BILL, AN INCREASE OVER 404 00:15:28,920 --> 00:15:30,640 2023 ENACTED BUDGET, FOR NIAMS 405 00:15:30,640 --> 00:15:33,640 THE AMOUNTED PROPOSED IN THE 406 00:15:33,640 --> 00:15:35,640 PRESIDENT'S BUDGET IS $688 407 00:15:35,640 --> 00:15:44,120 MILLION, WHICH REPRESENTS 408 00:15:44,120 --> 00:15:45,280 NO CHANGE FROM 2023. 409 00:15:45,280 --> 00:15:46,920 THE HOUSE AND SENATE WILL 410 00:15:46,920 --> 00:15:49,000 DEVELOP BUDGET PROPOSALS FOR 411 00:15:49,000 --> 00:15:50,840 FISCAL YEAR 2024, WHICH WILL BE 412 00:15:50,840 --> 00:15:52,400 RECONCILED AND A FINAL BILL WILL 413 00:15:52,400 --> 00:15:57,440 GO TO THE PRESIDENT FOR 414 00:15:57,440 --> 00:15:58,040 SIGNATURE. 415 00:15:58,040 --> 00:16:00,840 THE NEXT TWO SLIDES SHOW DETAILS 416 00:16:00,840 --> 00:16:03,840 ABOUT HOW NIAMS INVESTED ITS 417 00:16:03,840 --> 00:16:05,760 FISCAL YEAR $2,022. 418 00:16:05,760 --> 00:16:08,840 THE TWO PIECHARTS SHOW A 419 00:16:08,840 --> 00:16:11,040 BREAKDOWN OF THE NIH ON THE 420 00:16:11,040 --> 00:16:21,600 LEFT, AND NIAMS FOR FISCAL 202. 421 00:16:32,320 --> 00:16:35,280 THE EXPENSES ARE ON PAR WITH 422 00:16:35,280 --> 00:16:37,440 THOSE OF THE ENTIRE NIH AND 423 00:16:37,440 --> 00:16:38,400 EXTRAMURAL INVESTMENTS ARE 424 00:16:38,400 --> 00:16:42,760 SLIGHTLY LARGER COMPARED TO NIH 425 00:16:42,760 --> 00:16:43,280 OVERALL. 426 00:16:43,280 --> 00:16:45,280 AND THEN THIS SLIDE SHOWS 427 00:16:45,280 --> 00:16:48,200 BREAKDOWN OF NIAMS BUDGET BY 428 00:16:48,200 --> 00:16:50,720 ACTIVITY, WHICH INCLUDES 429 00:16:50,720 --> 00:16:51,640 INTRAMURAL RESEARCH PROGRAM, 430 00:16:51,640 --> 00:16:55,000 SHOWN IN THE MEDIUM BLUE, IRP, 431 00:16:55,000 --> 00:17:05,560 AS WELL AS FIVE SCIENTIFIC AREAS 432 00:17:05,960 --> 00:17:09,240 IN EXTRAMURAL PROGRAM. 433 00:17:09,240 --> 00:17:10,360 LAST MONTH PRESIDENT BIDEN 434 00:17:10,360 --> 00:17:13,240 ANNOUNCED HIS INTENT TO NOMINATE 435 00:17:13,240 --> 00:17:15,760 DR. MONICA BERTAGNOLLI TO BE THE 436 00:17:15,760 --> 00:17:19,000 17th DIRECTOR OF THE NIH. 437 00:17:19,000 --> 00:17:21,760 SHE STARTED AS 16th DIRECTOR 438 00:17:21,760 --> 00:17:24,680 AND FIRST FEMALE DIRECTOR OF THE 439 00:17:24,680 --> 00:17:26,960 NATIONAL CANCER INSTITUTE LAST 440 00:17:26,960 --> 00:17:27,600 FALL. 441 00:17:27,600 --> 00:17:29,160 PREVIOUSLY, SHE WAS RICHARD 442 00:17:29,160 --> 00:17:30,560 WILSON PROFESSOR OF SURGERY IN 443 00:17:30,560 --> 00:17:32,960 THE FIELD OF SURGICAL ONCOLOGY 444 00:17:32,960 --> 00:17:34,160 AT HARVARD MEDICAL SCHOOL, AS 445 00:17:34,160 --> 00:17:36,800 WELL AS SURGEON AT THE BRIGHAM 446 00:17:36,800 --> 00:17:41,000 AND WOMEN'S HOSPITAL AND MEMBER 447 00:17:41,000 --> 00:17:41,760 OF THE GASTROINTESTINAL CANCER 448 00:17:41,760 --> 00:17:48,120 AND SARCOMA DISEASE CENTER AT 449 00:17:48,120 --> 00:17:52,680 DANA-FARBER, MEDICAL DEGREE FRM 450 00:17:52,680 --> 00:17:55,280 UTAH SCHOOL OF MEDICINE. 451 00:17:55,280 --> 00:17:56,160 THE APPOINTMENT REQUIRES 452 00:17:56,160 --> 00:17:58,080 CONFIRMATION BY THE U.S. SENATE. 453 00:17:58,080 --> 00:18:00,080 AT THIS TIME WE DON'T HAVE 454 00:18:00,080 --> 00:18:02,440 INFORMATION ON WHEN THIS PROCESS 455 00:18:02,440 --> 00:18:07,240 WILL BEGIN OR HOW LONG IT MAY 456 00:18:07,240 --> 00:18:07,800 TAKE. 457 00:18:07,800 --> 00:18:10,640 NOW MOVING TO NIAMS PERSONNEL 458 00:18:10,640 --> 00:18:13,160 CHANGES, IN THE EXTRAMURAL 459 00:18:13,160 --> 00:18:17,880 PROGRAM, WE WARMLY WELCOME DR. 460 00:18:17,880 --> 00:18:28,440 MARY GARCIA-CAZARIN, FROM OFFICE 461 00:18:30,720 --> 00:18:32,960 OF DISEASE PREVENTION, WAS A 462 00:18:32,960 --> 00:18:34,760 SCIENTIFIC ADVISER FORETOBACCO 463 00:18:34,760 --> 00:18:36,360 REGULATORY SCIENCE PROGRAM SINCE 464 00:18:36,360 --> 00:18:38,320 2014, HAS EXTENSIVE EXPERIENCE 465 00:18:38,320 --> 00:18:40,560 WORKING ACROSS AND WITHIN 466 00:18:40,560 --> 00:18:42,120 FEDERAL AGENCIES TO IMPLEMENT 467 00:18:42,120 --> 00:18:44,960 INITIATIVES RELATED TO DISEASE 468 00:18:44,960 --> 00:18:48,200 PREVENTION AND PUBLIC HEALTH. 469 00:18:48,200 --> 00:18:57,200 SERVE THREE YEARS AS BOARD 470 00:18:57,200 --> 00:19:00,360 MEMBER FOR CHICANO AMERICANS IN 471 00:19:00,360 --> 00:19:02,680 SCIENCE, AND MENTORS WORKING TO 472 00:19:02,680 --> 00:19:04,440 INCREASE PARTICIPATION OF 473 00:19:04,440 --> 00:19:06,720 UNDERREPRESENTED GROUPS IN 474 00:19:06,720 --> 00:19:06,920 SCIENCE. 475 00:19:06,920 --> 00:19:12,480 SHE ALSO WON THE NIH RUTH 476 00:19:12,480 --> 00:19:13,120 KIRSCHSTEIN AWARD IN 2020, 477 00:19:13,120 --> 00:19:15,800 RECEIVED HER Ph.D. IN 478 00:19:15,800 --> 00:19:18,640 PHARMACOLOGY FROM UNIVERSITY OF 479 00:19:18,640 --> 00:19:21,040 KENTUCKY, WAS PREVIOUSLY AN AAAS 480 00:19:21,040 --> 00:19:22,920 SCIENCE AND TECHNOLOGY POLICY 481 00:19:22,920 --> 00:19:24,840 FELLOW IN OFFICE OF DIETARY 482 00:19:24,840 --> 00:19:35,280 SUPPLEMENTS AT THE NIH. 483 00:19:36,440 --> 00:19:38,560 SO WELCOME. 484 00:19:38,560 --> 00:19:38,920 [APPLAUSE] 485 00:19:38,920 --> 00:19:47,320 WE BID FAREWELL TO DR. HUNG 486 00:19:47,320 --> 00:19:49,200 TSENG AND WISH HUNG A WONDERFUL 487 00:19:49,200 --> 00:19:53,120 RETIREMENT AND HOPE TO HAVE AN 488 00:19:53,120 --> 00:19:56,040 ANNOUNCEMENT FOR REPLACEMENT 489 00:19:56,040 --> 00:19:58,080 SOON, AND DR. SHAHNAZ KHAN, WHO 490 00:19:58,080 --> 00:19:59,920 WORKED CLOSELY WITH MANY OF YOU 491 00:19:59,920 --> 00:20:02,560 ON THE CLINICAL TRIALS WORKING 492 00:20:02,560 --> 00:20:04,080 GROUP OF COUNCIL, WILL BE 493 00:20:04,080 --> 00:20:06,600 JOINING THE NHLBI CENTER FOR 494 00:20:06,600 --> 00:20:07,720 TRANSLATIONAL RESEARCH AND 495 00:20:07,720 --> 00:20:10,160 IMPLEMENTATION SCIENCE AS A 496 00:20:10,160 --> 00:20:10,960 PROGRAM OFFICER. 497 00:20:10,960 --> 00:20:13,560 WE THANK HER FOR HER DEDICATED 498 00:20:13,560 --> 00:20:15,760 EFFORTS IN OVERSEEING THE 499 00:20:15,760 --> 00:20:17,080 EXTRAMURAL CLINICAL TRIALS AND 500 00:20:17,080 --> 00:20:17,960 VERY IMPORTANT CONTRIBUTION TO 501 00:20:17,960 --> 00:20:21,920 THE CLINICAL TRIALS WORKING 502 00:20:21,920 --> 00:20:22,400 GROUP. 503 00:20:22,400 --> 00:20:26,360 DR. SLEDJESKI WILL BE POINT OF 504 00:20:26,360 --> 00:20:27,920 CONTACT FOR ADMINISTRATIVE 505 00:20:27,920 --> 00:20:28,880 ASPECTS OF NIAMS EXTRAMURAL 506 00:20:28,880 --> 00:20:29,640 CLINICAL TRIALS WHILE CONDUCTING 507 00:20:29,640 --> 00:20:32,200 A SEARCH FOR THE NEW RESEARCH 508 00:20:32,200 --> 00:20:37,440 OPERATIONS AND MANAGEMENT BRANCH 509 00:20:37,440 --> 00:20:37,640 CHIEF. 510 00:20:37,640 --> 00:20:38,960 IN THE INTRAMURAL RESEARCH 511 00:20:38,960 --> 00:20:45,000 PROGRAM I'M THRILLED TO SHARE 512 00:20:45,000 --> 00:20:47,640 DR. JOHN O'SHEA WAS ELECTED TO 513 00:20:47,640 --> 00:20:49,480 THE PRESTIGIOUS U.S. NATIONAL 514 00:20:49,480 --> 00:20:52,120 ACADEMY OF SCIENCES AT THE 515 00:20:52,120 --> 00:20:53,920 CONCLUSION OF THE ACADEMY'S 516 00:20:53,920 --> 00:20:55,400 160th ANNUAL MEETING. 517 00:20:55,400 --> 00:20:57,400 THIS DESIGNATION CONSIDERED ONE 518 00:20:57,400 --> 00:21:00,520 OF THE HIGHEST HONORS A 519 00:21:00,520 --> 00:21:02,200 SCIENTIST CAN ACHIEVE RECOGNIZES 520 00:21:02,200 --> 00:21:04,040 DISTINGUISHED AND CONTINUING 521 00:21:04,040 --> 00:21:05,880 ACHIEVEMENTS IN ORIGINAL 522 00:21:05,880 --> 00:21:10,280 RESEARCH, AND INDEED HIS 523 00:21:10,280 --> 00:21:12,240 ACHIEVEMENTS HAVE BEEN 524 00:21:12,240 --> 00:21:14,480 GROUNDBREAKING IN CYTOKINE 525 00:21:14,480 --> 00:21:16,400 SIGNALING, DISCOVERY OF JAK 3 526 00:21:16,400 --> 00:21:19,240 AND INHIBITORS AMONG MANY OTHER 527 00:21:19,240 --> 00:21:20,000 ACCOMPLISHMENTS. 528 00:21:20,000 --> 00:21:21,320 WE'VE BEEN PRIVILEGED TO HAVE 529 00:21:21,320 --> 00:21:23,840 HIM AT NIH FOR 40 YEARS, 18 530 00:21:23,840 --> 00:21:26,280 THOSE AS NIAMS SCIENTIFIC 531 00:21:26,280 --> 00:21:26,600 DIRECTOR. 532 00:21:26,600 --> 00:21:30,920 AND WITH THAT, IT'S BITTERSWEET 533 00:21:30,920 --> 00:21:31,600 TO ANNOUNCE DR. O'SHEA'S 534 00:21:31,600 --> 00:21:34,120 INTENTION TO STEP DOWN FROM THE 535 00:21:34,120 --> 00:21:35,520 POSITION OF SCIENTIFIC DIRECTOR. 536 00:21:35,520 --> 00:21:38,600 WE THANK HIM NOT ONLY FOR HIS 537 00:21:38,600 --> 00:21:39,200 CONSIDERABLE CONTRIBUTIONS TO 538 00:21:39,200 --> 00:21:41,440 OUR UNDERSTANDING OF THE IMMUNE 539 00:21:41,440 --> 00:21:43,400 SYSTEM AND TRANSLATION OF THESE 540 00:21:43,400 --> 00:21:45,320 DISCOVERIES INTO GROUNDBREAKING 541 00:21:45,320 --> 00:21:46,600 MEDICAL TREATMENTS, BUT FOR 542 00:21:46,600 --> 00:21:48,560 AGREEING TO REMAIN AS SCIENTIFIC 543 00:21:48,560 --> 00:21:50,120 DIRECTOR AS WE INITIATE A 544 00:21:50,120 --> 00:21:53,440 NATIONWIDE SEARCH FOR THIS 545 00:21:53,440 --> 00:21:54,520 CRITICALLY IMPORTANT LEADERSHIP 546 00:21:54,520 --> 00:21:54,720 ROLE. 547 00:21:54,720 --> 00:21:58,360 DR. 548 00:21:58,360 --> 00:22:00,360 DR. O'SHEA WILL CONTINUE EFFORTS 549 00:22:00,360 --> 00:22:02,600 TO PROMOTE DIVERSITY, COMMITTED 550 00:22:02,600 --> 00:22:04,600 MEANTOR, AND MAKING ADDITIONAL 551 00:22:04,600 --> 00:22:08,000 DISCOVERS IN HIS BUSY LAB IN 552 00:22:08,000 --> 00:22:11,840 ADDITION TO HIS EXTRACURRICULAR 553 00:22:11,840 --> 00:22:13,040 MUSICAL ACTIVITIES. 554 00:22:13,040 --> 00:22:15,880 I'M DELIGHTED TO ANNOUNCE DR. 555 00:22:15,880 --> 00:22:17,760 ROBERT WALKER JR. HERE TODAY IN 556 00:22:17,760 --> 00:22:20,080 THE BACK ON MY RIGHT HAS BEEN 557 00:22:20,080 --> 00:22:22,880 SELECTED AS THE CHIEF DIVERSITY 558 00:22:22,880 --> 00:22:24,320 OFFICER FOR NIAMS. 559 00:22:24,320 --> 00:22:26,040 UNTIL APRIL, DR. WALKER SERVED 560 00:22:26,040 --> 00:22:29,120 AS DIRECTOR OF THE OFFICE FOR 561 00:22:29,120 --> 00:22:31,520 SCIENTIFIC OPERATIONS WITHIN OUR 562 00:22:31,520 --> 00:22:33,880 INTRAMURAL RESEARCH PROGRAM. 563 00:22:33,880 --> 00:22:34,920 THERE HIS RESPONSIBILITIES 564 00:22:34,920 --> 00:22:36,560 INCLUDED LEADING CAREER AND 565 00:22:36,560 --> 00:22:38,960 PROFESSIONAL DEVELOPMENT FOR THE 566 00:22:38,960 --> 00:22:40,800 POSTBAC INTRAMURAL RESEARCH 567 00:22:40,800 --> 00:22:43,080 TRAINING AWARDEES, TECHNOLOGY 568 00:22:43,080 --> 00:22:44,840 TRANSFER, INNOVATION 569 00:22:44,840 --> 00:22:46,480 DEVELOPMENT, AND SCIENTIFIC 570 00:22:46,480 --> 00:22:47,600 COMMUNICATION POLICY DIVERSITY 571 00:22:47,600 --> 00:22:48,680 AND INCLUSION AND LOGISTICS, 572 00:22:48,680 --> 00:22:50,080 AMONG OTHERS. 573 00:22:50,080 --> 00:22:52,160 IN HIS NEW ROLE, DR. WALKER WILL 574 00:22:52,160 --> 00:22:55,040 LEAD THE DEVELOPMENT AND 575 00:22:55,040 --> 00:22:56,240 IMPLEMENTATION OF RESEARCH, 576 00:22:56,240 --> 00:22:57,960 RESEARCH CAPACITY BUILDING, 577 00:22:57,960 --> 00:22:59,360 TRAINING AND CAREER DEVELOPMENT 578 00:22:59,360 --> 00:23:03,880 PROGRAMS TO SUPPORT SCIENTIFIC 579 00:23:03,880 --> 00:23:06,160 MISSION AND ENHANCE SCIENTIFIC 580 00:23:06,160 --> 00:23:07,000 DIVERSITY, PROVIDE 581 00:23:07,000 --> 00:23:08,080 RECOMMENDATIONS ON SCIENTIFIC 582 00:23:08,080 --> 00:23:09,640 DIVERSITY GOALS AND OBJECTIVES 583 00:23:09,640 --> 00:23:11,240 TO ENSURE DIVERSITY IS 584 00:23:11,240 --> 00:23:13,040 CONSIDERED IN THE DEVELOPMENT, 585 00:23:13,040 --> 00:23:17,000 FUNDING, ADMINISTRATION OF GRANT 586 00:23:17,000 --> 00:23:17,640 AWARDS, COOPERATIVE AGREEMENTS, 587 00:23:17,640 --> 00:23:17,920 CONTRACTS. 588 00:23:17,920 --> 00:23:21,120 IN ADDITION, HE WILL SERVE AS 589 00:23:21,120 --> 00:23:22,080 NIAMS LIAISON WITH SCIENTIFIC 590 00:23:22,080 --> 00:23:24,680 COMMUNITY AND PARTNER WITH THE 591 00:23:24,680 --> 00:23:28,840 NIH CHIEF OFFICER FOR SCIENTIFIC 592 00:23:28,840 --> 00:23:31,440 WORKFORCE DIVERSITY, OFFICE OF 593 00:23:31,440 --> 00:23:35,200 EQUITY DIVERSITY AND INCLUSION, 594 00:23:35,200 --> 00:23:36,560 CHIEF DIVERSITY OFFICERS FROM 595 00:23:36,560 --> 00:23:39,800 OTHER NIH INSTITUTES AND 596 00:23:39,800 --> 00:23:40,560 CENTERS. 597 00:23:40,560 --> 00:23:42,400 BEFORE JOINING NIAMS IN 2013, 598 00:23:42,400 --> 00:23:45,800 DR. WALKER COMPLETED A 599 00:23:45,800 --> 00:23:48,560 POSTDOCTORAL FELLOWSHIP AT 600 00:23:48,560 --> 00:23:51,680 NIAID, PATHOGENESIS OF HIV-1, 601 00:23:51,680 --> 00:23:52,520 SUBSEQUENTLY COMPLETED SECOND 602 00:23:52,520 --> 00:23:55,160 FELLOWSHIP IN NIAID OFFICE OF 603 00:23:55,160 --> 00:23:56,960 TECHNOLOGY TRANSFER. 604 00:23:56,960 --> 00:24:00,480 DR. WALKER HAS ALSO HELD ADJUNCT 605 00:24:00,480 --> 00:24:01,320 PROFESSOR AND GUEST LECTURE 606 00:24:01,320 --> 00:24:04,120 POSITION AT UNIVERSITY OF 607 00:24:04,120 --> 00:24:07,560 MARYLAND, HOWARD UNIVERSITY, 608 00:24:07,560 --> 00:24:14,120 TENNESSEE STATE UNIVERSITY, 609 00:24:14,120 --> 00:24:20,280 MEHARRY COLLEGE, AND CHAPEL 610 00:24:20,280 --> 00:24:25,640 HILL. 611 00:24:25,640 --> 00:24:27,840 Ph.D. FROM MEHARRY MEDICAL 612 00:24:27,840 --> 00:24:28,680 COLLEGE. 613 00:24:28,680 --> 00:24:28,960 [APPLAUSE] 614 00:24:28,960 --> 00:24:34,520 NEXT, AN EXCITING ACTIVITY FROM 615 00:24:34,520 --> 00:24:36,560 THE INTRAMURAL LABS, THE NIH 616 00:24:36,560 --> 00:24:39,000 HOSTED THE WHITE HOUSE COVID-19 617 00:24:39,000 --> 00:24:44,400 RESPONSE COORDINATOR AT NIH 618 00:24:44,400 --> 00:24:45,240 BETHESDA CAMPUS. 619 00:24:45,240 --> 00:24:49,280 DR. KAPLAN, CHIEF OF NIAMS 620 00:24:49,280 --> 00:24:49,920 SYSTEMIC AUTOIMMUNITY BRANCHED, 621 00:24:49,920 --> 00:24:52,680 DISCUSSED IMPACT OF COVID-19 ON 622 00:24:52,680 --> 00:24:54,840 PEOPLE WITH SYSTEMIC AUTOIMMUNE 623 00:24:54,840 --> 00:24:57,240 DISEASES AND ROLE OF NEUTROPHIL 624 00:24:57,240 --> 00:24:59,360 DYSREGULATION IN COVID-19 AND 625 00:24:59,360 --> 00:25:02,080 POTENTIAL IMPACT ON LONG COVID. 626 00:25:02,080 --> 00:25:04,600 AT A TOUR OF DR. KAPLAN'S LAB, 627 00:25:04,600 --> 00:25:08,760 HE MET AND SPOKE WITH SEVERAL 628 00:25:08,760 --> 00:25:16,320 RESEARCHERS INCLUDING DR. BILL 629 00:25:16,320 --> 00:25:20,480 AMBLER, AND POSTBAC ALEXANDRA 630 00:25:20,480 --> 00:25:21,640 WU. 631 00:25:21,640 --> 00:25:22,640 DR. JAH MET WITH RESEARCHERS AT 632 00:25:22,640 --> 00:25:24,400 THE VACCINE CENTER AND NIH 633 00:25:24,400 --> 00:25:31,840 CLINTON CENTER, QUITE AN HONOR 634 00:25:31,840 --> 00:25:33,440 TO HOST HIS VISIT. 635 00:25:33,440 --> 00:25:36,040 I WAS INVITED TO PARTICIPATE 636 00:25:36,040 --> 00:25:39,080 WITH CONGRESSIONAL MEMBERS AND 637 00:25:39,080 --> 00:25:40,760 STAFF, THE FIRST BRIEFING, 638 00:25:40,760 --> 00:25:42,480 VIRTUALLY, PART OF THE HILL DAY 639 00:25:42,480 --> 00:25:44,480 ACTIVITIES ORGANIZED BY THE 640 00:25:44,480 --> 00:25:50,920 COALITION OF SKIN DISEASES. 641 00:25:50,920 --> 00:25:52,200 MY PRE-RECORDED REMARKS 642 00:25:52,200 --> 00:25:55,520 HIGHLIGHTED EXTRAMURAL AND 643 00:25:55,520 --> 00:25:57,600 INTRAMURAL RESEARCH PROGRAMS. 644 00:25:57,600 --> 00:25:59,880 DR. BROWNELL, SENIOR 645 00:25:59,880 --> 00:26:05,040 INVESTIGATOR IN DERMATOLOGY 646 00:26:05,040 --> 00:26:06,320 BRANCH REPRESENTED IN PERSON. 647 00:26:06,320 --> 00:26:11,920 A COUPLE WEEKS AGO I 648 00:26:11,920 --> 00:26:16,400 PARTICIPATED ON THE HILL IN THE 649 00:26:16,400 --> 00:26:18,600 FIGHT AGAINST LUPUS AND HIGH 650 00:26:18,600 --> 00:26:19,520 COST HIGH BURDEN DISEASES. 651 00:26:19,520 --> 00:26:21,320 I JOINED A PANEL OF SPEAKERS 652 00:26:21,320 --> 00:26:22,840 REPRESENTING THE FULL SPECTRUM 653 00:26:22,840 --> 00:26:24,800 OF HEALTH AND MEDICAL RESEARCH 654 00:26:24,800 --> 00:26:27,120 CONTINUUM, TO DISCUSS OUR ROLES 655 00:26:27,120 --> 00:26:28,840 TACKLING RESEARCH INTO AND 656 00:26:28,840 --> 00:26:30,800 TREATMENTS FOR LUPUS AND OTHER 657 00:26:30,800 --> 00:26:33,240 DISEASES FROM BENCH TO BEDSIDE. 658 00:26:33,240 --> 00:26:34,880 WE'RE GREAT FOLLOW HAVE THESE 659 00:26:34,880 --> 00:26:36,760 OPPORTUNITIES TO HIGHLIGHT THE 660 00:26:36,760 --> 00:26:44,120 OUTSTANDING WORK WE SUPPORT AND 661 00:26:44,120 --> 00:26:46,360 EDUCATE CONGRESS ABOUT NIAMS. 662 00:26:46,360 --> 00:26:47,800 I'LL NOW HIGHLIGHT A FEW NIH AND 663 00:26:47,800 --> 00:26:49,600 NIAMS ACTIVITIES THAT MIGHT BE 664 00:26:49,600 --> 00:26:52,120 OF INTEREST TO YOU. 665 00:26:52,120 --> 00:26:53,160 FIRST, EXCITED TO SHARE THE 666 00:26:53,160 --> 00:26:56,600 FIRST PROGRAM FROM THE ADVANCED 667 00:26:56,600 --> 00:27:00,160 RESEARCH PROJECT AGENCY FOR 668 00:27:00,160 --> 00:27:00,520 HEALTH, ARPA-H. 669 00:27:00,520 --> 00:27:04,800 THE NOVEL INNOVATIONS FOR TISSUE 670 00:27:04,800 --> 00:27:06,560 REGENERATION IN OSTEOARTHRITIS, 671 00:27:06,560 --> 00:27:08,400 NITRO, AIMS TO SOLVE TREATMENT 672 00:27:08,400 --> 00:27:10,480 CHALLENGES IN OSTEOARTHRITIS, 673 00:27:10,480 --> 00:27:13,840 THE FIRST SUCH PROGRAM LAUNCHED 674 00:27:13,840 --> 00:27:14,320 BY ARPA-H. 675 00:27:14,320 --> 00:27:16,120 SO NITRO WILL EXPLORE 676 00:27:16,120 --> 00:27:20,120 TECHNOLOGIES FOCUSED IN THREE 677 00:27:20,120 --> 00:27:20,760 AREAS. 678 00:27:20,760 --> 00:27:23,400 INJECTABLE BONE REGENERATION, 679 00:27:23,400 --> 00:27:24,280 INJECTABLE CARTILAGE 680 00:27:24,280 --> 00:27:25,720 REGENERATION, AND REPLACEMENT 681 00:27:25,720 --> 00:27:28,680 JOINTS BUILT FROM HUMAN CELLS. 682 00:27:28,680 --> 00:27:30,880 NITRO WILL FUND SEVERAL RESEARCH 683 00:27:30,880 --> 00:27:33,760 TEAMS TO DEVELOP AND LEVERAGE 684 00:27:33,760 --> 00:27:37,200 INNOVATIVE FORMS OF REGENERATIVE 685 00:27:37,200 --> 00:27:38,600 MEDICINE TO CREATE MINIMALLY 686 00:27:38,600 --> 00:27:39,480 INNOVATIVE THERAPEUTICS THAT 687 00:27:39,480 --> 00:27:41,640 REGENERATE DAMAGED JOINTS. 688 00:27:41,640 --> 00:27:43,000 IMPORTANTLY THERE'S A PROPOSER'S 689 00:27:43,000 --> 00:27:45,480 DAY FOR INTERESTED RESEARCH 690 00:27:45,480 --> 00:27:46,360 TEAMS OR PERFORMERS SCHEDULED 691 00:27:46,360 --> 00:27:49,520 FOR NEXT WEEK ON JUNE 15. 692 00:27:49,520 --> 00:27:53,160 WE'LL BE FOLLOWING THIS 693 00:27:53,160 --> 00:27:54,480 INITIATIVE CLOSELY. 694 00:27:54,480 --> 00:27:57,320 AND LAST MONTH THE FOUNDATION 695 00:27:57,320 --> 00:28:01,480 FOR NIH ANNOUNCED THE AMP BGTC, 696 00:28:01,480 --> 00:28:03,760 BESPOKE GENE THERAPY CONSORTIUM, 697 00:28:03,760 --> 00:28:06,080 SELECTED EIGHT RARE DISEASES FOR 698 00:28:06,080 --> 00:28:07,600 ITS CLINICAL TRIAL PORTFOLIO. 699 00:28:07,600 --> 00:28:11,520 ALSO A NEW PROGRAM. 700 00:28:11,520 --> 00:28:14,280 THE SELECTIONS WERE MADE BY A 701 00:28:14,280 --> 00:28:16,280 PANEL OF EXPERTS FOLLOWING 702 00:28:16,280 --> 00:28:19,520 REVIEW USING THE BGTC 703 00:28:19,520 --> 00:28:20,000 ESTABLISHED CRITERIA. 704 00:28:20,000 --> 00:28:30,600 THE CRITERIA INCLUDED INCLUDEE 705 00:28:31,920 --> 00:28:34,600 ADEQUACY OF GENE THERAPY, 706 00:28:34,600 --> 00:28:35,360 EXISTENCE ESTABLISHED DISEASE 707 00:28:35,360 --> 00:28:37,600 MODEL, LACK OF AVAILABLE 708 00:28:37,600 --> 00:28:39,880 TREATMENT, AND OVERALL READINESS 709 00:28:39,880 --> 00:28:40,960 FOR ENTERING INTO A CLINICAL 710 00:28:40,960 --> 00:28:41,160 TRIAL. 711 00:28:41,160 --> 00:28:43,200 AS SHOWN ON THE SLIDE AT LEAST 712 00:28:43,200 --> 00:28:49,880 TWO OF THE EIGHT DISEASES 713 00:28:49,880 --> 00:28:55,680 SELECTED ARE OF GREAT INTEREST 714 00:28:55,680 --> 00:29:01,440 TO THE NIAMS COMMUNITY. 715 00:29:01,440 --> 00:29:08,760 ONE IS A LYSOSOMAL STORAGE 716 00:29:08,760 --> 00:29:12,480 DISEASE, THE SYMPTOMS INCLUDE 717 00:29:12,480 --> 00:29:14,760 SHORT STATURE, SKELETAL 718 00:29:14,760 --> 00:29:17,600 DYSPLASIA, DENTAL ANOMALIES, 719 00:29:17,600 --> 00:29:27,880 CORNEAL CLOUDING. 720 00:29:28,880 --> 00:29:30,880 PROPIONIC ACIDEMIA IS INVOLVED 721 00:29:30,880 --> 00:29:32,440 IN ENZYME WITH BREAKDOWN OF 722 00:29:32,440 --> 00:29:34,280 AMINO ACIDS, APPARENT DURING THE 723 00:29:34,280 --> 00:29:38,120 FIRST WEEKS OF LIFE, AND MAY 724 00:29:38,120 --> 00:29:39,320 INCLUDE ABNORMALLY DIMINISHED 725 00:29:39,320 --> 00:29:45,200 MUSCLE TONE, POOR FEEDING, 726 00:29:45,200 --> 00:29:46,080 VOMITING, LETHARGY, DEHYDRATION, 727 00:29:46,080 --> 00:29:46,840 SEIZURES. 728 00:29:46,840 --> 00:29:48,800 WITH THE SELECTION OF THESE 729 00:29:48,800 --> 00:29:51,680 EIGHT RARE CONDITIONS, THE BGTC 730 00:29:51,680 --> 00:29:53,840 WILL BEGIN WORK OF STREAMLINING 731 00:29:53,840 --> 00:29:54,840 GENE THERAPY DEVELOPMENT PROCESS 732 00:29:54,840 --> 00:29:57,360 TO DEVELOP TREATMENTS FOR THESE 733 00:29:57,360 --> 00:30:00,080 CONDITIONS AND MAKE GENE THERAPY 734 00:30:00,080 --> 00:30:04,280 MORE GENERALIZABLE AND 735 00:30:04,280 --> 00:30:06,800 ACCESSIBLE SO THAT OTHERS CAN 736 00:30:06,800 --> 00:30:07,440 BENEFIT. 737 00:30:07,440 --> 00:30:09,280 AS I ANNOUNCED AT THE LAST 738 00:30:09,280 --> 00:30:10,880 MEETING CONGRESS ALLOCATED THIS 739 00:30:10,880 --> 00:30:15,640 YEAR $10 MILLION IN FUNDING FOR 740 00:30:15,640 --> 00:30:17,160 THE OFFICE OF RESEARCH ON 741 00:30:17,160 --> 00:30:21,680 WOMEN'S HEALTH TO ESTABLISH 742 00:30:21,680 --> 00:30:24,200 OFFICE OF AUTOIMMUNE DISEASE 743 00:30:24,200 --> 00:30:28,200 RESEARCH TO IMPLEMENT FUNDING OF 744 00:30:28,200 --> 00:30:30,520 A NASEM REPORT. 745 00:30:30,520 --> 00:30:32,280 AS A LEADING FUNDER, NIAMS IS 746 00:30:32,280 --> 00:30:33,600 WORKING CLOSELY WITH THE NEW 747 00:30:33,600 --> 00:30:36,360 OFFICE AS IT BEGINS TO 748 00:30:36,360 --> 00:30:39,080 ACCOMPLISH ITS SIX GOALS, 749 00:30:39,080 --> 00:30:41,360 DERIVED FROM THAT REPORT. 750 00:30:41,360 --> 00:30:44,120 DEVELOPING A MULTI-INSTITUTE AND 751 00:30:44,120 --> 00:30:44,760 CENTER STRATEGIC PLAN, 752 00:30:44,760 --> 00:30:46,720 IDENTIFYING EMERGING AREAS OF 753 00:30:46,720 --> 00:30:47,640 INNOVATION AND RESEARCH 754 00:30:47,640 --> 00:30:50,560 OPPORTUNITIES FOR THAT STRATEGIC 755 00:30:50,560 --> 00:30:52,240 PLAN, COORDINATING AND FOSTERING 756 00:30:52,240 --> 00:30:55,160 COLLABORATIVE RESEARCH ACROSS 757 00:30:55,160 --> 00:30:56,600 THE INSTITUTES, PERFORMING 758 00:30:56,600 --> 00:31:00,000 ANNUAL EVALUATION OF THE NIH 759 00:31:00,000 --> 00:31:01,080 AUTOIMMUNE RESEARCH PORTFOLIO, 760 00:31:01,080 --> 00:31:05,240 PROVIDING RESOURCES TO SUPPORT 761 00:31:05,240 --> 00:31:06,640 PLANNING, COLLABORATION, AND 762 00:31:06,640 --> 00:31:09,280 INNOVATION; DEVELOP AND OVERSEE 763 00:31:09,280 --> 00:31:10,560 PUBLICLY ACCESSIBLE CENTRAL 764 00:31:10,560 --> 00:31:15,080 REPOSITORY FOR AUTOIMMUNE 765 00:31:15,080 --> 00:31:15,600 DISEASE RESEARCH RESULTS. 766 00:31:15,600 --> 00:31:20,440 AND IN LINE WITH THE NEW OFFICE, 767 00:31:20,440 --> 00:31:22,560 ORWH, NIAMS, AND OTHER 768 00:31:22,560 --> 00:31:24,200 INSTITUTES AND CENTERS RECENTLY 769 00:31:24,200 --> 00:31:34,000 PUBLISHED A NOTICE ON THE 770 00:31:34,000 --> 00:31:35,240 EXPOSOME IN AUTOIMMUNE, EXACT 771 00:31:35,240 --> 00:31:38,520 PLAN, AND THIS IS A 772 00:31:38,520 --> 00:31:44,200 COLLABORATIVE EFFORT 773 00:31:44,200 --> 00:31:45,880 BETWEENORWH, NIAMS, NIEHS, AND 774 00:31:45,880 --> 00:31:48,560 OTHER NIH INSTITUTES AND CENTERS 775 00:31:48,560 --> 00:31:50,120 ENGAGED WITH AUTOIMMUNE DISEASE 776 00:31:50,120 --> 00:31:50,520 RESEARCH. 777 00:31:50,520 --> 00:31:55,040 THE GOAL IS TO INVITE 778 00:31:55,040 --> 00:31:56,920 APPLICATIONS FOR EXPLORATORY, 779 00:31:56,920 --> 00:31:58,880 EARLY, CONCEPTUAL STAGE RESEARCH 780 00:31:58,880 --> 00:31:59,960 PLANNING PROJECTS, AIMED AT 781 00:31:59,960 --> 00:32:03,440 DEVELOPING A FUTURE TEAM SCIENCE 782 00:32:03,440 --> 00:32:03,840 RESEARCH NETWORK. 783 00:32:03,840 --> 00:32:07,400 SO THE IDEA WOULD BE TO CONDUCT 784 00:32:07,400 --> 00:32:10,680 RESEARCH TO DISCOVER 785 00:32:10,680 --> 00:32:12,040 ENVIRONMENTAL EXPOSURES THAT 786 00:32:12,040 --> 00:32:13,000 INFLUENCE DISEASE 787 00:32:13,000 --> 00:32:14,120 SUSCEPTIBILITY, ONSET, OUTCOMES, 788 00:32:14,120 --> 00:32:17,680 AND THEN DEVELOP A SYSTEMS-LEVEL 789 00:32:17,680 --> 00:32:19,360 APPROACH TO UNDERSTANDING 790 00:32:19,360 --> 00:32:22,600 MECHANISMS UNDERLYING HOW THOSE 791 00:32:22,600 --> 00:32:27,280 EXPOSURES PERTURB CELLULAR, 792 00:32:27,280 --> 00:32:29,160 ORGAN AND TISSUE FUNCTION ACROSS 793 00:32:29,160 --> 00:32:31,000 AUTOIMMUNE DISEASES. 794 00:32:31,000 --> 00:32:32,560 AS ANOTHER EXAMPLE OF 795 00:32:32,560 --> 00:32:33,880 COLLABORATION BETWEEN NIAMS AND 796 00:32:33,880 --> 00:32:36,920 THE OFFICE OF RESEARCH AND 797 00:32:36,920 --> 00:32:40,000 WOMEN'S HEALTH, OUR TWO NOFOs, 798 00:32:40,000 --> 00:32:41,000 NOTICE OF FUNDING OPPORTUNITIES, 799 00:32:41,000 --> 00:32:45,040 THE NEW TERM THAT WE'RE NOW 800 00:32:45,040 --> 00:32:47,000 USING, THAT WERE FROM ORWH AND 801 00:32:47,000 --> 00:32:50,720 THAT WE SIGNED ON TO, THESE 802 00:32:50,720 --> 00:32:53,160 FUNDING OPPORTUNITIES INVITE R01 803 00:32:53,160 --> 00:32:59,040 AND R21 APPLICATIONS ON CHRONIC 804 00:32:59,040 --> 00:33:01,520 CONDITIONS UNDERSTUDIED AMONG 805 00:33:01,520 --> 00:33:03,840 WOMEN AND/OR DISPROPORTIONATELY 806 00:33:03,840 --> 00:33:08,440 AFFECT POPULATIONS OF WOMEN'S 807 00:33:08,440 --> 00:33:14,880 UNDERSTUDIED AND UNDERREPORTED 808 00:33:14,880 --> 00:33:17,840 IN BIOMEDICAL RESEARCH, NOTICES 809 00:33:17,840 --> 00:33:18,960 EXPIRE NEXT JUNE. 810 00:33:18,960 --> 00:33:20,600 NEXT I'D LIKE TO PROVIDE AN 811 00:33:20,600 --> 00:33:23,240 UPDATE ABOUT A PROGRAM THAT WAS 812 00:33:23,240 --> 00:33:26,600 CREATED BY ORWH AND THAT NIAMS 813 00:33:26,600 --> 00:33:29,120 AND MANY INSTITUTES HAVE BEEN 814 00:33:29,120 --> 00:33:31,080 HAPPY TO SUPPORT OVER A NUMBER 815 00:33:31,080 --> 00:33:32,520 OF YEARS. 816 00:33:32,520 --> 00:33:33,920 THE BUILDING INTERDISCIPLINARY 817 00:33:33,920 --> 00:33:37,560 RESEARCH CAREERS IN WOMEN'S 818 00:33:37,560 --> 00:33:39,160 HEALTH, BIRCWH, IS A MENTORED 819 00:33:39,160 --> 00:33:40,480 PROGRAM DESIGNED TO CONNECT 820 00:33:40,480 --> 00:33:44,120 JUNIOR FACULTY WHO ARE KNOWN AS 821 00:33:44,120 --> 00:33:45,200 BIRCWH SCHOLARS TO SENIOR 822 00:33:45,200 --> 00:33:46,840 FACULTY WHO HAVE SHARED 823 00:33:46,840 --> 00:33:49,360 INTERESTS IN WOMEN'S HEALTH AND 824 00:33:49,360 --> 00:33:50,440 SEX DIFFERENCES RESEARCH. 825 00:33:50,440 --> 00:33:53,520 SINCE THE PROGRAM WAS CREATED IN 826 00:33:53,520 --> 00:33:55,160 2000, OVER 700 JUNIOR FACULTY 827 00:33:55,160 --> 00:33:58,800 HAVE BEEN PART OF THIS PROGRAM. 828 00:33:58,800 --> 00:34:01,080 CURRENTLY, THERE ARE 19 ACTIVE 829 00:34:01,080 --> 00:34:02,600 BIRCWH PROGRAMS, SHOWN BY THE 830 00:34:02,600 --> 00:34:04,760 MAP ON THE SLIDE. 831 00:34:04,760 --> 00:34:07,400 AND STARTING THIS YEAR, NIAMS 832 00:34:07,400 --> 00:34:08,800 WILL BEGIN ADMINISTERING ON 833 00:34:08,800 --> 00:34:11,760 BEHALF OF OUR NIH PARTNERS. 834 00:34:11,760 --> 00:34:15,160 I SERVED AS A BIRCWH MENTOR WHEN 835 00:34:15,160 --> 00:34:20,160 I WAS AT UCSF AND SAY -- SAW 836 00:34:20,160 --> 00:34:23,040 FIRSTHAND THE IMPACT OF THE 837 00:34:23,040 --> 00:34:25,920 PROGRAM AND AM PROUD OF NIAMS' 838 00:34:25,920 --> 00:34:26,640 CONTINUED EFFORT. 839 00:34:26,640 --> 00:34:29,400 I'D LIKE TO HIGHLIGHT ANOTHER 840 00:34:29,400 --> 00:34:30,440 TRANS-NIH COLLABORATIVE EFFORT 841 00:34:30,440 --> 00:34:32,560 WHERE NIAMS HAS BEEN INVOLVED IN 842 00:34:32,560 --> 00:34:36,120 THE PLANNING AND DEVELOPMENT. 843 00:34:36,120 --> 00:34:38,160 I WANT TO THANK SUSANA 844 00:34:38,160 --> 00:34:40,120 SERATE-SZTEIN FOR HER EFFORT ON 845 00:34:40,120 --> 00:34:42,760 THIS FRONT, WHICH HAS BEEN 846 00:34:42,760 --> 00:34:43,040 TREMENDOUS. 847 00:34:43,040 --> 00:34:45,680 THE NATIONAL INSTITUTE OF CHILD 848 00:34:45,680 --> 00:34:49,200 HEALTH AND HUMAN DEVELOPMENT, 849 00:34:49,200 --> 00:34:51,400 NICHD, ISSUED TWO NOTICES OF 850 00:34:51,400 --> 00:34:54,200 INTENT TO PUBLISH FOR WHAT'S 851 00:34:54,200 --> 00:34:58,800 CALLED THE HEAL KIDS PAIN 852 00:34:58,800 --> 00:35:01,320 INITIATIVE, ONE OF THE NOTICES 853 00:35:01,320 --> 00:35:04,720 IS FOR A PAIN RESOURCE AND DATA 854 00:35:04,720 --> 00:35:06,600 CENTER, AND THE OTHER FOR 855 00:35:06,600 --> 00:35:09,120 SUPPORTING AN ACUTE PAIN 856 00:35:09,120 --> 00:35:10,200 CLINICAL TRIALS PROGRAM. 857 00:35:10,200 --> 00:35:11,520 WITHIN THE NIAMS MISSION THIS 858 00:35:11,520 --> 00:35:14,040 EFFORT COULD RELATE TO ACUTE 859 00:35:14,040 --> 00:35:16,160 ORTHOPEDIC PAIN FROM COMMON 860 00:35:16,160 --> 00:35:17,840 INJURIES, OR TO ACUTE PAIN 861 00:35:17,840 --> 00:35:25,080 CAUSED BY DISEASE FLARES, NIAMS 862 00:35:25,080 --> 00:35:28,920 IS WORKING WITH NICHD AND OTHER 863 00:35:28,920 --> 00:35:30,000 PARTICIPATING INSTITUTES AND 864 00:35:30,000 --> 00:35:31,560 CENTERS, WE'LL BE PROVIDING YOU 865 00:35:31,560 --> 00:35:36,520 WITH UPDATES AS THIS EFFORT 866 00:35:36,520 --> 00:35:36,840 PROGRESSES. 867 00:35:36,840 --> 00:35:39,080 NOW, SWITCHING TO THE NIH UNITE 868 00:35:39,080 --> 00:35:40,960 INITIATIVE, WHICH WE'VE TALKED 869 00:35:40,960 --> 00:35:43,800 ABOUT ON A NUMBER OF PREVIOUS 870 00:35:43,800 --> 00:35:45,880 COUNCIL MEETINGS, THE NIH 871 00:35:45,880 --> 00:35:47,440 RECENTLY ANNOUNCED ITS RESEARCH 872 00:35:47,440 --> 00:35:50,640 WITH ACTIVITIES RELATED TO 873 00:35:50,640 --> 00:35:52,560 DIVERSITY, REWARD PROGRAM, IN 874 00:35:52,560 --> 00:35:54,960 MARCH, REALLY EXCITED ABOUT THIS 875 00:35:54,960 --> 00:35:57,280 PROGRAM FOR SOME UNIQUE 876 00:35:57,280 --> 00:35:59,280 FEATURES, PROVIDES SUPPORT FOR 877 00:35:59,280 --> 00:36:02,360 SCIENTISTS MAKING A SIGNIFICANT 878 00:36:02,360 --> 00:36:02,880 CONTRIBUTION TO DIVERSITY, 879 00:36:02,880 --> 00:36:03,960 EQUITY, INCLUSION, AND 880 00:36:03,960 --> 00:36:05,800 ACCESSIBILITY, IN THE RESEARCH 881 00:36:05,800 --> 00:36:07,680 ENTERPRISE, AND WHO HAVE NO 882 00:36:07,680 --> 00:36:10,200 CURRENT NIH RESEARCH PROJECT 883 00:36:10,200 --> 00:36:11,520 GRANT FUNDING. 884 00:36:11,520 --> 00:36:12,280 SUCCESSFUL APPLICANTS WILL 885 00:36:12,280 --> 00:36:15,240 RECEIVE NIH SUPPORT THROUGH THE 886 00:36:15,240 --> 00:36:18,160 R01 MECHANISM FOR BOTH RESEARCH 887 00:36:18,160 --> 00:36:19,600 AND DEIA ACTIVITIES WHICH I 888 00:36:19,600 --> 00:36:21,120 THINK MAKES THIS UNIQUE. 889 00:36:21,120 --> 00:36:24,160 SO THE APPLICATIONS WILL BE 890 00:36:24,160 --> 00:36:26,040 ACCEPTED THROUGH EARLY 2026 AS 891 00:36:26,040 --> 00:36:28,680 SHOWN HERE AT THE BOTTOM OF THE 892 00:36:28,680 --> 00:36:31,840 SLIDE. 893 00:36:31,840 --> 00:36:33,240 SO REALLY EXCITING OPPORTUNITY. 894 00:36:33,240 --> 00:36:37,120 NOW, WE'LL BE HEARING FROM DR. 895 00:36:37,120 --> 00:36:38,760 NONI BYRNES, DIRECTOR OF CENTER 896 00:36:38,760 --> 00:36:39,360 FOR SCIENTIFIC REVIEW LATER 897 00:36:39,360 --> 00:36:41,800 TODAY BUT I WANT TO CALL YOUR 898 00:36:41,800 --> 00:36:44,640 ATTENTION TO A CURRENT CSR 899 00:36:44,640 --> 00:36:46,440 EFFORT TO IMPROVE THE WAY 900 00:36:46,440 --> 00:36:47,280 FELLOWSHIP APPLICATIONS ARE 901 00:36:47,280 --> 00:36:47,560 REVIEWED. 902 00:36:47,560 --> 00:36:50,040 IN RESPONSE TO A WORKING GROUP 903 00:36:50,040 --> 00:36:52,120 CONCLUSION THAT THE NIH IS 904 00:36:52,120 --> 00:36:54,520 POTENTIALLY LEAVING OUT HIGHLY 905 00:36:54,520 --> 00:36:56,920 PROMISING SCIENTISTS BECAUSE THE 906 00:36:56,920 --> 00:36:59,360 CURRENT PROCESS TOO HEAVILY 907 00:36:59,360 --> 00:37:01,640 FAVORS ELITE INSTITUTIONS, 908 00:37:01,640 --> 00:37:03,480 SENIOR WELL-KNOWN SPONSORS, AND 909 00:37:03,480 --> 00:37:05,640 OVERLY NARROW EMPHASIS ON 910 00:37:05,640 --> 00:37:08,000 TRADITIONAL MARKERS OF EARLY 911 00:37:08,000 --> 00:37:10,160 ACADEMIC SUCCESS, THE NIH HAS 912 00:37:10,160 --> 00:37:13,880 ISSUED THIS RFI, REQUEST FOR 913 00:37:13,880 --> 00:37:15,520 INFORMATION, REGARDING REVISED 914 00:37:15,520 --> 00:37:17,480 REVIEW CRITERIA AND 915 00:37:17,480 --> 00:37:18,040 CORRESPONDING CHANGES TO 916 00:37:18,040 --> 00:37:21,480 APPLICATIONS SO THEY ALIGN WITH 917 00:37:21,480 --> 00:37:22,400 THE PROPOSED NEW CRITERIA. 918 00:37:22,400 --> 00:37:24,800 COMMENTS WILL BE ACCEPTED UNTIL 919 00:37:24,800 --> 00:37:26,760 JUNE 23, SO PLEASE SHARE THIS 920 00:37:26,760 --> 00:37:27,760 INFORMATION WITH INTERESTED 921 00:37:27,760 --> 00:37:30,560 COLLEAGUES WHO ARE EITHER SENIOR 922 00:37:30,560 --> 00:37:32,920 MENTORS OR POTENTIAL APPLICANTS. 923 00:37:32,920 --> 00:37:34,240 ONCE AGAIN, DR. BYRNES WILL BE 924 00:37:34,240 --> 00:37:37,000 WITH US LATER TODAY AND YOU CAN 925 00:37:37,000 --> 00:37:38,560 DIRECT QUESTIONS TO HER ABOUT 926 00:37:38,560 --> 00:37:42,560 THIS OR OTHER THINGS SHE SHARES 927 00:37:42,560 --> 00:37:43,240 WITH US. 928 00:37:43,240 --> 00:37:45,720 SO AS YOU ALSO MIGHT RECALL FROM 929 00:37:45,720 --> 00:37:47,480 OUR LAST MEETING IN JANUARY DR. 930 00:37:47,480 --> 00:37:49,800 FAYE CHEN, ALSO WITH US HERE 931 00:37:49,800 --> 00:37:51,280 TODAY, FROM OUR EXTRAMURAL 932 00:37:51,280 --> 00:37:54,880 PROGRAM, SHARED AN EVALUATION OF 933 00:37:54,880 --> 00:37:56,760 THE INSTITUTE'S R21 PORTFOLIO 934 00:37:56,760 --> 00:38:00,720 AND PROPOSED CHANGES TO OUR 935 00:38:00,720 --> 00:38:02,560 PARTICIPATION IN NIH-WIDE 936 00:38:02,560 --> 00:38:03,360 PROGRAM. 937 00:38:03,360 --> 00:38:06,520 AND THANKS TO HER INPUT WE'VE 938 00:38:06,520 --> 00:38:09,800 ISSUED A NOSI, NOTICE OF SPECIAL 939 00:38:09,800 --> 00:38:10,720 INTEREST, TO NOTIFY RESEARCH 940 00:38:10,720 --> 00:38:13,760 COMMUNITY THAT NIAMS WILL NOW 941 00:38:13,760 --> 00:38:17,720 ONLY ACCEPT THESE EXPLORATORY 942 00:38:17,720 --> 00:38:18,800 DEVELOPMENTAL R21 GRANT 943 00:38:18,800 --> 00:38:20,120 APPLICATIONS FOCUSED ON NIAMS 944 00:38:20,120 --> 00:38:21,920 CORE MISSION AREAS THROUGH THIS 945 00:38:21,920 --> 00:38:26,160 NOSI, AND NOT THROUGH THE 946 00:38:26,160 --> 00:38:31,080 NIH-WIDE PARENT R21 FUNDING 947 00:38:31,080 --> 00:38:32,560 OPPORTUNITY ANNOUNCEMENT. 948 00:38:32,560 --> 00:38:34,320 AS WE MAKE DECISIONS LIKE THESE, 949 00:38:34,320 --> 00:38:37,720 MANY OF US AT NIAMS HAVE BEEN 950 00:38:37,720 --> 00:38:40,160 THINKING CAREFULLY ABOUT GOALS 951 00:38:40,160 --> 00:38:42,320 FOR EXTRAMURAL INVESTMENTS. 952 00:38:42,320 --> 00:38:46,120 ULTIMATELY OF COURSE WE WANT TO 953 00:38:46,120 --> 00:38:46,800 SUPPORT HIGHLY MERITORIOUS 954 00:38:46,800 --> 00:38:48,200 SCIENCE, DIVERSE PORTFOLIO OF 955 00:38:48,200 --> 00:38:50,160 RESEARCH ACROSS THE BROAD 956 00:38:50,160 --> 00:38:51,840 SPECTRUM OF OUR MISSION AREAS, 957 00:38:51,840 --> 00:38:54,880 PROJECTS THAT ALIGN WITH NIAMS' 958 00:38:54,880 --> 00:38:57,560 VALUES AND PRIORITIES, AND HAVE 959 00:38:57,560 --> 00:39:00,000 FLEXIBILITY TO ADDRESS EMERGING 960 00:39:00,000 --> 00:39:02,120 AREAS OR UNIQUE SCIENTIFIC 961 00:39:02,120 --> 00:39:02,680 CHALLENGES. 962 00:39:02,680 --> 00:39:04,120 SO WE'VE BEEN THINKING ABOUT HOW 963 00:39:04,120 --> 00:39:05,960 TO ACHIEVE GOALS AT THE 964 00:39:05,960 --> 00:39:08,280 LEADERSHIP LEVEL AND PART OF OUR 965 00:39:08,280 --> 00:39:09,920 STRATEGIC PLANNING YOU'LL BE 966 00:39:09,920 --> 00:39:12,440 HEARING ABOUT THIS FROM DR. 967 00:39:12,440 --> 00:39:13,120 STEPHANIE BURROWS, REALLY 968 00:39:13,120 --> 00:39:14,520 IMPORTANT QUESTIONS THAT WE'VE 969 00:39:14,520 --> 00:39:19,080 ALL BEEN THINKING CAREFULLY 970 00:39:19,080 --> 00:39:22,600 ABOUT. 971 00:39:22,600 --> 00:39:24,120 TO ENGAGE OUR COLLEAGUES 50 OF 972 00:39:24,120 --> 00:39:27,640 US GATHERED FOR A TWO-DAY 973 00:39:27,640 --> 00:39:29,280 RETREAT TO DISCUSS EXTRAMURAL 974 00:39:29,280 --> 00:39:30,600 STRATEGIES FOR FUTURE 975 00:39:30,600 --> 00:39:31,160 INVESTMENTS. 976 00:39:31,160 --> 00:39:33,000 THE FRAMEWORK FOR DISCUSSION WAS 977 00:39:33,000 --> 00:39:35,280 BASED ON NIAMS GOALS AND VALUES, 978 00:39:35,280 --> 00:39:37,280 OUR VISION FOR HOW TO ACCOMPLISH 979 00:39:37,280 --> 00:39:40,280 OUR GOALS, AND OUR APPROACH TO 980 00:39:40,280 --> 00:39:41,520 IMPLEMENTING OUR VISION. 981 00:39:41,520 --> 00:39:44,160 A SUMMARY WILL BE POSTED SOON TO 982 00:39:44,160 --> 00:39:46,280 THE NIAMS WEBSITE BUT WE'D BE 983 00:39:46,280 --> 00:39:48,440 INTERESTED IN HEARING COUNCIL 984 00:39:48,440 --> 00:39:49,960 THOUGHTS ON SOME TOPICS WE 985 00:39:49,960 --> 00:39:56,920 DISCUSSED AS SHOWN ON THIS NEXT 986 00:39:56,920 --> 00:39:57,120 SLIDE. 987 00:39:57,120 --> 00:40:00,120 FOR EXAMPLE, WE DISCUSSED HOW TO 988 00:40:00,120 --> 00:40:02,000 LEVERAGE STRATEGIC PARTNERSHIPS 989 00:40:02,000 --> 00:40:04,080 IN ORDER TO GROW OUR BUDGET FOR 990 00:40:04,080 --> 00:40:06,080 EXTRAMURAL FUNDING WHICH AS YOU 991 00:40:06,080 --> 00:40:08,480 KNOW HAS BEEN STRETCHED VERY 992 00:40:08,480 --> 00:40:09,560 THIN. 993 00:40:09,560 --> 00:40:13,360 WE'VE HAD SIGNIFICANT SUCCESSES 994 00:40:13,360 --> 00:40:14,240 WITH TRANS-NIH AND 995 00:40:14,240 --> 00:40:15,560 PUBLIC/PRIVATE PARTNERSHIPS SUCH 996 00:40:15,560 --> 00:40:16,760 AS ACCELERATING MEDICINES 997 00:40:16,760 --> 00:40:17,320 PARTNERSHIP. 998 00:40:17,320 --> 00:40:21,560 HOW CAN WE LEARN FROM THIS 999 00:40:21,560 --> 00:40:23,680 EXPERIENCE AND EXPAND STRATEGIC 1000 00:40:23,680 --> 00:40:25,520 PARTNERS WITH THIS GOAL IN MIND, 1001 00:40:25,520 --> 00:40:26,600 OUR STRATEGIC PARTNERSHIPS? 1002 00:40:26,600 --> 00:40:28,240 WE ALSO DISCUSSED HOW TO BEST 1003 00:40:28,240 --> 00:40:31,960 USE OUR FUNDS TO SUPPORT THE 1004 00:40:31,960 --> 00:40:35,480 MOST IMPACTFUL RESEARCH WHILE 1005 00:40:35,480 --> 00:40:37,680 ALSO FOSTERING ROBUST SCIENTIFIC 1006 00:40:37,680 --> 00:40:38,080 WORKFORCE. 1007 00:40:38,080 --> 00:40:40,200 AS YOU KNOW, RESEARCH IS 1008 00:40:40,200 --> 00:40:41,000 BECOMING INCREASINGLY EXPENSIVE, 1009 00:40:41,000 --> 00:40:44,320 SO HOW CAN WE ACCOUNT FOR THIS 1010 00:40:44,320 --> 00:40:45,760 FACT WITHOUT DECREASING THE POOL 1011 00:40:45,760 --> 00:40:49,160 OF INVESTIGATORS THAT WE 1012 00:40:49,160 --> 00:40:49,920 SUPPORT? 1013 00:40:49,920 --> 00:40:51,560 NIH POLICY STATES THAT 1014 00:40:51,560 --> 00:40:53,880 APPLICATIONS FROM INVESTIGATORS 1015 00:40:53,880 --> 00:40:56,400 WHO WOULD RECEIVE OVER $2 1016 00:40:56,400 --> 00:40:57,480 MILLION IN TOTAL COST SHOULD 1017 00:40:57,480 --> 00:41:01,440 THEIR MOST RECENT APPLICATIONS 1018 00:41:01,440 --> 00:41:03,680 BE FUNDED NEED TO BE CONSIDERED 1019 00:41:03,680 --> 00:41:04,600 BY RELEVANT INSTITUTE ADVISORY 1020 00:41:04,600 --> 00:41:07,240 COUNCIL, THAT IS THIS BODY. 1021 00:41:07,240 --> 00:41:09,400 BUT SOME OTHER NIH COMPONENTS 1022 00:41:09,400 --> 00:41:11,840 HAVE MORE STRINGENT POLICIES, 1023 00:41:11,840 --> 00:41:14,920 EITHER CAPPING AMOUNT OF NIH OR 1024 00:41:14,920 --> 00:41:17,480 INSTITUTE FUNDS OR THE NUMBER OF 1025 00:41:17,480 --> 00:41:21,320 NIH OR INSTITUTE GRANTS THAT AN 1026 00:41:21,320 --> 00:41:21,840 INVESTIGATOR CAN RECEIVE. 1027 00:41:21,840 --> 00:41:26,480 SO, WOULD WE BE BETTER SEARCHING 1028 00:41:26,480 --> 00:41:27,160 COMMUNITIES AND BROADER 1029 00:41:27,160 --> 00:41:28,560 SCIENTIFIC ENTERPRISE IF WE 1030 00:41:28,560 --> 00:41:32,120 PLACE LIMITS ON WHAT WE PROVIDE 1031 00:41:32,120 --> 00:41:32,680 THESE MOST HIGHLY SUCCESSFUL 1032 00:41:32,680 --> 00:41:36,120 INDIVIDUALS SO THAT WE CAN FUND 1033 00:41:36,120 --> 00:41:39,240 ADDITIONAL MERITORIOUS 1034 00:41:39,240 --> 00:41:43,880 APPLICATIONS FROM OTHERS? 1035 00:41:43,880 --> 00:41:45,400 AND HISTORICALLY, NIAMS HAS PAID 1036 00:41:45,400 --> 00:41:48,120 MOST APPLICATIONS ACCORDING TO 1037 00:41:48,120 --> 00:41:48,880 STRICT PAYLINE-DRIVEN APPROACH 1038 00:41:48,880 --> 00:41:51,720 WITH LIMITED FUNDS AVAILABLE FOR 1039 00:41:51,720 --> 00:41:52,920 AWARDS TO APPLICATIONS THAT 1040 00:41:52,920 --> 00:41:54,320 PROGRAM DIRECTORS MIGHT IDENTIFY 1041 00:41:54,320 --> 00:41:56,880 AS BEING OF THE HIGHEST PRIORITY 1042 00:41:56,880 --> 00:41:59,160 EVEN THOUGH THEY SCORED BEYOND 1043 00:41:59,160 --> 00:42:00,320 THE PUBLISHED PAYLINE. 1044 00:42:00,320 --> 00:42:01,720 SO, I WELCOME YOUR THOUGHTS 1045 00:42:01,720 --> 00:42:05,560 ABOUT HOW TO ACHIEVE THE 1046 00:42:05,560 --> 00:42:06,960 APPROPRIATE BALANCE, CONSIDERING 1047 00:42:06,960 --> 00:42:08,960 THE SIGNIFICANT BUDGETARY 1048 00:42:08,960 --> 00:42:11,200 CONSTRAINTS WE CURRENTLY HAVE. 1049 00:42:11,200 --> 00:42:12,880 AND IMPORTANTLY FOR ALL OF THE 1050 00:42:12,880 --> 00:42:14,160 STRATEGIES THAT WE'RE EXPLORING 1051 00:42:14,160 --> 00:42:18,480 AND WE MAY BE PURSUING, HOW CAN 1052 00:42:18,480 --> 00:42:19,880 WE COMMUNICATE OUR GOALS, 1053 00:42:19,880 --> 00:42:21,040 PRIORITIES, AND APPROACH TO 1054 00:42:21,040 --> 00:42:25,480 STAKEHOLDERS IN THE MOST 1055 00:42:25,480 --> 00:42:28,960 EFFICIENT AND EFFECTIVE WAY? 1056 00:42:28,960 --> 00:42:31,040 SO, ON THAT NOTE, WE HAVE NOW 1057 00:42:31,040 --> 00:42:32,800 TIME FOR SOME DISCUSSION AND I 1058 00:42:32,800 --> 00:42:35,160 WELCOME YOUR COMMENTS ON ANY OF 1059 00:42:35,160 --> 00:42:37,400 THE TOPICS I PRESENTED THUS FAR 1060 00:42:37,400 --> 00:42:38,920 AND ANYTHING ELSE ON YOUR MIND, 1061 00:42:38,920 --> 00:42:40,680 INCLUDING THESE TOPICS THAT I 1062 00:42:40,680 --> 00:42:41,800 JUST HIGHLIGHTED THERE IN THE 1063 00:42:41,800 --> 00:42:45,600 LAST COUPLE MINUTES THAT EMERGED 1064 00:42:45,600 --> 00:42:47,560 FROM OUR SCIENTIFIC PLANNING 1065 00:42:47,560 --> 00:42:47,800 RETREAT. 1066 00:42:47,800 --> 00:42:51,080 I WELCOME EARLY CAREER 1067 00:42:51,080 --> 00:42:55,280 INVESTIGATOR AD HOC MEMBERS 1068 00:42:55,280 --> 00:42:56,720 COMMENTS AS YOU REPRESENT THE 1069 00:42:56,720 --> 00:42:58,160 FUTURE AND WILL BE IMPACTED FOR 1070 00:42:58,160 --> 00:43:01,640 THE DURATION OF YOUR CAREERS. 1071 00:43:01,640 --> 00:43:03,560 I'LL JOIN YOU AT THE TABLE AND 1072 00:43:03,560 --> 00:43:14,120 WE'LL CONTINUE THIS DISCUSSION. 1073 00:43:36,880 --> 00:43:39,480 IN SPITE OF THE QUIET ROOM, NOW 1074 00:43:39,480 --> 00:43:41,920 I'M SURE THERE'S SOME COMMENTS 1075 00:43:41,920 --> 00:43:42,760 OR QUESTIONS. 1076 00:43:42,760 --> 00:43:42,960 GREAT. 1077 00:43:42,960 --> 00:43:45,240 >> FIRST I WANT TO CONGRATULATE 1078 00:43:45,240 --> 00:43:47,000 YOU ON THIS EXCITING PORTFOLIO 1079 00:43:47,000 --> 00:43:49,080 AND DIRECTIONS THAT YOU'RE GOING 1080 00:43:49,080 --> 00:43:49,240 IN. 1081 00:43:49,240 --> 00:43:50,640 I THINK THERE'S A LOT OF REALLY 1082 00:43:50,640 --> 00:43:53,920 NEW AND EXCITING THINGS HERE. 1083 00:43:53,920 --> 00:43:54,280 IT'S FANTASTIC. 1084 00:43:54,280 --> 00:43:56,760 BEFORE WE GET TO DISCUSSION THAT 1085 00:43:56,760 --> 00:43:58,000 YOU'RE TALKING ABOUT I WONDERED 1086 00:43:58,000 --> 00:44:00,080 IF YOU COULD EXPAND ON 1087 00:44:00,080 --> 00:44:01,120 AUTOIMMUNE DISEASES RESEARCH 1088 00:44:01,120 --> 00:44:03,080 THAT'S OCCURRING WITHIN THE 1089 00:44:03,080 --> 00:44:08,680 OFFICE OF WOMEN'S HEALTH AND 1090 00:44:08,680 --> 00:44:11,120 RELATIONSHIP BETWEEN NIAMS AND 1091 00:44:11,120 --> 00:44:14,520 OFFICE OF WOMEN'S HEALTH, WHERE 1092 00:44:14,520 --> 00:44:15,720 THE DATA CENTRAL STORAGE WOULD 1093 00:44:15,720 --> 00:44:16,280 BE TAKING PLACE? 1094 00:44:16,280 --> 00:44:26,040 >>THIS IS A BRAND-NEW EFFORT. 1095 00:44:26,040 --> 00:44:27,640 CONGRESS DESIGNATED ORWH, BUT IT 1096 00:44:27,640 --> 00:44:29,200 CAN'T ADMINISTER GRANTS AND 1097 00:44:29,200 --> 00:44:30,520 AWARDS. 1098 00:44:30,520 --> 00:44:32,480 IT'S THROUGH PARTNERSHIPS WITH 1099 00:44:32,480 --> 00:44:33,600 INSTITUTES AND CENTERS THE 1100 00:44:33,600 --> 00:44:36,960 VALUABLE $10 MILLION CAN BE 1101 00:44:36,960 --> 00:44:38,520 DISTRIBUTED TO SUPPORT VARIOUS 1102 00:44:38,520 --> 00:44:38,840 ACTIVITIES. 1103 00:44:38,840 --> 00:44:41,120 AND THEY HAVE DONE A 1104 00:44:41,120 --> 00:44:42,760 TREMENDOUSLY IMPRESSIVE JOB AT 1105 00:44:42,760 --> 00:44:43,960 OUTLINING SOME PLANS FOR THE 1106 00:44:43,960 --> 00:44:46,360 COMING YEAR AND BEYOND GIVEN THE 1107 00:44:46,360 --> 00:44:48,560 SHORT TIME THEY'VE HAD, 1108 00:44:48,560 --> 00:44:52,120 INCLUDING A REPORT BACK TO 1109 00:44:52,120 --> 00:44:52,800 IMPORTANT CONGRESSIONAL STAFF, 1110 00:44:52,800 --> 00:44:55,680 LAUNCHING THE EXACT PLAN THAT I 1111 00:44:55,680 --> 00:44:59,000 MENTIONED, THEY HAVE DEVELOPED 1112 00:44:59,000 --> 00:45:01,160 SOME INTRAMURAL RESEARCH PROGRAM 1113 00:45:01,160 --> 00:45:02,160 OPPORTUNITIES, ET CETERA, ET 1114 00:45:02,160 --> 00:45:02,400 CETERA. 1115 00:45:02,400 --> 00:45:05,960 BY THE WAY, WE'RE GOING TO HAVE 1116 00:45:05,960 --> 00:45:08,680 JANINE CLAYTON OR SOMEONE FROM 1117 00:45:08,680 --> 00:45:11,200 THE OFFICE OF RESEARCH ON 1118 00:45:11,200 --> 00:45:14,720 WOMEN'S HEALTH NEXT COUNCIL 1119 00:45:14,720 --> 00:45:15,120 MEETING. 1120 00:45:15,120 --> 00:45:17,000 SHE REACHED OUT BECAUSE SHE 1121 00:45:17,000 --> 00:45:20,720 KNOWS HOW COMMITTED WE TO 1122 00:45:20,720 --> 00:45:21,280 AUTOIMMUNE DISEASE RESEARCH, 1123 00:45:21,280 --> 00:45:23,800 COUNTING ON US TO BE A STRONG 1124 00:45:23,800 --> 00:45:24,040 PARTNER. 1125 00:45:24,040 --> 00:45:30,840 AND DR. SUSANA SERATE-SZTEIN HD 1126 00:45:30,840 --> 00:45:33,760 A GREAT AMOUNT OF EFFORT IN THE 1127 00:45:33,760 --> 00:45:40,880 PLAN AND PROPOSAL WHICH WE'RE 1128 00:45:40,880 --> 00:45:42,160 EXCITED ABOUT, RICARDO SABATI 1129 00:45:42,160 --> 00:45:45,280 ALSO WORKED HARD ON THE PROJECT. 1130 00:45:45,280 --> 00:45:47,720 FULL DESCRIPTION FROM DR. 1131 00:45:47,720 --> 00:45:53,240 CLAYTON AT OUR NEXT MEETING. 1132 00:45:53,240 --> 00:45:53,440 YEAH? 1133 00:45:53,440 --> 00:45:56,200 >> YES, CONGRATULATIONS ALSO, 1134 00:45:56,200 --> 00:45:57,280 VERY COMPREHENSIVE PORTFOLIO, 1135 00:45:57,280 --> 00:46:01,640 I'M EXCITED ABOUT SOME ISSUES 1136 00:46:01,640 --> 00:46:03,320 YOU'RE DISCUSSING IN THE 1137 00:46:03,320 --> 00:46:04,400 RETREAT. 1138 00:46:04,400 --> 00:46:07,640 I HAD A MORE FOCUSED QUESTION 1139 00:46:07,640 --> 00:46:08,800 ABOUT THE R21s NOW THAT THEY 1140 00:46:08,800 --> 00:46:10,640 ARE SEPARATING FROM THE GENERAL 1141 00:46:10,640 --> 00:46:11,040 PROGRAM. 1142 00:46:11,040 --> 00:46:12,840 BASICALLY IS THERE GOING TO BE A 1143 00:46:12,840 --> 00:46:14,920 DEDICATED BUDGET EVERY YEAR FOR 1144 00:46:14,920 --> 00:46:21,520 THOSE R21s OR ARE THEY PART OF 1145 00:46:21,520 --> 00:46:23,960 THE GENERAL BUDGET, IS THERE 1146 00:46:23,960 --> 00:46:26,200 GOING TO BE A SEPARATE STUDY 1147 00:46:26,200 --> 00:46:28,360 SECTION AS OPPOSED TO GENERAL 1148 00:46:28,360 --> 00:46:30,440 CSR REVIEW AND IS IT GOING TO BE 1149 00:46:30,440 --> 00:46:33,760 OPEN TO ANY TOPIC OR SPECIFIC 1150 00:46:33,760 --> 00:46:37,800 RFAs FOR THOSE R21s, IF YOU 1151 00:46:37,800 --> 00:46:39,080 CAN EXPAND MORE. 1152 00:46:39,080 --> 00:46:41,520 >> YEAH, SO, THE MOTIVATION 1153 00:46:41,520 --> 00:46:44,840 BEHIND MAKING THIS CHANGE WAS 1154 00:46:44,840 --> 00:46:46,080 CONCERN ABOUT SOMETHING 1155 00:46:46,080 --> 00:46:48,520 CHARACTERIZED AS MISSION CREEP. 1156 00:46:48,520 --> 00:46:51,720 SO WHAT NIAMS PROGRAM STAFF WERE 1157 00:46:51,720 --> 00:46:53,280 OBSERVING WAS THAT INCREASINGLY, 1158 00:46:53,280 --> 00:46:55,200 R21 APPLICATIONS WOULD BE 1159 00:46:55,200 --> 00:46:57,040 DIRECTED TO NIAMS FOR POTENTIAL 1160 00:46:57,040 --> 00:46:58,600 FUNDING THAT REALLY WEREN'T 1161 00:46:58,600 --> 00:47:01,040 STRONGLY ALIGNED WITH OUR 1162 00:47:01,040 --> 00:47:01,280 MISSION. 1163 00:47:01,280 --> 00:47:02,320 WE'RE TERRIBLY CONCERNED ABOUT 1164 00:47:02,320 --> 00:47:03,760 THE LIMITED DOLLARS WE HAVE GIVE 1165 00:47:03,760 --> 00:47:06,160 BE THE BREADTH OF OUR MISSION 1166 00:47:06,160 --> 00:47:06,600 AREAS. 1167 00:47:06,600 --> 00:47:10,000 AND THE REASON FOR THAT WAS THAT 1168 00:47:10,000 --> 00:47:12,040 A NUMBER OF INSTITUTES AND 1169 00:47:12,040 --> 00:47:13,400 CENTERS STOPPED SUPPORTING R21 1170 00:47:13,400 --> 00:47:15,880 APPLICATIONS ALTOGETHER. 1171 00:47:15,880 --> 00:47:16,880 WHAT HAPPENS IS R 21 1172 00:47:16,880 --> 00:47:19,080 APPLICATIONS COME IN AND HAVE TO 1173 00:47:19,080 --> 00:47:21,680 FIND A HOME SOMEWHERE AND 1174 00:47:21,680 --> 00:47:23,880 THERE'S PROCESS FOR TRIAGING 1175 00:47:23,880 --> 00:47:24,360 APPLICATIONS. 1176 00:47:24,360 --> 00:47:26,840 SO, ANYTHING THAT WAS VAGUELY 1177 00:47:26,840 --> 00:47:29,440 RELATED TO NIAMS MISSION AREAS 1178 00:47:29,440 --> 00:47:31,880 WOULD COME TO US IF WHAT WOULD 1179 00:47:31,880 --> 00:47:34,320 LOGICALLY BE THE BETTER HOME WAS 1180 00:47:34,320 --> 00:47:35,680 NO LONGER ACCEPTING R21 1181 00:47:35,680 --> 00:47:36,000 APPLICATIONS. 1182 00:47:36,000 --> 00:47:37,640 THIS POSED A CHALLENGE. 1183 00:47:37,640 --> 00:47:39,960 WE WANT TO SUPPORT MERITORIOUS 1184 00:47:39,960 --> 00:47:41,800 RESEARCH BUT WE'RE CONCERNED 1185 00:47:41,800 --> 00:47:44,240 ABOUT THE DOLLARS THAT WE HAVE. 1186 00:47:44,240 --> 00:47:46,760 SO BY PUBLISHING THIS NOSI, AND 1187 00:47:46,760 --> 00:47:49,160 PULLING OUT OF THE PARENT R21, 1188 00:47:49,160 --> 00:47:51,760 WHICH MANY OTHER INSTITUTES AND 1189 00:47:51,760 --> 00:47:54,640 CENTERS HAVE DONE, WE HAVE MORE 1190 00:47:54,640 --> 00:47:56,480 CONTROL OVER THE R21 1191 00:47:56,480 --> 00:47:56,960 APPLICATION. 1192 00:47:56,960 --> 00:47:59,800 THAT WAS THE SOLE INTENT AND 1193 00:47:59,800 --> 00:48:03,240 PURPOSE OF MAKING THIS CHANGE. 1194 00:48:03,240 --> 00:48:05,760 YOU RAISE A GOOD QUESTION WHICH 1195 00:48:05,760 --> 00:48:11,360 I CAN'T REMEMBER TECHNICALLY BUT 1196 00:48:11,360 --> 00:48:13,400 FAYE CHEN MAY KNOW IF ANYTHING 1197 00:48:13,400 --> 00:48:15,200 DIFFERENT HAPPENS IN TERMS OF 1198 00:48:15,200 --> 00:48:15,400 REVIEW. 1199 00:48:15,400 --> 00:48:17,840 MAYBE YOU COULD SPEAK TO THAT 1200 00:48:17,840 --> 00:48:18,040 PART. 1201 00:48:18,040 --> 00:48:23,480 >> AS FAR AS I KNOW THEY ARE 1202 00:48:23,480 --> 00:48:26,840 STILL REVIEWED THROUGH THE 1203 00:48:26,840 --> 00:48:29,280 NORMAL PROCESS, PERCENTILED 1204 00:48:29,280 --> 00:48:30,280 ACCORDING TO OTHER R21s, 1205 00:48:30,280 --> 00:48:32,240 CONSIDERED BASED ON OUR PAYLINE 1206 00:48:32,240 --> 00:48:33,600 OR FUNDING DECISION PROCESS. 1207 00:48:33,600 --> 00:48:36,200 SO I DON'T THINK IT WILL BE TOO 1208 00:48:36,200 --> 00:48:36,520 DISRUPTIVE. 1209 00:48:36,520 --> 00:48:38,960 FAYE, IS THERE ANYTHING ELSE YOU 1210 00:48:38,960 --> 00:48:49,560 COULD CLARIFY THERE? ? 1211 00:48:49,560 --> 00:48:51,960 >> WHAT DR. CRISWELL HAS SAID 1212 00:48:51,960 --> 00:48:56,160 AND WHAT GAIL HAS SAID, THEY ARE 1213 00:48:56,160 --> 00:48:57,440 ALL CORRECT. 1214 00:48:57,440 --> 00:48:59,560 ONE THING THAT PEOPLE, 1215 00:48:59,560 --> 00:49:00,920 INVESTIGATORS, SHOULD REMEMBER 1216 00:49:00,920 --> 00:49:04,120 IS THEY ABSOLUTELY HAVE TO PUT 1217 00:49:04,120 --> 00:49:09,360 THE NOSI NUMBER IN THE BOX. 1218 00:49:09,360 --> 00:49:11,880 AND WE ENCOURAGE INVESTIGATORS 1219 00:49:11,880 --> 00:49:15,040 TO TALK TO PROGRAM DIRECTORS 1220 00:49:15,040 --> 00:49:16,400 BEFORE THEY SUBMIT THE R21 1221 00:49:16,400 --> 00:49:20,000 APPLICATION JUST TO MAKE SURE 1222 00:49:20,000 --> 00:49:22,520 THE PROJECT IS WITHIN THE CORE 1223 00:49:22,520 --> 00:49:23,360 MISSION OF NIAMS. 1224 00:49:23,360 --> 00:49:26,960 THAT WILL BE THE ONLY 1225 00:49:26,960 --> 00:49:27,760 DIFFERENCE. 1226 00:49:27,760 --> 00:49:30,360 >> YES, THANK YOU FOR THAT VERY 1227 00:49:30,360 --> 00:49:31,120 IMPORTANT NOTE AS WELL. 1228 00:49:31,120 --> 00:49:32,800 AND THAT'S ONE OF THE REASONS WE 1229 00:49:32,800 --> 00:49:35,680 WANTED TO HIGHLIGHT THIS TO MAKE 1230 00:49:35,680 --> 00:49:36,720 SURE THE COMMUNITY UNDERSTANDS, 1231 00:49:36,720 --> 00:49:38,400 YOU KNOW, THE CHANGE THAT WE'VE 1232 00:49:38,400 --> 00:49:41,320 MADE AND THANKS FOR GIVING ME AN 1233 00:49:41,320 --> 00:49:49,800 OPPORTUNITY TO EXPLAIN THE 1234 00:49:49,800 --> 00:49:50,200 RATIONALE. 1235 00:49:50,200 --> 00:49:50,520 YES, SUZANNE? 1236 00:49:50,520 --> 00:49:53,400 >> THIS RELATES TO DIFFERENT 1237 00:49:53,400 --> 00:49:55,600 THINGS COVERED, THE GENERAL 1238 00:49:55,600 --> 00:49:59,280 CONCEPT OF MAKING SURE WE'RE NOT 1239 00:49:59,280 --> 00:50:00,920 LEAVING VIABLE RESEARCH OR 1240 00:50:00,920 --> 00:50:02,160 VIABLE RESEARCHERS OUT OF 1241 00:50:02,160 --> 00:50:04,080 FUNDING DECISIONS OR OTHER 1242 00:50:04,080 --> 00:50:04,800 PROGRAMMATIC DECISIONS. 1243 00:50:04,800 --> 00:50:06,200 IT'S SOMETHING I THINK ALL OF US 1244 00:50:06,200 --> 00:50:11,800 IN THE PATIENT ENGAGEMENT FIELD 1245 00:50:11,800 --> 00:50:13,960 ARE ACUTELY AWARE OF, THAT 1246 00:50:13,960 --> 00:50:15,520 HAVING ENGAGEMENT PROWESS, 1247 00:50:15,520 --> 00:50:18,360 HAVING A DEMONSTRATED RECORD IN 1248 00:50:18,360 --> 00:50:20,120 ENGAGEMENT, SO PROOF THAT YOU 1249 00:50:20,120 --> 00:50:21,200 UNDERSTAND THE CONCEPTS AND 1250 00:50:21,200 --> 00:50:22,800 PRINCIPLES AND THAT YOU HAVE 1251 00:50:22,800 --> 00:50:24,120 DEMONSTRATED HOW TO PARTNER WITH 1252 00:50:24,120 --> 00:50:26,880 PATIENTS AND PATIENT GROUPS AND 1253 00:50:26,880 --> 00:50:28,200 PLANNING AND DISSEMINATION OF 1254 00:50:28,200 --> 00:50:31,160 RESEARCH IS NOT SOMETHING THAT'S 1255 00:50:31,160 --> 00:50:32,360 REALLY REWARDED. 1256 00:50:32,360 --> 00:50:33,520 CERTAINLY NOT ON PAPER, AND NOT 1257 00:50:33,520 --> 00:50:36,520 IN A LOT OF THE TRADITIONAL 1258 00:50:36,520 --> 00:50:38,600 FUNDING MECHANISMS SO I WONDER 1259 00:50:38,600 --> 00:50:40,560 ABOUT SOME WAY, MAYBE A QUESTION 1260 00:50:40,560 --> 00:50:45,880 AND A COMMENT, SOME WAY TO ADD 1261 00:50:45,880 --> 00:50:48,000 THAT COMPONENT AS PROOF OF 1262 00:50:48,000 --> 00:50:50,280 VIABILITY OR JUST A NEW WAY TO 1263 00:50:50,280 --> 00:50:53,360 THINK ABOUT THAT SKILL SET AND 1264 00:50:53,360 --> 00:50:57,400 HONOR IT BECAUSE WE PUSH SO HARD 1265 00:50:57,400 --> 00:51:00,400 AND WE COMPASSIONATE RESEARCHERS 1266 00:51:00,400 --> 00:51:02,000 ARE ALMOST DOING IT TANGENTALLY, 1267 00:51:02,000 --> 00:51:03,320 IT'S SOMETHING THEY HAVE TO GO 1268 00:51:03,320 --> 00:51:07,480 OUT MUCH HERE WAY TO -- OUT OF 1269 00:51:07,480 --> 00:51:09,440 THEIR WAY TO DO, SO IF IT WAS 1270 00:51:09,440 --> 00:51:11,240 EMBEDDED IT WOULD ADVANCE THE 1271 00:51:11,240 --> 00:51:14,080 FIELD OF ENGAGEMENT AND BY 1272 00:51:14,080 --> 00:51:15,480 VIRTUE OF THAT MAKE SCIENCE 1273 00:51:15,480 --> 00:51:16,680 BETTER, THAT'S WHAT ENGAGEMENT 1274 00:51:16,680 --> 00:51:17,880 IS ALL ABOUT. 1275 00:51:17,880 --> 00:51:18,720 JUST A THOUGHT. 1276 00:51:18,720 --> 00:51:20,600 >> YEAH, THAT'S A REALLY 1277 00:51:20,600 --> 00:51:21,600 IMPORTANT TOPIC. 1278 00:51:21,600 --> 00:51:23,160 I'M THINKING WE SHOULD TRY TO 1279 00:51:23,160 --> 00:51:24,440 IDENTIFY MAYBE SOMEONE WHO COULD 1280 00:51:24,440 --> 00:51:27,840 PRESENT AT A FUTURE COUNCIL 1281 00:51:27,840 --> 00:51:29,360 MEETING ON THIS TOPIC BECAUSE, 1282 00:51:29,360 --> 00:51:31,640 YOU KNOW, THE COMMENTS YOU MADE 1283 00:51:31,640 --> 00:51:33,520 WERE VERY SIMILAR TO COMMENTS 1284 00:51:33,520 --> 00:51:35,280 MADE AT THAT RECENT 1285 00:51:35,280 --> 00:51:36,160 CONGRESSIONAL BRIEFING THAT 1286 00:51:36,160 --> 00:51:38,320 FOCUSED ON LUPUS, THE ACTING CEO 1287 00:51:38,320 --> 00:51:40,000 OF THE LUPUS FOUNDATION OF 1288 00:51:40,000 --> 00:51:41,240 AMERICA WAS THERE AND SPOKE TO 1289 00:51:41,240 --> 00:51:42,040 THAT SPECIFIC. 1290 00:51:42,040 --> 00:51:46,200 WHAT I CAN SAY IS THAT 1291 00:51:46,200 --> 00:51:48,000 INCREASINGLY I HEAR DISCUSSION, 1292 00:51:48,000 --> 00:51:48,840 HIGHLIGHTING THE IMPORTANCE, 1293 00:51:48,840 --> 00:51:50,360 CRITICAL IMPORTANCE OF PATIENT 1294 00:51:50,360 --> 00:51:51,920 ENGAGEMENT AND PATIENT 1295 00:51:51,920 --> 00:51:52,760 INVOLVEMENT THROUGHOUT THE 1296 00:51:52,760 --> 00:51:55,840 ENTIRE LIFE CYCLE OF RESEARCH. 1297 00:51:55,840 --> 00:51:57,480 EVERYWHERE I LOOK, NOW EXACTLY 1298 00:51:57,480 --> 00:51:59,360 WHAT'S HAPPENING ON THAT FRONT, 1299 00:51:59,360 --> 00:52:01,200 I'M NOT THE BEST PERSON TO 1300 00:52:01,200 --> 00:52:03,080 OUTLINE BUT, FOR EXAMPLE, ON THE 1301 00:52:03,080 --> 00:52:05,480 CONTEXT OF "HEAL," THE HELPING 1302 00:52:05,480 --> 00:52:07,920 END ADDICTION LONG-TERM PROGRAM, 1303 00:52:07,920 --> 00:52:10,520 PATIENT ENGAGEMENT IS VERY 1304 00:52:10,520 --> 00:52:10,880 IMPORTANT. 1305 00:52:10,880 --> 00:52:12,200 AND I'M JUST TRYING TO THINK. 1306 00:52:12,200 --> 00:52:15,360 THIS IS A GOOD QUESTION FOR DR. 1307 00:52:15,360 --> 00:52:15,640 BYRNES. 1308 00:52:15,640 --> 00:52:17,240 I SUSPECT THAT'S SOMETHING THAT 1309 00:52:17,240 --> 00:52:18,880 IS BEING DISCUSSED IN TERMS OF 1310 00:52:18,880 --> 00:52:23,440 HOW TO INCORPORATE THAT INTO THE 1311 00:52:23,440 --> 00:52:24,120 REVIEW PROCESS. 1312 00:52:24,120 --> 00:52:25,080 THERE'S ALSO DISCUSSION ALONG 1313 00:52:25,080 --> 00:52:26,640 THOSE LINES ABOUT A FUTURE IN 1314 00:52:26,640 --> 00:52:28,360 WHICH CLINICAL TRIALS ARE 1315 00:52:28,360 --> 00:52:29,920 REVIEWED THROUGH A COMPLETELY 1316 00:52:29,920 --> 00:52:36,120 SEPARATE PROCESS INSTEAD OF R01 1317 00:52:36,120 --> 00:52:36,360 PROCESS. 1318 00:52:36,360 --> 00:52:37,680 PATIENT ENGAGEMENT SHOULD 1319 00:52:37,680 --> 00:52:38,840 TRANSLATE INTO MORE SUCCESSFUL 1320 00:52:38,840 --> 00:52:39,600 RESEARCH, RIGHT? 1321 00:52:39,600 --> 00:52:41,600 SO I MEAN THIS SHOULD PAY OFF IN 1322 00:52:41,600 --> 00:52:44,120 THE END BUT HOW DO WE GET FROM 1323 00:52:44,120 --> 00:52:46,000 HERE TO THERE, I'M NOT SURE, AND 1324 00:52:46,000 --> 00:52:48,400 I WOULD INVITE ANY COLLEAGUES OR 1325 00:52:48,400 --> 00:52:50,120 OTHERS WHO KNOW MORE, HAVE 1326 00:52:50,120 --> 00:52:51,120 ADDITIONAL INFORMATION ABOUT 1327 00:52:51,120 --> 00:52:53,200 ACTIVITIES ON THIS FRONT, TO 1328 00:52:53,200 --> 00:52:54,640 SPEAK AT THIS POINT OR ONCE 1329 00:52:54,640 --> 00:52:56,720 AGAIN THIS MIGHT BE A GOOD TOPIC 1330 00:52:56,720 --> 00:52:59,440 FOR A FUTURE COUNCIL MEETING. 1331 00:52:59,440 --> 00:53:00,400 IT LOOKS LIKE -- 1332 00:53:00,400 --> 00:53:02,400 >>I'M NOT AN EXPERT IN THIS BUT 1333 00:53:02,400 --> 00:53:06,560 I THINK IT'S A FANTASTIC IDEA 1334 00:53:06,560 --> 00:53:09,640 AND SOME FUNDING PROPOSALS HAVE 1335 00:53:09,640 --> 00:53:13,480 REQUIRED IT, SOME COMPARATIVE 1336 00:53:13,480 --> 00:53:14,000 EFFECTIVENESS APPLICATIONS 1337 00:53:14,000 --> 00:53:14,800 REQUIRED ENGAGEMENT AND HAVE 1338 00:53:14,800 --> 00:53:16,960 SECTIONS IN THE GRANT REQUIRED 1339 00:53:16,960 --> 00:53:18,720 FOR PATIENT ENGAGEMENT AND 1340 00:53:18,720 --> 00:53:19,240 INPUT. 1341 00:53:19,240 --> 00:53:20,920 IT WOULDN'T WORK FOR EVERY GRANT 1342 00:53:20,920 --> 00:53:22,800 IN NIAMS BUT IT WOULD BE 1343 00:53:22,800 --> 00:53:24,120 INTERESTING TO THINK WHICH ONES 1344 00:53:24,120 --> 00:53:28,880 WHERE THAT MIGHT BE A REQUIRED 1345 00:53:28,880 --> 00:53:30,000 APPENDIX OR ADDITIONAL DOCUMENT 1346 00:53:30,000 --> 00:53:31,520 THAT IS REQUIRED, I THINK IT'S 1347 00:53:31,520 --> 00:53:32,920 AN IMPORTANT TOPIC TO DIG 1348 00:53:32,920 --> 00:53:34,720 FURTHER INTO. 1349 00:53:34,720 --> 00:53:37,000 I CAN ALSO SAY SOME SEARCH 1350 00:53:37,000 --> 00:53:38,840 COMMITTEES AND REVIEW COMMITTEES 1351 00:53:38,840 --> 00:53:42,760 ALSO TYPICALLY NOW HAVE A 1352 00:53:42,760 --> 00:53:44,320 PATIENT OR, YOU KNOW, PUBLIC 1353 00:53:44,320 --> 00:53:47,280 MEMBER TO MAKE SURE THAT VIEW IS 1354 00:53:47,280 --> 00:53:50,400 REPRESENTED, YOU KNOW, AS AN 1355 00:53:50,400 --> 00:53:50,640 EXAMPLE. 1356 00:53:50,640 --> 00:53:52,120 >> VOLUNTEER TO -- I CAN OFFER 1357 00:53:52,120 --> 00:53:54,040 ANY OF MY SORT OF PCORI 1358 00:53:54,040 --> 00:53:55,600 EXPERIENCE, THERE ARE SO MANY 1359 00:53:55,600 --> 00:53:57,560 MODELS TO DRAW FROM NOW WE DON'T 1360 00:53:57,560 --> 00:54:00,560 HAVE TO START FROM SCRATCH. 1361 00:54:00,560 --> 00:54:03,920 >> IT'S SOMETHING THE CLINICAL 1362 00:54:03,920 --> 00:54:05,120 TRIALS WORKING GROUP SHOULD 1363 00:54:05,120 --> 00:54:06,720 INCORPORATE AND STUART, ONE OF 1364 00:54:06,720 --> 00:54:08,160 THE CO-CHAIRS, SO I THINK IT'S 1365 00:54:08,160 --> 00:54:09,360 ON MY LIST OF SOMETHING THAT 1366 00:54:09,360 --> 00:54:13,120 SHOULD BE PART OF THE 1367 00:54:13,120 --> 00:54:13,480 RECOMMENDATIONS. 1368 00:54:13,480 --> 00:54:20,640 WE DO THAT, CERTAINLY ASMC, WE 1369 00:54:20,640 --> 00:54:23,480 TRY TO WRITE IT BUT IT SHOULD BE 1370 00:54:23,480 --> 00:54:25,880 STANDARD PRACTICE NOW. 1371 00:54:25,880 --> 00:54:28,200 I THINK THE INSTITUTE, NIH AS AN 1372 00:54:28,200 --> 00:54:32,080 AGENCY, IS GETTING THERE. 1373 00:54:32,080 --> 00:54:32,400 >> DAVID. 1374 00:54:32,400 --> 00:54:34,280 >> I WAS GOING TO CHANGE GEARS, 1375 00:54:34,280 --> 00:54:37,040 IF SOMEONE HAS A COMMENT ABOUT 1376 00:54:37,040 --> 00:54:39,720 THE PATIENT ENGAGEMENT PLEASE GO 1377 00:54:39,720 --> 00:54:39,920 AHEAD. 1378 00:54:39,920 --> 00:54:40,880 >> I WANTED TO SAY WOULDN'T 1379 00:54:40,880 --> 00:54:45,360 THIS FIT WITH THE PLAN FOR 1380 00:54:45,360 --> 00:54:46,160 ENHANCING DIVERSE PERSPECTIVES 1381 00:54:46,160 --> 00:54:50,480 SOME GRANTS ARE NOW REQUIRING? 1382 00:54:50,480 --> 00:54:53,600 THE PATIENT ENGAGEMENT PIECE? 1383 00:54:53,600 --> 00:54:54,360 WOULD THAT BE DIFFERENT? 1384 00:54:54,360 --> 00:54:57,760 >> I THINK IT'S A LITTLE BIT OF 1385 00:54:57,760 --> 00:54:58,080 BOTH. 1386 00:54:58,080 --> 00:54:59,640 I THINK DIVERSITY NEEDS TO 1387 00:54:59,640 --> 00:55:01,640 HAPPEN IN SO MANY DIFFERENT 1388 00:55:01,640 --> 00:55:02,080 REALMS. 1389 00:55:02,080 --> 00:55:04,160 WHEN I THINK ABOUT BOTH PATIENT 1390 00:55:04,160 --> 00:55:12,120 ENGAGEMENT AND D.E.I. HONESTLY 1391 00:55:12,120 --> 00:55:15,400 THERE ARE EMERGING PRACTICES WE 1392 00:55:15,400 --> 00:55:19,760 WANT TO CODIFY NOT JUST 1393 00:55:19,760 --> 00:55:20,680 EVALUATING PRESENCE OR ABSENCE 1394 00:55:20,680 --> 00:55:22,080 BUT THE QUALITY OF. 1395 00:55:22,080 --> 00:55:24,120 THAT'S ONE OF THE REASONS, ONE 1396 00:55:24,120 --> 00:55:25,680 OF THE THINGS THAT MADE ME WANT 1397 00:55:25,680 --> 00:55:28,200 TO SHARE THAT COMMENT. 1398 00:55:28,200 --> 00:55:29,720 THAT'S ONE POTENTIAL HOME. 1399 00:55:29,720 --> 00:55:34,240 I THINK THERE ARE PROBABLY 1400 00:55:34,240 --> 00:55:34,960 OTHERS AS WELL. 1401 00:55:34,960 --> 00:55:36,320 >> ALSO SOMETIMES CALLED 1402 00:55:36,320 --> 00:55:37,640 COMMUNITY ENGAGEMENT IS ABILITY 1403 00:55:37,640 --> 00:55:39,360 TO REACH OUT TO DIVERSE 1404 00:55:39,360 --> 00:55:41,560 POPULATION AS WELL AS GETTING 1405 00:55:41,560 --> 00:55:42,880 THE PARTICIPANT VOICE. 1406 00:55:42,880 --> 00:55:45,320 SO BOTH THINGS ARE IMPORTANT. 1407 00:55:45,320 --> 00:55:48,640 >> ALSO YOU MIGHT HAVE BEEN 1408 00:55:48,640 --> 00:55:50,120 REFERRING TO, PEDP, I CAN'T 1409 00:55:50,120 --> 00:55:52,080 REMEMBER WHAT THAT STANDS FOR, 1410 00:55:52,080 --> 00:55:55,440 ALSO FOCUSED ON THE DIVERSITY OF 1411 00:55:55,440 --> 00:55:59,200 THE SCIENTIFIC WORKFORCE, ALL 1412 00:55:59,200 --> 00:56:00,400 THESE ASPECTS, WORKFORCE, 1413 00:56:00,400 --> 00:56:01,280 PARTICIPANTS, ENGAGEMENT WITH 1414 00:56:01,280 --> 00:56:03,000 BROADER COMMUNITY. 1415 00:56:03,000 --> 00:56:04,040 YEAH, IT'S COMPLEX BUT I THINK 1416 00:56:04,040 --> 00:56:06,320 THIS WOULD BE A GREAT TOPIC AND 1417 00:56:06,320 --> 00:56:07,960 MAYBE SUZANNE WOULD BE A 1418 00:56:07,960 --> 00:56:09,800 PRESENTER AT A FUTURE COUNCIL 1419 00:56:09,800 --> 00:56:13,520 MEMBER -- THAT WOULD BE GREAT. 1420 00:56:13,520 --> 00:56:13,720 DAVID? 1421 00:56:13,720 --> 00:56:16,120 >> THANK YOU FOR HAVING ME AS 1422 00:56:16,120 --> 00:56:17,520 AN EARLY CAREER INVESTIGATOR. 1423 00:56:17,520 --> 00:56:19,440 IT'S EXCITING TO SHARE MY POINT 1424 00:56:19,440 --> 00:56:20,440 OF VIEW. 1425 00:56:20,440 --> 00:56:23,520 I WANTED TO DISCUSS THE RETREAT 1426 00:56:23,520 --> 00:56:24,920 QUESTIONS YOU ENDED WITH, 1427 00:56:24,920 --> 00:56:27,240 STARTING OUT MY CAREER AND 1428 00:56:27,240 --> 00:56:29,320 HAVING GRANTS BE SORT OF A 1429 00:56:29,320 --> 00:56:31,000 PRESSING QUESTION, HOW ARE YOU 1430 00:56:31,000 --> 00:56:34,240 APPROACHING -- WHAT ARE STEPS 1431 00:56:34,240 --> 00:56:37,960 THAT HAPPEN TO ADDRESS THOSE 1432 00:56:37,960 --> 00:56:39,240 FIXED LIMITS VERSUS 1433 00:56:39,240 --> 00:56:40,160 DISCRETIONARY DECISIONS BY 1434 00:56:40,160 --> 00:56:43,320 PROGRAM DIRECTORS? 1435 00:56:43,320 --> 00:56:45,960 I SEE ADVANTAGES AND 1436 00:56:45,960 --> 00:56:47,920 DISADVANTAGES ABOUT SET RULES, 1437 00:56:47,920 --> 00:56:49,920 OR AD HOC DECISIONS THAT HAPPEN 1438 00:56:49,920 --> 00:56:52,840 WITH EACH GRANT CYCLE, HOW DOES 1439 00:56:52,840 --> 00:56:54,400 IT GET BROACHED? 1440 00:56:54,400 --> 00:56:57,960 EACH SCENARIO IS UNIQUE AND 1441 00:56:57,960 --> 00:56:58,240 DIFFERENT. 1442 00:56:58,240 --> 00:56:59,400 >> ALONG THOSE LINES, WHAT I 1443 00:56:59,400 --> 00:57:01,040 OBSERVED OVER THE LAST COUPLE 1444 00:57:01,040 --> 00:57:03,120 YEARS IN THIS ROLE, OF COURSE MY 1445 00:57:03,120 --> 00:57:04,320 COLLEAGUES ARE WELL AWARE, 1446 00:57:04,320 --> 00:57:05,760 THERE'S A LOT OF VARIATION 1447 00:57:05,760 --> 00:57:06,760 ACROSS THE INSTITUTES AND 1448 00:57:06,760 --> 00:57:07,840 CENTERS ON THEIR APPROACH TO 1449 00:57:07,840 --> 00:57:09,400 THIS ISSUE. 1450 00:57:09,400 --> 00:57:10,840 AND THAT'S SOMETHING THAT IN 1451 00:57:10,840 --> 00:57:13,240 ADDITION TO DEEP DISCUSSION AT 1452 00:57:13,240 --> 00:57:14,840 THE RETREAT WE HAD SEVERAL 1453 00:57:14,840 --> 00:57:15,960 PRESENTATIONS LEADING UP TO THE 1454 00:57:15,960 --> 00:57:19,360 RETREAT TO HEAR FROM OTHER 1455 00:57:19,360 --> 00:57:20,880 INSTITUTES AND CENTERS HOW THEY 1456 00:57:20,880 --> 00:57:22,960 APPROACH THIS. 1457 00:57:22,960 --> 00:57:26,320 DARREN WAS AT NIGMS THAT TAK%S A 1458 00:57:26,320 --> 00:57:28,040 úVERY DIFFERENT APPROACH, AND 1459 00:57:28,040 --> 00:57:29,600 EVERYBODY RECOGNIZED THE SCORE 1460 00:57:29,600 --> 00:57:32,200 THAT COMES OUT OF CSR STUDY 1461 00:57:32,200 --> 00:57:32,960 SECTIONS IS INCREDIBLY IMPORTANT 1462 00:57:32,960 --> 00:57:35,920 AS A REFLECTION OF SOME ASPECT 1463 00:57:35,920 --> 00:57:38,400 OF THE RESEARCH, OF COURSE. 1464 00:57:38,400 --> 00:57:40,120 BUT INSTITUTES AND CENTERS HAVE 1465 00:57:40,120 --> 00:57:42,400 THEIR OWN GOALS, OTHER 1466 00:57:42,400 --> 00:57:44,080 CONSIDERATIONS THAT ARE NOT 1467 00:57:44,080 --> 00:57:45,600 NECESSARILY PART OF THE FOCUS OF 1468 00:57:45,600 --> 00:57:46,160 STUDY SECTIONS. 1469 00:57:46,160 --> 00:57:48,360 SO HOW DO YOU PULL THAT IN AT 1470 00:57:48,360 --> 00:57:52,120 WHAT LEVEL TO WHAT DEGREE BY 1471 00:57:52,120 --> 00:57:53,640 WHOM? 1472 00:57:53,640 --> 00:57:57,240 BUT SOME INSTITUTES HAVE I GUESS 1473 00:57:57,240 --> 00:57:58,320 A RELATIVELY WEAK CORRELATION 1474 00:57:58,320 --> 00:58:01,280 BETWEEN A SCORE FROM STUDY 1475 00:58:01,280 --> 00:58:04,000 SECTION AND THE GRANT, THE 1476 00:58:04,000 --> 00:58:04,200 AWARD. 1477 00:58:04,200 --> 00:58:05,520 SOME INSTITUTES PUBLISH 1478 00:58:05,520 --> 00:58:06,960 PAYLINES, OTHERS DON'T. 1479 00:58:06,960 --> 00:58:08,160 SOME INSTITUTES DON'T PUBLISH 1480 00:58:08,160 --> 00:58:11,280 PAYLINES BUT HAVE INTERNAL 1481 00:58:11,280 --> 00:58:13,280 PAYLINE, SOMETIMES THE PAYLINES 1482 00:58:13,280 --> 00:58:14,200 DIFFER ACCORDING TO PORTFOLIO 1483 00:58:14,200 --> 00:58:17,920 AREAS BECAUSE OF COURSE WHAT'S 1484 00:58:17,920 --> 00:58:24,800 NEEDED AND HOW APPLICATIONS ARE 1485 00:58:24,800 --> 00:58:26,680 FARING IN THE REVIEW PROCESS IS 1486 00:58:26,680 --> 00:58:27,880 NOT THE SAME, ESPECIALLY AS 1487 00:58:27,880 --> 00:58:29,160 BROAD AS NIAMS. 1488 00:58:29,160 --> 00:58:32,360 TO WHAT EXTENT IS THE PAYLINE 1489 00:58:32,360 --> 00:58:35,200 THE DRIVING FOCUS IN FUNDING 1490 00:58:35,200 --> 00:58:37,280 DECISIONS VERSUS SOME OTHER 1491 00:58:37,280 --> 00:58:37,640 CONSIDERATIONS? 1492 00:58:37,640 --> 00:58:38,920 ONE OF THE REASONS THIS HAS 1493 00:58:38,920 --> 00:58:40,240 BECOME SO CRITICALLY IMPORTANT 1494 00:58:40,240 --> 00:58:42,640 TO DISCUSS AT NIAMS IS THE 1495 00:58:42,640 --> 00:58:44,120 FUNDING IS SO TIGHT. 1496 00:58:44,120 --> 00:58:46,440 SO I MEAN BOB AND I REMEMBER THE 1497 00:58:46,440 --> 00:58:47,960 DAYS AS INVESTIGATORS WHEN THE 1498 00:58:47,960 --> 00:58:51,520 PAYLINE WAS A LOT MORE GENEROUS 1499 00:58:51,520 --> 00:58:56,880 THAN 10 PERCENTILE, GOOD DAYS 1500 00:58:56,880 --> 00:58:58,480 BUT WE'RE NOT THERE ANYMORE. 1501 00:58:58,480 --> 00:59:00,360 WE DON'T HAVE A STRAIGHTFORWARD 1502 00:59:00,360 --> 00:59:03,480 WAY JUST TO SECURE MORE FUNDING 1503 00:59:03,480 --> 00:59:05,320 FOR OUR MISSION AREAS, WHICH IS 1504 00:59:05,320 --> 00:59:06,640 WHY PARTNERSHIPS ARE CRITICALLY 1505 00:59:06,640 --> 00:59:09,120 IMPORTANT, RIGHT? 1506 00:59:09,120 --> 00:59:10,360 AND LEVERAGING "HEAL" DOLLARS. 1507 00:59:10,360 --> 00:59:12,320 WHAT WE HAVE BEEN DISCUSSING 1508 00:59:12,320 --> 00:59:15,360 SPECIFICALLY IS WHAT IS THE BEST 1509 00:59:15,360 --> 00:59:18,000 BALANCE TO STRIKE AT NIAMS, AT 1510 00:59:18,000 --> 00:59:22,600 THIS TIME, GIVEN THE FUNDING WE 1511 00:59:22,600 --> 00:59:24,680 HAVE BETWEEN PAYLINE AS THE 1512 00:59:24,680 --> 00:59:26,840 DRIVING FACTOR VERSUS PROGRAM 1513 00:59:26,840 --> 00:59:28,640 DIRECTOR DISCRETION, AND PART OF 1514 00:59:28,640 --> 00:59:31,480 MY THINKING ABOUT THIS IS OUR 1515 00:59:31,480 --> 00:59:32,760 PROGRAM DIRECTORS HAVE 1516 00:59:32,760 --> 00:59:34,800 SCIENTIFIC EXPERTISE AND VERY 1517 00:59:34,800 --> 00:59:36,120 IMPORTANT PERSPECTIVE THAT STUDY 1518 00:59:36,120 --> 00:59:37,760 SECTION MEMBERS DON'T HAVE, THAT 1519 00:59:37,760 --> 00:59:39,560 INDIVIDUAL INVESTIGATORS DON'T 1520 00:59:39,560 --> 00:59:40,520 HAVE, THAT THE INSTITUTE 1521 00:59:40,520 --> 00:59:41,720 DIRECTOR DOESN'T HAVE, THAT'S 1522 00:59:41,720 --> 00:59:43,760 LOOKING AT THE WHOLE PICTURE. 1523 00:59:43,760 --> 00:59:46,400 SO, I WANT TO MAKE SURE WE'RE 1524 00:59:46,400 --> 00:59:48,560 FULLY LEVERAGING THE KNOWLEDGE 1525 00:59:48,560 --> 00:59:49,680 AND PERSPECTIVES THEY HAVE AND 1526 00:59:49,680 --> 00:59:53,040 CAN LOOK TO THEM FOR SOME 1527 00:59:53,040 --> 00:59:53,720 GUIDANCE ABOUT THESE 1528 00:59:53,720 --> 00:59:54,680 APPLICATIONS THAT, YES, OKAY, 1529 00:59:54,680 --> 00:59:57,320 THEY MAY NOT BE WITHIN THIS 1530 00:59:57,320 --> 00:59:59,280 EXTREMELY TIGHT PAYLINE BUT MAY 1531 00:59:59,280 --> 01:00:01,040 BE CRITICALLY IMPORTANT TO FUND 1532 01:00:01,040 --> 01:00:03,000 TO, YOU KNOW, ENSURE MAXIMAL 1533 01:00:03,000 --> 01:00:06,480 PROGRESS ACROSS OUR DISEASE 1534 01:00:06,480 --> 01:00:06,680 AREAS. 1535 01:00:06,680 --> 01:00:07,040 SO -- 1536 01:00:07,040 --> 01:00:08,720 >>IT SOUNDS CHALLENGING TO 1537 01:00:08,720 --> 01:00:10,320 BALANCE THOSE DIFFERENT ASPECTS. 1538 01:00:10,320 --> 01:00:12,520 IS THERE A POSSIBILITY, WHICH 1539 01:00:12,520 --> 01:00:13,800 EVER APPROACH, BALANCED APPROACH 1540 01:00:13,800 --> 01:00:16,680 YOU TAKE, THAT THERE COULD BE AN 1541 01:00:16,680 --> 01:00:17,920 OUTCOMES RESEARCH OR PILOT TO 1542 01:00:17,920 --> 01:00:19,640 LOOK AT WHAT HAPPENS DURING THAT 1543 01:00:19,640 --> 01:00:22,160 PERIOD, WHERE THERE'S PROGRAM 1544 01:00:22,160 --> 01:00:22,800 DIRECTOR DISCRETIONARY GRANTS IF 1545 01:00:22,800 --> 01:00:26,000 THERE'S SOME SORT OF WAY TO LOOK 1546 01:00:26,000 --> 01:00:28,400 AT WHAT OUTCOMES IS, THERE'S A 1547 01:00:28,400 --> 01:00:29,600 DISADVANTAGE, NO MATTER WHAT, 1548 01:00:29,600 --> 01:00:32,040 VERY HARD TO CHOOSE WHAT THE 1549 01:00:32,040 --> 01:00:33,080 OUTCOME WOULD BE, BUT AT LEAST 1550 01:00:33,080 --> 01:00:35,960 THAT MIGHT BE ABLE TO BE A 1551 01:00:35,960 --> 01:00:37,680 METRIC-DRIVEN WAY TO APPROACH A 1552 01:00:37,680 --> 01:00:38,480 DIFFICULT DECISION. 1553 01:00:38,480 --> 01:00:39,760 >> THAT SPEAKS TO I THINK THE 1554 01:00:39,760 --> 01:00:40,880 IMPORTANCE OF BEING AS DATA 1555 01:00:40,880 --> 01:00:43,280 DRIVEN AS POSSIBLE. 1556 01:00:43,280 --> 01:00:44,920 AND WE'RE LOOKING FOR, YOU KNOW, 1557 01:00:44,920 --> 01:00:46,760 WHAT DATA CAN WE LOOK TO THAT 1558 01:00:46,760 --> 01:00:50,520 CAN INFORM THIS AND WHAT CAN WE 1559 01:00:50,520 --> 01:00:52,600 FOLLOW, AND THIS GETS AT THE 1560 01:00:52,600 --> 01:00:53,720 ISSUE OF COMMUNICATION. 1561 01:00:53,720 --> 01:00:57,320 SO, YOU KNOW, WE WANT TO ENGAGE 1562 01:00:57,320 --> 01:00:58,800 THE BROADER COMMUNITY TO THE 1563 01:00:58,800 --> 01:01:00,240 EXTENT THEY UNDERSTAND WHAT 1564 01:01:00,240 --> 01:01:01,640 WE'RE THINKING, WHAT WE'RE 1565 01:01:01,640 --> 01:01:02,520 CONCERNED ABOUT, WHAT OUR 1566 01:01:02,520 --> 01:01:03,560 RATIONALE IS FOR CONSIDERING 1567 01:01:03,560 --> 01:01:03,960 SOME THINGS. 1568 01:01:03,960 --> 01:01:07,120 WE MAY NOT GET IT RIGHT. 1569 01:01:07,120 --> 01:01:09,520 AND THIS IS A DYNAMIC SITUATION. 1570 01:01:09,520 --> 01:01:10,560 WHAT'S BEST FOR TODAY MIGHT NOT 1571 01:01:10,560 --> 01:01:12,160 BE THE SAME AS WHAT'S BEST FOR 1572 01:01:12,160 --> 01:01:12,720 FIVE YEARS. 1573 01:01:12,720 --> 01:01:14,480 SO WE NEED TO FOLLOW THIS 1574 01:01:14,480 --> 01:01:19,360 CLOSELY AND WE CAN LOOK BROADLY, 1575 01:01:19,360 --> 01:01:21,040 LOOK WITHIN PORTFOLIO. 1576 01:01:21,040 --> 01:01:22,760 WE'D LIKE TO SEE IMPACT IN TERMS 1577 01:01:22,760 --> 01:01:24,360 OF QUALITY OF SCIENCE, 1578 01:01:24,360 --> 01:01:26,520 TRANSLATION TO CLINICAL MEDICINE 1579 01:01:26,520 --> 01:01:27,920 AND SCIENTIFIC WORKFORCE. 1580 01:01:27,920 --> 01:01:30,080 ALSO IN THE MIX OF COURSE IS 1581 01:01:30,080 --> 01:01:31,080 THIS NOTION OF CAPPING, IF YOU 1582 01:01:31,080 --> 01:01:33,400 WANT TO CONSIDER IT THAT WAY. 1583 01:01:33,400 --> 01:01:35,240 BUT BALANCING, YOU KNOW, 1584 01:01:35,240 --> 01:01:37,040 CONCENTRATING RESOURCES BECAUSE 1585 01:01:37,040 --> 01:01:38,440 WE'RE NOT CONCERNED -- WE'RE 1586 01:01:38,440 --> 01:01:40,080 CONCERNED NOT ONLY SCIENCE BUT 1587 01:01:40,080 --> 01:01:41,160 SCIENTIFIC WORKFORCE. 1588 01:01:41,160 --> 01:01:43,960 IF WE PUT ALL OUR MONEY INTO THE 1589 01:01:43,960 --> 01:01:45,480 PERCEIVED TO BE BEST SCIENTIST 1590 01:01:45,480 --> 01:01:53,400 THERE WON'T BE ANY SIGH SCIENCF 1591 01:01:53,400 --> 01:01:54,040 THE FUTURE. 1592 01:01:54,040 --> 01:01:56,160 WE NEED TO STRIKE A BALANCE. 1593 01:01:56,160 --> 01:01:57,400 >> ONE THING TOWARD YOUR 1594 01:01:57,400 --> 01:01:59,360 QUESTION, DAVID, THAT IS THAT 1595 01:01:59,360 --> 01:02:00,800 THE PROGRAM DIRECTORS, THERE'S 1596 01:02:00,800 --> 01:02:03,320 NOT ONE PROGRAM DIRECTOR MAKING 1597 01:02:03,320 --> 01:02:04,200 THAT DECISION. 1598 01:02:04,200 --> 01:02:06,040 THEY WORK IN TEAMS. 1599 01:02:06,040 --> 01:02:09,000 AND THEY DISCUSS IT WITH EACH 1600 01:02:09,000 --> 01:02:10,120 OTHER, THEY GO THROUGH THEIR 1601 01:02:10,120 --> 01:02:13,520 KNOWLEDGE OF WHERE THINGS ARE IN 1602 01:02:13,520 --> 01:02:13,800 THE FIELD. 1603 01:02:13,800 --> 01:02:15,040 IT'S NOT REALLY JUST, YOU KNOW, 1604 01:02:15,040 --> 01:02:17,000 I KNOW THIS PERSON AND THEY ARE 1605 01:02:17,000 --> 01:02:19,520 GOING TO GET MY GRANT FUNDED 1606 01:02:19,520 --> 01:02:20,280 TYPE THING. 1607 01:02:20,280 --> 01:02:23,480 SO, IT'S A DECISION THAT'S MADE 1608 01:02:23,480 --> 01:02:25,880 BASED ON CRITERIA, AND A LOT 1609 01:02:25,880 --> 01:02:26,880 MORE INFORMATION THAN JUST 1610 01:02:26,880 --> 01:02:29,600 WHAT'S IN THE SUMMARY STATEMENT. 1611 01:02:29,600 --> 01:02:32,560 >> I WASN'T SUGGESTING. 1612 01:02:32,560 --> 01:02:34,760 I WAS THINK FIGURE THERE'S A 1613 01:02:34,760 --> 01:02:37,600 SUBJECTIVE COMPONENT EVEN IN A 1614 01:02:37,600 --> 01:02:38,480 VOTING AMONG PROGRAM DIRECTORS 1615 01:02:38,480 --> 01:02:40,200 THERE'S STILL TWO ROUTES THAT 1616 01:02:40,200 --> 01:02:42,640 COULD OCCUR, THERE COULD BE SOME 1617 01:02:42,640 --> 01:02:44,240 OUTCOME OF THIS SUBJECTIVE 1618 01:02:44,240 --> 01:02:47,120 DECISION AMONG THE PROGRAM 1619 01:02:47,120 --> 01:02:50,680 DIRECTORS THAT OCCURS VERSUS THE 1620 01:02:50,680 --> 01:02:51,640 QUANTITATIVE CSR SYSTEM THAT'S 1621 01:02:51,640 --> 01:02:51,840 USED. 1622 01:02:51,840 --> 01:02:54,680 AND TO LOOK AT THE OUTCOMES 1623 01:02:54,680 --> 01:02:57,240 HOWEVER THEY MAY BE, NOT JUST IN 1624 01:02:57,240 --> 01:02:58,520 TERMS OF PUBLICATION OUTPUT, 1625 01:02:58,520 --> 01:03:00,920 MISSION DRIVEN, HOW IT AFFECTS 1626 01:03:00,920 --> 01:03:01,840 EARLY-STAGE INVESTIGATORS, 1627 01:03:01,840 --> 01:03:05,200 DIVERSITY OF THE WORK, SOMETHING 1628 01:03:05,200 --> 01:03:06,800 THAT'S COMPLEX, I UNDERSTAND. 1629 01:03:06,800 --> 01:03:08,120 >> TWO COMMENTS AND I WANT TO 1630 01:03:08,120 --> 01:03:09,560 HEAR FROM MARY. 1631 01:03:09,560 --> 01:03:11,000 PORTFOLIO ANALYSIS IS A TOOL WE 1632 01:03:11,000 --> 01:03:13,080 THINK IS GOING TO BE VERY 1633 01:03:13,080 --> 01:03:17,240 VALUABLE, AND ALSO A LOT OF 1634 01:03:17,240 --> 01:03:18,240 INSTITUTES CONNECT VERY STRONGLY 1635 01:03:18,240 --> 01:03:20,200 THEIR STRATEGIC PLAN AND THEIR 1636 01:03:20,200 --> 01:03:21,960 GOALS WITH THEIR FUNDING 1637 01:03:21,960 --> 01:03:23,600 DECISIONS. 1638 01:03:23,600 --> 01:03:25,880 AS YOU'LL HEAR FROM DR. BURROWS 1639 01:03:25,880 --> 01:03:28,640 WE ALMOST A YEAR INTO THE 1640 01:03:28,640 --> 01:03:30,320 STRATEGIC PLANNING PROCESS. 1641 01:03:30,320 --> 01:03:30,520 MARY? 1642 01:03:30,520 --> 01:03:31,560 >> MUCH OF WHAT I WAS GOING TO 1643 01:03:31,560 --> 01:03:34,080 SAY HAS BEEN SAID. 1644 01:03:34,080 --> 01:03:35,720 I THINK HAVING -- IF YOU'RE 1645 01:03:35,720 --> 01:03:38,200 GOING TO CHANGE THE WAY, WE KNOW 1646 01:03:38,200 --> 01:03:40,440 OUR COMMUNITY, THAT WILL BE 1647 01:03:40,440 --> 01:03:43,600 UPSETTING TO SOME, AND WELCOME 1648 01:03:43,600 --> 01:03:45,680 TO OTHERS. 1649 01:03:45,680 --> 01:03:49,840 BUT I THINK HAVING THIS AND 1650 01:03:49,840 --> 01:03:52,160 ARTICULATING WHAT YOU DEFINE AS 1651 01:03:52,160 --> 01:03:54,160 SUCCESS AND AS A BETTER OUTCOME 1652 01:03:54,160 --> 01:03:56,080 WILL BE REALLY IMPORTANT FOR THE 1653 01:03:56,080 --> 01:03:59,240 COMMUNITY TO BUY IN, IF THE 1654 01:03:59,240 --> 01:04:00,040 APPROACH IS CHANGED. 1655 01:04:00,040 --> 01:04:01,000 SO I THINK -- I DON'T THINK 1656 01:04:01,000 --> 01:04:03,640 THERE'S AN EASY ANSWER. 1657 01:04:03,640 --> 01:04:08,520 YOU'VE ARTICULATED AND GAIL DID, 1658 01:04:08,520 --> 01:04:10,600 WHAT THE OUTCOME WOULD BE. 1659 01:04:10,600 --> 01:04:12,440 WHAT YOU KNOW AND HAVE PUBLISHED 1660 01:04:12,440 --> 01:04:14,560 AS STRATEGIC MISSION AND PLAN 1661 01:04:14,560 --> 01:04:16,840 WILL BE REALLY IMPORTANT. 1662 01:04:16,840 --> 01:04:17,280 >> THANK YOU. 1663 01:04:17,280 --> 01:04:19,280 >> I HAVE OTHER COMMENTS BUT 1664 01:04:19,280 --> 01:04:20,800 WE'LL STAY ON THIS. 1665 01:04:20,800 --> 01:04:21,080 >> ELLEN? 1666 01:04:21,080 --> 01:04:22,200 >> THANK YOU. 1667 01:04:22,200 --> 01:04:23,840 DAVID IS ASKING TWO DIFFERENT 1668 01:04:23,840 --> 01:04:24,280 QUESTIONS. 1669 01:04:24,280 --> 01:04:26,200 THE FIRST ONE IS CAN WE ASSESS 1670 01:04:26,200 --> 01:04:27,800 THE OUTCOMES IF WE CHANGE THE 1671 01:04:27,800 --> 01:04:28,880 WAY WE DO THINGS, AND THE OTHER 1672 01:04:28,880 --> 01:04:30,880 IS WHAT ARE THE CRITERIA THAT 1673 01:04:30,880 --> 01:04:33,160 ARE BEING USED BY THE PROGRAM 1674 01:04:33,160 --> 01:04:33,440 OFFICERS. 1675 01:04:33,440 --> 01:04:34,680 GAIL, YOU MENTIONED THERE ARE 1676 01:04:34,680 --> 01:04:35,080 CRITERIA. 1677 01:04:35,080 --> 01:04:38,200 ARE THOSE PUBLISHED CRITERIA OR 1678 01:04:38,200 --> 01:04:39,720 ARE THEY LOOSE? 1679 01:04:39,720 --> 01:04:41,240 >> NO, THEY ARE RELATIVELY 1680 01:04:41,240 --> 01:04:42,760 LOOSE AT THIS POINT, ELLEN, 1681 01:04:42,760 --> 01:04:45,320 BECAUSE THEY VARY FROM DISEASE 1682 01:04:45,320 --> 01:04:47,760 STATE TO DISEASE AREA FROM ONE 1683 01:04:47,760 --> 01:04:49,640 TO ANOTHER BECAUSE OF THE 1684 01:04:49,640 --> 01:04:51,320 RELATIVE DIFFERENCES IN 1685 01:04:51,320 --> 01:04:53,600 DEVELOPMENT OF RESEARCH AND 1686 01:04:53,600 --> 01:04:55,440 DIFFERENT CLINICAL AREAS. 1687 01:04:55,440 --> 01:04:59,880 SO, I WOULDN'T SAY EACH OF THE 1688 01:04:59,880 --> 01:05:01,240 PROGRAMMATIC TEAMS USES 1689 01:05:01,240 --> 01:05:04,120 IDENTICAL BALANCE OF THESE 1690 01:05:04,120 --> 01:05:06,080 CRITERIA, BUT THEY ARE PRETTY 1691 01:05:06,080 --> 01:05:07,400 OBVIOUS CRITERIA, SIMILAR TO 1692 01:05:07,400 --> 01:05:11,880 WHAT YOU WOULD SEE IN A CSR TYPE 1693 01:05:11,880 --> 01:05:15,720 REVIEW, BUT FOCUSED IN PORTFOLIO 1694 01:05:15,720 --> 01:05:19,560 BALANCE, AND THAT'S A VERY LARGE 1695 01:05:19,560 --> 01:05:20,160 PORTION OF IT. 1696 01:05:20,160 --> 01:05:20,960 >> THAT'S ANOTHER COMMUNICATION 1697 01:05:20,960 --> 01:05:24,280 I WANT TO ADD, THAT'S ANOTHER 1698 01:05:24,280 --> 01:05:26,200 COMMUNICATION PIECE ABOUT HOW 1699 01:05:26,200 --> 01:05:28,680 TRANSPARENT SHOULD WE BE. 1700 01:05:28,680 --> 01:05:33,800 THE CRITERIA INCLUDE THINGS LIKE 1701 01:05:33,800 --> 01:05:36,120 EARLY-STAGE INVESTIGATOR, AN 1702 01:05:36,120 --> 01:05:37,400 IMPORTANT GAP OR OPPORTUNITY 1703 01:05:37,400 --> 01:05:39,480 AREA WITHIN NIAMS MISSION WHICH 1704 01:05:39,480 --> 01:05:42,760 IS NOT SOMETHING THAT CSR STUDY 1705 01:05:42,760 --> 01:05:46,040 SECTION MEMBERS ARE CONSIDERING. 1706 01:05:46,040 --> 01:05:49,240 THERE IS -- WOULD FUNDING THIS 1707 01:05:49,240 --> 01:05:52,280 APPLICATION ENHANCE THE 1708 01:05:52,280 --> 01:05:52,960 DIVERSITY OF PERSPECTIVES 1709 01:05:52,960 --> 01:05:54,120 REPRESENTED IN THE RESEARCH 1710 01:05:54,120 --> 01:05:56,160 WORKFORCE OR IN TERMS OF 1711 01:05:56,160 --> 01:05:58,840 RESEARCH OUTPUT, MY COLLEAGUES 1712 01:05:58,840 --> 01:06:03,760 BEHIND ME CAN HELP ADD TO THESE 1713 01:06:03,760 --> 01:06:04,080 ALSO. 1714 01:06:04,080 --> 01:06:07,840 THE NOTION OF HARDSHIP IS A 1715 01:06:07,840 --> 01:06:10,920 REALLY TOUGH ONE, BUT, YOU KNOW, 1716 01:06:10,920 --> 01:06:14,920 IF THERE'S CONVINCING EVIDENCE 1717 01:06:14,920 --> 01:06:16,480 THAT THIS HIGHLY PROMISING OR 1718 01:06:16,480 --> 01:06:17,640 IMPORTANT INVESTIGATOR IS ABOUT 1719 01:06:17,640 --> 01:06:22,720 TO LOSE THEIR LAB, THAT CAN BE 1720 01:06:22,720 --> 01:06:23,000 CONSIDERED. 1721 01:06:23,000 --> 01:06:24,520 SO, YES, HOW THEY ARE WEIGHTED, 1722 01:06:24,520 --> 01:06:26,360 THE POINT GAYLE WAS MAKING HOW 1723 01:06:26,360 --> 01:06:28,840 THEY ARE WEIGHTED FOR INDIVIDUAL 1724 01:06:28,840 --> 01:06:29,600 APPLICATIONS MIGHT DIFFER. 1725 01:06:29,600 --> 01:06:31,440 I WANT TO LOOK TO MY COLLEAGUES 1726 01:06:31,440 --> 01:06:33,040 BACK HERE. 1727 01:06:33,040 --> 01:06:35,360 DOES ANYBODY WANT TO ADD TO 1728 01:06:35,360 --> 01:06:35,560 THAT? 1729 01:06:35,560 --> 01:06:37,120 SOME OF THE THINGS THAT YOU WERE 1730 01:06:37,120 --> 01:06:38,640 FACTORING IN, YOU DON'T HAVE TO, 1731 01:06:38,640 --> 01:06:41,000 BUT IN TERMS OF, YOU KNOW, 1732 01:06:41,000 --> 01:06:50,760 MAKING THESE AT THE CURRENT TIME 1733 01:06:50,760 --> 01:06:51,240 SELECT PAY DECISIONS. 1734 01:06:51,240 --> 01:06:55,360 >> I DO THINK YOU SAID IT VERY 1735 01:06:55,360 --> 01:06:56,120 WELL, LINDSEY. 1736 01:06:56,120 --> 01:06:57,920 I THINK THE -- YOU KNOW, WE'RE 1737 01:06:57,920 --> 01:06:59,200 GOING TO EVALUATE THIS. 1738 01:06:59,200 --> 01:07:00,840 THIS IS OUR FIRST ROUND OF 1739 01:07:00,840 --> 01:07:01,200 THESE. 1740 01:07:01,200 --> 01:07:03,040 AND SO WE'RE GOING TO BE GOING 1741 01:07:03,040 --> 01:07:05,920 BACK AND LOOKING AT THESE 1742 01:07:05,920 --> 01:07:07,640 DECISIONS AND TRYING TO IMPROVE 1743 01:07:07,640 --> 01:07:08,800 OUR PROCESS FOR THIS. 1744 01:07:08,800 --> 01:07:10,920 AND CERTAINLY WE WOULD TRY TO 1745 01:07:10,920 --> 01:07:12,360 PUT SOMETHING ON THE WEBSITE IF 1746 01:07:12,360 --> 01:07:15,880 IT SEEMS LIKE IT'S QUANTIFIABLE. 1747 01:07:15,880 --> 01:07:19,800 BUT THESE DECISIONS HAVE TO BE A 1748 01:07:19,800 --> 01:07:21,000 LITTLE BIT FLUID, DEPENDING ON 1749 01:07:21,000 --> 01:07:23,800 THE AMOUNT OF FUNDS WE HAVE, AND 1750 01:07:23,800 --> 01:07:27,600 HOW WE CAN PARTNER WITH OTHER 1751 01:07:27,600 --> 01:07:29,680 INSTITUTES AND OFFICES TO GET 1752 01:07:29,680 --> 01:07:31,960 FUNDING TO BE ABLE TO SUPPORT AN 1753 01:07:31,960 --> 01:07:32,320 APPLICATION. 1754 01:07:32,320 --> 01:07:36,320 SO WE LOOK AT A LOT OF DIFFERENT 1755 01:07:36,320 --> 01:07:36,640 ASPECTS HERE. 1756 01:07:36,640 --> 01:07:37,800 >> MARIA? 1757 01:07:37,800 --> 01:07:39,400 YEAH, OKAY, GREAT. 1758 01:07:39,400 --> 01:07:40,240 MARIA? 1759 01:07:40,240 --> 01:07:42,680 >>I WAS WONDERING HOWS THEY 1760 01:07:42,680 --> 01:07:48,120 GOING TO BE OPERATIONALIZED WITH 1761 01:07:48,120 --> 01:07:49,840 RESPECT TO THE BUDGET, JUST, YOU 1762 01:07:49,840 --> 01:07:53,560 KNOW, TIME BY TIME YOU'LL SEE 1763 01:07:53,560 --> 01:07:54,240 THERE'S A MERITORIOUS 1764 01:07:54,240 --> 01:07:56,320 APPLICATION THAT FALLS UNDER 1765 01:07:56,320 --> 01:07:57,480 THOSE CHARACTERISTICS OR IT'S 1766 01:07:57,480 --> 01:08:00,000 GOING TO BE MORE RIGIDLY SET, 1767 01:08:00,000 --> 01:08:01,880 FOR INSTANCE 10% OF THE BUDGET 1768 01:08:01,880 --> 01:08:05,240 IS GOING TO GO TO APPLICATIONS 1769 01:08:05,240 --> 01:08:09,640 THAT I THINK WE NEED TO REVIEW? 1770 01:08:09,640 --> 01:08:11,760 >> FIRST ONE OF THE THINGS THAT 1771 01:08:11,760 --> 01:08:16,800 HAS BEEN OF CONCERN TO ME 1772 01:08:16,800 --> 01:08:20,120 RELATED TO THE TIGHT BUDGET AND 1773 01:08:20,120 --> 01:08:21,080 PAYLINE AND UNCERTAINTIES IS 1774 01:08:21,080 --> 01:08:22,560 INVESTIGATORS WHO, YOU KNOW, 1775 01:08:22,560 --> 01:08:23,880 EARLY IN THE YEAR, HOWEVER YOU 1776 01:08:23,880 --> 01:08:25,720 WANT TO DEFINE THIS, GET A SCORE 1777 01:08:25,720 --> 01:08:27,320 THAT, YOU KNOW, THEY THINK IS 1778 01:08:27,320 --> 01:08:28,840 VERY CLOSE TO THE PAYLINE BUT 1779 01:08:28,840 --> 01:08:30,280 MAY NOT MAKE IT. 1780 01:08:30,280 --> 01:08:32,200 YOU KNOW, THEY HAVE TO DECIDE 1781 01:08:32,200 --> 01:08:34,040 ARE THEY GOING TO SPEND A TON OF 1782 01:08:34,040 --> 01:08:37,360 EXTRA TIME AND SUBMIT A REVISED 1783 01:08:37,360 --> 01:08:41,600 APPLICATION JUST AS A BACKUP, OR 1784 01:08:41,600 --> 01:08:43,400 ARE THEY ABLE TO WAIT AND HEAR 1785 01:08:43,400 --> 01:08:45,240 IF THAT APPLICATION GETS FUNDED? 1786 01:08:45,240 --> 01:08:47,280 HERE IS WHERE EARLY CAREER 1787 01:08:47,280 --> 01:08:48,800 INVESTIGATORS, THAT'S A CRITICAL 1788 01:08:48,800 --> 01:08:50,320 ISSUE. 1789 01:08:50,320 --> 01:08:52,440 AND I -- YOU KNOW, I AM 1790 01:08:52,440 --> 01:08:54,440 DISCOURAGED AT THE NOTION OF 1791 01:08:54,440 --> 01:08:57,600 INVESTIGATORS SPENDING A LOT OF 1792 01:08:57,600 --> 01:08:58,280 TIME RESUBMITTING APPLICATIONS 1793 01:08:58,280 --> 01:09:00,400 JUST TO COVER THEIR BASES. 1794 01:09:00,400 --> 01:09:02,840 FOR THAT REASON, WE'RE ALSO 1795 01:09:02,840 --> 01:09:04,320 TRYING TO FACILITATE MAKING SOME 1796 01:09:04,320 --> 01:09:05,520 OF THESE DECISIONS THROUGHOUT 1797 01:09:05,520 --> 01:09:07,080 THE FISCAL YEAR INSTEAD OF 1798 01:09:07,080 --> 01:09:09,680 WAITING TILL THE VERY END OF THE 1799 01:09:09,680 --> 01:09:11,000 YEAR WHEN WE FINALLY KNOW, OKAY, 1800 01:09:11,000 --> 01:09:13,000 THIS IS HOW MUCH MONEY WE HAVE. 1801 01:09:13,000 --> 01:09:14,600 BECAUSE WE CAN'T PUT ANY MONEY 1802 01:09:14,600 --> 01:09:19,200 ASIDE AND USE IT NEXT YEAR. 1803 01:09:19,200 --> 01:09:22,760 WE HAVE TO SPEND TO THE DOLLAR, 1804 01:09:22,760 --> 01:09:24,240 IT'S A STRESSFUL TIME OF YEAR. 1805 01:09:24,240 --> 01:09:25,920 WE HAVE TO GET THIS RIGHT. 1806 01:09:25,920 --> 01:09:27,240 IN SOME RESPECTS THE EASIEST 1807 01:09:27,240 --> 01:09:28,440 THING IS WAIT TILL THE END OF 1808 01:09:28,440 --> 01:09:30,600 THE YEAR AND ALL THE EXTRA MONEY 1809 01:09:30,600 --> 01:09:34,240 AND YOU MAKE A ZILLION AWARDS 1810 01:09:34,240 --> 01:09:37,640 BUT THAT DOESN'T MAKE ANYBODY 1811 01:09:37,640 --> 01:09:39,840 HAPPY. 1812 01:09:39,840 --> 01:09:41,240 WE'RE TRYING TO SYSTEMATIZE AND 1813 01:09:41,240 --> 01:09:42,120 HAVE CERTAIN TIMES DURING THE 1814 01:09:42,120 --> 01:09:46,960 YEAR WHEN WE CAN MAKE SOME OF 1815 01:09:46,960 --> 01:09:48,120 THESE SELECT PAY DECISIONS. 1816 01:09:48,120 --> 01:09:49,360 THE OTHER PART OF THE QUESTION 1817 01:09:49,360 --> 01:09:50,640 IS THE BALANCE, RIGHT? 1818 01:09:50,640 --> 01:09:52,720 HOW MUCH OF OUR BUDGET SHOULD 1819 01:09:52,720 --> 01:09:56,440 GO, THAT WE CAN DIRECT TOWARDS 1820 01:09:56,440 --> 01:09:57,840 THESE RESEARCH PROGRAM GRANTS, 1821 01:09:57,840 --> 01:10:01,840 COULD GO TO -- SHOULD GO TO THE 1822 01:10:01,840 --> 01:10:03,120 STRAIGHT PAYLINE VERSUS 1823 01:10:03,120 --> 01:10:04,240 DISCRETIONARY. 1824 01:10:04,240 --> 01:10:07,000 IN THIS PAST YEAR, WHEN WE'RE 1825 01:10:07,000 --> 01:10:08,280 THINKING MORE CAREFULLY ABOUT 1826 01:10:08,280 --> 01:10:12,760 SELECT PAY, ABOUT 10% OF OUR 1827 01:10:12,760 --> 01:10:14,600 BUDGET WAS USED TO NOMINATE 1828 01:10:14,600 --> 01:10:18,600 GRANTS APPLICATIONS THAT WERE 1829 01:10:18,600 --> 01:10:20,200 HIGHLY MERITORIOUS BUT HAVE NOT 1830 01:10:20,200 --> 01:10:21,400 MADE THE PAYLINE. 1831 01:10:21,400 --> 01:10:23,720 IS THAT THE RIGHT BALANCE OR 1832 01:10:23,720 --> 01:10:25,160 SHOULD WE SHIFT THINGS? 1833 01:10:25,160 --> 01:10:26,360 >> AN UNWANTED CONSEQUENCE MAY 1834 01:10:26,360 --> 01:10:28,960 BE THE PAYLINE GETS WORSE, 1835 01:10:28,960 --> 01:10:30,840 DEDICATING AN AMOUNT DO THAT. 1836 01:10:30,840 --> 01:10:32,840 >> I'M GLAD YOU SAID THAT. 1837 01:10:32,840 --> 01:10:34,320 THAT RAISES AN IMPORTANT 1838 01:10:34,320 --> 01:10:35,800 DISTINCTION BETWEEN PAYLINE AND 1839 01:10:35,800 --> 01:10:37,040 SUCCESS RATE. 1840 01:10:37,040 --> 01:10:42,760 SO, ALL ELSE BEING EQUAL, IF WE 1841 01:10:42,760 --> 01:10:47,840 SHIFT THE PAYLINE, IF WE MAKE IT 1842 01:10:47,840 --> 01:10:51,320 TIGHTER, AND SHIFT THOSE DOLLARS 1843 01:10:51,320 --> 01:10:52,600 TO MORE DISCRETIONARY DECISIONS 1844 01:10:52,600 --> 01:10:54,280 THE SUCCESS RATE DOESN'T CHANGE. 1845 01:10:54,280 --> 01:10:55,720 THE SUCCESS RATE STAYS THE SAME. 1846 01:10:55,720 --> 01:10:58,840 THIS IS A REALLY, REALLY 1847 01:10:58,840 --> 01:10:59,200 IMPORTANT POINT. 1848 01:10:59,200 --> 01:11:01,400 I WANT MANY OPPORTUNITIES TO 1849 01:11:01,400 --> 01:11:04,960 SHOW THIS GRAPH WHERE WE CAN 1850 01:11:04,960 --> 01:11:08,240 SHOW IF YOU PUT 10% OF YOUR 1851 01:11:08,240 --> 01:11:09,640 TOTAL RPG BUDGET TO 1852 01:11:09,640 --> 01:11:11,320 DISCRETIONARY, WHAT IS THE 1853 01:11:11,320 --> 01:11:11,560 PAYLINE? 1854 01:11:11,560 --> 01:11:13,880 IF YOU PUT 20 OR 30, WHAT IS THE 1855 01:11:13,880 --> 01:11:14,160 PAYLINE? 1856 01:11:14,160 --> 01:11:16,880 THE SUCCESS RIGHT, ALL ELSE 1857 01:11:16,880 --> 01:11:18,520 BEING EQUAL, STAYS EXACTLY THE 1858 01:11:18,520 --> 01:11:20,920 SAME, SO WE HAVE TO START 1859 01:11:20,920 --> 01:11:22,480 TALKING ABOUT -- KEEP IN MIND 1860 01:11:22,480 --> 01:11:24,560 NOT ALL INSTITUTES HAVE 1861 01:11:24,560 --> 01:11:26,920 PAYLINES, THEY DON'T PUBLISH 1862 01:11:26,920 --> 01:11:27,360 THEM. 1863 01:11:27,360 --> 01:11:28,800 SUCCESS RATE IS A MORE IMPORTANT 1864 01:11:28,800 --> 01:11:29,040 METRIC. 1865 01:11:29,040 --> 01:11:31,120 THAT'S GOING TO BE A HARD THING 1866 01:11:31,120 --> 01:11:32,880 FOR PEOPLE TO GET OVER, I CAN 1867 01:11:32,880 --> 01:11:35,800 TELL BY THE LOOK ON YOUR FACE. 1868 01:11:35,800 --> 01:11:37,360 >> HOPE TO SOME DEGREE IT 1869 01:11:37,360 --> 01:11:40,640 REMAINS THE SAME FOR THE PAYLINE 1870 01:11:40,640 --> 01:11:42,400 BUT THERE'S AN INCREASING RATE 1871 01:11:42,400 --> 01:11:44,480 THROUGH THESE ONES FUNDED 1872 01:11:44,480 --> 01:11:50,120 BECAUSE THEY ARE MERITORIOUS. 1873 01:11:50,120 --> 01:11:51,280 >>THAT'S WHERE PARTNERSHIPS AND 1874 01:11:51,280 --> 01:11:53,400 FUNDING THAT GAYLE ALLUDED TO, 1875 01:11:53,400 --> 01:11:55,200 THAT'S WHERE, YOU KNOW, THAT 1876 01:11:55,200 --> 01:11:56,160 COMES IN. 1877 01:11:56,160 --> 01:11:56,720 YEAH, ANN? 1878 01:11:56,720 --> 01:11:58,880 >> THIS IS SUCH AN IMPORTANT 1879 01:11:58,880 --> 01:11:59,480 DISCUSSION. 1880 01:11:59,480 --> 01:12:02,760 THANK YOU FOR BROADENING IT OUT. 1881 01:12:02,760 --> 01:12:04,120 THE SCIENTIFIC SOCIETIES NEED TO 1882 01:12:04,120 --> 01:12:06,200 BE ENGAGED IN THIS AS WELL, 1883 01:12:06,200 --> 01:12:09,520 HAVING LIVED IN THAT WORLD FOR 1884 01:12:09,520 --> 01:12:11,640 SO MANY YEARS. 1885 01:12:11,640 --> 01:12:12,480 SCIENTIFIC SOCIETIES ARE DEALING 1886 01:12:12,480 --> 01:12:14,200 WITH WHERE THE GAPS ARE THAT 1887 01:12:14,200 --> 01:12:15,680 THEY SEE THAT AREN'T GETTING 1888 01:12:15,680 --> 01:12:17,760 FUNDED BECAUSE OF THE PAY LINE, 1889 01:12:17,760 --> 01:12:20,480 TRYING TO COME UP WITH THEIR OWN 1890 01:12:20,480 --> 01:12:22,080 FUNDING MECHANISMS, THERE MIGHT 1891 01:12:22,080 --> 01:12:23,360 BE OPPORTUNITIES FOR PARTNERSHIP 1892 01:12:23,360 --> 01:12:25,520 BUT MORE IMPORTANTLY RIGHT NOW 1893 01:12:25,520 --> 01:12:26,680 IS THE COMMUNICATION ABOUT WHAT 1894 01:12:26,680 --> 01:12:32,520 ARE THE CRITERIA THAT ARE BEING 1895 01:12:32,520 --> 01:12:36,440 USED SO THAT PEOPLE -- YOU KNOW, 1896 01:12:36,440 --> 01:12:38,960 THIS WILL BE CONTROVERSIAL. 1897 01:12:38,960 --> 01:12:40,160 >> ON THAT NOTE, I MEANT TO 1898 01:12:40,160 --> 01:12:42,720 ALSO MENTION THAT I HAD A GREAT 1899 01:12:42,720 --> 01:12:45,280 DISCUSSION IN TOKYO RIGHT AFTER 1900 01:12:45,280 --> 01:12:47,080 I ARRIVED, SO IT WAS A LITTLE 1901 01:12:47,080 --> 01:12:53,480 BIT TRICKY, WITH THE SOCIETY FOR 1902 01:12:53,480 --> 01:12:56,120 INVESTIGATIVE DERMATOLOGY BOARD. 1903 01:12:56,120 --> 01:12:57,080 UNFORTUNATELY A MEETING 1904 01:12:57,080 --> 01:12:57,920 PRECLUDED ATTENDANCE OF SOME 1905 01:12:57,920 --> 01:12:59,560 FOLKS THERE BUT WE TALKED ABOUT 1906 01:12:59,560 --> 01:12:59,920 THIS. 1907 01:12:59,920 --> 01:13:08,760 I WAS INTERESTED TO HEAR AND SEE 1908 01:13:08,760 --> 01:13:11,920 RECEPTEVITY, SPECIAL LIP TO 1909 01:13:11,920 --> 01:13:13,360 CAPPING NOTION, DIVERSE FUNDING 1910 01:13:13,360 --> 01:13:14,240 SOURCES, NOT EXPECTING 1911 01:13:14,240 --> 01:13:24,280 EVERYTHING FROM NIH, TRYING TO 1912 01:13:24,280 --> 01:13:26,800 SPREAD THE WEALTH, PARTICULARLY 1913 01:13:26,800 --> 01:13:32,600 LOOKING AT PAYLINE OF TENTH 1914 01:13:32,600 --> 01:13:37,400 PERCENTILE, WE'LL HEAR FROM DR. 1915 01:13:37,400 --> 01:13:42,120 BYRNES LATER, A 10th 1916 01:13:42,120 --> 01:13:43,640 PERCENTILE IS EQUAL THAT'S 1917 01:13:43,640 --> 01:13:44,280 STATISTICALLY IDENTICAL. 1918 01:13:44,280 --> 01:13:48,800 WHEN YOU CONSIDER THAT, WOW, 1919 01:13:48,800 --> 01:13:50,760 REALLY SUGGESTING KINDS OF 1920 01:13:50,760 --> 01:13:52,520 LOOKING NOT TAKING QUITE THE 1921 01:13:52,520 --> 01:13:54,600 STRICT PAYLINE APPROACH IS 1922 01:13:54,600 --> 01:13:56,240 REALLY IMPORTANT BUT -- ONE LAST 1923 01:13:56,240 --> 01:13:58,000 COMMENT AND I WANT TO HEAR FROM 1924 01:13:58,000 --> 01:13:59,040 MARY AGAIN. 1925 01:13:59,040 --> 01:14:00,880 WE THINK THERE'S AN IMPORTANT 1926 01:14:00,880 --> 01:14:02,360 OPPORTUNITY WE HAVE TO 1927 01:14:02,360 --> 01:14:03,160 COLLABORATE WITH THESE DIFFERENT 1928 01:14:03,160 --> 01:14:05,120 SOCIETIES ALSO IN TERMS OF 1929 01:14:05,120 --> 01:14:06,920 STRATEGIC PLANNING, TO TRY TO 1930 01:14:06,920 --> 01:14:10,760 COMPLEMENT AND SUPPORT AND NOT 1931 01:14:10,760 --> 01:14:12,080 REPLICATE, YOU KNOW, IMPORTANT 1932 01:14:12,080 --> 01:14:12,440 RESEARCH AREAS. 1933 01:14:12,440 --> 01:14:15,760 SO WE'VE TALKED TO LUPUS 1934 01:14:15,760 --> 01:14:17,360 RESEARCH ALLIANCE, TALKED TO 1935 01:14:17,360 --> 01:14:18,800 STEVE TAYLOR AT ARTHRITIS 1936 01:14:18,800 --> 01:14:19,880 FOUNDATION, WE'RE EAGER TO DO 1937 01:14:19,880 --> 01:14:21,840 MORE AS WELL. 1938 01:14:21,840 --> 01:14:22,480 SO MARY? 1939 01:14:22,480 --> 01:14:23,800 >> TOTALLY DIFFERENT TOPIC. 1940 01:14:23,800 --> 01:14:28,000 I GUESS I WANTED TO HEAR MORE 1941 01:14:28,000 --> 01:14:32,880 ABOUT THE NITRO PROJECT AND IT 1942 01:14:32,880 --> 01:14:34,280 SOUNDS SUPER INNOVATIVE. 1943 01:14:34,280 --> 01:14:36,760 AND MAYBE SOMETHING DIFFERENT WE 1944 01:14:36,760 --> 01:14:38,160 AREN'T USED TO SEEING. 1945 01:14:38,160 --> 01:14:44,280 IT WAS QUICK SO WOUND -- WONDEF 1946 01:14:44,280 --> 01:14:45,960 YOU COULD EXPAND ON PROJECTS 1947 01:14:45,960 --> 01:14:52,400 SELECTED, WHO HAS BEEN INVITED 1948 01:14:52,400 --> 01:14:53,160 FOR PROPOSEERS DAY. 1949 01:14:53,160 --> 01:14:55,160 >> WE'VE BEEN HEARING ABOUT 1950 01:14:55,160 --> 01:14:59,080 ARPA-H, TOOK A WHILE FOR FUNDING 1951 01:14:59,080 --> 01:15:02,720 AND A DIRECTOR, SHE IS 1952 01:15:02,720 --> 01:15:03,920 FANTASTIC, VERY ACTIVE WITH 1953 01:15:03,920 --> 01:15:06,000 INSTITUTES AND CENTERS. 1954 01:15:06,000 --> 01:15:07,680 MY BEST UNDERSTANDING OF THE 1955 01:15:07,680 --> 01:15:09,960 VISION AND CONCEPT BEHIND THIS 1956 01:15:09,960 --> 01:15:20,080 IS THAT IT'S A A HIGH-RISK, 1957 01:15:20,080 --> 01:15:20,560 HIGH-REWARD EFFORT, 1958 01:15:20,560 --> 01:15:22,360 COMPLEMENTARY TO RESEARCH NIH 1959 01:15:22,360 --> 01:15:24,920 FUNDS, TAKING HUGE RISKS, AND 1960 01:15:24,920 --> 01:15:29,760 THE PROJECTS ARE DRIVEN BY 1961 01:15:29,760 --> 01:15:33,480 PROGRAM MANAGERS, THEY ARE 1962 01:15:33,480 --> 01:15:34,240 ACTIVELY RECRUITING PROJECT 1963 01:15:34,240 --> 01:15:35,880 MANAGERS, IF THERE ARE FOLKS YOU 1964 01:15:35,880 --> 01:15:37,440 THINK MIGHT BE EXCITED ABOUT 1965 01:15:37,440 --> 01:15:43,080 THIS 3 TO 6 YEAR OPPORTUNITY, 1966 01:15:43,080 --> 01:15:46,000 KEEP THAT IN MIND. 1967 01:15:46,000 --> 01:15:53,800 THEY RECRUIT RECRUIT LARGELY BN 1968 01:15:53,800 --> 01:15:58,840 IDEAS THEY BRING, KICKING OFF 1969 01:15:58,840 --> 01:16:00,400 AMBITIOUS HIGH-RISK EFFORT, 1970 01:16:00,400 --> 01:16:03,520 WE'RE THRILLED THAT 1971 01:16:03,520 --> 01:16:06,560 OSTEOARTHRITIS ANDS REGENERATIVE 1972 01:16:06,560 --> 01:16:08,520 MEDICINE WERE IDENTIFIED AS THE 1973 01:16:08,520 --> 01:16:09,920 FIRST PROJECT. 1974 01:16:09,920 --> 01:16:13,960 WE'LL SEE HOW IT GOES. 1975 01:16:13,960 --> 01:16:14,720 WE WANT TO COLLABORATE AS MUCH 1976 01:16:14,720 --> 01:16:16,720 AS POSSIBLE BECAUSE WE HAVE A 1977 01:16:16,720 --> 01:16:18,600 LOT OF THINGS GOING ON 1978 01:16:18,600 --> 01:16:20,720 INTERNALLY TO NIAMS AND NIH 1979 01:16:20,720 --> 01:16:22,480 RELATED TO REGENERATIVE 1980 01:16:22,480 --> 01:16:24,080 MEDICINE. 1981 01:16:24,080 --> 01:16:30,760 SOME OF YOU PARTICIPATED IN 1982 01:16:30,760 --> 01:16:31,560 REGENERATING CARTILAGE, ET 1983 01:16:31,560 --> 01:16:33,080 CETERA, WE'RE GETTING THE 1984 01:16:33,080 --> 01:16:36,160 RELEVANT ARPA-H FOLKS TODAY FOR 1985 01:16:36,160 --> 01:16:37,680 NITRO AND NIAMS LEADERSHIP AND 1986 01:16:37,680 --> 01:16:38,240 STAFF. 1987 01:16:38,240 --> 01:16:41,680 WE'RE TALKING TO NIH LEADERSHIP, 1988 01:16:41,680 --> 01:16:46,680 TO DO EVERYTHING WE CAN TO BE 1989 01:16:46,680 --> 01:16:49,480 SUPPORTIVE AND TO NOT COMPETE 1990 01:16:49,480 --> 01:16:50,880 WITH, NOT REPLICATE, BUT TO SIT 1991 01:16:50,880 --> 01:16:53,200 BY AND WATCH AND SEE WHAT WE 1992 01:16:53,200 --> 01:16:56,720 DO -- DO WHAT WE CAN TO MAKE IT 1993 01:16:56,720 --> 01:16:57,240 SUCCESSFUL. 1994 01:16:57,240 --> 01:17:01,080 THEY ARE EXPECTING A HIGH RATE 1995 01:17:01,080 --> 01:17:01,680 OF FAILURE. 1996 01:17:01,680 --> 01:17:03,360 >> IN NIAMS WE HAVE A 1997 01:17:03,360 --> 01:17:04,600 TREMENDOUS AMOUNT OF EXPERTISE 1998 01:17:04,600 --> 01:17:07,600 IN THIS AREA AND HOPEFULLY THOSE 1999 01:17:07,600 --> 01:17:12,320 TALENTED PROGRAM OFFICERS ARE 2000 01:17:12,320 --> 01:17:13,960 PART OF THE PROCESS AND -- OKAY, 2001 01:17:13,960 --> 01:17:15,720 IT'S NICE TO HAVE FAILURES BUT 2002 01:17:15,720 --> 01:17:17,120 YOU DON'T WANT TO WASTE YOUR 2003 01:17:17,120 --> 01:17:19,880 MONEY AND YOU WANT TO MAKE SURE 2004 01:17:19,880 --> 01:17:21,760 THEY ARE HIGH RISK THERE IS THE 2005 01:17:21,760 --> 01:17:22,320 OPPORTUNITY FOR LEARNING. 2006 01:17:22,320 --> 01:17:24,760 >> IT'S THEIR MONEY, NOT OUR 2007 01:17:24,760 --> 01:17:24,960 MONEY. 2008 01:17:24,960 --> 01:17:25,920 >> I APPRECIATE THAT. 2009 01:17:25,920 --> 01:17:27,320 >> BUT YOU'RE RIGHT. 2010 01:17:27,320 --> 01:17:30,120 AND OUR PROGRAM OFFICER, SOME 2011 01:17:30,120 --> 01:17:32,800 PROGRAM OFFICERS, TED AND AARON 2012 01:17:32,800 --> 01:17:34,600 AND MAYBE CHUCK, WERE 2013 01:17:34,600 --> 01:17:35,760 IDENTIFIED, AND PART OF THE 2014 01:17:35,760 --> 01:17:37,520 THING THAT'S HARD FOR US IS 2015 01:17:37,520 --> 01:17:38,920 TIMELINES ARE SO QUICK. 2016 01:17:38,920 --> 01:17:40,880 BOOM, THEY HIRE THIS PERSON, AND 2017 01:17:40,880 --> 01:17:43,960 THE NEXT THING WE KNOW THERE'S A 2018 01:17:43,960 --> 01:17:44,400 PRESS RELEASE. 2019 01:17:44,400 --> 01:17:45,400 SO THEY WORK QUICKLY. 2020 01:17:45,400 --> 01:17:47,920 THEY REACHED OUT TO PROGRAM 2021 01:17:47,920 --> 01:17:49,560 OFFICERS, TO GAYLE, AND LOOPED 2022 01:17:49,560 --> 01:17:50,560 LEADERSHIP IN. 2023 01:17:50,560 --> 01:17:52,080 WOW, YOU'RE READY TO GO, WHO IS 2024 01:17:52,080 --> 01:17:53,880 GOING TO RECEIVE THE FUNDING? 2025 01:17:53,880 --> 01:18:00,560 THAT'S TO BE DETERMINED. 2026 01:18:00,560 --> 01:18:02,240 THERE'S THIS PROPOSER'S DAY, SO 2027 01:18:02,240 --> 01:18:03,240 SOON AFTER THE PRESS RELEASE 2028 01:18:03,240 --> 01:18:05,000 TELLS YOU ABOUT THE TIMELINES. 2029 01:18:05,000 --> 01:18:06,120 >> OUR INSTITUTE WOULD BE ABLE 2030 01:18:06,120 --> 01:18:08,360 TO SUGGEST NAMES OF PEOPLE WHO 2031 01:18:08,360 --> 01:18:10,560 SHOULD BE INVITED OR GET AN 2032 01:18:10,560 --> 01:18:11,880 E-MAIL THAT SAYS GET THIS ON 2033 01:18:11,880 --> 01:18:16,480 YOUR RADAR, THIS IS COMING. 2034 01:18:16,480 --> 01:18:21,520 WE KNOW AT NIAMS WHO IS DOING 2035 01:18:21,520 --> 01:18:23,280 REGENERATIVE MEDICINE, HOPEFULLY 2036 01:18:23,280 --> 01:18:26,080 WE CAN GET THE RIGHT FOLKS AT 2037 01:18:26,080 --> 01:18:26,440 THE TABLE. 2038 01:18:26,440 --> 01:18:30,800 >>WE HAVE MEMBERS OF THE 2039 01:18:30,800 --> 01:18:31,320 COMMUNICATION TEAM HERE. 2040 01:18:31,320 --> 01:18:32,800 >> IT'S VERY INTERESTING 2041 01:18:32,800 --> 01:18:35,880 BECAUSE THE WHOLE POINT THAT 2042 01:18:35,880 --> 01:18:38,520 THEY ARE DIFFERENT, SEPARATE, 2043 01:18:38,520 --> 01:18:39,720 ADMINISTERED WITHIN NIH BUT 2044 01:18:39,720 --> 01:18:41,720 CONSIDERED -- THEY REPORT TO THE 2045 01:18:41,720 --> 01:18:43,560 HEAD OF HHS. 2046 01:18:43,560 --> 01:18:47,000 NOT TO HEAD OF NIH. 2047 01:18:47,000 --> 01:18:49,200 PART OF THE CONCEPT THEY DO 2048 01:18:49,200 --> 01:18:50,080 THINGS DIFFERENTLY. 2049 01:18:50,080 --> 01:18:55,640 PART IS THEY DON'T LISTEN TO US. 2050 01:18:55,640 --> 01:18:58,280 THEY SEE AN OPPORTUNITY AND TAKE 2051 01:18:58,280 --> 01:18:59,680 AN ENTIRELY DIFFERENT APPROACH, 2052 01:18:59,680 --> 01:19:01,960 WHICH IS TELL US THE DELIVERABLE 2053 01:19:01,960 --> 01:19:03,360 YOU CAN ACHIEVE, YOU GET A 2054 01:19:03,360 --> 01:19:04,640 CERTAIN AMOUNT OF TIME. 2055 01:19:04,640 --> 01:19:07,800 IF YOU CAN ACHIEVE IT, YOU'RE 2056 01:19:07,800 --> 01:19:08,800 CONSIDERED FOR THE NEXT STEP. 2057 01:19:08,800 --> 01:19:11,040 IF YOU DON'T ACHIEVE IT YOU'RE 2058 01:19:11,040 --> 01:19:11,280 OUT. 2059 01:19:11,280 --> 01:19:12,120 COMPLETELY DIFFERENT FROM THE 2060 01:19:12,120 --> 01:19:13,160 WAY WE WORK. 2061 01:19:13,160 --> 01:19:15,120 HERE IS A LOT OF DOLLARS FOR 2062 01:19:15,120 --> 01:19:16,360 FIVE YEARS AND COME BACK AND SEE 2063 01:19:16,360 --> 01:19:18,120 IF YOU CAN DO IT AGAIN. 2064 01:19:18,120 --> 01:19:20,520 IT'S A WHOLE DIFFERENT MINDSET. 2065 01:19:20,520 --> 01:19:21,800 BUT IT'S FASCINATING TO US 2066 01:19:21,800 --> 01:19:23,680 BECAUSE WE DO KNOW THE PLAYERS. 2067 01:19:23,680 --> 01:19:25,440 WE KNOW THE PEOPLE WHO CAN DO 2068 01:19:25,440 --> 01:19:28,920 THIS. 2069 01:19:28,920 --> 01:19:30,680 WE ACTUALLY KNOW THE PEOPLE WHO 2070 01:19:30,680 --> 01:19:32,240 HAVE A TRACK RECORD. 2071 01:19:32,240 --> 01:19:33,760 WE KNOW PEOPLE'S TRACK RECORD, 2072 01:19:33,760 --> 01:19:35,880 PUT IT THAT WAY. 2073 01:19:35,880 --> 01:19:37,480 BUT THAT'S NOT -- WE'RE NOT 2074 01:19:37,480 --> 01:19:38,920 ASKED THAT. 2075 01:19:38,920 --> 01:19:40,480 IT'S A DIFFERENT APPROACH. 2076 01:19:40,480 --> 01:19:42,320 AND SO IT IS FASCINATING TO SEE 2077 01:19:42,320 --> 01:19:45,360 WHAT BRIDGES WE CAN BUILD 2078 01:19:45,360 --> 01:19:47,560 BECAUSE WE DO KNOW A LOT VERSUS 2079 01:19:47,560 --> 01:19:52,120 THE EFFORT TO DO SOMETHING 2080 01:19:52,120 --> 01:19:54,440 DIFFERENT AND INDEPENDENTLY. 2081 01:19:54,440 --> 01:20:04,960 >> ONE OF THE CLOSEST PALLORS 2082 01:20:05,880 --> 01:20:09,960 WILL WOULD BE RADx OUT OF 2083 01:20:09,960 --> 01:20:11,240 NIBIB. 2084 01:20:11,240 --> 01:20:13,360 THEY WERE PRETTY SUCCESSFUL WITH 2085 01:20:13,360 --> 01:20:15,080 THE PROJECTS THAT CAME OUT OF 2086 01:20:15,080 --> 01:20:15,320 THAT. 2087 01:20:15,320 --> 01:20:17,120 THIS IS MODELED AFTER THAT BUT 2088 01:20:17,120 --> 01:20:21,960 AS BOB SAID IT'S A DIFFERENT 2089 01:20:21,960 --> 01:20:22,640 BALL GAME. 2090 01:20:22,640 --> 01:20:24,400 THEY CAN GIVE YOU MONEY, THEY 2091 01:20:24,400 --> 01:20:30,640 CAN TAKE IT BACK. 2092 01:20:30,640 --> 01:20:31,040 WE CAN'T DO THAT. 2093 01:20:31,040 --> 01:20:33,360 >> I THINK IT'S A GREAT 2094 01:20:33,360 --> 01:20:33,640 OPPORTUNITY. 2095 01:20:33,640 --> 01:20:36,400 I'M NOT TRYING TO BE NEGATIVE. 2096 01:20:36,400 --> 01:20:38,240 I'M TRYING TO MAKE SURE WE'RE 2097 01:20:38,240 --> 01:20:39,000 OPTIMIZING THE OPPORTUNITY, SO 2098 01:20:39,000 --> 01:20:41,000 THIS IS A PARTNERSHIP THAT CAN 2099 01:20:41,000 --> 01:20:42,160 CLEARLY BENEFIT NIAMS. 2100 01:20:42,160 --> 01:20:48,480 THIS IS MONEY WE'RE NOT SPENDING 2101 01:20:48,480 --> 01:20:50,000 THAT ADVANCES SCIENCE IN OUR 2102 01:20:50,000 --> 01:20:51,400 FIELD, JUST MAKING SURE WE HAVE 2103 01:20:51,400 --> 01:20:54,680 THE RIGHT PEOPLE AT THE TABLE, 2104 01:20:54,680 --> 01:20:56,240 MINIMALLY ADVISING, THIS MAY OR 2105 01:20:56,240 --> 01:21:06,760 MAY NOT LISTEN, AND THE RIGHT 2106 01:21:14,440 --> 01:21:14,880 INVESTIGATORS APPLYING. 2107 01:21:14,880 --> 01:21:18,640 >> HOW DO YOU GET ON THE TABLE 2108 01:21:18,640 --> 01:21:21,600 FOR PROPOSER'S DAY? 2109 01:21:21,600 --> 01:21:23,040 YOU WRITE A PROPOSAL DUE JUNE 16 2110 01:21:23,040 --> 01:21:24,800 OR INVITED FOR THE MEETING ON 2111 01:21:24,800 --> 01:21:25,560 JUNE 16? 2112 01:21:25,560 --> 01:21:27,280 I'M NOT SURE. 2113 01:21:27,280 --> 01:21:30,320 MY POINT IS DON'T BE PASSIVE. 2114 01:21:30,320 --> 01:21:31,960 LOOK AT THE WEBSITE. 2115 01:21:31,960 --> 01:21:34,080 FIGURE OUT WHAT'S TAKEN AND GET 2116 01:21:34,080 --> 01:21:35,200 SOMETHING IN THERE. 2117 01:21:35,200 --> 01:21:39,400 I'M SAYING THIS BROADLY TO THE 2118 01:21:39,400 --> 01:21:39,640 COMMUNITY. 2119 01:21:39,640 --> 01:21:43,200 >> WE DID BROADLY DISTRIBUTE 2120 01:21:43,200 --> 01:21:46,200 THAT ANNOUNCEMENT FROM NIAMS TO 2121 01:21:46,200 --> 01:21:48,320 OUR INVESTIGATORS, SO -- AND WE 2122 01:21:48,320 --> 01:21:49,480 HAVE SUGGESTED NAMES OF PEOPLE 2123 01:21:49,480 --> 01:21:52,120 WHO WOULD BE WORTH REACHING OUT 2124 01:21:52,120 --> 01:21:54,120 TO, TO THESE FOLKS, AND WE'VE 2125 01:21:54,120 --> 01:21:57,520 ALSO GIVEN THEM KIND OF OUR 2126 01:21:57,520 --> 01:21:59,520 GESTALT OF WHERE WE'RE ARE AND 2127 01:21:59,520 --> 01:22:01,560 WHAT NEEDS TO BE DONE. 2128 01:22:01,560 --> 01:22:02,800 I THINK WE'VE DONE AS MUCH AS WE 2129 01:22:02,800 --> 01:22:08,120 CAN WITH REGARD TO THE FACT THAT 2130 01:22:08,120 --> 01:22:09,440 THIS IS NOT OUR AGENCY. 2131 01:22:09,440 --> 01:22:11,640 >> SO, I'M JUST GOING TO DO A 2132 01:22:11,640 --> 01:22:15,040 LITTLE BIT OF TIME CHECK. 2133 01:22:15,040 --> 01:22:19,000 DARREN AND I WERE CONFERRING, 2134 01:22:19,000 --> 01:22:21,000 WE'RE INCLINED TO TAKE A BREAK 2135 01:22:21,000 --> 01:22:23,680 UNTIL 11:00, I CAN ALSO TAKE ONE 2136 01:22:23,680 --> 01:22:28,840 QUICK QUESTION BEFORE WE BREAK. 2137 01:22:28,840 --> 01:22:32,840 DR. BYRNES IS HERE FROM CSR AND 2138 01:22:32,840 --> 01:22:33,960 WE'LL HAVE ANOTHER PRESENTATION 2139 01:22:33,960 --> 01:22:34,720 AFTER DR. BYRNES. 2140 01:22:34,720 --> 01:22:36,280 ANY LAST THOUGHTS BEFORE WE TAKE 2141 01:22:36,280 --> 01:22:39,880 OUR BREAK? 2142 01:22:39,880 --> 01:22:40,680 I'LL BE MILLING AROUND. 2143 01:22:40,680 --> 01:22:47,360 >> LET ME JUST ASK IF DOCTORS 2144 01:22:47,360 --> 01:22:48,880 FINDLEY OR GOODMAN ON THE ZOOM 2145 01:22:48,880 --> 01:22:50,880 METING HAVE ANY QUESTIONS YOU 2146 01:22:50,880 --> 01:22:53,040 WANT TO RAISE? 2147 01:22:53,040 --> 01:22:55,080 >> THIS IS STUART GOODMAN 2148 01:22:55,080 --> 01:22:55,600 SPEAKING. 2149 01:22:55,600 --> 01:22:59,840 I'VE ENJOYED THIS CONVERSATION. 2150 01:22:59,840 --> 01:23:03,520 WE'VE TALKED ABOUT HOW TO AWARD 2151 01:23:03,520 --> 01:23:05,200 GREAT RESEARCH. 2152 01:23:05,200 --> 01:23:11,280 I KNOW THAT NSF AND DARPA GIVE 2153 01:23:11,280 --> 01:23:14,160 OUT AWARDS THAT ARE BY AND LARGE 2154 01:23:14,160 --> 01:23:18,320 MERIT BASED BUT ALSO AS I 2155 01:23:18,320 --> 01:23:21,840 UNDERSTAND IT THE DIRECTOR PICKS 2156 01:23:21,840 --> 01:23:24,160 AND CHOOSES TOO. 2157 01:23:24,160 --> 01:23:26,520 AND I AGREE WITH OUR AD HOC 2158 01:23:26,520 --> 01:23:28,800 MEMBER THAT IT'S GOING TO TAKE A 2159 01:23:28,800 --> 01:23:30,920 LOT OF THOUGHT AND A LOT OF 2160 01:23:30,920 --> 01:23:32,840 ANALYSIS TO FIGURE OUT IF WE'RE 2161 01:23:32,840 --> 01:23:34,600 GOING TO CHANGE A SYSTEM THAT'S 2162 01:23:34,600 --> 01:23:37,760 BEEN GOING ON FOR DECADES INTO A 2163 01:23:37,760 --> 01:23:38,880 SLIGHTLY DIFFERENT SYSTEM BUT 2164 01:23:38,880 --> 01:23:41,360 THERE'S PROS AND CONS AND I 2165 01:23:41,360 --> 01:23:44,840 THINK IF WE DO THIS JUDICIOUSLY 2166 01:23:44,840 --> 01:23:48,480 AND DO A LOT OF ANALYSIS OF HOW 2167 01:23:48,480 --> 01:23:51,240 IT'S AFFECTING THE AWARDEES AND 2168 01:23:51,240 --> 01:23:55,480 NON-AWARDEES, I THINK IT'S 2169 01:23:55,480 --> 01:23:56,040 CERTAINLY WORTH CONSIDERING. 2170 01:23:56,040 --> 01:23:59,760 >> THANK YOU VERY MUCH, STUART. 2171 01:23:59,760 --> 01:24:01,520 I COMPLETELY AGREE. 2172 01:24:01,520 --> 01:24:03,280 YOUR COMMENTS ARE REALLY 2173 01:24:03,280 --> 01:24:04,680 IMPORTANT TO US, AND, YOU KNOW, 2174 01:24:04,680 --> 01:24:06,680 THAT'S WHY WE WANTED TO BRING 2175 01:24:06,680 --> 01:24:08,680 SOME OF THESE ISSUES TO YOU AND 2176 01:24:08,680 --> 01:24:09,720 CONTINUE TO HAVE THIS 2177 01:24:09,720 --> 01:24:12,760 CONVERSATION WITH OUR COUNCIL 2178 01:24:12,760 --> 01:24:13,240 MOVING FORWARD. 2179 01:24:13,240 --> 01:24:15,040 AND OF COURSE WE HAVE THE REST 2180 01:24:15,040 --> 01:24:19,080 OF TODAY AND WE HAVE IN BETWEEN 2181 01:24:19,080 --> 01:24:20,280 COUNCIL MEETINGS TO CONTINUE 2182 01:24:20,280 --> 01:24:21,480 SOME OF THESE CONVERSATIONS. 2183 01:24:21,480 --> 01:24:24,720 PLEASE FEEL FREE TO REACH OUT, 2184 01:24:24,720 --> 01:24:25,240 ANYTIME AS WELL. 2185 01:24:25,240 --> 01:24:29,040 >> I THINK DREW WANTS TO SAY 2186 01:24:29,040 --> 01:24:30,680 SOMETHING. 2187 01:24:30,680 --> 01:24:32,360 HE UNMUTED HIMSELF. 2188 01:24:32,360 --> 01:24:34,520 >> THIS IS ANDREW FINDLEY. 2189 01:24:34,520 --> 01:24:37,680 THANK YOU FOR THE INVITATION TO 2190 01:24:37,680 --> 01:24:39,560 ATTEND. 2191 01:24:39,560 --> 01:24:44,000 I HAD A COMMENT. 2192 01:24:44,000 --> 01:24:44,920 I'M PHYSICALLY DISABLED, I WANT 2193 01:24:44,920 --> 01:24:47,000 TO POINT OUT IT'S VERY NICE TO 2194 01:24:47,000 --> 01:24:48,600 HAVE THIS VIRTUAL OPTION TO 2195 01:24:48,600 --> 01:24:49,720 ATTEND MEETINGS LIKE THIS, SO 2196 01:24:49,720 --> 01:24:51,800 CONTINUING TO DO SO GOING TO THE 2197 01:24:51,800 --> 01:24:55,800 FUTURE I THINK IS A VERY 2198 01:24:55,800 --> 01:24:56,200 IMPORTANT THING. 2199 01:24:56,200 --> 01:24:57,200 >> THANKS VERY MUCH. 2200 01:24:57,200 --> 01:24:59,680 THAT'S VERY IMPORTANT TO ME AND 2201 01:24:59,680 --> 01:25:02,760 THAT'S ONE OF THE SILVER LININGS 2202 01:25:02,760 --> 01:25:04,960 OF THE PANDEMIC, THE REALIZATION 2203 01:25:04,960 --> 01:25:06,720 WE CAN BE INCLUSIVE AND 2204 01:25:06,720 --> 01:25:08,160 ACCOMMODATING AND WE ALL BENEFIT 2205 01:25:08,160 --> 01:25:09,480 FROM THAT. 2206 01:25:09,480 --> 01:25:16,120 THANKS VERY MUCH FOR SHARING 2207 01:25:16,120 --> 01:25:16,320 THAT. 2208 01:25:16,320 --> 01:25:19,880 LET'S TAKE A FIVE-MINUTE BREAK. 2209 01:25:19,880 --> 01:25:21,120 RESTROOMS ARE OUT HERE TO THE 2210 01:25:21,120 --> 01:25:21,400 RIGHT. 2211 01:25:21,400 --> 01:25:22,160 WE'LL SEE YOU BACK AT 11:00. 2212 01:25:22,160 --> 01:25:24,760 I'M SO EXCITED THAT WE HAVE DR. 2213 01:25:24,760 --> 01:25:27,840 NONI BYRNES HERE TODAY. 2214 01:25:27,840 --> 01:25:30,000 I'VE BEEN TALKING ABOUT HER 2215 01:25:30,000 --> 01:25:31,200 MEETING WITH COUNCIL FOR A LONG 2216 01:25:31,200 --> 01:25:33,120 TIME, SO THANK YOU SO MUCH FOR 2217 01:25:33,120 --> 01:25:34,200 BEING HERE. 2218 01:25:34,200 --> 01:25:36,600 DR. BYRNES IS DIRECTOR OF THE 2219 01:25:36,600 --> 01:25:38,440 CENTER FOR SCIENTIFIC REVIEW, 2220 01:25:38,440 --> 01:25:39,640 CSR, AT THE NIH. 2221 01:25:39,640 --> 01:25:42,280 SHE LEADS THE STAFF OF OVER 600 2222 01:25:42,280 --> 01:25:44,680 PERSONNEL, AND IS RESPONSIBLE 2223 01:25:44,680 --> 01:25:46,760 FOR OVERSEEING THE MAJORITY OF 2224 01:25:46,760 --> 01:25:49,880 THE NIH PEER REVIEW PROCESS, AS 2225 01:25:49,880 --> 01:25:51,720 CSR HANDLES ABOUT 76% OF ALL OF 2226 01:25:51,720 --> 01:25:53,720 THE GRANT APPLICATIONS THAT ARE 2227 01:25:53,720 --> 01:25:57,840 SUBMITTED TO THE NIH. 2228 01:25:57,840 --> 01:25:59,920 AND PRIOR TO BEING APPOINTED 2229 01:25:59,920 --> 01:26:04,280 DIRECTOR SERVED IN A VARIETY OF 2230 01:26:04,280 --> 01:26:07,000 ROLES AT CSR, SCIENTIFIC REVIEW 2231 01:26:07,000 --> 01:26:08,760 OFFICER, EVENTUALLY ACTING 2232 01:26:08,760 --> 01:26:10,720 DEPUTY DIRECTOR AND THEN ACTING 2233 01:26:10,720 --> 01:26:12,480 DIRECTOR OF CSR BEFORE WE GO 2234 01:26:12,480 --> 01:26:13,640 NAMED DIRECTOR. 2235 01:26:13,640 --> 01:26:15,240 SHE HAS VERY DEEP EXPERIENCE 2236 01:26:15,240 --> 01:26:17,880 WITH CSR AS YOU CAN SEE. 2237 01:26:17,880 --> 01:26:20,880 SHE'S LEDDED DEVELOPMENT OF 2238 01:26:20,880 --> 01:26:22,880 RECOMMENDATIONS TO STRENGTHEN 2239 01:26:22,880 --> 01:26:25,640 PEER REVIEW AND CSR HAS 2240 01:26:25,640 --> 01:26:29,960 INCREASED 2241 01:26:29,960 --> 01:26:32,760 INCREASED DIVERSITY AND TAKEN 2242 01:26:32,760 --> 01:26:34,960 ACTIONS TO ADDRESS BIAS REVIEW. 2243 01:26:34,960 --> 01:26:36,320 DURING THE PAST TWO YEARS I'VE 2244 01:26:36,320 --> 01:26:43,920 BEEN HERE I'VEED A -- I'VE 2245 01:26:43,920 --> 01:26:44,600 ADMIRED HER INITIATIVES. 2246 01:26:44,600 --> 01:26:47,760 TODAY SHE'D WILL TALK ABOUT CSR 2247 01:26:47,760 --> 01:26:53,920 INITIATIVES TO STRENGTH BE PEER 2248 01:26:53,920 --> 01:26:55,080 REVIEW INCLUDING MITIGATION 2249 01:26:55,080 --> 01:26:55,520 AWARENESS TRAINING. 2250 01:26:55,520 --> 01:26:57,200 >> IT'S GREAT TO BE HERE. 2251 01:26:57,200 --> 01:26:59,120 THANK YOU, LINDSEY AND DARREN 2252 01:26:59,120 --> 01:27:03,560 AND BOB AND EVERYONE FOR 2253 01:27:03,560 --> 01:27:04,880 INVITING ME. 2254 01:27:04,880 --> 01:27:06,600 I MISSED A ROBUST DISCUSSION, 2255 01:27:06,600 --> 01:27:08,760 HAPPY TO ENGAGE WITH THAT AFTER 2256 01:27:08,760 --> 01:27:15,920 THE TALK. 2257 01:27:15,920 --> 01:27:21,600 LET ME GET STARTED. 2258 01:27:21,600 --> 01:27:24,520 OUR MISSION IS TO ENSURE 2259 01:27:24,520 --> 01:27:27,280 IDENTIFICATION OF HIGHEST IMPACT 2260 01:27:27,280 --> 01:27:29,280 APPLICATIONS FOR NIH FUNDING BY 2261 01:27:29,280 --> 01:27:32,680 ENSURING THE PROCESS IS FAIR, 2262 01:27:32,680 --> 01:27:33,840 INDEPENDENT, EXPERT, AND TIMELY 2263 01:27:33,840 --> 01:27:39,200 AND FREE FROM INAPPROPRIATE 2264 01:27:39,200 --> 01:27:39,520 INFLUENCES. 2265 01:27:39,520 --> 01:27:42,200 LINDSEY ALREADY MENTIONED, THIS 2266 01:27:42,200 --> 01:27:44,520 IS FISCAL YEAR 23 NUMBERS, WE 2267 01:27:44,520 --> 01:27:46,080 REVIEWED AROUND 60,000 2268 01:27:46,080 --> 01:27:47,720 APPLICATIONS, A LITTLE OVER 2269 01:27:47,720 --> 01:27:49,320 THREE-QUARTERS OF ALL NIH 2270 01:27:49,320 --> 01:27:50,200 APPLICATIONS. 2271 01:27:50,200 --> 01:27:52,760 THAT'S MAJORITY OF THE R01s, 2272 01:27:52,760 --> 01:27:57,640 SMALL BUSINESS, AND NRSA 2273 01:27:57,640 --> 01:27:58,880 FELLOWSHIP PORTFOLIO WITH 2274 01:27:58,880 --> 01:28:01,680 ASSISTANCE OF OVER 19,000 2275 01:28:01,680 --> 01:28:06,480 REVIEWERS, 275 SROs, IT'S A 2276 01:28:06,480 --> 01:28:08,520 LARGE OPERATION, 1200 MEETINGS 2277 01:28:08,520 --> 01:28:09,800 EACH FISCAL YEAR. 2278 01:28:09,800 --> 01:28:12,040 IN ADDITION TO THE REGULAR 2279 01:28:12,040 --> 01:28:13,440 STANDING STUDY SECTIONS THAT 2280 01:28:13,440 --> 01:28:15,360 YOU'RE FAMILIAR WITH CSR HANDLES 2281 01:28:15,360 --> 01:28:18,760 A NUMBER OF MOST SPECIAL 2282 01:28:18,760 --> 01:28:21,160 INITIATIVES ANYWHERE, AND THAT 2283 01:28:21,160 --> 01:28:22,160 INCLUDES TRANS-NIH INITIATIVES, 2284 01:28:22,160 --> 01:28:26,600 SOME MAY BE FAMILIAR TO YOU, AS 2285 01:28:26,600 --> 01:28:28,520 WELL AS RFAs AND SUCH THAT 2286 01:28:28,520 --> 01:28:33,680 INSTITUTES ASK US TO TAKE ON, ON 2287 01:28:33,680 --> 01:28:34,120 THEIR BEHALF. 2288 01:28:34,120 --> 01:28:37,200 SO WE ISSUED A NEW STRATEGIC 2289 01:28:37,200 --> 01:28:38,600 PLAN LAST YEAR, FIVE-YEAR 2290 01:28:38,600 --> 01:28:41,800 STRATEGIC PLAN, AND IT WAS BUILT 2291 01:28:41,800 --> 01:28:44,320 ON OUR EXISTING FRAMEWORK THAT'S 2292 01:28:44,320 --> 01:28:45,760 BEEN IN PLACE SINCE 2019. 2293 01:28:45,760 --> 01:28:48,560 AND THE FRAMEWORK IS REALLY TO 2294 01:28:48,560 --> 01:28:50,680 OPTIMIZE OUTPUT OF PEER REVIEW, 2295 01:28:50,680 --> 01:28:52,520 LIES IN THREE DOMAINS. 2296 01:28:52,520 --> 01:28:55,680 FIRST IS MORE LIKE A 2297 01:28:55,680 --> 01:28:56,440 STRUCTURE/FUNCTION PROBLEM, 2298 01:28:56,440 --> 01:28:58,080 FIRST IS STRUCTURE OF STUDY 2299 01:28:58,080 --> 01:29:01,440 SECTIONS, WHAT THAT MEANS IS 2300 01:29:01,440 --> 01:29:02,040 SOME STANDING PANELS, WHAT IS 2301 01:29:02,040 --> 01:29:04,480 THE SCOPE OF THE SCIENCE? 2302 01:29:04,480 --> 01:29:10,240 ARE THEY OPTIMAL SIZE? 2303 01:29:10,240 --> 01:29:12,200 ARE THEY ADAPTING TO EMERGING 2304 01:29:12,200 --> 01:29:12,400 AREAS? 2305 01:29:12,400 --> 01:29:14,160 I'LL TALK ABOUT THE INQUIRE 2306 01:29:14,160 --> 01:29:16,320 PROCESS THAT LOOKS INTO 2307 01:29:16,320 --> 01:29:17,760 RESTRUCTURING STUDY SECTIONS. 2308 01:29:17,760 --> 01:29:19,640 EVEN IF HAVE YOU PERFECTLY 2309 01:29:19,640 --> 01:29:20,640 DESIGNED STUDY SECTIONS, THE 2310 01:29:20,640 --> 01:29:24,000 OUTPUT IS ALSO INFLUENCED BY WHO 2311 01:29:24,000 --> 01:29:25,680 WE SELECT AS REVIEWERS, THERE'S 2312 01:29:25,680 --> 01:29:28,120 A SECOND DOMAIN OF REVIEWERS, 2313 01:29:28,120 --> 01:29:29,920 REVIEWER SELECTION AND TRAINING 2314 01:29:29,920 --> 01:29:31,600 AND SO FORTH. 2315 01:29:31,600 --> 01:29:35,800 s YOU CAN HAVE REALLY STRONG 2316 01:29:35,800 --> 01:29:36,840 REVIEWERS, PERFECT STUDY SECTION 2317 01:29:36,840 --> 01:29:38,480 STRUCTURE BUT PROCESS CAN AFFECT 2318 01:29:38,480 --> 01:29:41,440 OUTCOMES SOMETIMES IN A NEGATIVE 2319 01:29:41,440 --> 01:29:41,760 WAY. 2320 01:29:41,760 --> 01:29:44,280 THAT'S WHERE SOME PROCESS ISSUES 2321 01:29:44,280 --> 01:29:46,240 COME UP LIKE INTEGRITY, BIAS, 2322 01:29:46,240 --> 01:29:46,880 OTHERS. 2323 01:29:46,880 --> 01:29:50,520 WE DO THIS BECAUSE WE'RE PUBLIC, 2324 01:29:50,520 --> 01:29:52,280 ENSURING A LEVEL OF 2325 01:29:52,280 --> 01:29:52,760 TRANSPARENCY, DECISIONS, 2326 01:29:52,760 --> 01:29:53,760 HOPEFULLY YOU'LL SEE IN SOME OF 2327 01:29:53,760 --> 01:29:56,000 WHAT I PRESENT THAT ARE 2328 01:29:56,000 --> 01:29:59,080 DECISIONS, DATA DRIVEN AND WE 2329 01:29:59,080 --> 01:30:01,600 ENGAGE WITH OUR STAKEHOLDERS 2330 01:30:01,600 --> 01:30:02,520 THROUGHOUT THE PROCESSES. 2331 01:30:02,520 --> 01:30:05,240 WE CAN'T DO ANYTHING WITHOUT OUR 2332 01:30:05,240 --> 01:30:06,440 STAFF. 2333 01:30:06,440 --> 01:30:07,760 WE'VE INVESTED A LOT OF 2334 01:30:07,760 --> 01:30:12,080 RESOURCES IN DEVELOPING AND 2335 01:30:12,080 --> 01:30:13,760 TRAINING STAFFER AND REVIEWERS. 2336 01:30:13,760 --> 01:30:17,280 TODAY I'M GOING TO TALK ABOUT 2337 01:30:17,280 --> 01:30:20,480 INQUIRE, THE STUDY SECTION 2338 01:30:20,480 --> 01:30:21,640 RESTRUCTURING PROCESS, ABOUT 2339 01:30:21,640 --> 01:30:24,000 SIMPLIFYING THE REVIEW OF 2340 01:30:24,000 --> 01:30:26,960 RESEARCH PROJECT GRANTS AND NRSA 2341 01:30:26,960 --> 01:30:28,880 FELLOWSHIPS, INITIATIVES IN 2342 01:30:28,880 --> 01:30:31,520 DIFFERENT STAGES OF DEVELOPMENT. 2343 01:30:31,520 --> 01:30:33,560 AND THEN MORE ABOUT PROMOTING 2344 01:30:33,560 --> 01:30:38,200 FAIRNESS IN THE PROCESS AND 2345 01:30:38,200 --> 01:30:40,800 DIVERSIFYING OUR COMMITTEES. 2346 01:30:40,800 --> 01:30:43,800 SO ENQUIRE IS THIS TORTURED 2347 01:30:43,800 --> 01:30:44,040 ACRONYM. 2348 01:30:44,040 --> 01:30:50,040 IT'S NAY -- IT'S NIH SO WE HAVO 2349 01:30:50,040 --> 01:30:51,480 HAVE A TORTURED ACRONYM, 2350 01:30:51,480 --> 01:30:52,520 ENQUIRE. 2351 01:30:52,520 --> 01:30:54,560 THE GOAL IS TO TAKE A CAREFUL 2352 01:30:54,560 --> 01:30:57,000 DEEP SYSTEMATIC LOOK AT OUR 2353 01:30:57,000 --> 01:30:58,040 STUDY SECTION STRUCTURE, WHAT IS 2354 01:30:58,040 --> 01:30:59,240 THE SCIENCE THAT'S BEING 2355 01:30:59,240 --> 01:31:01,640 REVIEWED TOGETHER AND COMPARED 2356 01:31:01,640 --> 01:31:03,640 TO EACH OTHER, RIGHT? 2357 01:31:03,640 --> 01:31:06,720 SO WE INITIATED THIS IN 2019. 2358 01:31:06,720 --> 01:31:08,760 IT'S SUPPOSED TO EVALUATE AROUND 2359 01:31:08,760 --> 01:31:11,160 20% OF CSR STUDY SECTIONS SO WE 2360 01:31:11,160 --> 01:31:13,440 HAVE 180 STANDING COMMITTEES IN 2361 01:31:13,440 --> 01:31:15,440 AREAS RANGING FROM BASIC TO 2362 01:31:15,440 --> 01:31:17,640 COMMUNITY HEALTH, AND OUTREACH. 2363 01:31:17,640 --> 01:31:19,800 SO AROUND 20% ARE ASSESSED EACH 2364 01:31:19,800 --> 01:31:20,880 YEAR WHICH MEANS EVERY STUDY 2365 01:31:20,880 --> 01:31:22,440 SECTION IS SCHEDULED TO GET A 2366 01:31:22,440 --> 01:31:23,640 DEEP DIVE EVERY FIVE YEARS TO 2367 01:31:23,640 --> 01:31:27,680 TAKE A LOOK AT HOW IT'S 2368 01:31:27,680 --> 01:31:27,960 PROGRESSING. 2369 01:31:27,960 --> 01:31:31,560 IT'S A TWO-STAGE PROCESS, FIRST 2370 01:31:31,560 --> 01:31:33,800 STAGE INVOLVES EXTERNAL REVIEW 2371 01:31:33,800 --> 01:31:34,560 COMMITTEE, EXTERNAL SCIENTIFIC 2372 01:31:34,560 --> 01:31:35,360 EVALUATION PANEL. 2373 01:31:35,360 --> 01:31:38,880 WE MAKE SURE WE GET PEOPLE WHOSE 2374 01:31:38,880 --> 01:31:40,680 OWN SUPPORT IS NOT TIED TO 2375 01:31:40,680 --> 01:31:41,800 EXISTENCE OF ONE STUDY SECTION. 2376 01:31:41,800 --> 01:31:43,680 WE WANT TO MAKE SURE WE GET 2377 01:31:43,680 --> 01:31:46,000 BROAD PEOPLE TO GIVE US HIGHER 2378 01:31:46,000 --> 01:31:47,400 LEVEL INPUT. 2379 01:31:47,400 --> 01:31:50,680 AND WE ASK THEM JUST -- I GUESS 2380 01:31:50,680 --> 01:31:53,680 ONE QUESTION, WHAT IS -- TELL US 2381 01:31:53,680 --> 01:32:02,320 ABOUT HOW SCIENTIFICALLY CURRET 2382 01:32:02,320 --> 01:32:02,560 IS THIS? 2383 01:32:02,560 --> 01:32:05,120 WE GIVE THEM A BUNCH OF DATA, 2384 01:32:05,120 --> 01:32:06,640 OUTPUT, PUBLICATION DATA. 2385 01:32:06,640 --> 01:32:10,000 WE GIVE THEM ESI DATA, EARLY 2386 01:32:10,000 --> 01:32:11,880 STAGE INVESTIGATOR, IS IT STUDY 2387 01:32:11,880 --> 01:32:13,200 SECTION OPEN TO EARLY-STAGE 2388 01:32:13,200 --> 01:32:13,600 INVESTIGATORS? 2389 01:32:13,600 --> 01:32:16,200 IS THE SCIENCE FRESH ENOUGH TO 2390 01:32:16,200 --> 01:32:17,640 HAVE ENOUGH ESIs COMING IN 2391 01:32:17,640 --> 01:32:19,440 THROUGH THE SYSTEM? 2392 01:32:19,440 --> 01:32:21,680 A NUMBER OF SAMPLE ABSTRACTS AND 2393 01:32:21,680 --> 01:32:22,000 AIMS. 2394 01:32:22,000 --> 01:32:25,480 WE GIVE THEM FREE REIN TO 2395 01:32:25,480 --> 01:32:27,880 IDENTIFY EMERGING AREAS, GET RID 2396 01:32:27,880 --> 01:32:32,560 OF STUDY SECTIONS, MERGE, 2397 01:32:32,560 --> 01:32:32,920 CREATE. 2398 01:32:32,920 --> 01:32:35,200 SECOND STAGE IS A PROCESS 2399 01:32:35,200 --> 01:32:35,520 EVALUATION. 2400 01:32:35,520 --> 01:32:40,440 THIS IS ITEMS WE CAN DO 2401 01:32:40,440 --> 01:32:43,160 INTERNALLY, WITHIN NIH, IT 2402 01:32:43,160 --> 01:32:44,600 INVOLVES NIH STAKEHOLDERS, 2403 01:32:44,600 --> 01:32:46,600 INSTITUTES SERVED BY THAT STUDY 2404 01:32:46,600 --> 01:32:46,920 SECTION. 2405 01:32:46,920 --> 01:32:48,400 THEY GET THE REPORT OF THE FIRST 2406 01:32:48,400 --> 01:32:53,680 STAGE AND ALSO ROSTER EXPERTIS, 2407 01:32:53,680 --> 01:32:55,040 ET CETERA. 2408 01:32:55,040 --> 01:32:56,640 WE GET PROGRAM FEEDBACK IN 2409 01:32:56,640 --> 01:32:58,040 THROUGH SURVEYS THAT WE THEN 2410 01:32:58,040 --> 01:33:01,120 PROVIDE TO THE SECOND STAGE 2411 01:33:01,120 --> 01:33:01,480 PANEL. 2412 01:33:01,480 --> 01:33:03,960 SIMILAR TO FIRST PANEL WE DON'T 2413 01:33:03,960 --> 01:33:05,280 INVOLVE INDIVIDUAL SROs, 2414 01:33:05,280 --> 01:33:10,560 VESTED IN THE STUDY SECTION OR 2415 01:33:10,560 --> 01:33:14,240 POs BUT HIGHER LEVEL FOLKS AT 2416 01:33:14,240 --> 01:33:16,480 THE INSTITUTES. 2417 01:33:16,480 --> 01:33:18,200 AND THEN ALL OF THIS GOES IN 2418 01:33:18,200 --> 01:33:21,360 FRONT OF CSR ADVISORY COUNCIL, 2419 01:33:21,360 --> 01:33:22,560 OVERSEEN BY SCIENTIFIC DIVISION 2420 01:33:22,560 --> 01:33:22,920 DIRECTORS. 2421 01:33:22,920 --> 01:33:24,120 I WON'T GO THROUGH STEPS OTHER 2422 01:33:24,120 --> 01:33:26,400 THAN TO TELL YOU THAT AFTER 2423 01:33:26,400 --> 01:33:30,240 APPROVAL BY THE ADVISORY COUNCIL 2424 01:33:30,240 --> 01:33:32,760 THERE ARE MULTIPLE STEPS TO HAVE 2425 01:33:32,760 --> 01:33:35,000 MOCK REFERRALS TO FINALIZE 2426 01:33:35,000 --> 01:33:35,480 GUIDELINES AND OVERLAP 2427 01:33:35,480 --> 01:33:37,560 STATEMENTS, PUBLIC THOSE TO 2428 01:33:37,560 --> 01:33:39,760 PUBLICIZE THEM TO THE COMMUNITY, 2429 01:33:39,760 --> 01:33:43,680 AND THEN TRANSFER STUDY SECTION 2430 01:33:43,680 --> 01:33:45,280 MEMBERS BASED ON EXPERTISE IF 2431 01:33:45,280 --> 01:33:46,800 NEW PANELS ARE CREATED. 2432 01:33:46,800 --> 01:33:49,000 TAKES 12 TO 18 MONTHS, CLOSER TO 2433 01:33:49,000 --> 01:33:50,680 18 MONTHS, FROM THE TIME WE 2434 01:33:50,680 --> 01:33:52,120 BEGIN OUR FIRST STAGE TO THE 2435 01:33:52,120 --> 01:33:55,200 TIME WE HAVE NEW STUDY SECTIONS. 2436 01:33:55,200 --> 01:33:58,200 SO, SO FAR WE'VE DURN 13 2437 01:33:58,200 --> 01:34:00,960 SCIENTIFIC CLUSTERS WHICH IS 2438 01:34:00,960 --> 01:34:03,280 ABOUT 152 STUDY SECTIONS DONE OR 2439 01:34:03,280 --> 01:34:05,360 IN VARIOUS STAGES OF PROGRESS, 2440 01:34:05,360 --> 01:34:15,240 THAT INCLUDES ALL DIFFERENT 2441 01:34:15,240 --> 01:34:18,040 AREAS OF SCIENCE. 2442 01:34:18,040 --> 01:34:21,200 BECAUSE WE GIVE FREE REIN TO THE 2443 01:34:21,200 --> 01:34:22,800 COMMUNITY THEY GIVE US REAL 2444 01:34:22,800 --> 01:34:25,200 CHANGE WHICH IS GREAT. 2445 01:34:25,200 --> 01:34:27,480 SO, IT'S RESULTED IN SUBSTANTIVE 2446 01:34:27,480 --> 01:34:29,600 CHANGE, ELIMINATION OF SMALLER 2447 01:34:29,600 --> 01:34:31,800 BOUTIQUE PANELS, AND NEW STUDY 2448 01:34:31,800 --> 01:34:35,040 SECTIONS, ESPECIALLY 2449 01:34:35,040 --> 01:34:38,000 INCORPORATION OF NEWER 2450 01:34:38,000 --> 01:34:40,480 SCIENTIFIC AREAS. 2451 01:34:40,480 --> 01:34:45,320 SOME EXAMPLES, LATE STAGE 2452 01:34:45,320 --> 01:34:45,840 PRE-CLINICAL THERAPEUTICS, 2453 01:34:45,840 --> 01:34:47,120 SOCIAL DETERMINANTS OF HEALTH 2454 01:34:47,120 --> 01:34:49,720 WAS NOT CREATED AS A NEW STUDY 2455 01:34:49,720 --> 01:34:51,680 SECTION BUT INCORPORATED INTO 2456 01:34:51,680 --> 01:34:54,600 MULTIPLE STUDY SECTIONS BASED ON 2457 01:34:54,600 --> 01:34:55,800 RECOMMENDATIONS, MOBILE HEALTH 2458 01:34:55,800 --> 01:34:56,560 TECHNOLOGY, CANCER 2459 01:34:56,560 --> 01:34:58,680 IMMUNOTHERAPY, A REAL GROWTH 2460 01:34:58,680 --> 01:35:06,040 AREA, RESULTED IN ADDITIONAL 2461 01:35:06,040 --> 01:35:12,240 STUDY SECTIONS BEING CREATED. 2462 01:35:12,240 --> 01:35:15,880 A MAJOR INITIATIVE HAS BEEN TO 2463 01:35:15,880 --> 01:35:17,520 SIMPLIFY THE REVIEW, AND 2464 01:35:17,520 --> 01:35:18,920 OPTIMIZE REVIEW OF RESEARCH 2465 01:35:18,920 --> 01:35:20,080 PROJECT GRANT APPLICATIONS WHICH 2466 01:35:20,080 --> 01:35:25,440 IS THE BREAD AND BUTTER OF WHAT 2467 01:35:25,440 --> 01:35:26,600 OF WHAT NIH FUNDS. 2468 01:35:26,600 --> 01:35:33,520 TWO MAIN GOALS. 2469 01:35:33,520 --> 01:35:35,840 FIRST LEVEL OF PEER REVIEW TO 2470 01:35:35,840 --> 01:35:36,800 PROVIDE SCIENTIFIC MERIT ADVICE 2471 01:35:36,800 --> 01:35:37,920 TO THE AGENCY. 2472 01:35:37,920 --> 01:35:40,080 OVER THE LAST MANY YEARS, MORE 2473 01:35:40,080 --> 01:35:41,400 AND MORE ADMINISTRATIVE ITEMS 2474 01:35:41,400 --> 01:35:42,920 HAVE BEEN ADDED TO THE 2475 01:35:42,920 --> 01:35:44,360 REVIEWER'S PLATE WHICH HAS BEEN 2476 01:35:44,360 --> 01:35:49,480 A BURDEN AND MORE IMPORTANTLY IT 2477 01:35:49,480 --> 01:35:50,560 DETRACTS ATTENTION FROM 2478 01:35:50,560 --> 01:35:52,000 SCIENTIFIC MERIT EVALUATION SO 2479 01:35:52,000 --> 01:35:54,200 TO OPTIMIZE WE WANTED TO REFOCUS 2480 01:35:54,200 --> 01:35:55,520 THE FIRST LEVEL OF PEER REVIEW 2481 01:35:55,520 --> 01:35:58,720 ON THE SINGULAR GOAL OF 2482 01:35:58,720 --> 01:36:00,360 PROVIDING SCIENTIFIC MERIT 2483 01:36:00,360 --> 01:36:00,640 EVALUATION. 2484 01:36:00,640 --> 01:36:03,040 ALONG WITH THAT, THIS WAS AN 2485 01:36:03,040 --> 01:36:04,160 OPPORTUNITY TO REALLY MITIGATE 2486 01:36:04,160 --> 01:36:07,200 OR MAKE AN ATTEMPT TO MITIGATE 2487 01:36:07,200 --> 01:36:08,080 WHAT I'M CALLING REPUTATIONAL 2488 01:36:08,080 --> 01:36:10,840 BIAS IN THE PEER REVIEW PROCESS. 2489 01:36:10,840 --> 01:36:13,760 PEER REVIEW IS NOT ITS OWN 2490 01:36:13,760 --> 01:36:14,880 ENTITY. 2491 01:36:14,880 --> 01:36:16,760 IT'S PART -- INVOLVES 19,000 2492 01:36:16,760 --> 01:36:19,040 RESEARCHERS, ALL PART OF YOUR 2493 01:36:19,040 --> 01:36:20,880 INSTITUTIONS AND THE LARGER 2494 01:36:20,880 --> 01:36:22,320 BIOMEDICAL PARADIGM. 2495 01:36:22,320 --> 01:36:24,960 THAT HAS REPUTATIONAL BIAS. 2496 01:36:24,960 --> 01:36:26,640 WHO TRAINED WITH WHO, WHO WENT 2497 01:36:26,640 --> 01:36:29,760 TO WHICH SCHOOL, T1 SCHOOLS 2498 01:36:29,760 --> 01:36:31,560 VERSUS NEXT LEVEL, THAT COMES 2499 01:36:31,560 --> 01:36:35,160 THROUGH IN PEER REVIEW LIKE IT 2500 01:36:35,160 --> 01:36:36,760 DOES IN OTHER PLACES IN THE 2501 01:36:36,760 --> 01:36:37,160 COMMUNITY. 2502 01:36:37,160 --> 01:36:39,320 SO THE GOAL HERE WAS TO GET BACK 2503 01:36:39,320 --> 01:36:42,000 TO THE MAIN GOAL OF PEER REVIEW, 2504 01:36:42,000 --> 01:36:43,920 WHICH IS IDENTIFICATION OF THE 2505 01:36:43,920 --> 01:36:45,000 STRONGEST HIGHEST IMPACT 2506 01:36:45,000 --> 01:36:45,320 RESEARCH. 2507 01:36:45,320 --> 01:36:47,840 WE DO THAT BY ENSURING THAT THE 2508 01:36:47,840 --> 01:36:48,840 EVALUATION OF THE INVESTIGATOR 2509 01:36:48,840 --> 01:36:50,360 AND ENVIRONMENT IS DONE IN THE 2510 01:36:50,360 --> 01:36:55,280 CONTEXT OF THE PROJECT THAT'S 2511 01:36:55,280 --> 01:36:55,680 BEING PROPOSED. 2512 01:36:55,680 --> 01:37:00,440 I'LL TELL YOU A BIT MORE ABOUT 2513 01:37:00,440 --> 01:37:00,760 THAT. 2514 01:37:00,760 --> 01:37:02,320 A LONG SLIDE BUT THE GOAL TO 2515 01:37:02,320 --> 01:37:05,880 SHOW YOU WE'VE BEEN DOING THIS 2516 01:37:05,880 --> 01:37:06,560 SINCE EARLY -- SINCE JANUARY 2517 01:37:06,560 --> 01:37:09,520 2020 AND OF COURSE THE PANDEMIC 2518 01:37:09,520 --> 01:37:11,960 HIT, BUT WE CONTINUED THROUGH 2519 01:37:11,960 --> 01:37:12,160 IT. 2520 01:37:12,160 --> 01:37:13,680 WE ENGAGED OUR CSR ADVISORY 2521 01:37:13,680 --> 01:37:15,000 COUNCIL AND FORMED WORKING 2522 01:37:15,000 --> 01:37:16,520 GROUPS OF THE ADVISORY COUNCIL 2523 01:37:16,520 --> 01:37:18,600 TO COME UP WITH RECOMMENDATIONS 2524 01:37:18,600 --> 01:37:20,600 THAT WOULD ADDRESS THOSE TWO 2525 01:37:20,600 --> 01:37:24,040 GOALS OF REDUCING ADMINISTRATIVE 2526 01:37:24,040 --> 01:37:25,480 BURDEN, MITIGATING REPUTATIONAL 2527 01:37:25,480 --> 01:37:25,680 BIAS. 2528 01:37:25,680 --> 01:37:27,880 IT WENT THROUGH A SERIES OF 2529 01:37:27,880 --> 01:37:28,480 APPROVALS AND PROCESS. 2530 01:37:28,480 --> 01:37:31,600 WE GOT A LOT OF INPUT AT THE 2531 01:37:31,600 --> 01:37:32,400 FRONT END. 2532 01:37:32,400 --> 01:37:33,520 WE PROVIDED SOME LEGAL AND 2533 01:37:33,520 --> 01:37:34,920 REGULATORY GUARD RAILS TO THE 2534 01:37:34,920 --> 01:37:37,120 WORKING GROUPS. 2535 01:37:37,120 --> 01:37:39,280 ONE IS THAT THE PUBLIC HEALTH 2536 01:37:39,280 --> 01:37:40,600 SERVICE CODE OF FEDERAL 2537 01:37:40,600 --> 01:37:42,520 REGULATIONS BY WHICH PEER REVIEW 2538 01:37:42,520 --> 01:37:45,440 FUNCTIONS AND WHICH IS HARD 2539 01:37:45,440 --> 01:37:46,600 WIRED REQUIRES FIVE REVIEW 2540 01:37:46,600 --> 01:37:47,840 CRITERIA. 2541 01:37:47,840 --> 01:37:49,160 AND THOSE ARE THE FIVE REVIEW 2542 01:37:49,160 --> 01:37:50,560 CRITERIA YOU'RE FAMILIAR WITH. 2543 01:37:50,560 --> 01:37:53,880 WE CAN'T REALLY CHANGE THAT 2544 01:37:53,880 --> 01:37:57,120 WITHOUT GOING TO CONGRESS. 2545 01:37:57,120 --> 01:37:59,760 BUT NIH HAS DISCRETION HOW WE 2546 01:37:59,760 --> 01:38:00,760 INTERPRET CRITERIA, GROUP THEM, 2547 01:38:00,760 --> 01:38:01,640 SCORE THEM. 2548 01:38:01,640 --> 01:38:04,800 SO THE WORKING GROUP TOOK THAT 2549 01:38:04,800 --> 01:38:05,760 VERY SERIOUSLY. 2550 01:38:05,760 --> 01:38:07,440 IN DECEMBER THROUGH MARCH WE HAD 2551 01:38:07,440 --> 01:38:09,160 A PUBLIC REQUEST FOR 2552 01:38:09,160 --> 01:38:12,360 INFORMATION, RFI, THAT WAS OPEN. 2553 01:38:12,360 --> 01:38:14,760 AND I'LL TELL YOU ABOUT THE 2554 01:38:14,760 --> 01:38:15,560 FEEDBACK FROM THAT. 2555 01:38:15,560 --> 01:38:20,440 LET ME SHOW WHAT IS BEING 2556 01:38:20,440 --> 01:38:20,720 PROPOSED. 2557 01:38:20,720 --> 01:38:21,560 SO, THE MAIN RECOMMENDATION 2558 01:38:21,560 --> 01:38:24,040 THAT'S COME OUT IS TO TAKE THE 2559 01:38:24,040 --> 01:38:26,600 EXISTING FIVE CRITERIA AND GROUP 2560 01:38:26,600 --> 01:38:28,320 THEM INTO THREE FACTORS, YOU 2561 01:38:28,320 --> 01:38:29,080 KNOW, WHICH IS REALLY IF YOU 2562 01:38:29,080 --> 01:38:30,720 THINK ABOUT IT SHOULD IT BE 2563 01:38:30,720 --> 01:38:39,320 DONE, CAN IT BE DONE, WILL IT E 2564 01:38:39,320 --> 01:38:40,920 DONE, RIGOR AND FEASIBILITY, 2565 01:38:40,920 --> 01:38:45,360 EACH FACTOR WILL BE SCORED 1 TO 2566 01:38:45,360 --> 01:38:47,160 9, AFFECTING OVERALL IMPACT 2567 01:38:47,160 --> 01:38:48,160 SCORE. 2568 01:38:48,160 --> 01:38:50,320 THE FACTOR 3 EXPERTISE AND 2569 01:38:50,320 --> 01:38:51,640 RESOURCE, REMEMBER WE'RE 2570 01:38:51,640 --> 01:38:52,680 EVALUATING INVESTIGATOR AND 2571 01:38:52,680 --> 01:38:54,680 ENVIRONMENT, THE CONTEXT OF THE 2572 01:38:54,680 --> 01:38:57,200 RESEARCH PROJECT GRANT, DO THEY 2573 01:38:57,200 --> 01:38:58,760 HAVE THE EXPERTISE, THE 2574 01:38:58,760 --> 01:39:00,240 INVESTIGATORS, AND DOES THE 2575 01:39:00,240 --> 01:39:01,920 ENVIRONMENT HAVE THE RESOURCES? 2576 01:39:01,920 --> 01:39:06,880 AND HERE WE TOOK AWAY THE 1-9 2577 01:39:06,880 --> 01:39:11,800 BECAUSE WHEN YOU GIVE 9, BIAS 2578 01:39:11,800 --> 01:39:13,280 CREEPS IN. 2579 01:39:13,280 --> 01:39:14,200 SOMEONE'S AT HARVARD, THEY WILL 2580 01:39:14,200 --> 01:39:16,600 GET A 1 RIGHT NOW IN 2581 01:39:16,600 --> 01:39:16,920 ENVIRONMENT. 2582 01:39:16,920 --> 01:39:19,000 SOMEONE IS -- I DON'T KNOW, 2583 01:39:19,000 --> 01:39:21,200 MIDDLE OF THE COUNTRY, HBCU, 2584 01:39:21,200 --> 01:39:22,560 THEY HAVE THE RESOURCES, 2585 01:39:22,560 --> 01:39:24,600 EVERYTHING THAT'S NEEDED TO DO 2586 01:39:24,600 --> 01:39:33,040 THE R01, MIGHT GET A 3. 2587 01:39:33,040 --> 01:39:35,560 BY MAKING THE BINARY, OR THERE'S 2588 01:39:35,560 --> 01:39:38,160 A GAP, IF THERE'S A GAP THEY ARE 2589 01:39:38,160 --> 01:39:39,360 DROPPED DOWN, PICK THE GAPS, 2590 01:39:39,360 --> 01:39:42,880 THEY HAVE TO GET SPECIFIC ABOUT 2591 01:39:42,880 --> 01:39:45,280 WHAT'S LACKING. 2592 01:39:45,280 --> 01:39:47,240 THE MORE SPECIFIC REVIEW 2593 01:39:47,240 --> 01:39:48,880 CRITERIA ARE, THE LESS LIKELY 2594 01:39:48,880 --> 01:39:50,960 BIAS WILL CREEP IN, NOT JUST 2595 01:39:50,960 --> 01:39:52,280 SCIENTIFIC, THAT'S IN THE 2596 01:39:52,280 --> 01:39:56,240 LITERATURE TO MAKE THE CRITERIA 2597 01:39:56,240 --> 01:39:56,440 CLEAR. 2598 01:39:56,440 --> 01:39:58,840 THE FACTOR 3 WILL STILL AFFECT 2599 01:39:58,840 --> 01:40:00,960 OVERALL IMPACT SCORE. 2600 01:40:00,960 --> 01:40:02,480 IF EXPERTISE IS LACKING IT 2601 01:40:02,480 --> 01:40:09,640 SHOULD AFFECT THE SCORE. 2602 01:40:09,640 --> 01:40:11,120 HUMAN SUBJECTS, ANIMALS, REMAINS 2603 01:40:11,120 --> 01:40:11,520 UNCHANGED. 2604 01:40:11,520 --> 01:40:13,520 THERE WERE A NUMBER OF REVIEW 2605 01:40:13,520 --> 01:40:15,280 CONSIDERATIONS, THESE ARE THINGS 2606 01:40:15,280 --> 01:40:16,760 THAT DON'T AFFECT OVERALL IMPACT 2607 01:40:16,760 --> 01:40:17,800 SCORE RIGHT NOW BUT THERE'S A 2608 01:40:17,800 --> 01:40:21,040 LOT OF STUFF THAT REVIEWERS HAVE 2609 01:40:21,040 --> 01:40:27,440 TO ADDRESS, THOSE HAVE BEEN 2610 01:40:27,440 --> 01:40:28,000 REMOVED. 2611 01:40:28,000 --> 01:40:29,600 WE ASKED FOR SCIENTIFIC INPUT, 2612 01:40:29,600 --> 01:40:31,200 THIS CAN BE DONE 2613 01:40:31,200 --> 01:40:33,000 ADMINISTRATIVELY INTERNALLY. 2614 01:40:33,000 --> 01:40:35,120 SO THE RFI CLOSED IN MARCH. 2615 01:40:35,120 --> 01:40:38,920 WE GOT OVER 800 RESPONSES FROM 2616 01:40:38,920 --> 01:40:39,800 SOCIETIES, YOU KNOW, 2617 01:40:39,800 --> 01:40:41,240 INSTITUTIONS, INDIVIDUALS. 2618 01:40:41,240 --> 01:40:42,600 BECAUSE WE GOT SO MUCH INPUT ON 2619 01:40:42,600 --> 01:40:44,440 THE FRONT END OF THIS WHOLE 2620 01:40:44,440 --> 01:40:46,840 PROCESS AND WE INVOLVED OUR 2621 01:40:46,840 --> 01:40:48,600 WORKING GROUPS OF THE COUNCIL, 2622 01:40:48,600 --> 01:40:51,840 IT WASN'T A SURPRISE WE GOT A 2623 01:40:51,840 --> 01:40:53,320 LOT OF POSITIVE FEEDBACK. 2624 01:40:53,320 --> 01:40:54,800 A MAJORITY OF PEOPLE THOUGHT 2625 01:40:54,800 --> 01:40:57,560 THESE WERE GOOD CHANGES. 2626 01:40:57,560 --> 01:40:59,160 MINORITY STILL FELT FACTOR 3 2627 01:40:59,160 --> 01:41:00,160 SHOULD BE SCORED, INVESTIGATOR 2628 01:41:00,160 --> 01:41:00,800 AND ENVIRONMENT. 2629 01:41:00,800 --> 01:41:04,520 WE EXPECTED A BIT OF THAT TOO. 2630 01:41:04,520 --> 01:41:06,400 MOST RECOMMENDED THAT WE 2631 01:41:06,400 --> 01:41:07,000 DEVELOPED STRONG TRAINING 2632 01:41:07,000 --> 01:41:10,000 RESOURCES, THIS WILL BE A BIG 2633 01:41:10,000 --> 01:41:11,120 SOCIALIZED CHANGE FOR REVIEWERS, 2634 01:41:11,120 --> 01:41:13,080 WE'RE PLANNING TO DO THAT IN A 2635 01:41:13,080 --> 01:41:13,960 SYSTEMATIC WAY. 2636 01:41:13,960 --> 01:41:15,680 WE HAVE A WHOLE OFFICE OF 2637 01:41:15,680 --> 01:41:16,760 TRAINING AND DEVELOPMENT AND I 2638 01:41:16,760 --> 01:41:18,920 DON'T KNOW IF YOU HAD A CHANCE 2639 01:41:18,920 --> 01:41:21,400 TO TAKE MODULES THAT WE RECENTLY 2640 01:41:21,400 --> 01:41:25,000 DEVELOPED BUT WE PLAN TO DO THAT 2641 01:41:25,000 --> 01:41:26,720 CENTRALLY AND CAREFULLY TOO. 2642 01:41:26,720 --> 01:41:30,080 THERE IS A TRANS-NIH 2643 01:41:30,080 --> 01:41:30,760 IMPLEMENTATION COMMITTEE THAT 2644 01:41:30,760 --> 01:41:32,440 HAS I.C. REPRESENTATIVES, OFFICE 2645 01:41:32,440 --> 01:41:33,760 OF EXTRAMURAL RESEARCH, SYSTEMS 2646 01:41:33,760 --> 01:41:35,280 CHANGES THAT NEED TO HAPPEN. 2647 01:41:35,280 --> 01:41:37,120 A LOT OF DOMAIN EXPERTISE. 2648 01:41:37,120 --> 01:41:41,600 THEY ARE READY TO MOVE FORWARD 2649 01:41:41,600 --> 01:41:44,680 WITH SOCIALIZING THIS FORWARD. 2650 01:41:44,680 --> 01:41:48,600 TENTATIVE IMPLEMENTATION DATE IS 2651 01:41:48,600 --> 01:41:51,720 FOR OCTOBER 2024 WHICH WOULD BE 2652 01:41:51,720 --> 01:41:52,920 FEBRUARY/MARCH 2025, MAY GET 2653 01:41:52,920 --> 01:41:56,960 PUSHED ANOTHER ROUND BUT WE'RE 2654 01:41:56,960 --> 01:41:57,960 NOT SURE YET. 2655 01:41:57,960 --> 01:41:59,720 I WANT TO ACKNOWLEDGE OUR 2656 01:41:59,720 --> 01:42:01,360 ADVISORY COUNCIL WORKING GROUPS 2657 01:42:01,360 --> 01:42:03,400 ON SIMPLIFYING REVIEW. 2658 01:42:03,400 --> 01:42:04,360 WE HAD TWO WORKING GROUPS, ONE 2659 01:42:04,360 --> 01:42:06,280 ON CLINICAL TRIALS, ONE ON 2660 01:42:06,280 --> 01:42:07,960 NON-CLINICAL TRIALS, SO THAT'S 2661 01:42:07,960 --> 01:42:10,480 10% OF NIH APPLICATIONS ARE 2662 01:42:10,480 --> 01:42:11,000 CLINICAL TRIALS. 2663 01:42:11,000 --> 01:42:12,000 MAJORITY ARE NOT. 2664 01:42:12,000 --> 01:42:16,360 WE GOT EXPERTISE FROM OUR 2665 01:42:16,360 --> 01:42:20,360 COUNCIL AS WELL AS OUTSIDE AD 2666 01:42:20,360 --> 01:42:22,800 HOC MEMBERS. 2667 01:42:22,800 --> 01:42:25,360 THAT WAS RPGs, RESEARCH 2668 01:42:25,360 --> 01:42:32,000 PROJECT GARAGES. 2669 01:42:32,000 --> 01:42:33,480 GRANTS. 2670 01:42:33,480 --> 01:42:34,520 WE'RE TACKLING RESEARCH 2671 01:42:34,520 --> 01:42:35,920 APPLICATIONS. 2672 01:42:35,920 --> 01:42:38,280 THIS ENDED UP MOVING A LOT 2673 01:42:38,280 --> 01:42:39,480 FASTER THAN RPGs DID. 2674 01:42:39,480 --> 01:42:42,400 WE CONVENED A WORKING GROUP OF 2675 01:42:42,400 --> 01:42:44,040 OUR ADVISORY COUNCIL IN 2022, 2676 01:42:44,040 --> 01:42:45,800 AND AGAIN SIMILAR TO THE 2677 01:42:45,800 --> 01:42:49,000 PREVIOUS GROUP THEY GATHERED 2678 01:42:49,000 --> 01:42:50,400 DATA, COMMUNITY FEEDBACK. 2679 01:42:50,400 --> 01:42:52,160 THE BIG FEEDBACK WE HEARD WAS 2680 01:42:52,160 --> 01:42:54,240 THAT NIH IS LEAVING OUT REALLY 2681 01:42:54,240 --> 01:42:55,360 PROMISING SCIENTISTS OF THE 2682 01:42:55,360 --> 01:42:57,720 FUTURE BECAUSE WE HAVE A PROCESS 2683 01:42:57,720 --> 01:43:01,160 THAT ONCE AGAIN HAS REPUTATIONAL 2684 01:43:01,160 --> 01:43:04,840 BIAS BUILT INTO IT. 2685 01:43:04,840 --> 01:43:08,760 SO, WE -- THE CONCERNS WERE 2686 01:43:08,760 --> 01:43:11,920 MATCHED BY DATA WE OBTAINED 2687 01:43:11,920 --> 01:43:13,800 WHICH IS THE FELLOWSHIP 2688 01:43:13,800 --> 01:43:15,480 APPLICATIONS CONCENTRATED IN A 2689 01:43:15,480 --> 01:43:17,320 SMALL NUMBER OF INSTITUTIONS. 2690 01:43:17,320 --> 01:43:19,120 THEY SUBMIT THE MOST 2691 01:43:19,120 --> 01:43:19,440 APPLICATIONS. 2692 01:43:19,440 --> 01:43:20,720 THOSE THAT SUBMIT THE MOST 2693 01:43:20,720 --> 01:43:23,920 APPLICATIONS TEND TO BE REALLY 2694 01:43:23,920 --> 01:43:24,920 SUCCESSFUL IN REVIEW. 2695 01:43:24,920 --> 01:43:32,760 AND THEN THE THE RANK OF THE SR 2696 01:43:32,760 --> 01:43:34,360 MATTERS, STRONG ASSISTANT 2697 01:43:34,360 --> 01:43:36,120 PROFESSORS WANT FELLOWS IN THEIR 2698 01:43:36,120 --> 01:43:37,920 LAB, NOT ABLE TO GET THROUGH THE 2699 01:43:37,920 --> 01:43:38,360 REVIEW PROCESS. 2700 01:43:38,360 --> 01:43:41,600 HERE IS A LITTLE BIT OF DATA 2701 01:43:41,600 --> 01:43:42,200 FROM ONE YEAR, 2021. 2702 01:43:42,200 --> 01:43:46,160 YOU LOOK AT THE NUMBER OF 2703 01:43:46,160 --> 01:43:47,520 APPLICATIONS SUBMITTED. 2704 01:43:47,520 --> 01:43:49,160 15 INSTITUTIONS ACCOUNT FOR MORE 2705 01:43:49,160 --> 01:43:52,440 THAN 100 APPLICATIONS PER YEAR. 2706 01:43:52,440 --> 01:43:55,080 AND THEN MAJORITY OF 2707 01:43:55,080 --> 01:43:56,600 INSTITUTIONS, 106 OR SO, COMMIT 2708 01:43:56,600 --> 01:43:59,120 JUST ONE TO TWO APPLICATIONS PER 2709 01:43:59,120 --> 01:44:03,320 YEAR. 2710 01:44:03,320 --> 01:44:05,040 AND EVERYTHING IN THE MIDDLE IF 2711 01:44:05,040 --> 01:44:08,760 YOU LOOK AT THOSE INSTITUTIONS 2712 01:44:08,760 --> 01:44:10,520 THAT SUBMIT 1-25 APPLICATIONS A 2713 01:44:10,520 --> 01:44:13,760 YEAR, MOST ARE NOT SCORED, AND 2714 01:44:13,760 --> 01:44:15,160 29 PERCENT GET HIGH IMPACT 2715 01:44:15,160 --> 01:44:15,360 SCORE. 2716 01:44:15,360 --> 01:44:17,520 IF YOU LOOK AT THE 100+ 2717 01:44:17,520 --> 01:44:18,160 APPLICATION INSTITUTIONS THEY 2718 01:44:18,160 --> 01:44:19,480 ARE MUCH BETTER AT DOING THIS. 2719 01:44:19,480 --> 01:44:20,720 THEY HAVE A FACTORY GOING. 2720 01:44:20,720 --> 01:44:22,960 THEY KNOW WHAT THEY ARE DOING. 2721 01:44:22,960 --> 01:44:26,720 THEY GET HIGHER IMPACT SCORES. 2722 01:44:26,720 --> 01:44:29,400 SO WHATEVER WE HEARD FROM THE 2723 01:44:29,400 --> 01:44:32,440 COMMUNITY WAS BORNE OUT BY THE 2724 01:44:32,440 --> 01:44:32,640 DATA. 2725 01:44:32,640 --> 01:44:34,600 SIMILAR TO THIS, THE ACADEMIC 2726 01:44:34,600 --> 01:44:37,120 RANK OF THE SPONSOR, RIGHT? 2727 01:44:37,120 --> 01:44:40,720 ASSISTANT PROFESSORS, IF YOU'RE 2728 01:44:40,720 --> 01:44:41,400 ASSISTANT PROFESSOR SINGLE 2729 01:44:41,400 --> 01:44:44,840 SPONSOR MOST LIKELY YOU'LL GET 2730 01:44:44,840 --> 01:44:45,400 UNSCORED. 2731 01:44:45,400 --> 01:44:48,320 25% GET HIGH IMPACT. 2732 01:44:48,320 --> 01:44:49,200 ASSOCIATE PROFESSOR, FULL 2733 01:44:49,200 --> 01:44:50,640 PROFESSOR TENDS TO INCREASE. 2734 01:44:50,640 --> 01:44:51,560 OTHER IS EVEN HIGHER. 2735 01:44:51,560 --> 01:44:53,560 YOU WOULD THINK WHY IS OTHER 2736 01:44:53,560 --> 01:44:54,000 HIGHER? 2737 01:44:54,000 --> 01:44:58,000 THESE ARE DEANS AND PROVOSTS, 2738 01:44:58,000 --> 01:44:58,920 SORT OF THE UBER-PROFESSORS, YOU 2739 01:44:58,920 --> 01:45:02,000 CAN THINK OF IDENTIFY THAT WAY. 2740 01:45:02,000 --> 01:45:06,440 SIMILAR TREND WITH MULTIPLE 2741 01:45:06,440 --> 01:45:06,720 SPONSORS. 2742 01:45:06,720 --> 01:45:10,320 SO OUR APPROACH HERE WAS TO 2743 01:45:10,320 --> 01:45:10,960 REVISE FELLOWSHIP APPLICATIONS, 2744 01:45:10,960 --> 01:45:13,600 RECOMMENDATION OF THE WORKING 2745 01:45:13,600 --> 01:45:14,400 GROUP, REVISE FELLOWSHIP 2746 01:45:14,400 --> 01:45:17,360 APPLICATION TO MAKE SURE THE 2747 01:45:17,360 --> 01:45:18,640 CANDIDATES' ACCOMPLISHMENTS CAN 2748 01:45:18,640 --> 01:45:21,280 REALLY BE HIGHLIGHTED IN A VERY 2749 01:45:21,280 --> 01:45:22,200 TARGETED WAY. 2750 01:45:22,200 --> 01:45:25,040 AND THEN TO ALSO REVISE REVIEW 2751 01:45:25,040 --> 01:45:26,400 CRITERIA, AGAIN TO BETTER FOCUS 2752 01:45:26,400 --> 01:45:27,680 ON POTENTIAL OF THE APPLICANT 2753 01:45:27,680 --> 01:45:30,480 AND STRENGTH OF THE SCIENCE AND 2754 01:45:30,480 --> 01:45:33,400 HOW GOOD AND TARGETED THAT 2755 01:45:33,400 --> 01:45:34,600 TRAINING PLAN IS. 2756 01:45:34,600 --> 01:45:38,120 WE WANTED TO REMOVE INFLUENCE OF 2757 01:45:38,120 --> 01:45:40,760 INSTITUTION'S REPUTATION OR 2758 01:45:40,760 --> 01:45:42,920 SPONSOR'S REPUTATION, SIMILAR TO 2759 01:45:42,920 --> 01:45:43,120 RPGs. 2760 01:45:43,120 --> 01:45:44,160 THE BROADER GOAL, WE'RE TRYING 2761 01:45:44,160 --> 01:45:47,040 TO IDENTIFY THE MOST PROMISING 2762 01:45:47,040 --> 01:45:52,040 TRAINEES, NOT JUST MOST FROM 2763 01:45:52,040 --> 01:45:53,000 CERTAIN INSTITUTIONS AND 2764 01:45:53,000 --> 01:45:53,520 PEDIGREES. 2765 01:45:53,520 --> 01:45:53,920 OKAY. 2766 01:45:53,920 --> 01:45:56,080 I WON'T GO THROUGH ALL THIS. 2767 01:45:56,080 --> 01:45:59,240 IT'S AN RFI, IT'S PUBLIC, OPEN 2768 01:45:59,240 --> 01:46:00,040 FOR PUBLIC INPUT. 2769 01:46:00,040 --> 01:46:02,440 THE BIG CHANGE HAS BEEN TO 2770 01:46:02,440 --> 01:46:04,360 ELIMINATE GRADES, THAT WAS SORT 2771 01:46:04,360 --> 01:46:07,320 OF A UNANIMOUS KIND OF PUSH FROM 2772 01:46:07,320 --> 01:46:08,800 THE WORKING GROUP AND REALLY HAS 2773 01:46:08,800 --> 01:46:12,240 BEEN ONE OF OUR ISSUES. 2774 01:46:12,240 --> 01:46:16,760 A NUMBER OF OTHER CHANGES THAT 2775 01:46:16,760 --> 01:46:19,480 VERY MUCH FOCUS ON TARGETED 2776 01:46:19,480 --> 01:46:22,680 REVIEWS, MAKING SURE THAT 2777 01:46:22,680 --> 01:46:26,240 APPLICANTS GET TO PRESENT THEIR 2778 01:46:26,240 --> 01:46:28,760 ACCOMPLISHMENTS, IN LIGHT OF 2779 01:46:28,760 --> 01:46:29,480 THEIR OPPORTUNITIES. 2780 01:46:29,480 --> 01:46:31,960 IT ALSO ALLOWS -- THE LETTERS OF 2781 01:46:31,960 --> 01:46:33,160 SUPPORT ARE REVISED, ONE OF THE 2782 01:46:33,160 --> 01:46:36,240 THINGS WE SAW WAS BOILERPLATE 2783 01:46:36,240 --> 01:46:39,640 LANGUAGE, IS THIS A BIG FACTORY 2784 01:46:39,640 --> 01:46:41,480 LAB PRODUCING THE SAME LETTER, 2785 01:46:41,480 --> 01:46:42,480 WHICH STILL GETS THROUGH BECAUSE 2786 01:46:42,480 --> 01:46:44,000 IT'S COMING FROM THAT LAB, 2787 01:46:44,000 --> 01:46:44,560 RIGHT? 2788 01:46:44,560 --> 01:46:47,240 SO REALLY TO MAKE IT MUCH MORE 2789 01:46:47,240 --> 01:46:50,360 TARGETED AND REQUIRE TARGETED 2790 01:46:50,360 --> 01:46:51,160 SUPPORT LETTERS. 2791 01:46:51,160 --> 01:46:52,880 OPTIONAL STATEMENTS OF SPECIAL 2792 01:46:52,880 --> 01:46:53,520 CIRCUMSTANCES, AND THAT'S 2793 01:46:53,520 --> 01:46:54,280 RELATED TO SOMEONE WHO MIGHT 2794 01:46:54,280 --> 01:46:57,680 HAVE HAD TO SWITCH LABS AND THEY 2795 01:46:57,680 --> 01:46:59,800 HAVE AN OPPORTUNITY TO STATE 2796 01:46:59,800 --> 01:47:00,920 THAT. 2797 01:47:00,920 --> 01:47:04,720 SO, THIS IS STILL VERY MUCH OUT 2798 01:47:04,720 --> 01:47:06,520 THERE. 2799 01:47:06,520 --> 01:47:08,040 AND AVAILABLE FOR INPUT. 2800 01:47:08,040 --> 01:47:09,120 SECOND RECOMMENDATION TO CHANGE 2801 01:47:09,120 --> 01:47:10,760 REVIEW CRITERIA. 2802 01:47:10,760 --> 01:47:12,960 REALLY WHAT HAS CHANGED IS 2803 01:47:12,960 --> 01:47:15,320 NOT -- IS THIS SPONSORS 2804 01:47:15,320 --> 01:47:16,200 COLLABORATORS AND CONSULTANTS 2805 01:47:16,200 --> 01:47:17,200 AND INSTITUTIONAL ENVIRONMENT 2806 01:47:17,200 --> 01:47:19,360 AND COMMITMENT TO TRAINING. 2807 01:47:19,360 --> 01:47:20,440 THESE ARE REALLY IMPORTANT, 2808 01:47:20,440 --> 01:47:24,640 THESE ARE REALLY IMPORTANT FOR 2809 01:47:24,640 --> 01:47:25,760 TRAINING FELLOWS. 2810 01:47:25,760 --> 01:47:27,480 BUT SITTING OUT HERE BY 2811 01:47:27,480 --> 01:47:32,200 THEMSELVES THEY TEND TO BE OPEN 2812 01:47:32,200 --> 01:47:33,440 TO BIAS. 2813 01:47:33,440 --> 01:47:35,360 THEY ARE INCORPORATED INTO 2814 01:47:35,360 --> 01:47:38,440 SCIENCE AND SCIENTIFIC RESOURCES 2815 01:47:38,440 --> 01:47:40,600 AND INTO POTENTIAL PREPAREDNESS 2816 01:47:40,600 --> 01:47:41,720 TRAINING PLANNED AND RESOURCES, 2817 01:47:41,720 --> 01:47:43,680 SPONSOR REMAINS IMPORTANT BUT IN 2818 01:47:43,680 --> 01:47:47,720 THE CONTEXT OF THE FELLOWS 2819 01:47:47,720 --> 01:47:48,280 TRAINING PLAN. 2820 01:47:48,280 --> 01:47:48,960 ENVIRONMENT FOR INSTITUTION 2821 01:47:48,960 --> 01:47:53,520 REMAINS IMPORTANT BUT IN CONTEXT 2822 01:47:53,520 --> 01:47:54,520 OF RESOURCES. 2823 01:47:54,520 --> 01:47:59,440 SO THIS WAS APPROVED BY FULL 2824 01:47:59,440 --> 01:48:00,280 ADVISORY COUNCIL, ENDORSED 2825 01:48:00,280 --> 01:48:01,840 WITHOUT CHANGE BY NIH 2826 01:48:01,840 --> 01:48:02,920 LEADERSHIP. 2827 01:48:02,920 --> 01:48:05,320 CURRENTLY WE HAVE THIS RFI OPEN 2828 01:48:05,320 --> 01:48:06,600 THROUGH JUNE 23, IF YOU WANT TO 2829 01:48:06,600 --> 01:48:08,760 KNOW MORE THERE'S A BUNCH OF 2830 01:48:08,760 --> 01:48:10,800 LINKS AND BLOGS. 2831 01:48:10,800 --> 01:48:13,560 I WOULD APPRECIATE IF YOU WOULD 2832 01:48:13,560 --> 01:48:14,560 SHARE WITH YOUR COMMUNITIES 2833 01:48:14,560 --> 01:48:17,520 BECAUSE THERE'S STILL TIME TO 2834 01:48:17,520 --> 01:48:18,440 PROVIDE FEEDBACK. 2835 01:48:18,440 --> 01:48:19,720 AND, AGAIN, I WANT TO 2836 01:48:19,720 --> 01:48:22,320 ACKNOWLEDGE THIS WORKING GROUP 2837 01:48:22,320 --> 01:48:24,840 THAT REALLY WAS VERY COMMITTED, 2838 01:48:24,840 --> 01:48:26,040 WORKED HARD, CAREFULLY LOOKED AT 2839 01:48:26,040 --> 01:48:31,760 THE DATA AND ENGAGED IN A LOT OF 2840 01:48:31,760 --> 01:48:34,240 DISCUSSIONS, THOUGHTFULLY. 2841 01:48:34,240 --> 01:48:34,440 OKAY. 2842 01:48:34,440 --> 01:48:36,960 WHEN I PRESENT THESE CHANGES TO 2843 01:48:36,960 --> 01:48:38,720 THE CRITERIA, SO IF I ONLY HAVE, 2844 01:48:38,720 --> 01:48:43,960 I DON'T KNOW, 20 MINUTES TO 2845 01:48:43,960 --> 01:48:46,240 PRESENT, WHAT ABOUT BIAS IN 2846 01:48:46,240 --> 01:48:47,800 REVIEW AND DIVERSIFYING YOUR 2847 01:48:47,800 --> 01:48:49,640 PANELS, ISN'T THAT JUST AS 2848 01:48:49,640 --> 01:48:50,320 IMPORTANT? 2849 01:48:50,320 --> 01:48:53,280 NOW I NO LONGER TAKE ON SPEAKING 2850 01:48:53,280 --> 01:48:54,320 ASSIGNMENTS UNTIL I CAN PRESENTS 2851 01:48:54,320 --> 01:48:57,560 ALL OF WHAT WE'RE DOING IN THIS 2852 01:48:57,560 --> 01:48:58,000 SPACE. 2853 01:48:58,000 --> 01:49:00,800 THANK YOU FOR ALLOWING THAT 2854 01:49:00,800 --> 01:49:01,160 TIME. 2855 01:49:01,160 --> 01:49:04,760 SO, FIRST OF ALL CSR HAS AROUND 2856 01:49:04,760 --> 01:49:06,640 180 STANDING STUDY SECTIONS 2857 01:49:06,640 --> 01:49:08,600 WHICH MEANS -- MOST CHAIRS SERVE 2858 01:49:08,600 --> 01:49:11,960 TWO-YEAR TERMS SO EVERY TWO 2859 01:49:11,960 --> 01:49:13,600 YEARS -- EVERY YEAR WE GET 90 2860 01:49:13,600 --> 01:49:15,520 NEW CHAIRS INCOMING. 2861 01:49:15,520 --> 01:49:19,960 EVERY SUMMER WE HOLD TWO-HOUR 2862 01:49:19,960 --> 01:49:21,000 INTERACTIVE FACILITATIVE SECTION 2863 01:49:21,000 --> 01:49:22,880 FOR INCOMING CHAIRS. 2864 01:49:22,880 --> 01:49:23,920 THERE'S A NUMBER OF OVERVIEWS 2865 01:49:23,920 --> 01:49:25,680 AND NUTS AND BOLTS BUT A VAST 2866 01:49:25,680 --> 01:49:28,120 MAJORITY OF THE TIME IT'S 2867 01:49:28,120 --> 01:49:30,720 FACILITATED DISCUSSIONS AMONG 2868 01:49:30,720 --> 01:49:31,840 THE CHAIRS USING VIGNETTE-BASED 2869 01:49:31,840 --> 01:49:32,120 FRAMEWORK. 2870 01:49:32,120 --> 01:49:33,720 WE SPEND A LOT OF TIME TALKING 2871 01:49:33,720 --> 01:49:35,560 ABOUT THE INFLUENCE OF THE 2872 01:49:35,560 --> 01:49:37,080 CHAIR, SETTING THE CULTURE OF 2873 01:49:37,080 --> 01:49:42,520 THE STUDY SECTION, HOW TO FOSTER 2874 01:49:42,520 --> 01:49:45,800 INVOLVEMENT, BROADER GROUP OF 2875 01:49:45,800 --> 01:49:47,280 REVIEWERS, AND FOCUSING ON 2876 01:49:47,280 --> 01:49:48,920 SIGNIFICANCE, RIGHT? 2877 01:49:48,920 --> 01:49:52,200 AND IF IT ISN'T MENTIONED WE'RE 2878 01:49:52,200 --> 01:49:55,280 TRAINING CHAIRS TO ASK THE 2879 01:49:55,280 --> 01:49:57,480 QUESTION WHY DO WE CARE BEFORE 2880 01:49:57,480 --> 01:50:00,560 WE GET RIGHT INTO THE DETAILS. 2881 01:50:00,560 --> 01:50:03,840 SO, A COUPLE YEARS AGO WE 2882 01:50:03,840 --> 01:50:05,880 RELEASED THE CSR BIAS AWARENESS 2883 01:50:05,880 --> 01:50:07,040 TRAINING FOR REVIEWERS, WE NOW 2884 01:50:07,040 --> 01:50:09,920 HAVE A CENTRALIZED TRAINING 2885 01:50:09,920 --> 01:50:15,480 OFFICE COMMITTED TO PUSHING OUT 2886 01:50:15,480 --> 01:50:17,400 SOME CENTRALIZED MODULES. 2887 01:50:17,400 --> 01:50:20,200 ONE WAS BIAS AWARE OF TRAINING. 2888 01:50:20,200 --> 01:50:21,440 IT'S NOT IMPLICIT TRAINING, YOU 2889 01:50:21,440 --> 01:50:23,720 GET AS AN EMPLOYEE AT YOUR 2890 01:50:23,720 --> 01:50:25,040 INSTITUTION, IT'S MORE ABOUT 2891 01:50:25,040 --> 01:50:26,720 WHAT'S IN YOUR HEAD, RIGHT? 2892 01:50:26,720 --> 01:50:28,440 ONE OF THE THINGS I WAS VERY 2893 01:50:28,440 --> 01:50:30,520 CAREFUL ABOUT HERE IS THAT WE 2894 01:50:30,520 --> 01:50:32,680 CAN'T GET INSIDE PEOPLE'S HEADS, 2895 01:50:32,680 --> 01:50:35,120 BUT WE CAN MAKE SURE THAT IT 2896 01:50:35,120 --> 01:50:36,880 DOESN'T COME INTO THE PEER 2897 01:50:36,880 --> 01:50:38,280 REVIEW PROCESS, SO WE 2898 01:50:38,280 --> 01:50:40,040 SPECIFICALLY TARGETED THE KINDS 2899 01:50:40,040 --> 01:50:42,240 OF BIASES THAT WE SEE IN THE 2900 01:50:42,240 --> 01:50:43,120 PEER REVIEW PROCESS. 2901 01:50:43,120 --> 01:50:45,840 WE ALSO HAD A WORKING GROUP OF 2902 01:50:45,840 --> 01:50:50,000 COUNCIL HELP US DEVELOP THIS. 2903 01:50:50,000 --> 01:50:51,520 IT'S 30 MINUTES, DELIVERED TO 2904 01:50:51,520 --> 01:50:53,400 REVIEWERS, FOUR WEEKS PRIOR TO 2905 01:50:53,400 --> 01:50:55,160 REVIEW MEETINGS. 2906 01:50:55,160 --> 01:50:56,440 SO FAR MORE THAN 19,000 2907 01:50:56,440 --> 01:50:58,760 REVIEWERS HAVE TAKEN THE 2908 01:50:58,760 --> 01:50:59,080 TRAINING. 2909 01:50:59,080 --> 01:51:02,560 IT'S BEEN VERY POPULAR, FOR 2910 01:51:02,560 --> 01:51:04,640 GOVERNMENT TRAINING IT'S REALLY 2911 01:51:04,640 --> 01:51:04,920 GOOD. 2912 01:51:04,920 --> 01:51:06,600 ACTUALLY IT'S REALLY GOOD ANYWAY 2913 01:51:06,600 --> 01:51:12,000 BUT THIS IS ONE OF THE TWEETS WE 2914 01:51:12,000 --> 01:51:14,400 SAW, FOR GOVERNMENT TRAINING 2915 01:51:14,400 --> 01:51:15,600 THIS WAS REALLY GOOD. 2916 01:51:15,600 --> 01:51:16,320 YEAH, OKAY. 2917 01:51:16,320 --> 01:51:18,320 THE BIGGEST CHANGE HAS BEEN SORT 2918 01:51:18,320 --> 01:51:21,520 OF HOW COMFORTABLE PEOPLE FEEL 2919 01:51:21,520 --> 01:51:22,640 INTERVENING WITH EACH OTHER IN 2920 01:51:22,640 --> 01:51:24,200 THE CONTEXT OF THE STUDY 2921 01:51:24,200 --> 01:51:24,680 SECTION. 2922 01:51:24,680 --> 01:51:31,680 WE'RE ACTUALLY SEEING THAT AN 2923 01:51:31,680 --> 01:51:33,000 ANECDOTALLY. 2924 01:51:33,000 --> 01:51:34,760 THERE'S A FULL SURVEY ANALYSIS 2925 01:51:34,760 --> 01:51:36,040 AFTER WE FIRST LAUNCHED, IT WILL 2926 01:51:36,040 --> 01:51:40,320 BE REQUIRED FOR ALL NIH 2927 01:51:40,320 --> 01:51:45,120 REVIEWERS BEGINNING WITH 2928 01:51:45,120 --> 01:51:47,240 FEBRUARY/MARCH 2024 MEETINGS. 2929 01:51:47,240 --> 01:51:50,400 SIMILAR TO THIS IS INTEGRITY. 2930 01:51:50,400 --> 01:51:51,480 REVIEWER INTEGRITY VERY MUCH 2931 01:51:51,480 --> 01:51:53,240 AFFECTS OUTCOMES EVEN IF THERE'S 2932 01:51:53,240 --> 01:51:55,080 ONE APPLICATION WHERE SOMEONE 2933 01:51:55,080 --> 01:51:57,600 CALLS SOMEONE AND TIPPED THE 2934 01:51:57,600 --> 01:52:00,240 SCALE, IT HAS SORT OF RIPPLING 2935 01:52:00,240 --> 01:52:01,760 EFFECTS ON EVERYONE ELSE. 2936 01:52:01,760 --> 01:52:02,520 USUALLY THE PEOPLE WHO TIP ARE 2937 01:52:02,520 --> 01:52:04,840 THE PEOPLE WHO ARE HIGHLY 2938 01:52:04,840 --> 01:52:05,960 NETWORKED, NOT THE ONES WHO 2939 01:52:05,960 --> 01:52:06,600 AREN'T. 2940 01:52:06,600 --> 01:52:08,560 THIS IS A VERY, VERY IMPORTANT 2941 01:52:08,560 --> 01:52:11,520 INITIATIVE TO MAKE SURE THAT WE 2942 01:52:11,520 --> 01:52:12,800 HAVE SET UP EXPECTATIONS FOR 2943 01:52:12,800 --> 01:52:14,720 WHAT WE WANT REVIEWERS TO BE 2944 01:52:14,720 --> 01:52:15,480 DOING. 2945 01:52:15,480 --> 01:52:17,000 WE HAD A VOLUME 1 BUT WE HAVE A 2946 01:52:17,000 --> 01:52:19,640 VOLUME 2 NOW THAT WE HAVE A 2947 01:52:19,640 --> 01:52:23,040 TRAINING OFFICE AND WE HAVE 2948 01:52:23,040 --> 01:52:24,040 EXPERTISE, VIDEO, TRAINING 2949 01:52:24,040 --> 01:52:24,320 DELIVERY. 2950 01:52:24,320 --> 01:52:28,440 THIS IS, AGAIN, AND INTERACTIVE 2951 01:52:28,440 --> 01:52:28,920 SCENARIO-BASED TRAINING. 2952 01:52:28,920 --> 01:52:30,480 THE CONTENT, IF YOU TAKE THIS 2953 01:52:30,480 --> 01:52:32,120 TRAINING AND SAY THIS CAN'T 2954 01:52:32,120 --> 01:52:34,960 HAPPEN, LET ME TELL YOU IT DID 2955 01:52:34,960 --> 01:52:35,920 HAPPEN. 2956 01:52:35,920 --> 01:52:37,600 EVERYTHING IN THERE IS BASED ON 2957 01:52:37,600 --> 01:52:41,760 REAL CASES THAT WE HAVE. 2958 01:52:41,760 --> 01:52:43,200 MORE THAN 12,000 REVIEWERS 2959 01:52:43,200 --> 01:52:45,040 COMPLETED THE TRAINING. 2960 01:52:45,040 --> 01:52:48,880 THE GOAL IS TO MANAGE INTEGRITY. 2961 01:52:48,880 --> 01:52:50,880 REVIEWERS INTERACT WITH EACH 2962 01:52:50,880 --> 01:52:52,640 OTHER OUTSIDE PEER REVIEW, 2963 01:52:52,640 --> 01:52:54,600 CONFERENCES, WHAT HAPPENS IF 2964 01:52:54,600 --> 01:52:55,880 SOMEONE APPROACHES, WERE YOU 2965 01:52:55,880 --> 01:52:57,200 REVIEWER 2 ON MY APPLICATION? 2966 01:52:57,200 --> 01:52:59,840 I KNOW YOU'RE A MEMBER, THIS IS 2967 01:52:59,840 --> 01:53:01,080 COMING UP NEXT ROUND, WE'RE 2968 01:53:01,080 --> 01:53:02,640 GETTING A LOT MORE REPORTS 2969 01:53:02,640 --> 01:53:04,040 COMING IN BECAUSE I THINK PEOPLE 2970 01:53:04,040 --> 01:53:06,080 FEEL LIKE THEY CAN NOW REPORT 2971 01:53:06,080 --> 01:53:12,960 AND THERE'S -- WE FOLLOW 2972 01:53:12,960 --> 01:53:13,360 THROUGH. 2973 01:53:13,360 --> 01:53:15,760 THIS WILL BE REQUIRED FOR ALL 2974 01:53:15,760 --> 01:53:17,680 NIH REVIEWERS BEGINNING WITH THE 2975 01:53:17,680 --> 01:53:18,800 SAME MEETINGS. 2976 01:53:18,800 --> 01:53:22,600 THEN WHEN HAVE YOU 60,000 2977 01:53:22,600 --> 01:53:23,880 APPLICATIONS AND 1200 MEETINGS, 2978 01:53:23,880 --> 01:53:25,880 I'M NOT UNDER ILLUSION THE 2979 01:53:25,880 --> 01:53:28,400 SYSTEM IS PERFECT. 2980 01:53:28,400 --> 01:53:30,880 THERE ARE BIASES THAT WE NEVER 2981 01:53:30,880 --> 01:53:32,000 KNOW ABOUT. 2982 01:53:32,000 --> 01:53:33,480 WE'RE ENCOURAGING ANYONE, 2983 01:53:33,480 --> 01:53:36,080 APPLICANTS, REVIEWERS, PROGRAM 2984 01:53:36,080 --> 01:53:39,360 STAFF, TO REPORT DIRECTLY ANY 2985 01:53:39,360 --> 01:53:41,280 INSTANCES OF BIAS OR DISRESPECT 2986 01:53:41,280 --> 01:53:43,400 IN STUDY SECTION THAT OCCURS. 2987 01:53:43,400 --> 01:53:50,320 WE HEARD THAT THROUGH LISTENING 2988 01:53:50,320 --> 01:53:50,800 SESSIONS. 2989 01:53:50,800 --> 01:53:52,200 GABRIEL FOSU IS THE CHIEF 2990 01:53:52,200 --> 01:53:54,320 DIVERSITY OFFICER, HE GETS THE 2991 01:53:54,320 --> 01:53:59,040 E-MAIL DIRECTLY, IT'S HIS MAIL 2992 01:53:59,040 --> 01:54:01,760 MAILBOX, HE REPORTS TO ME. 2993 01:54:01,760 --> 01:54:05,280 WE INVESTIGATE EVERY ALLEGATION. 2994 01:54:05,280 --> 01:54:07,480 IF WE AGREE IT WAS FLAWED, WE'LL 2995 01:54:07,480 --> 01:54:09,040 REVIEW IN THE SAME ROUND AND FIX 2996 01:54:09,040 --> 01:54:11,000 THE ISSUE SO IT DOESN'T AFFECT 2997 01:54:11,000 --> 01:54:14,520 THE APPLICANT OR HIS OR HER 2998 01:54:14,520 --> 01:54:14,720 FUNDING. 2999 01:54:14,720 --> 01:54:17,480 IF WE DON'T AGREE WE GUIDE THEM 3000 01:54:17,480 --> 01:54:19,880 THROUGH NORMAL NIH APPEALS 3001 01:54:19,880 --> 01:54:21,400 PROCESS THAT COMES TO COUNCIL. 3002 01:54:21,400 --> 01:54:22,920 BUT THE MOST IMPORTANT THING IS 3003 01:54:22,920 --> 01:54:24,680 THIS LAST BULLET THAT WE ADDED 3004 01:54:24,680 --> 01:54:26,120 MORE RECENTLY OVER THE LAST YEAR 3005 01:54:26,120 --> 01:54:30,680 WHICH IS WE FOLLOW UP WITH THE 3006 01:54:30,680 --> 01:54:31,880 REVIEWERS, IF THERE WAS 3007 01:54:31,880 --> 01:54:32,760 INAPPROPRIATE BIASED COMMENT 3008 01:54:32,760 --> 01:54:34,080 THAT RESULT IN THE RE-REVIEW OF 3009 01:54:34,080 --> 01:54:37,600 APPLICATION ONE OF OUR DIVISION 3010 01:54:37,600 --> 01:54:41,440 DIRECTORS REACHES OUT, HEY, YOU 3011 01:54:41,440 --> 01:54:44,480 WROTE THIS, AND WE WATCH THE 3012 01:54:44,480 --> 01:54:45,000 REACTION. 3013 01:54:45,000 --> 01:54:46,880 MOST ARE CONTRITE, THEY LEARN 3014 01:54:46,880 --> 01:54:48,200 SOMETHING. 3015 01:54:48,200 --> 01:54:48,520 THAT'S GREAT. 3016 01:54:48,520 --> 01:54:50,600 MINORITY OF PEOPLE ARGUE. 3017 01:54:50,600 --> 01:54:54,120 SO WE TAKE ACTION BASED ON WHAT 3018 01:54:54,120 --> 01:54:54,880 WE GET BACK. 3019 01:54:54,880 --> 01:54:57,360 BUT THIS IS ONE WAY TO FOSTER 3020 01:54:57,360 --> 01:54:59,720 CULTURE CHANGE IN THE REVIEWER 3021 01:54:59,720 --> 01:55:00,200 COMMUNITY. 3022 01:55:00,200 --> 01:55:03,680 AND THEN FINALLY I WANT TO TALK 3023 01:55:03,680 --> 01:55:04,840 ABOUT DIVERSIFYING OUR PANEL. 3024 01:55:04,840 --> 01:55:09,240 FIRST OF ALL WE HAVE THIS TOOL 3025 01:55:09,240 --> 01:55:12,000 CALLED REVIEWER FINDER TOOL FOR 3026 01:55:12,000 --> 01:55:12,320 SROs. 3027 01:55:12,320 --> 01:55:14,280 IF YOU INTERACTED YOU KNOW THEY 3028 01:55:14,280 --> 01:55:16,440 ARE VERY BUSY AND ON A SHORT 3029 01:55:16,440 --> 01:55:18,080 TIME LINE TRYING TO FIND 3030 01:55:18,080 --> 01:55:18,520 REVIEWERS. 3031 01:55:18,520 --> 01:55:24,560 THIS IS A VERY NICE USER 3032 01:55:24,560 --> 01:55:27,080 FRIENDLY INTERFACE THAT 3033 01:55:27,080 --> 01:55:27,960 INCORPORATES NORMAL NIH-FUNDED 3034 01:55:27,960 --> 01:55:31,000 APPLICANT POOL BUT OTHER AGENCY 3035 01:55:31,000 --> 01:55:32,320 FUNDED, RECOMMENDED BY 3036 01:55:32,320 --> 01:55:34,000 SOCIETIES, INSTITUTE PROGRAM 3037 01:55:34,000 --> 01:55:35,640 STAFF RECOMMENDATIONS, EARLY 3038 01:55:35,640 --> 01:55:38,000 CAREER REVIEWERS, AND A NUMBER 3039 01:55:38,000 --> 01:55:39,440 OF OTHER SOURCES THAT THEY CAN 3040 01:55:39,440 --> 01:55:41,640 SEE, IF THEY PUNCH IN JUST THE 3041 01:55:41,640 --> 01:55:43,240 KEY TERMS OR STUDY SECTION NAME 3042 01:55:43,240 --> 01:55:45,240 THEY GET A BUNCH OF NAMES AND 3043 01:55:45,240 --> 01:55:46,760 HOPEFULLY SEE NAMES THEY DON'T 3044 01:55:46,760 --> 01:55:47,480 KNOW. 3045 01:55:47,480 --> 01:55:49,120 IT'S NOT THEIR NETWORK. 3046 01:55:49,120 --> 01:55:49,920 SROs HAVE NETWORKS. 3047 01:55:49,920 --> 01:55:51,240 I HAVE A NETWORK. 3048 01:55:51,240 --> 01:55:52,200 YOU HAVE A NETWORK. 3049 01:55:52,200 --> 01:55:54,200 WE WANT TO MAKE SURE THEY HAVE 3050 01:55:54,200 --> 01:55:57,520 ACCESS TO A BROAD POOL. 3051 01:55:57,520 --> 01:55:59,680 BUT IT'S BEYOND TOOLS. 3052 01:55:59,680 --> 01:56:00,680 IT'S CULTURE EVERYWHERE. 3053 01:56:00,680 --> 01:56:02,480 YOU CAN'T JUST THROW OUT A TOOL 3054 01:56:02,480 --> 01:56:06,120 AND EXPECT THINGS TO WORK. 3055 01:56:06,120 --> 01:56:09,000 AND OVER THE LAST THREE YEARS 3056 01:56:09,000 --> 01:56:10,000 WE'VE BEEN REALLY EMPHASIZING 3057 01:56:10,000 --> 01:56:12,120 HOW IMPORTANT IT IS FOR THE 3058 01:56:12,120 --> 01:56:14,400 AGENCY TO HEAR DIVERSE 3059 01:56:14,400 --> 01:56:15,600 PERSPECTIVES, TO MAKE SURE WE'RE 3060 01:56:15,600 --> 01:56:17,800 IDENTIFYING THE BEST AND MOST 3061 01:56:17,800 --> 01:56:19,640 DISRUPTIVE SCIENCE, IF WE INVITE 3062 01:56:19,640 --> 01:56:22,360 THE SAME PEOPLE FROM THE SAME 3063 01:56:22,360 --> 01:56:23,960 LABS, FROM THE SAME PEDIGREE 3064 01:56:23,960 --> 01:56:26,240 WE'RE NOT GOING TO SEE THAT. 3065 01:56:26,240 --> 01:56:29,080 SO GETTING THAT THROUGH FOR OUR 3066 01:56:29,080 --> 01:56:31,760 STAFF HAS BEEN IMPORTANT. 3067 01:56:31,760 --> 01:56:33,560 AND ALSO LINKING TO QUALITY, THE 3068 01:56:33,560 --> 01:56:35,120 HIGHEST QUALITY REVIEW 3069 01:56:35,120 --> 01:56:37,520 COMMITTEES ARE THOSE THAT ARE 3070 01:56:37,520 --> 01:56:40,440 DIVERSE IN MULTIPLE DIMENSIONS. 3071 01:56:40,440 --> 01:56:41,880 AND THAT'S DEMOGRAPHIC AND 3072 01:56:41,880 --> 01:56:45,600 GEOGRAPHIC BUT ALSO CAREER STAGE 3073 01:56:45,600 --> 01:56:46,720 AND ALSO SCIENTIFIC BACKGROUND 3074 01:56:46,720 --> 01:56:48,960 AND PERSPECTIVE. 3075 01:56:48,960 --> 01:56:50,640 YOU DON'T WANT PEOPLE FROM THE 3076 01:56:50,640 --> 01:56:51,440 SAME LINEAGE. 3077 01:56:51,440 --> 01:56:54,120 YOU WANT AN OPENNESS TO 3078 01:56:54,120 --> 01:56:55,920 DIFFERENT IDEAS. 3079 01:56:55,920 --> 01:56:57,640 OUR STANDING STUDY SECTION 3080 01:56:57,640 --> 01:56:59,120 MEMBERSHIP PROCESS IS VERY 3081 01:56:59,120 --> 01:57:01,120 THOROUGH, GOES THROUGH MULTIPLE 3082 01:57:01,120 --> 01:57:02,920 LEVELS OF OVERSIGHT, I APPROVE 3083 01:57:02,920 --> 01:57:04,680 EVERY NOMINEE. 3084 01:57:04,680 --> 01:57:09,560 SO WE'VE BEEN -- IN A -- THAT 3085 01:57:09,560 --> 01:57:11,200 HAS BEEN MORE ENHANCED THAN THAT 3086 01:57:11,200 --> 01:57:14,040 OF APPLICANT POOL BUT FOR 3087 01:57:14,040 --> 01:57:16,000 SPECIAL EMPHASIS PANELS HASTILY 3088 01:57:16,000 --> 01:57:20,000 PUT TOGETHER, PEOPLE TRYING TO 3089 01:57:20,000 --> 01:57:22,040 FIND AD HOCS, THEY GO TO THE 3090 01:57:22,040 --> 01:57:22,680 NETWORKS. 3091 01:57:22,680 --> 01:57:26,080 I'M GUILTY, I UNDERSTAND. 3092 01:57:26,080 --> 01:57:27,400 YOU CAN CALL THREE 3093 01:57:27,400 --> 01:57:30,880 RHEUMATOLOGISTS WHEN YOU'RE IN A 3094 01:57:30,880 --> 01:57:31,080 HURRY. 3095 01:57:31,080 --> 01:57:35,280 SO RAISING COLLECTIVE AWARENESS, 3096 01:57:35,280 --> 01:57:37,320 SHARE DATA WITH STAFF AND 3097 01:57:37,320 --> 01:57:38,560 MANAGEMENT, PROVIDING TOOLS LIKE 3098 01:57:38,560 --> 01:57:39,960 REVIEWER FINDER THAT I TALKED 3099 01:57:39,960 --> 01:57:44,400 ABOUT, HAVING A LOT OF 3100 01:57:44,400 --> 01:57:46,320 SRO-TO-SRO TRAINING, SOME ARE 3101 01:57:46,320 --> 01:57:47,400 REALLY SKILLED AT IDENTIFYING 3102 01:57:47,400 --> 01:57:49,280 DIVERSE POOL OF REVIEWERS AND 3103 01:57:49,280 --> 01:57:50,520 SHARING RECRUITMENT PRACTICES. 3104 01:57:50,520 --> 01:57:54,240 SO, I THINK WE'VE HAD SOME LEVEL 3105 01:57:54,240 --> 01:57:54,640 OF SUCCESS. 3106 01:57:54,640 --> 01:57:57,840 SO THIS IS, YOU KNOW, STARTING 3107 01:57:57,840 --> 01:58:00,880 WITH OCTOBER 2019, EVERY ROUND 3108 01:58:00,880 --> 01:58:01,440 OF DATA. 3109 01:58:01,440 --> 01:58:04,840 THE BROWN LINE AT THE BOTTOM IS 3110 01:58:04,840 --> 01:58:08,360 THE PERCENTAGE OF -- THIS IS FOR 3111 01:58:08,360 --> 01:58:12,680 CSR, PERCENTAGE OF P.I.s THAT 3112 01:58:12,680 --> 01:58:14,320 ARE WOMEN, FAIRLY FLAT. 3113 01:58:14,320 --> 01:58:16,960 YOU CAN SEE RIGHT AROUND 35, 3114 01:58:16,960 --> 01:58:18,880 JUST UNDER 35%. 3115 01:58:18,880 --> 01:58:20,600 STUDY SECTION MEMBERS HAS ALWAYS 3116 01:58:20,600 --> 01:58:24,400 BEEN HIGH BUT IS GETTING HIGHER. 3117 01:58:24,400 --> 01:58:27,360 ABOUT 45% OF OUR STUDY SECTION 3118 01:58:27,360 --> 01:58:27,920 MEMBERS ARE WOMEN. 3119 01:58:27,920 --> 01:58:30,120 BUT I THINK I'M ESPECIALLY 3120 01:58:30,120 --> 01:58:32,720 HEARTENED TO SEE THAT OUR STAFF 3121 01:58:32,720 --> 01:58:36,520 HAVE MADE A REAL EFFORT IN 3122 01:58:36,520 --> 01:58:39,440 INCREASING GENDER DIVERSITY ON 3123 01:58:39,440 --> 01:58:41,200 SPECIAL EMPHASIS PANELS. 3124 01:58:41,200 --> 01:58:48,080 IN FACT, IN A HELPS MEMBERSHIP 3125 01:58:48,080 --> 01:58:49,600 TOO, YOU TRY THEM OUT AND 3126 01:58:49,600 --> 01:58:51,600 NOMINATE FOR MEMBERSHIP. 3127 01:58:51,600 --> 01:58:52,880 UNDERREPRESENTED MINORITY, DARK 3128 01:58:52,880 --> 01:58:54,760 BLUE LINE IS THE CONTACT 3129 01:58:54,760 --> 01:58:56,320 P.I.s, IT'S JUST AROUND, I 3130 01:58:56,320 --> 01:58:59,240 DON'T KNOW, 8 OR 9% STARTING IN 3131 01:58:59,240 --> 01:58:59,440 2019. 3132 01:58:59,440 --> 01:59:02,680 IT'S GOING UP A LITTLE. 3133 01:59:02,680 --> 01:59:08,440 AGAINP OUR -- OUR MEMBERSHIP 3134 01:59:08,440 --> 01:59:10,520 DATA LOOKS GOOD AND IS GETTING 3135 01:59:10,520 --> 01:59:11,840 BETTER BUT HERE IS INFLECTION 3136 01:59:11,840 --> 01:59:14,560 POINT WHERE REAL EFFORT BY OUR 3137 01:59:14,560 --> 01:59:17,120 STAFF TO RECRUIT 3138 01:59:17,120 --> 01:59:18,320 UNDERREPRESENTED MINORITIES TO 3139 01:59:18,320 --> 01:59:20,280 SPECIAL EMPHASIS PANELS LEADS TO 3140 01:59:20,280 --> 01:59:22,040 MORE MEMBERS WHO HAVE BEEN TRIED 3141 01:59:22,040 --> 01:59:22,400 OUT. 3142 01:59:22,400 --> 01:59:23,880 I THINK WE'RE ON OUR WAY. 3143 01:59:23,880 --> 01:59:27,400 WE HAVE A WAYS TO GO BUT WE'RE 3144 01:59:27,400 --> 01:59:28,120 MAKING PROGRESS. 3145 01:59:28,120 --> 01:59:30,680 IF YOU WANT TO SEE ANY OF THESE 3146 01:59:30,680 --> 01:59:33,080 DATA OR ANYTHING ELSE RELATED TO 3147 01:59:33,080 --> 01:59:35,320 OUR INITIATIVES TO ADDRESS BIAS 3148 01:59:35,320 --> 01:59:38,440 IN REVIEW, THAT'S OUR WEBSITE. 3149 01:59:38,440 --> 01:59:46,040 I'M HAPPY TO TAKE QUESTIONS. 3150 01:59:46,040 --> 01:59:55,840 [APPLAUSE] 3151 01:59:55,840 --> 01:59:57,560 >>I DON'T REALLY HAVE A 3152 01:59:57,560 --> 01:59:59,800 QUESTION BUT I JUST WANT TO 3153 01:59:59,800 --> 02:00:00,960 APPLAUD YOU FOR THESE EFFORTS 3154 02:00:00,960 --> 02:00:03,600 AND I THINK THIS WAS SOMETHING 3155 02:00:03,600 --> 02:00:06,920 THAT IS FROM THE DIVERSITY SIDE 3156 02:00:06,920 --> 02:00:09,640 TO THINKING ABOUT BROADLY HOW TO 3157 02:00:09,640 --> 02:00:12,320 CHANGE THE REVIEW PROCESS IS 3158 02:00:12,320 --> 02:00:13,880 IMPORTANT, DIFFICULT, AND YOU'VE 3159 02:00:13,880 --> 02:00:15,080 MADE MEANINGFUL CHANGES ALREADY. 3160 02:00:15,080 --> 02:00:18,400 SO JUST KUDOS TO YOU FOR BEING 3161 02:00:18,400 --> 02:00:20,160 IN THIS SPACE AND STICKING WITH 3162 02:00:20,160 --> 02:00:20,320 IT. 3163 02:00:20,320 --> 02:00:24,520 >> THANK YOU. 3164 02:00:24,520 --> 02:00:26,760 >> NONI, I ALSO WANTED TO 3165 02:00:26,760 --> 02:00:30,440 MENTION I'VE BEEN SO IMPRESSED 3166 02:00:30,440 --> 02:00:32,720 AND APPLAUD THE DATA-DRIVEN 3167 02:00:32,720 --> 02:00:33,600 ANALYSIS ORIENTED APPROACH 3168 02:00:33,600 --> 02:00:34,760 YOU'VE TAKEN. 3169 02:00:34,760 --> 02:00:38,080 YOU MAY RECALL THAT WE 3170 02:00:38,080 --> 02:00:40,160 APPROACHED CSR, YOU AND YOUR 3171 02:00:40,160 --> 02:00:41,440 DEPUTY, ABOUT SOME CONCERNS WE 3172 02:00:41,440 --> 02:00:44,440 HAD HEARD RELATED TO ONE OF THE 3173 02:00:44,440 --> 02:00:45,760 STUDY SECTIONS, OF THE 3174 02:00:45,760 --> 02:00:47,600 APPLICANTS, P.I.s WERE 3175 02:00:47,600 --> 02:00:49,360 CONCERNED ABOUT BIAS IN TERMS OF 3176 02:00:49,360 --> 02:00:52,200 THIS TYPE OF INVESTIGATOR VERSUS 3177 02:00:52,200 --> 02:00:53,760 THAT TYPE INVESTIGATOR, AND THE 3178 02:00:53,760 --> 02:00:56,720 EFFORT THAT YOU AND YOUR STAFF 3179 02:00:56,720 --> 02:00:58,120 DEVOTED TO ANALYZE AND WASN'T 3180 02:00:58,120 --> 02:01:00,320 ALL JUST KIND OF PUSH A BUTTON 3181 02:01:00,320 --> 02:01:02,160 AND GET THE DATA, YOU KNOW, BUT 3182 02:01:02,160 --> 02:01:04,200 THE TIME AND EFFORT YOU TOOK TO 3183 02:01:04,200 --> 02:01:06,640 CAREFULLY ANALYZE WHAT WAS 3184 02:01:06,640 --> 02:01:09,720 HAPPENING IN THAT STUDY SECTION 3185 02:01:09,720 --> 02:01:10,800 WAS SO MUCH APPRECIATED. 3186 02:01:10,800 --> 02:01:14,400 YOU'VE DONE THAT FOR TWO STUDY 3187 02:01:14,400 --> 02:01:15,440 SECTIONS WE'VE INQUIRED ABOUT, 3188 02:01:15,440 --> 02:01:16,760 WE WERE ALSO IMPRESSED TO SEE 3189 02:01:16,760 --> 02:01:19,360 ONE OF THE STUDY SECTIONS WENT 3190 02:01:19,360 --> 02:01:22,560 THROUGH THE ENQUIRE PROCESS AND 3191 02:01:22,560 --> 02:01:22,880 HAS EVOLVED. 3192 02:01:22,880 --> 02:01:23,240 >> YEAH, YEAH. 3193 02:01:23,240 --> 02:01:24,640 >> IT'S BEEN SO IMPRESSIVE TO 3194 02:01:24,640 --> 02:01:27,280 SEE SOME OF THESE CHANGES AND 3195 02:01:27,280 --> 02:01:28,400 APPLAUD YOUR EFFORT AND 3196 02:01:28,400 --> 02:01:29,320 EMPHASIS, SO THANK YOU. 3197 02:01:29,320 --> 02:01:30,320 >> GREAT. 3198 02:01:30,320 --> 02:01:35,760 THANK YOU. 3199 02:01:35,760 --> 02:01:36,240 >> SUSANA, PLEASE. 3200 02:01:36,240 --> 02:01:38,640 >> YEAH, THANK YOU FOR THE 3201 02:01:38,640 --> 02:01:39,000 PRESENTATION. 3202 02:01:39,000 --> 02:01:41,760 I WAS WONDERING IF YOU WOULD 3203 02:01:41,760 --> 02:01:43,600 ELABORATE A LITTLE BIT ON THE 3204 02:01:43,600 --> 02:01:48,480 CHANGES TO THE REVIEW CRITERIA, 3205 02:01:48,480 --> 02:01:50,680 THE TWO REVIEW CRITERIA SCORED 3206 02:01:50,680 --> 02:01:53,440 FROM 1-9, HOW THAT IS BROUGHT 3207 02:01:53,440 --> 02:01:56,040 BACK TO THE OVERALL SCORE FOR 3208 02:01:56,040 --> 02:01:56,480 THE APPLICATION. 3209 02:01:56,480 --> 02:01:58,560 HOW DO YOU THINK THAT'S GOING TO 3210 02:01:58,560 --> 02:01:59,800 IMPROVE THE QUALITY OF THE 3211 02:01:59,800 --> 02:02:00,120 REVIEW? 3212 02:02:00,120 --> 02:02:03,320 BECAUSE YOU TALKED ABOUT 3213 02:02:03,320 --> 02:02:05,120 FAIRNESS AND ET CETERA, AND 3214 02:02:05,120 --> 02:02:06,480 BURDEN OF REVIEWERS, BUT I 3215 02:02:06,480 --> 02:02:11,680 WONDER IF YOU WOULD COMMENT ON 3216 02:02:11,680 --> 02:02:13,680 THE QUALITY OF THE REVIEW AND 3217 02:02:13,680 --> 02:02:16,000 HOW CRITERIA WOULD ALLOW YOU TO 3218 02:02:16,000 --> 02:02:17,200 IMPROVE THAT IF THAT'S THE 3219 02:02:17,200 --> 02:02:17,800 PURPOSE, THE GOAL. 3220 02:02:17,800 --> 02:02:18,320 >> RIGHT. 3221 02:02:18,320 --> 02:02:18,840 THANK YOU. 3222 02:02:18,840 --> 02:02:20,640 SO RIGHT NOW WE HAVE FIVE REVIEW 3223 02:02:20,640 --> 02:02:22,800 CRITERIA, EACH OF THEM GET A 3224 02:02:22,800 --> 02:02:25,400 SCORE FROM 1-9. 3225 02:02:25,400 --> 02:02:26,920 THAT CHANGE OCCURRED IN I THINK 3226 02:02:26,920 --> 02:02:27,120 2009. 3227 02:02:27,120 --> 02:02:28,800 PRIOR TO THAT THERE WERE NO 3228 02:02:28,800 --> 02:02:30,240 SCORES FOR ANY CRITERIA. 3229 02:02:30,240 --> 02:02:34,280 SO OVERALL IS WHAT MATTERED. 3230 02:02:34,280 --> 02:02:36,040 WHAT THIS IS CHANGING IS THERE'S 3231 02:02:36,040 --> 02:02:39,400 STILL GOING TO BE A SCORE FOR 3232 02:02:39,400 --> 02:02:41,640 FACTOR 1 AND 2, BUT NOT FOR 3 3233 02:02:41,640 --> 02:02:43,080 FOR REASONS I BROUGHT UP. 3234 02:02:43,080 --> 02:02:45,000 IT'S GOING TO INFORM. 3235 02:02:45,000 --> 02:02:48,440 ALL THREE REMAIN REVIEW FACTORS 3236 02:02:48,440 --> 02:02:49,320 WILL AFFECT OVERALL SCORE. 3237 02:02:49,320 --> 02:02:53,600 IT WAS NEVER SET UP AS 3238 02:02:53,600 --> 02:02:54,640 MATHEMATICAL AVERAGE, WE'RE 3239 02:02:54,640 --> 02:02:55,720 GOING TO REQUIRE REVIEWERS TO 3240 02:02:55,720 --> 02:02:57,200 EXPLAIN HOW THEY CAME UP WITH 3241 02:02:57,200 --> 02:02:59,360 THE OVERALL SCORE, THAT'S THE 3242 02:02:59,360 --> 02:03:03,440 ONE THAT MATTERS, THAT GETS 3243 02:03:03,440 --> 02:03:03,720 PERCENTILED. 3244 02:03:03,720 --> 02:03:05,720 THE WAY THE FACTORS TIE THINGS 3245 02:03:05,720 --> 02:03:08,720 TOGETHER, ONE OF THEM, FACTOR 1 3246 02:03:08,720 --> 02:03:10,200 INCLUDES SIGNIFICANCE AND 3247 02:03:10,200 --> 02:03:10,720 INNOVATION. 3248 02:03:10,720 --> 02:03:13,160 ONE FEEDBACK WE HEARD AND WE'VE 3249 02:03:13,160 --> 02:03:17,440 SEEN IS SOME CONFUSION RELATED 3250 02:03:17,440 --> 02:03:19,000 TO INNOVATION, RIGHT? 3251 02:03:19,000 --> 02:03:20,720 DOES EVERYTHING NEED TO BE 3252 02:03:20,720 --> 02:03:21,160 INNOVATIVE? 3253 02:03:21,160 --> 02:03:22,200 WHAT IF IT'S SIGNIFICANT AND 3254 02:03:22,200 --> 02:03:24,640 IMPORTANT FOR A COMMUNITY BUT 3255 02:03:24,640 --> 02:03:32,880 NOT INNOVATIVE, WHAT ABOUT 3256 02:03:32,880 --> 02:03:33,320 GENERALIZABILITY? 3257 02:03:33,320 --> 02:03:35,960 IS IT TECHNICAL OR CONCEPTUAL? 3258 02:03:35,960 --> 02:03:37,240 BY PUTTING IT TOGETHER, 3259 02:03:37,240 --> 02:03:39,120 IMPORTANCE OF RESEARCH, YOU CAN 3260 02:03:39,120 --> 02:03:40,760 LOOK AT DETAILS OF WHAT THE 3261 02:03:40,760 --> 02:03:42,040 REVIEWERS ARE BEING ASKED TO 3262 02:03:42,040 --> 02:03:44,480 ASSESS IN THE RFI AND ON OUR 3263 02:03:44,480 --> 02:03:44,720 WEBSITE. 3264 02:03:44,720 --> 02:03:46,360 IT'S VERY SPECIFIC. 3265 02:03:46,360 --> 02:03:50,720 ARE YOU KNOW, REVIEWERS CAN 3266 02:03:50,720 --> 02:03:52,880 WEIGHT WHATEVER THEY WANT, 3267 02:03:52,880 --> 02:03:54,680 WEIGHT SIGNIFICANCE A LOT, IF 3268 02:03:54,680 --> 02:03:56,120 SOMETHING IS JUST DEVELOPING A 3269 02:03:56,120 --> 02:03:58,400 RESOURCE THAT'S IMPORTANT FOR A 3270 02:03:58,400 --> 02:03:59,680 COMMUNITY BUT FUNDAMENTALLY NOT 3271 02:03:59,680 --> 02:04:01,600 INNOVATIVE IT CAN GET A GOOD 3272 02:04:01,600 --> 02:04:02,880 FACTOR 1 SCORE, RIGHT? 3273 02:04:02,880 --> 02:04:05,480 SO I THINK PART OF IT IS 3274 02:04:05,480 --> 02:04:06,840 FOCUSING REVIEWERS IN ON WHAT 3275 02:04:06,840 --> 02:04:10,640 DRIVES THE OVERALL SCORE IN A 3276 02:04:10,640 --> 02:04:10,920 BETTER WAY. 3277 02:04:10,920 --> 02:04:11,800 THAT SHOULD HOPEFULLY INFORM 3278 02:04:11,800 --> 02:04:18,960 PROGRAM AND INFORM US AS TO WHAT 3279 02:04:18,960 --> 02:04:20,400 MATTERED IN THEIR SCORE. 3280 02:04:20,400 --> 02:04:21,840 >> IF I MAY FOLLOW UP, THANK 3281 02:04:21,840 --> 02:04:23,040 YOU FOR YOUR ANSWER. 3282 02:04:23,040 --> 02:04:25,560 ONE OF THE MOST FRUSTRATING 3283 02:04:25,560 --> 02:04:32,440 ASPECTS OF THE ENTIRE PROCESS IS 3284 02:04:32,440 --> 02:04:35,080 THE A1 APPLICATION AND THE 3285 02:04:35,080 --> 02:04:37,000 CONSISTENCY OR LACK THEREOF 3286 02:04:37,000 --> 02:04:39,680 BETWEEN THE INITIAL REVIEW AND 3287 02:04:39,680 --> 02:04:44,040 THE REVIEW OF THE A1. 3288 02:04:44,040 --> 02:04:46,120 I'M WONDERING IF THE NEW 3289 02:04:46,120 --> 02:04:46,600 CRITERIA ADDRESS THAT. 3290 02:04:46,600 --> 02:04:48,040 >> SO, I THINK THIS IS NOT A 3291 02:04:48,040 --> 02:04:48,640 NEW PROBLEM. 3292 02:04:48,640 --> 02:04:51,520 IT WAS THERE WHEN THERE WAS AN 3293 02:04:51,520 --> 02:04:54,720 A2, AND A1, AND PART IS SIMPLY 3294 02:04:54,720 --> 02:04:57,440 THE SAME PEOPLE AREN'T ALWAYS 3295 02:04:57,440 --> 02:04:58,800 GOING TO BE THERE. 3296 02:04:58,800 --> 02:05:00,800 I'M NOT EVEN SURE WE WANT 3297 02:05:00,800 --> 02:05:02,240 NECESSARILY EXACTLY THE SAME 3298 02:05:02,240 --> 02:05:02,600 PEOPLE THERE. 3299 02:05:02,600 --> 02:05:04,360 IN THE END, THE INTEREST OF PEER 3300 02:05:04,360 --> 02:05:06,240 REVIEW IS TO IDENTIFY STRONGEST 3301 02:05:06,240 --> 02:05:07,640 SCIENCE AND BRING IN THE 3302 02:05:07,640 --> 02:05:08,120 EXPERTS. 3303 02:05:08,120 --> 02:05:09,640 SOMETIMES NEW THINGS ARE 3304 02:05:09,640 --> 02:05:11,680 IDENTIFIED AS AN ISSUE. 3305 02:05:11,680 --> 02:05:13,240 WE ENCOURAGE REVIEWERS TO RAISE 3306 02:05:13,240 --> 02:05:13,440 THAT. 3307 02:05:13,440 --> 02:05:17,720 IT'S NOT AN IT RATIVE PROCESS. 3308 02:05:17,720 --> 02:05:19,520 IT'S NOT A CONTRACT. 3309 02:05:19,520 --> 02:05:21,200 IT'S THAT STRUGGLE IN MAKING 3310 02:05:21,200 --> 02:05:28,080 SURE THE STRONGEST SCIENCE IS 3311 02:05:28,080 --> 02:05:28,360 IDENTIFIED. 3312 02:05:28,360 --> 02:05:31,520 YOU HAVE 19,000 INDIVIDUALS 3313 02:05:31,520 --> 02:05:32,320 INVOLVED, ALL HUMAN BEINGS. 3314 02:05:32,320 --> 02:05:34,000 THERE'S GOING TO BE SOME LEVEL 3315 02:05:34,000 --> 02:05:34,720 OF INCONSISTENCY. 3316 02:05:34,720 --> 02:05:36,560 YOU CAN'T DO THINGS THE WAY A 3317 02:05:36,560 --> 02:05:37,960 COMPUTER MIGHT, FOR EXAMPLE. 3318 02:05:37,960 --> 02:05:42,640 MOST OF THE TIME A1s DO BETTER 3319 02:05:42,640 --> 02:05:42,920 THAN A0s. 3320 02:05:42,920 --> 02:05:44,840 HOW MUCH BETTER THEY DO, WE'VE 3321 02:05:44,840 --> 02:05:46,360 LOOKED AT THESE DATA, TRACKED 3322 02:05:46,360 --> 02:05:48,280 DIRECTLY WITH HOW MANY OF THE 3323 02:05:48,280 --> 02:05:50,280 PREVIOUS REVIEWERS REVIEWED IT. 3324 02:05:50,280 --> 02:05:52,080 THREE PREVIOUS REVIEWERS, OR 3325 02:05:52,080 --> 02:05:53,800 TWO, ARE PRESENT, IT DOES MUCH 3326 02:05:53,800 --> 02:05:54,960 BETTER. 3327 02:05:54,960 --> 02:06:02,080 IF ONLY ONE OR ZERO, IT CAN, BUT 3328 02:06:02,080 --> 02:06:03,120 NOT AS MUCH. 3329 02:06:03,120 --> 02:06:04,400 OUR THERE IN LEVELING THE 3330 02:06:04,400 --> 02:06:06,960 PLAYING FIELD NOT HAVING IT BE 3331 02:06:06,960 --> 02:06:08,160 DEPENDENT ON RANDOM STUDY 3332 02:06:08,160 --> 02:06:09,360 SECTIONS HOW MANY PREVIOUS 3333 02:06:09,360 --> 02:06:11,400 REVIEWERS WE CAN BRING IN. 3334 02:06:11,400 --> 02:06:14,040 LANGUAGE AROUND A1 HAS CHANGED 3335 02:06:14,040 --> 02:06:15,720 IN ASKING REVIEWERS TO ASSESS 3336 02:06:15,720 --> 02:06:19,200 THE FULL APPLICATION FOR ITS 3337 02:06:19,200 --> 02:06:19,640 MERIT. 3338 02:06:19,640 --> 02:06:25,640 WHICH INCLUDES THE RESPONSE TO 3339 02:06:25,640 --> 02:06:25,800 A0. 3340 02:06:25,800 --> 02:06:26,080 >> DAVID? 3341 02:06:26,080 --> 02:06:27,840 >> THANK YOU FOR THAT 3342 02:06:27,840 --> 02:06:28,480 PRESENTATION. 3343 02:06:28,480 --> 02:06:29,160 IT'S FASCINATING TO WATCH 3344 02:06:29,160 --> 02:06:31,360 CHANGES OCCUR WITH THE GRANT 3345 02:06:31,360 --> 02:06:32,320 PROCESS AND REVIEW PROCESS. 3346 02:06:32,320 --> 02:06:33,880 I GUESS THE ONE AREA I DIDN'T 3347 02:06:33,880 --> 02:06:39,120 SEE AND AIMED -- I'M SURE IT'S 3348 02:06:39,120 --> 02:06:42,080 IN THE WORKS, CAREER TRANSITION 3349 02:06:42,080 --> 02:06:43,600 AWARDS, K AWARDS, MAYBE THEY 3350 02:06:43,600 --> 02:06:45,480 HAVE THE SAME PROBLEMS OR SAME 3351 02:06:45,480 --> 02:06:46,600 BIASES THAT THE FELLOWSHIP 3352 02:06:46,600 --> 02:06:49,440 AWARDS DO IN TERMS OF 3353 02:06:49,440 --> 02:06:51,680 INSTITUTIONS THAT ARE HIGH 3354 02:06:51,680 --> 02:06:53,240 SUBMITTERS HAVING SOME BIAS IN 3355 02:06:53,240 --> 02:06:54,320 TERMS OF MORE SUCCESS. 3356 02:06:54,320 --> 02:06:57,960 IS THAT IN THE WORKS OR PART OF 3357 02:06:57,960 --> 02:06:58,560 THE FELLOWSHIP ANALYSIS? 3358 02:06:58,560 --> 02:07:00,240 >>RIGHT. 3359 02:07:00,240 --> 02:07:02,120 WE TACKLE FELLOWSHIP BECAUSE CSR 3360 02:07:02,120 --> 02:07:03,200 DOESN'T USUALLY HANDLE Ks, 3361 02:07:03,200 --> 02:07:05,120 THOSE ARE DONE AT THE INSTITUTES 3362 02:07:05,120 --> 02:07:05,360 USUALLY. 3363 02:07:05,360 --> 02:07:09,400 WE DO A FEW BUT NOT THAT MANY. 3364 02:07:09,400 --> 02:07:11,520 THAT SAID, I THINK ONE ONE 3365 02:07:11,520 --> 02:07:12,800 TRAINING MECHANISM CHANGES IT'S 3366 02:07:12,800 --> 02:07:15,160 A GOOD TIME TO SEE WHERE ELSE 3367 02:07:15,160 --> 02:07:16,600 CHANGES CAN BE APPLIED. 3368 02:07:16,600 --> 02:07:19,000 THAT MIGHT BE SOMETHING COMING 3369 02:07:19,000 --> 02:07:19,160 UP. 3370 02:07:19,160 --> 02:07:21,360 >> A FOLLOW-UP QUESTION, WHY IS 3371 02:07:21,360 --> 02:07:23,400 THERE A DIFFERENCE BETWEEN WHERE 3372 02:07:23,400 --> 02:07:24,960 THE FELLOWSHIP AND K -- JUST 3373 02:07:24,960 --> 02:07:26,560 MAYBE IT'S NOT WITHIN THE -- 3374 02:07:26,560 --> 02:07:35,760 >>THE LOBING -- LOCUS OF 3375 02:07:35,760 --> 02:07:36,000 REVIEW? 3376 02:07:36,000 --> 02:07:36,280 >> YES. 3377 02:07:36,280 --> 02:07:37,760 >> I'LL HAVE WILL BE OR DARREN 3378 02:07:37,760 --> 02:07:38,240 TALK ABOUT THAT. 3379 02:07:38,240 --> 02:07:40,760 PART OF THAT IS WHAT IS THE 3380 02:07:40,760 --> 02:07:43,160 INTEREST OF INSTITUTE, MOST RFIS 3381 02:07:43,160 --> 02:07:44,600 THAT ARE INSTITUTE SCIENCE 3382 02:07:44,600 --> 02:07:46,800 FOCUSED TEND TO GO INSIDE THE 3383 02:07:46,800 --> 02:07:48,280 INSTITUTE, CLINICAL TRIALS, SOME 3384 02:07:48,280 --> 02:07:50,600 PEOPLE REVIEW THEIR OWN. 3385 02:07:50,600 --> 02:07:52,240 SOME ARRANGEMENTS HAVE PRECEDED 3386 02:07:52,240 --> 02:07:59,280 ME AND LINDSEY AND PROBABLY EVEN 3387 02:07:59,280 --> 02:07:59,480 BOB. 3388 02:07:59,480 --> 02:08:04,640 I'LL DEFER TO LOCUS OF REVIEW. 3389 02:08:04,640 --> 02:08:05,640 IF MULTIPLE INSTITUTES ARE 3390 02:08:05,640 --> 02:08:11,200 INVOLVED CSR HANDLES THE REVIEW 3391 02:08:11,200 --> 02:08:13,000 USUALLY, WHATEVER IT IS. 3392 02:08:13,000 --> 02:08:13,280 >> MARIA? 3393 02:08:13,280 --> 02:08:16,240 >>THANK YOU VERY MUCH. 3394 02:08:16,240 --> 02:08:17,760 I'M ASSUMING THE TEMPLATE IS 3395 02:08:17,760 --> 02:08:19,400 STILL SIMILAR WITH STRENGTH AND 3396 02:08:19,400 --> 02:08:21,080 WEAKNESSES IN THE SAME WAY AS 3397 02:08:21,080 --> 02:08:22,160 NOW, THAT DOESN'T CHANGE? 3398 02:08:22,160 --> 02:08:24,320 >>YEAH, YEAH, RIGHT. 3399 02:08:24,320 --> 02:08:29,920 FACTOR 1, STRENGTHS, WEAKNESS. 3400 02:08:29,920 --> 02:08:30,200 FACTOR 2. 3401 02:08:30,200 --> 02:08:31,560 >> THIS WOULD BE MORE EFFORT 3402 02:08:31,560 --> 02:08:36,120 FOR RUE -- REVIEWERERS BUT YOU 3403 02:08:36,120 --> 02:08:38,880 OFFER ELEMENTS TO CONSIDER RIGHT 3404 02:08:38,880 --> 02:08:41,520 NOW, APPROACH, SIGNIFICANCE, BUT 3405 02:08:41,520 --> 02:08:44,760 THERE'S NO WAY TO FORCE THE 3406 02:08:44,760 --> 02:08:46,320 REVIEWER TO ANSWER THOSE 3407 02:08:46,320 --> 02:08:48,080 ELEMENTS, AND SOME PEOPLE DO AND 3408 02:08:48,080 --> 02:08:51,000 OTHERS DON'T, WONDERING IF THERE 3409 02:08:51,000 --> 02:08:56,880 WAS ANY DISCUSSION AS TO GIVE AN 3410 02:08:56,880 --> 02:08:59,000 EXAMPLE, APPROACH, POWER, 3411 02:08:59,000 --> 02:08:59,520 STATISTICAL SIGNIFICANCE. 3412 02:08:59,520 --> 02:09:05,880 >> I DON'T KNOW IF IT'S 3413 02:09:05,880 --> 02:09:06,800 INCLUDED IN THE APPENDIX. 3414 02:09:06,800 --> 02:09:09,440 I DON'T KNOW IF -- WE HAVE THE 3415 02:09:09,440 --> 02:09:12,720 DETAILS OF -- I DIDN'T SHOW KIND 3416 02:09:12,720 --> 02:09:16,000 OF THE QUESTIONS REVIEWERS ARE 3417 02:09:16,000 --> 02:09:16,200 ASKED. 3418 02:09:16,200 --> 02:09:17,240 RIGOR, EXPERIMENTAL DESIGN, 3419 02:09:17,240 --> 02:09:19,320 SAMPLE SIZE, ALL OF THAT IS 3420 02:09:19,320 --> 02:09:21,080 CALLED OUT BECAUSE FACTOR 2 IS 3421 02:09:21,080 --> 02:09:22,040 NOTE CALLED APPROACH. 3422 02:09:22,040 --> 02:09:25,320 IT'S CALLED RIGOR AND 3423 02:09:25,320 --> 02:09:25,600 FEASIBILITY. 3424 02:09:25,600 --> 02:09:27,400 WE'VE ELEVATED RIGOR TO THE 3425 02:09:27,400 --> 02:09:27,600 NAME. 3426 02:09:27,600 --> 02:09:29,520 >> JUST SOME RECOMMENDATIONS 3427 02:09:29,520 --> 02:09:31,280 FOR REVIEWERS TO LOOK AT. 3428 02:09:31,280 --> 02:09:31,640 >> YEAH. 3429 02:09:31,640 --> 02:09:36,040 >> IT'S NOT SPECIFIC ELEMENTS 3430 02:09:36,040 --> 02:09:36,680 WITHIN THAT DOMAIN THAT THEY 3431 02:09:36,680 --> 02:09:41,160 WILL BE ASKED TO SPECIFICALLY 3432 02:09:41,160 --> 02:09:41,400 ADDRESS. 3433 02:09:41,400 --> 02:09:43,360 IT REMAINS AS IT IS NOW WHERE 3434 02:09:43,360 --> 02:09:45,680 THERE ARE SUGGESTIONS OF WHAT IS 3435 02:09:45,680 --> 02:09:46,800 IMPORTANT UNDER THAT DOMAIN BUT 3436 02:09:46,800 --> 02:09:50,080 YOU DON'T REALLY NEED TO ADDRESS 3437 02:09:50,080 --> 02:09:50,240 IT. 3438 02:09:50,240 --> 02:09:51,800 >> YOU NEED TO ADDRESS WHATEVER 3439 02:09:51,800 --> 02:09:56,520 IS SCORE DRIVING FOR THE 3440 02:09:56,520 --> 02:09:56,840 REVIEWER, YES. 3441 02:09:56,840 --> 02:09:57,920 THERE'S A NUMBER, SEX AS A 3442 02:09:57,920 --> 02:09:59,480 BIOLOGICAL VARIABLE, STILL 3443 02:09:59,480 --> 02:10:00,560 LISTED UNDER APPROACH SECTION 3444 02:10:00,560 --> 02:10:01,200 UNDER RIGOR. 3445 02:10:01,200 --> 02:10:05,160 IS THAT WHAT YOU MEAN? 3446 02:10:05,160 --> 02:10:06,640 >> TO SOME DEGREE. 3447 02:10:06,640 --> 02:10:08,040 I HAVEN'T BEEN IN A STUDY 3448 02:10:08,040 --> 02:10:10,200 SECTION FOR A WHILE NOW BUT SOME 3449 02:10:10,200 --> 02:10:11,560 ELEMENTS MAY BE IMPORTANT FOR 3450 02:10:11,560 --> 02:10:12,960 SOME PEOPLE BUT NOT FOR OTHERS 3451 02:10:12,960 --> 02:10:15,640 IN THE WAY THEY DO THE REVIEW SO 3452 02:10:15,640 --> 02:10:17,760 I WAS WONDERING IF THERE WAS A 3453 02:10:17,760 --> 02:10:19,040 DISCUSSION, YOU KNOW, IN 3454 02:10:19,040 --> 02:10:22,680 ADDITION TO JUST HAVING THE 3455 02:10:22,680 --> 02:10:23,880 DOMAIN, LIST STRENGTHS AND 3456 02:10:23,880 --> 02:10:25,400 WEAKNESSES, HAVING PEOPLE ALMOST 3457 02:10:25,400 --> 02:10:28,720 FORCING THEM TO COME INTO AN 3458 02:10:28,720 --> 02:10:32,560 AREA THAT JUST BY LISTENING, BUT 3459 02:10:32,560 --> 02:10:32,880 I GUESS -- 3460 02:10:32,880 --> 02:10:34,040 >>I DON'T KNOW. 3461 02:10:34,040 --> 02:10:36,680 I DON'T KNOW WHEN YOU SERVED AND 3462 02:10:36,680 --> 02:10:40,760 WHEN I LAST WENT, LAST YEAR, 3463 02:10:40,760 --> 02:10:42,400 EARLIER THIS YEAR, THEY DO TALK 3464 02:10:42,400 --> 02:10:43,440 ABOUT RIGOR. 3465 02:10:43,440 --> 02:10:47,080 BY HAVING RIGOR AND SPECIFIC 3466 02:10:47,080 --> 02:10:49,880 ELEMENTS IN THE LANGUAGE, IN THE 3467 02:10:49,880 --> 02:10:53,120 TRAINING, WE MAKE SURE THAT THEY 3468 02:10:53,120 --> 02:10:54,360 DO MENTION THOSE, THEY SHOULD 3469 02:10:54,360 --> 02:10:59,160 DRIVE THE SCORE OF THE APPROACH. 3470 02:10:59,160 --> 02:10:59,680 SO, YEAH. 3471 02:10:59,680 --> 02:11:01,960 >> I'M GOING -- I WANT TO GIVE 3472 02:11:01,960 --> 02:11:04,080 STUART AND DREW, WHO ARE 3473 02:11:04,080 --> 02:11:06,040 PARTICIPATING VIRTUALLY, AN 3474 02:11:06,040 --> 02:11:08,640 OPPORTUNITY TO POSE QUESTIONS 3475 02:11:08,640 --> 02:11:11,840 THEY MIGHT HAVE. 3476 02:11:11,840 --> 02:11:16,640 >> NO QUESTIONS FOR ME. 3477 02:11:16,640 --> 02:11:18,480 3478 02:11:18,480 --> 02:11:18,960 >> OKAY. 3479 02:11:18,960 --> 02:11:20,280 >> THIS IS STUART SPEAKING. 3480 02:11:20,280 --> 02:11:22,000 I HAVE HOURS OF QUESTIONS BUT IN 3481 02:11:22,000 --> 02:11:23,320 THE INTEREST OF TIME LET'S 3482 02:11:23,320 --> 02:11:27,160 PROCEED. 3483 02:11:27,160 --> 02:11:32,960 >> NONI.BYRNES@NIH.GOV. 3484 02:11:32,960 --> 02:11:34,480 >> AND I HAVE FOLLOW QUESTIONS 3485 02:11:34,480 --> 02:11:34,640 TOO. 3486 02:11:34,640 --> 02:11:35,480 THANK YOU. 3487 02:11:35,480 --> 02:11:38,160 WE'RE GOING TO MOVE ON. 3488 02:11:38,160 --> 02:11:40,200 NEIL, DID YOU NEED TO MAKE -- 3489 02:11:40,200 --> 02:11:41,400 >>I WOULD LIKE TO REMIND THOSE 3490 02:11:41,400 --> 02:11:43,960 AT THE TABLE TO SPEAK DIRECTLY 3491 02:11:43,960 --> 02:11:45,640 INTO YOUR MICROPHONES SO THOSE 3492 02:11:45,640 --> 02:11:47,640 ON THE VIDEOCAST CAN HEAR. 3493 02:11:47,640 --> 02:11:49,800 WHEN YOU TURN YOUR HEAD AWAY 3494 02:11:49,800 --> 02:11:51,240 FROM THE MICROPHONE WE CANNOT 3495 02:11:51,240 --> 02:11:54,360 HEAR THE AUDIO. 3496 02:11:54,360 --> 02:11:55,360 THANK YOU. 3497 02:11:55,360 --> 02:11:56,680 >> THANKS, NEIL. 3498 02:11:56,680 --> 02:11:58,160 THANK YOU AGAIN. 3499 02:11:58,160 --> 02:12:00,800 REALLY APPRECIATED THAT. 3500 02:12:00,800 --> 02:12:03,920 [APPLAUSE] 3501 02:12:03,920 --> 02:12:04,040 3502 02:12:04,040 --> 02:12:11,160 AND NOW WE'RE GOING TO HEAR FROM 3503 02:12:11,160 --> 02:12:18,680 DR. STEPHANIE BURROWS. 3504 02:12:18,680 --> 02:12:19,360 HERE WE GO. 3505 02:12:19,360 --> 02:12:24,240 SHE 3506 02:12:24,240 --> 02:12:25,680 SHE'S CHIEF OF THE ANALYSIS 3507 02:12:25,680 --> 02:12:26,800 BRANCH, AND SHE'S GOING TO 3508 02:12:26,800 --> 02:12:28,800 PROVIDE AN UPDATE ABOUT THE 3509 02:12:28,800 --> 02:12:29,920 NIAMS STRATEGIC PLANNING PROCESS 3510 02:12:29,920 --> 02:12:32,360 THAT YOU HEARD ABOUT, AND I 3511 02:12:32,360 --> 02:12:33,840 ALLUDED TO, AND I'M EXCITED 3512 02:12:33,840 --> 02:12:34,680 ABOUT IT. 3513 02:12:34,680 --> 02:12:36,840 THANK YOU SO MUCH, STEPHANIE. 3514 02:12:36,840 --> 02:12:38,840 >> THANK YOU, DR. CRISWELL. 3515 02:12:38,840 --> 02:12:41,360 I'M VERY PLEASED TO HAVE THE 3516 02:12:41,360 --> 02:12:43,080 OPPORTUNITY TODAY TO TALK ABOUT 3517 02:12:43,080 --> 02:12:46,120 NIAMS PLANS FOR UPDATING THE 3518 02:12:46,120 --> 02:12:47,160 INSTITUTE STRATEGIC PLAN AS WELL 3519 02:12:47,160 --> 02:12:52,640 AS WAYS THAT COUNCIL MEMBERS CAN 3520 02:12:52,640 --> 02:12:53,960 PROVIDE INPUT. 3521 02:12:53,960 --> 02:12:56,800 SO WHY NIAMS STRATEGIC PLAN? 3522 02:12:56,800 --> 02:12:57,560 FIRST, CONGRESS REQUIRES NIH 3523 02:12:57,560 --> 02:13:00,280 INSTITUTES AND CENTERS TO HAVE A 3524 02:13:00,280 --> 02:13:03,160 STRATEGIC PLAN. 3525 02:13:03,160 --> 02:13:06,280 BUT AS IMPORTANT, THE PLAN 3526 02:13:06,280 --> 02:13:07,160 SERVESES AS PUBLIC STATEMENT OF 3527 02:13:07,160 --> 02:13:08,720 INTEREST, SINCE THIS WILL BE THE 3528 02:13:08,720 --> 02:13:10,760 FIRST PLAN WE'RE ISSUING UNDER 3529 02:13:10,760 --> 02:13:11,880 DR. CRISWELL'S LEADERSHIP WE 3530 02:13:11,880 --> 02:13:14,240 EXPECT THE COMMUNITY WILL BE 3531 02:13:14,240 --> 02:13:15,600 VERY INTERESTED IN IT. 3532 02:13:15,600 --> 02:13:18,000 THAT ALIGNS WITH MY SECOND 3533 02:13:18,000 --> 02:13:19,320 POINT, THE PLAN SERVES AS A 3534 02:13:19,320 --> 02:13:20,640 GUIDE POST FOR RESEARCHERS TO 3535 02:13:20,640 --> 02:13:23,800 MAKE SURE IT COVERS THE 3536 02:13:23,800 --> 02:13:24,680 INSTITUTE'S BROAD MISSION AND 3537 02:13:24,680 --> 02:13:28,280 REFLECTS INTEREST OF ALL OF OUR 3538 02:13:28,280 --> 02:13:29,520 INVESTIGATORS AND COALITION 3539 02:13:29,520 --> 02:13:29,960 MEMBERS. 3540 02:13:29,960 --> 02:13:32,800 FINALLY THE PLAN SERVES AS 3541 02:13:32,800 --> 02:13:36,680 INTERNAL REFERENCE FOR NIAMS 3542 02:13:36,680 --> 02:13:36,920 STAFF. 3543 02:13:36,920 --> 02:13:38,920 THIS SLIDE LAYS OUT PROPOSED 3544 02:13:38,920 --> 02:13:40,200 CONTENTS FOR NEW PLAN. 3545 02:13:40,200 --> 02:13:43,920 I'M GOING OVER THIS QUICKLY AND 3546 02:13:43,920 --> 02:13:44,520 HIGHLIGHT SOME CHANGES. 3547 02:13:44,520 --> 02:13:46,440 ONE OF THE THINGS YOU CAN EXPECT 3548 02:13:46,440 --> 02:13:48,200 IS A SHORTER PLAN. 3549 02:13:48,200 --> 02:13:51,120 THE CURRENT NIAMS STRATEGIC PLAN 3550 02:13:51,120 --> 02:13:53,600 FOR FISCAL YEARS 2020 THROUGH 3551 02:13:53,600 --> 02:13:55,360 2024 IS 144 PAGES LONG. 3552 02:13:55,360 --> 02:13:57,720 SO WE EXPECT THIS TO BE ABOUT A 3553 02:13:57,720 --> 02:13:58,400 THIRD OF THAT. 3554 02:13:58,400 --> 02:14:00,680 NOW, SOME OF THE ELEMENTS WILL 3555 02:14:00,680 --> 02:14:02,840 REMAIN THE SAME BECAUSE THEY ARE 3556 02:14:02,840 --> 02:14:05,240 REQUIRED OR BECAUSE THEY COVER 3557 02:14:05,240 --> 02:14:06,880 IMPORTANT ASPECTS OF OUR MISSION 3558 02:14:06,880 --> 02:14:11,000 SUCH AS COMMUNICATIONS AND 3559 02:14:11,000 --> 02:14:12,720 ENGAGEMENT ACTIVITIES. 3560 02:14:12,720 --> 02:14:14,280 SO THE MAIN SCIENTIFIC ASPECTS 3561 02:14:14,280 --> 02:14:17,960 OF THE PLAN WILL CONSIST OF 3562 02:14:17,960 --> 02:14:18,960 THREE CROSS-CUTTING THEMATIC 3563 02:14:18,960 --> 02:14:20,480 RESEARCH OPPORTUNITIES, AS WELL 3564 02:14:20,480 --> 02:14:23,360 AS SHORTENED DESCRIPTIONS OF OUR 3565 02:14:23,360 --> 02:14:24,760 FIVE DISEASE AND TISSUE-SPECIFIC 3566 02:14:24,760 --> 02:14:26,600 SCIENTIFIC AREAS, AS WELL AS 3567 02:14:26,600 --> 02:14:30,320 DESCRIPTION OF THE NIAMS 3568 02:14:30,320 --> 02:14:32,600 INTRAMURAL RESEARCH PROGRAM. 3569 02:14:32,600 --> 02:14:36,160 SO WE'VE ALREADY RECEIVED SOME 3570 02:14:36,160 --> 02:14:36,920 SUGGESTIONS FOR CROSS-CUTTING 3571 02:14:36,920 --> 02:14:37,840 THEMATIC RESEARCH OPPORTUNITIES 3572 02:14:37,840 --> 02:14:39,640 THROUGH OUR REQUEST FOR 3573 02:14:39,640 --> 02:14:41,480 INFORMATION THAT WAS OPENED THIS 3574 02:14:41,480 --> 02:14:41,920 FALL. 3575 02:14:41,920 --> 02:14:43,360 THROUGH THAT REQUEST FOR 3576 02:14:43,360 --> 02:14:45,440 INFORMATION, WE ASKED ABOUT TWO 3577 02:14:45,440 --> 02:14:46,720 THINGS. 3578 02:14:46,720 --> 02:14:47,960 ONE WAS CROSS-CUTTING THEMATIC 3579 02:14:47,960 --> 02:14:49,320 RESEARCH OPPORTUNITIES, THE 3580 02:14:49,320 --> 02:14:51,520 OTHER WAS BOLD ASPIRATIONS THAT 3581 02:14:51,520 --> 02:14:53,360 THE INSTITUTE CAN PURSUE OVER 3582 02:14:53,360 --> 02:14:55,640 THE NEXT FIVE YEARS. 3583 02:14:55,640 --> 02:14:56,960 WE RECEIVED 46 RESPONSES, MOST 3584 02:14:56,960 --> 02:14:59,240 OF THESE WERE FROM INDIVIDUALS 3585 02:14:59,240 --> 02:15:01,360 AT UNIVERSITIES OR HOSPITALS AND 3586 02:15:01,360 --> 02:15:06,680 FROM PROFESSIONAL AND VOLUNTARY 3587 02:15:06,680 --> 02:15:07,040 ORGANIZATIONS. 3588 02:15:07,040 --> 02:15:09,080 MY BRANCH WHICH LED THE RFI 3589 02:15:09,080 --> 02:15:11,040 EFFORT HAS SHARED THIS WITH OUR 3590 02:15:11,040 --> 02:15:12,240 NIAMS PROGRAM DIRECTORS AND 3591 02:15:12,240 --> 02:15:13,680 WE'LL BE WORKING WITH THEM GOING 3592 02:15:13,680 --> 02:15:15,960 FORWARD TO MAKE SURE THIS INPUT 3593 02:15:15,960 --> 02:15:22,760 HELPS TO INFORM OUR PLANNING 3594 02:15:22,760 --> 02:15:23,000 PROCESS. 3595 02:15:23,000 --> 02:15:26,480 TO COMPLEMENT THE SUGGESTIONS 3596 02:15:26,480 --> 02:15:28,000 WE'RE PLANNING FOR IDEA 3597 02:15:28,000 --> 02:15:30,960 GENERATION MEETING, A VIRTUAL 3598 02:15:30,960 --> 02:15:35,240 MEETING ON SEPTEMBER 11, 12, AND 3599 02:15:35,240 --> 02:15:37,600 14, PLANNING FOR ABOUT 170 3600 02:15:37,600 --> 02:15:38,600 PARTICIPANTS, WE EXPECT THE 3601 02:15:38,600 --> 02:15:40,640 INVITATIONS TO GO OUT IN JULY, 3602 02:15:40,640 --> 02:15:42,760 COUNCIL MEMBERS ARE ENCOURAGED 3603 02:15:42,760 --> 02:15:43,840 TO PARTICIPATE. 3604 02:15:43,840 --> 02:15:46,280 SO, IN CONTRAST TO SOME 3605 02:15:46,280 --> 02:15:46,920 TRADITIONAL LISTENING SESSIONS 3606 02:15:46,920 --> 02:15:48,560 THAT SOME OF YOU MAY HAVE 3607 02:15:48,560 --> 02:15:49,880 PARTICIPATED IN, IN THE PAST, 3608 02:15:49,880 --> 02:15:52,920 FOR THIS WE'RE USING A DIFFERENT 3609 02:15:52,920 --> 02:15:54,360 APPROACH CALLED OPEN-SPACE. 3610 02:15:54,360 --> 02:15:55,600 WHAT THIS MEANS IS PARTICIPANTS 3611 02:15:55,600 --> 02:15:57,000 WILL COME TO THE MEETING AND 3612 02:15:57,000 --> 02:15:58,720 THEY WILL NAME THE TOPICS THAT 3613 02:15:58,720 --> 02:16:01,800 THEY ARE INTERESTED IN 3614 02:16:01,800 --> 02:16:04,240 DISCUSSING AND LEAD BREAKOUTS ON 3615 02:16:04,240 --> 02:16:04,560 THE TOPICS. 3616 02:16:04,560 --> 02:16:07,440 SO I WOULD SAY THIS MEETING, TO 3617 02:16:07,440 --> 02:16:09,520 BE CLEAR, REPLACES THE 3618 02:16:09,520 --> 02:16:10,520 TRADITIONAL DISEASE AND 3619 02:16:10,520 --> 02:16:11,200 TISSUE-SPECIFIC LISTENING 3620 02:16:11,200 --> 02:16:12,200 SESSIONS WE'VE HAD IN THE PAST. 3621 02:16:12,200 --> 02:16:16,000 THIS IS JUST IN LINE WITH OUR 3622 02:16:16,000 --> 02:16:19,280 FOCUS ON CROSS-CUTTING THEMES. 3623 02:16:19,280 --> 02:16:22,120 EVEN THOUGH IT'S ONE MEETING FOR 3624 02:16:22,120 --> 02:16:24,200 THREE DAYS, WE EXPECT THE ACTUAL 3625 02:16:24,200 --> 02:16:25,600 NUMBER OF PARTICIPANTS IS GOING 3626 02:16:25,600 --> 02:16:31,920 TO BE GREATER THAN THE NUMBER WE 3627 02:16:31,920 --> 02:16:32,720 HAD IN INDIVIDUAL LISTENING 3628 02:16:32,720 --> 02:16:34,240 SESSIONS DISEASE AND TISSUE 3629 02:16:34,240 --> 02:16:34,520 SPECIFIC. 3630 02:16:34,520 --> 02:16:35,720 ONCE WE COMPLETED THE MEETING 3631 02:16:35,720 --> 02:16:37,040 WE'RE GOING HAVE A SECOND 3632 02:16:37,040 --> 02:16:38,480 REQUEST FOR INFORMATION SO WE 3633 02:16:38,480 --> 02:16:41,840 CAN GET BROAD FEEDBACK ON WHAT 3634 02:16:41,840 --> 02:16:42,960 WAS DISCUSSED. 3635 02:16:42,960 --> 02:16:45,600 AND THEN WE'LL INTERNALLY REFINE 3636 02:16:45,600 --> 02:16:47,760 AND PRIORITIZE PUBLIC INPUT FROM 3637 02:16:47,760 --> 02:16:51,360 THE TWO REQUEST FOR INFORMATION 3638 02:16:51,360 --> 02:16:52,800 AND MEETING AND WE WILL -- STAFF 3639 02:16:52,800 --> 02:16:54,080 WILL DETERMINE WHICH THING WE 3640 02:16:54,080 --> 02:16:56,640 WANT TO MOVE FORWARD TO 3641 02:16:56,640 --> 02:16:57,640 LEADERSHIP FOR POTENTIAL 3642 02:16:57,640 --> 02:16:59,240 INCLUSION IN THE PLAN. 3643 02:16:59,240 --> 02:17:01,880 WE'RE ALSO GOING TO BE PROPOSING 3644 02:17:01,880 --> 02:17:02,720 IMPLEMENTATION STRATEGIES. 3645 02:17:02,720 --> 02:17:04,320 ONCE WE KNOW THAT'S WHAT LIKELY 3646 02:17:04,320 --> 02:17:07,760 TO BE INCLUDED AS A TOPIC WE'LL 3647 02:17:07,760 --> 02:17:18,320 COLLECT BASELINE INFORMATION ON 3648 02:17:18,800 --> 02:17:19,400 THOSE THEMES. 3649 02:17:19,400 --> 02:17:19,600 OKAY. 3650 02:17:19,600 --> 02:17:21,600 WE PLAN TO HAVE A DRAFT REVIEW 3651 02:17:21,600 --> 02:17:23,640 PLAN IN THE SPRING, AROUND THE 3652 02:17:23,640 --> 02:17:26,840 TIME OF OUR MAY 29, 2024 COUNCIL 3653 02:17:26,840 --> 02:17:28,160 MEETING, AND WE'LL ISSUE A THIRD 3654 02:17:28,160 --> 02:17:33,360 REQUEST FOR INFORMATION SO THE 3655 02:17:33,360 --> 02:17:35,920 PUBLIC AND COUNCIL CAN PROVIDE 3656 02:17:35,920 --> 02:17:38,040 BROAD INPUT ON THE PLAN AND THEN 3657 02:17:38,040 --> 02:17:41,200 WE WOULD EXPECT TO HAVE A DRAFT 3658 02:17:41,200 --> 02:17:43,240 FINAL STRATEGIC PLAN FOR YOU TO 3659 02:17:43,240 --> 02:17:48,160 REVIEW AROUND THE TIME OF THE 3660 02:17:48,160 --> 02:17:52,200 AUGUST 27, 2024, COUNCIL 3661 02:17:52,200 --> 02:17:52,600 MEETING. 3662 02:17:52,600 --> 02:17:56,440 SO, NEW THIS ROUND WE'RE ALSO 3663 02:17:56,440 --> 02:17:59,240 PLANNING FOR AN INTERNAL 3664 02:17:59,240 --> 02:18:00,200 IMPLEMENTATION PLAN. 3665 02:18:00,200 --> 02:18:01,600 ALONG WITH THAT WE'RE 3666 02:18:01,600 --> 02:18:03,560 CONSIDERING WAYS WE CAN PUBLICLY 3667 02:18:03,560 --> 02:18:04,880 TRACK PROGRESS ON OUR STRATEGIC 3668 02:18:04,880 --> 02:18:05,080 PLAN. 3669 02:18:05,080 --> 02:18:06,480 AND SO SOME OF THE IDEAS WE'RE 3670 02:18:06,480 --> 02:18:08,760 THINKING ABOUT IS A WEBSITE THAT 3671 02:18:08,760 --> 02:18:10,880 WOULD LINK TO MEETING SUMMARIES, 3672 02:18:10,880 --> 02:18:12,600 FUNDING OPPORTUNITIES, AND 3673 02:18:12,600 --> 02:18:14,240 RESULTS OF NIAMS-FUNDED RESEARCH 3674 02:18:14,240 --> 02:18:18,080 THAT RELATE TO VARIOUS SECTIONS 3675 02:18:18,080 --> 02:18:19,600 OF THE PLAN. 3676 02:18:19,600 --> 02:18:22,480 SO IN SUMMARY, PLEASE MARK YOUR 3677 02:18:22,480 --> 02:18:24,400 CALENDARS FOR SEPTEMBER 11, 12, 3678 02:18:24,400 --> 02:18:24,800 AND 14. 3679 02:18:24,800 --> 02:18:26,520 THERE WILL BE MORE DETAILS TO 3680 02:18:26,520 --> 02:18:28,360 FOLLOW IN THE SUMMER. 3681 02:18:28,360 --> 02:18:30,160 TWO MORE OPPORTUNITIES FOR INPUT 3682 02:18:30,160 --> 02:18:31,960 FROM THE COMMUNITY AND COUNCIL 3683 02:18:31,960 --> 02:18:33,720 THROUGH THE SECOND AND THIRD 3684 02:18:33,720 --> 02:18:35,480 REQUEST FOR INFORMATION. 3685 02:18:35,480 --> 02:18:38,200 AND ALSO ADDITIONAL 3686 02:18:38,200 --> 02:18:40,720 OPPORTUNITIES FOR COUNCIL MEMBER 3687 02:18:40,720 --> 02:18:44,040 INPUT THROUGH REQUEST, REVIEW OF 3688 02:18:44,040 --> 02:18:45,320 DRAFT PLAN IN A YEAR'S TIME AND 3689 02:18:45,320 --> 02:18:48,440 REVIEW OF THE FINAL PLAN AS 3690 02:18:48,440 --> 02:18:49,080 WE'RE HEADING INTO FISCAL YEAR 3691 02:18:49,080 --> 02:18:51,120 2025. 3692 02:18:51,120 --> 02:18:54,000 SO THANK YOU VERY MUCH FOR YOUR 3693 02:18:54,000 --> 02:18:54,400 ATTENTION. 3694 02:18:54,400 --> 02:18:56,480 WE LOOK FORWARD TO COUNCIL'S 3695 02:18:56,480 --> 02:18:58,400 INPUT AS WE MOVE FORWARD WITH 3696 02:18:58,400 --> 02:18:59,720 OUR PLANNING PROCESS. 3697 02:18:59,720 --> 02:19:01,200 AND DR. CRISWELL, I'LL TURN THE 3698 02:19:01,200 --> 02:19:08,520 MEETING BACK OVER TO YOU. 3699 02:19:08,520 --> 02:19:13,400 >>WE HAVE TIME FOR A COUPLE 3700 02:19:13,400 --> 02:19:14,680 QUICK QUESTIONS IF YOU HAVE ANY. 3701 02:19:14,680 --> 02:19:17,000 WE WANT TO GIVE YOU A 3702 02:19:17,000 --> 02:19:18,520 FIVE-MINUTE STRETCH BREAK, WALK 3703 02:19:18,520 --> 02:19:24,920 AROUND THE TABLE, SAY HELL HELO 3704 02:19:24,920 --> 02:19:26,760 SOMEONE, COME BACK AT NOON AND 3705 02:19:26,760 --> 02:19:35,240 HEAR FROM DR. SUSANA 3706 02:19:35,240 --> 02:19:36,800 SERATE-SZTEIN AND GAYLE LESTER 3707 02:19:36,800 --> 02:19:38,440 BEFORE WE CONCLUDE AT 1:00. 3708 02:19:38,440 --> 02:19:40,880 FIRST IF YOU HAVE ANY QUICK 3709 02:19:40,880 --> 02:19:42,880 QUESTIONS FOR STEPHANIE SHE CAN 3710 02:19:42,880 --> 02:19:43,440 TAKE THOSE NOW. 3711 02:19:43,440 --> 02:19:44,560 >> A COMMENT, THE LAST 3712 02:19:44,560 --> 02:19:46,840 STRATEGIC PLAN COUNCIL PLAYED A 3713 02:19:46,840 --> 02:19:47,600 REALLY IMPORTANT ROLE, IN FACT 3714 02:19:47,600 --> 02:19:50,560 WHAT THEY DID WAS PUSH US TO BE 3715 02:19:50,560 --> 02:19:52,720 MORE OUT THERE, TO BE MORE 3716 02:19:52,720 --> 02:19:54,160 ADVENTUROUS, TO THINK BEYOND 3717 02:19:54,160 --> 02:20:00,080 WHERE WE WERE. 3718 02:20:00,080 --> 02:20:01,720 IT ENDED UP, PIE IN THE SKY, 3719 02:20:01,720 --> 02:20:05,080 WHAT DO WE CALL THEM? 3720 02:20:05,080 --> 02:20:05,560 >> BOLD ASPIRATIONS. 3721 02:20:05,560 --> 02:20:07,320 >> PARTLY AS A RESPONSE TO 3722 02:20:07,320 --> 02:20:09,200 INPUT FROM COUNCIL MEMBERS. 3723 02:20:09,200 --> 02:20:11,640 SO PLEASE PUSH US AGAIN. 3724 02:20:11,640 --> 02:20:14,120 >> AND WE'VE HEARD GREAT THINGS 3725 02:20:14,120 --> 02:20:15,400 ABOUT THIS OPEN-SPACE APPROACH 3726 02:20:15,400 --> 02:20:18,560 SO I'M REALLY EXCITED ABOUT IS 3727 02:20:18,560 --> 02:20:18,760 THAT. 3728 02:20:18,760 --> 02:20:22,320 >> WE'RE VERY EXCITED. 3729 02:20:22,320 --> 02:20:22,720 THANK YOU. 3730 02:20:22,720 --> 02:20:23,720 >> QUICK STRETCH BREAK AND IF 3731 02:20:23,720 --> 02:20:26,760 YOU CAN GET BACK HERE AROUND 3732 02:20:26,760 --> 02:20:28,560 12:00 WE'LL MOVE TO THE LAST TWO 3733 02:20:28,560 --> 02:20:28,840 SECTIONS. 3734 02:20:28,840 --> 02:20:32,720 THANK YOU. 3735 02:20:32,720 --> 02:20:34,920 >> I KNOW YOU'RE SUPER EXCITED 3736 02:20:34,920 --> 02:20:41,120 TO HEAR ABOUT OUR DATA SCIENCE 3737 02:20:41,120 --> 02:20:51,280 STRATEGY. 3738 02:20:54,520 --> 02:20:56,040 WE HAVE TO GET TOGETHER IN 3739 02:20:56,040 --> 02:20:59,600 PERSON MORE OFTEN. 3740 02:20:59,600 --> 02:21:01,320 ANYWAY, NONI REFERRED TOO 3741 02:21:01,320 --> 02:21:03,760 WORKING GROUPS OF COUNCIL, WE'VE 3742 02:21:03,760 --> 02:21:05,560 BEEN UTILIZING THAT APPROACH TO 3743 02:21:05,560 --> 02:21:07,760 EXPAND THE SCOPE AND DEPTH OF 3744 02:21:07,760 --> 02:21:11,160 THINGS WE CAN DELIBERATE ON. 3745 02:21:11,160 --> 02:21:13,280 SUSANA IS GOING TO TALK ABOUT 3746 02:21:13,280 --> 02:21:14,280 THE DATA SCIENCE STRATEGY 3747 02:21:14,280 --> 02:21:15,800 WORKING GROUP AND WHERE WE ARE 3748 02:21:15,800 --> 02:21:17,120 ON THAT FRONT. 3749 02:21:17,120 --> 02:21:19,040 THANK YOU SO MUCH. 3750 02:21:19,040 --> 02:21:20,120 >> THANK YOU. 3751 02:21:20,120 --> 02:21:28,360 I'M GRIOTED TO PROVIDE -- 3752 02:21:28,360 --> 02:21:29,240 DELIGHTED TO PROVIDE AN UPDATE, 3753 02:21:29,240 --> 02:21:31,840 SOME ON THE WORKING GROUP 3754 02:21:31,840 --> 02:21:37,080 COUNCIL ON DATA SCIENCE 3755 02:21:37,080 --> 02:21:43,840 STRATEGY. 3756 02:21:43,840 --> 02:21:45,400 WE HAVE AN EXTENSIVE MEMBERSHIP 3757 02:21:45,400 --> 02:21:47,080 IN THE WORKING GROUP THAT 3758 02:21:47,080 --> 02:21:48,160 INCLUDES CURRENT AND PREVIOUS 3759 02:21:48,160 --> 02:21:53,080 MEMBERS OF COUNCIL AS WELL AS 3760 02:21:53,080 --> 02:21:57,160 INVESTIGATORS WHO ARE ENGAGED IN 3761 02:21:57,160 --> 02:21:59,000 PROJECTS THAT HAVE SIGNIFICANT 3762 02:21:59,000 --> 02:22:00,760 DATA SCIENCE OR BIOINFORMATICS 3763 02:22:00,760 --> 02:22:01,120 COMPONENTS. 3764 02:22:01,120 --> 02:22:03,800 WE HAVE REPRESENTATIVES FROM THE 3765 02:22:03,800 --> 02:22:11,160 OFFICE OF DATA SCIENCE STRATEGY, 3766 02:22:11,160 --> 02:22:13,080 AND NATIONAL EYE INSTITUTES AND 3767 02:22:13,080 --> 02:22:15,480 REPRESENTATIVES FROM EXTRAMURAL 3768 02:22:15,480 --> 02:22:15,720 PROGRAM. 3769 02:22:15,720 --> 02:22:17,600 AND DR. MANCINI. 3770 02:22:17,600 --> 02:22:21,120 WE HAVE TWO LIAISONS, ONE WITH 3771 02:22:21,120 --> 02:22:28,000 OUR DIVISION OF EXTRAMURAL 3772 02:22:28,000 --> 02:22:29,000 RESEARCH. 3773 02:22:29,000 --> 02:22:34,680 A BIG SHOUT OUT TO TOM BOND AND 3774 02:22:34,680 --> 02:22:37,120 SHARMA WHO WORK WITH ME HANDLING 3775 02:22:37,120 --> 02:22:40,720 THE ACTIVITIES OF THE WORKING 3776 02:22:40,720 --> 02:22:47,080 GROUP AND TO DR. PINE WHO IS THE 3777 02:22:47,080 --> 02:22:48,720 DATA SCHOLAR. 3778 02:22:48,720 --> 02:22:51,200 SO, DR. CRISWELL GAVE THE CHARGE 3779 02:22:51,200 --> 02:22:53,520 TO THE WORKING GROUP, AND WE ARE 3780 02:22:53,520 --> 02:22:55,480 FOCUSED ON A NUMBER OF ISSUES 3781 02:22:55,480 --> 02:22:57,240 WITH THE UNDERSTANDING THAT AN 3782 02:22:57,240 --> 02:23:00,280 INSTITUTE LIKE OURS WILL HAVE TO 3783 02:23:00,280 --> 02:23:02,000 RELY HEAVILY ON LEVERAGE AND 3784 02:23:02,000 --> 02:23:04,160 INTERACTION AND PARTNERSHIPS 3785 02:23:04,160 --> 02:23:06,640 WITH THE COMMUNITY, ACADEMIC 3786 02:23:06,640 --> 02:23:07,960 COMMUNITY AND THE COMMUNITY 3787 02:23:07,960 --> 02:23:11,640 WITHIN THE NIH IN ORDER TO 3788 02:23:11,640 --> 02:23:17,480 ADVANCE OUR INVESTMENT IN DATA 3789 02:23:17,480 --> 02:23:17,760 SCIENCE. 3790 02:23:17,760 --> 02:23:18,680 DR. CRISWELL EMPHASIZED NEED TO 3791 02:23:18,680 --> 02:23:20,000 ADDRESS THE ISSUE OF CULTURE 3792 02:23:20,000 --> 02:23:22,960 BECAUSE DATA SCIENCE IS HIGHLY 3793 02:23:22,960 --> 02:23:24,920 DEPENDENT ON DATA SHARING, AND 3794 02:23:24,920 --> 02:23:28,200 THAT INVOLVES SOME CHANGES IN 3795 02:23:28,200 --> 02:23:30,840 THE WAY WE CONCEIVE WHEN AND HOW 3796 02:23:30,840 --> 02:23:34,560 THE DATA AND OTHER RESOURCES ARE 3797 02:23:34,560 --> 02:23:35,320 SHARED. 3798 02:23:35,320 --> 02:23:37,080 THE DELIBERATIONS OF THE WORKING 3799 02:23:37,080 --> 02:23:39,680 GROUP ARE BASED ON PARAMETERS OR 3800 02:23:39,680 --> 02:23:43,320 PILLARS THAT HAVE BEEN SET UP BY 3801 02:23:43,320 --> 02:23:46,280 THE NIH DATA SCIENCE STRATEGY 3802 02:23:46,280 --> 02:23:49,320 WHICH IS ABOUT TO BE -- IT'S 3803 02:23:49,320 --> 02:23:51,200 UNDER REVIEW, NEW PLAN WILL BE 3804 02:23:51,200 --> 02:23:54,480 RELEASED SOON. 3805 02:23:54,480 --> 02:23:56,440 BUT NEVERTHELESS THE MAIN ISSUES 3806 02:23:56,440 --> 02:24:00,720 ARE STILL VERY RELEVANT. 3807 02:24:00,720 --> 02:24:02,560 THE WORKING GROUP DECIDED TO 3808 02:24:02,560 --> 02:24:05,040 FOCUS INITIALLY ON DATA 3809 02:24:05,040 --> 02:24:06,160 INFRASTRUCTURE AND WORKFORCE 3810 02:24:06,160 --> 02:24:06,480 DEVELOPMENT. 3811 02:24:06,480 --> 02:24:09,200 WE HAVE HAD A NUMBER OF 3812 02:24:09,200 --> 02:24:11,200 PRESENTATIONS IN THE CONTEXT OF 3813 02:24:11,200 --> 02:24:13,960 THE WORKING GROUP THAT EXPLORED 3814 02:24:13,960 --> 02:24:14,920 DIFFERENT APPROACHES TO THE 3815 02:24:14,920 --> 02:24:17,240 DEVELOPMENT OF INFRASTRUCTURE 3816 02:24:17,240 --> 02:24:18,960 WITHIN AND OUTSIDE NIH. 3817 02:24:18,960 --> 02:24:21,920 WITHIN THE NIH WE HEARD ABOUT 3818 02:24:21,920 --> 02:24:24,320 APPROACHES TO SUPPORT DATA 3819 02:24:24,320 --> 02:24:25,600 ECOSYSTEMS LARGE AND AMBITIOUS 3820 02:24:25,600 --> 02:24:29,040 PROJECTS, IN PARTICULAR WE HEARD 3821 02:24:29,040 --> 02:24:30,920 ABOUT THE BIODATA CATALYST 3822 02:24:30,920 --> 02:24:33,320 SUPPORTED BY NHLBI. 3823 02:24:33,320 --> 02:24:35,040 WE ALSO HEARD PRESENTATIONS 3824 02:24:35,040 --> 02:24:37,080 ABOUT KNOWLEDGE PORTALS, 3825 02:24:37,080 --> 02:24:39,200 KNOWLEDGE BASES. 3826 02:24:39,200 --> 02:24:42,000 ONE IN MUSCULOSKELETAL DISEASES, 3827 02:24:42,000 --> 02:24:44,200 THE OTHER FROM SAGE BIONETWORKS 3828 02:24:44,200 --> 02:24:47,040 THAT SUPPORTS A NUMBER OF 3829 02:24:47,040 --> 02:24:48,640 KNOWLEDGE-BASED IMPORTANCE FOR 3830 02:24:48,640 --> 02:24:50,120 ALZHEIMER'S DISEASE AND MORE 3831 02:24:50,120 --> 02:24:53,000 RECENTLY FOR ONE OF THE 3832 02:24:53,000 --> 02:24:53,480 ACCELERATING MEDICINE 3833 02:24:53,480 --> 02:25:02,200 PARTNERSHIPS INITIATIVES THAT IS 3834 02:25:02,200 --> 02:25:12,280 MANAGEDDED BY NIEMS. 3835 02:25:12,280 --> 02:25:12,760 WE HEARD ABOUT BUILDING 3836 02:25:12,760 --> 02:25:23,280 INTEROPERABILITY BETWEEN WHITE 3837 02:25:24,880 --> 02:25:24,960 . 3838 02:25:24,960 --> 02:25:26,480 AND THE UNIQUE APPROACH TO DATA 3839 02:25:26,480 --> 02:25:31,200 MANAGEMENT OF THE CLINICAL 3840 02:25:31,200 --> 02:25:33,560 STUDIES THROUGH THE DASHBOARD, 3841 02:25:33,560 --> 02:25:35,920 THAT BUILDS PRIMARILY ON 3842 02:25:35,920 --> 02:25:41,080 CLINICAL DATA, WHICH DESERVES A 3843 02:25:41,080 --> 02:25:42,840 SPECIAL CONSIDERATION. 3844 02:25:42,840 --> 02:25:47,560 WE HAD A SESSION DEVOTED TO 3845 02:25:47,560 --> 02:25:49,960 DISCUSSION BY WORKING GROUP. 3846 02:25:49,960 --> 02:25:54,320 THE THEMES THAT EMERGED REVOLVE 3847 02:25:54,320 --> 02:25:56,040 AROUND APPROACHES RELYING ON 3848 02:25:56,040 --> 02:26:00,040 DEVELOPMENT OF KNOWLEDGE BASES 3849 02:26:00,040 --> 02:26:01,320 OR KNOWLEDGE PORTALS GEARED TO 3850 02:26:01,320 --> 02:26:08,200 NEEDS OF SPECIFIC COMMUNITIES 3851 02:26:08,200 --> 02:26:12,360 SERVED BY NIAMS. 3852 02:26:12,360 --> 02:26:16,000 THE NIAMS JOINED A TRANS-NIH 3853 02:26:16,000 --> 02:26:21,600 ODSS SPONSORED NOTICE OF FUNDING 3854 02:26:21,600 --> 02:26:22,240 OPPORTUNITY, APPLICATIONS FOR 3855 02:26:22,240 --> 02:26:23,800 CREATION OF KNOWLEDGE BASES AND 3856 02:26:23,800 --> 02:26:26,400 APPLICATIONS CAME AT THE END OF 3857 02:26:26,400 --> 02:26:27,760 JANUARY, COUNCIL WILL SEE THE 3858 02:26:27,760 --> 02:26:32,320 OUTCOMES OF THE REVIEW AT OUR 3859 02:26:32,320 --> 02:26:33,840 NEXT COUNCIL MEETING. 3860 02:26:33,840 --> 02:26:35,600 BUT WORKING GROUP TOOK INTO 3861 02:26:35,600 --> 02:26:36,840 CONSIDERATION THE FACT THAT 3862 02:26:36,840 --> 02:26:39,320 KNOWLEDGE BASES AND DATA 3863 02:26:39,320 --> 02:26:44,800 REPOSITORIES HAVE COVERED A WIDE 3864 02:26:44,800 --> 02:26:47,760 SPECTRUM OF SPECIFICITY FROM 3865 02:26:47,760 --> 02:26:49,120 GENERALIST REPOSITORIES THAT, 3866 02:26:49,120 --> 02:26:54,120 FOR EXAMPLE, dbGAP TO VERY 3867 02:26:54,120 --> 02:26:55,200 SPECIFIC STUDY-RELATED DATA 3868 02:26:55,200 --> 02:26:57,480 REPOSITORIES OR DATA SOURCES. 3869 02:26:57,480 --> 02:27:01,120 AND THE NEED TO HAVE GOOD 3870 02:27:01,120 --> 02:27:05,840 UNDERSTANDING THAT A RANGE 3871 02:27:05,840 --> 02:27:08,560 EXISTS AND MAKE SURE THE 3872 02:27:08,560 --> 02:27:16,040 COMMUNITY IS AWARE OF THOSE 3873 02:27:16,040 --> 02:27:18,400 DIFFERENT TYPES OF RESOURCES AND 3874 02:27:18,400 --> 02:27:21,000 THINKING ABOUT DATA REPOSITORIES 3875 02:27:21,000 --> 02:27:22,240 FOR UPLOADING OF DATA OBTAINED 3876 02:27:22,240 --> 02:27:24,360 WITH PROJECTS SUPPORTED BY THE 3877 02:27:24,360 --> 02:27:31,880 INSTITUTE, MORE TO FOLLOW THERE. 3878 02:27:31,880 --> 02:27:33,080 ALSO RELATED TO CREATION OF 3879 02:27:33,080 --> 02:27:35,200 INFRASTRUCTURE THE INSTITUTE IS 3880 02:27:35,200 --> 02:27:36,480 MOVING SLOWLY BUT STEADILY 3881 02:27:36,480 --> 02:27:37,200 TOWARDS CREATION OF SOME 3882 02:27:37,200 --> 02:27:39,880 RESOURCES FOR THE COMMUNITY. 3883 02:27:39,880 --> 02:27:44,280 THERE IS A WEB PAGE AND THE 3884 02:27:44,280 --> 02:27:48,680 INSTITUTE WEBSITE DEVOTED TO 3885 02:27:48,680 --> 02:27:50,520 DATA SCIENCE AND THERE IS ALSO 3886 02:27:50,520 --> 02:27:55,560 IN PARALLEL OR RELATED TO A 3887 02:27:55,560 --> 02:28:00,160 BIOINFORMATICS WEB PAGE BY THE 3888 02:28:00,160 --> 02:28:03,080 NIAMS IRP AND VERY SOON WEB PAGE 3889 02:28:03,080 --> 02:28:05,600 BY OUR DIVISION OF EXTRAMURAL 3890 02:28:05,600 --> 02:28:07,600 RESEARCH, THERE IS GOING TO BE 3891 02:28:07,600 --> 02:28:09,600 FOCUS ON PROVIDING CRITICAL 3892 02:28:09,600 --> 02:28:12,840 UPDATES ON POLICY RELATED TO 3893 02:28:12,840 --> 02:28:19,320 DATA SHARING AND MANAGEMENT. 3894 02:28:19,320 --> 02:28:23,280 WE ALSO HAVE SUPPORTED AN ARK 3895 02:28:23,280 --> 02:28:26,440 PORTAL CURRENTLY HOUSING DATA OF 3896 02:28:26,440 --> 02:28:27,760 ACCELERATING MEDICINES 3897 02:28:27,760 --> 02:28:29,920 PARTNERSHIP IN AUTOIMMUNE AND 3898 02:28:29,920 --> 02:28:31,240 MEDIATED DISEASES AND ARTHRITIS 3899 02:28:31,240 --> 02:28:35,000 AND RELATED DISEASES, AND SOME 3900 02:28:35,000 --> 02:28:39,440 INFLAMMATORY SKIN DISEASES WITH 3901 02:28:39,440 --> 02:28:41,960 THE IDEA KNOWLEDGE-BASED PORTAL 3902 02:28:41,960 --> 02:28:43,320 WILL GROW. 3903 02:28:43,320 --> 02:28:47,120 AS I MENTIONED BEFORE, THE 3904 02:28:47,120 --> 02:28:50,200 INSTITUTE IS INCREASINGLY 3905 02:28:50,200 --> 02:28:52,280 JOINING NIH-SPONSORED NOTICES OF 3906 02:28:52,280 --> 02:28:56,120 FUNDING OPPORTUNITIES, WITH THE 3907 02:28:56,120 --> 02:28:59,480 IDEA TO ENHANCE OUR INVESTMENT 3908 02:28:59,480 --> 02:29:00,920 ON CERTAIN INFRASTRUCTURE TO 3909 02:29:00,920 --> 02:29:03,320 FACILITATE DATA SHARING AND DATA 3910 02:29:03,320 --> 02:29:06,040 ACCESS, BUT ALSO DATA USE AS YOU 3911 02:29:06,040 --> 02:29:08,120 CAN SEE IN THE LAST FOUR BULLETS 3912 02:29:08,120 --> 02:29:10,000 IN THE SLIDE. 3913 02:29:10,000 --> 02:29:14,400 WE ALSO HAD A SESSION, A 3914 02:29:14,400 --> 02:29:17,440 WORKFORCE, AGAIN WITH THE IDEA 3915 02:29:17,440 --> 02:29:19,720 THE THEME EMERGED RELY ON 3916 02:29:19,720 --> 02:29:21,280 LEVERAGING EXISTING ONGOING 3917 02:29:21,280 --> 02:29:23,240 RESOURCES AT DIFFERENT 3918 02:29:23,240 --> 02:29:25,440 INSTITUTIONS AND PERHAPS 3919 02:29:25,440 --> 02:29:30,120 POSITIONING SOME OF OUR SPECIAL 3920 02:29:30,120 --> 02:29:31,680 FUNDING MECHANISMS LIKE THE 3921 02:29:31,680 --> 02:29:34,960 RESEARCH RESOURCE CENTERS TO 3922 02:29:34,960 --> 02:29:37,360 FACILITATE THE TRAINING OF 3923 02:29:37,360 --> 02:29:39,200 JUNIOR INVESTIGATORS WHO 3924 02:29:39,200 --> 02:29:43,240 SPECIALIZE ON BIOINFORMATICS AND 3925 02:29:43,240 --> 02:29:44,680 DATA SCIENCE. 3926 02:29:44,680 --> 02:29:46,840 WE'RE ALSO BEGINNING TO USE DATA 3927 02:29:46,840 --> 02:29:48,080 SCIENCE APPROACHES IN SOME OF 3928 02:29:48,080 --> 02:29:50,160 THE PROJECTS THAT WE'RE 3929 02:29:50,160 --> 02:29:50,680 SPONSORING. 3930 02:29:50,680 --> 02:29:53,240 SO, YOU HAVE HEARD FROM DR. 3931 02:29:53,240 --> 02:30:01,080 CARTER IN PREVIOUS MEETINGS 3932 02:30:01,080 --> 02:30:05,480 ABOUT THE AMP PROJECT, A NEW 3933 02:30:05,480 --> 02:30:08,640 INITIATIVE BY THE AMP 3934 02:30:08,640 --> 02:30:10,520 PARTNERSHIP, THAT COMBINES THE 3935 02:30:10,520 --> 02:30:13,440 EFFORTS THAT HAVE -- THAT ARE IN 3936 02:30:13,440 --> 02:30:17,280 PLACE THROUGH DIFFERENT PROJECTS 3937 02:30:17,280 --> 02:30:20,200 INCLUDING FOR EXAMPLE THE AMP IN 3938 02:30:20,200 --> 02:30:22,240 ALZHEIMER'S DISEASE, CHRONIC 3939 02:30:22,240 --> 02:30:22,920 METABOLIC DISEASES, PARKINSON'S, 3940 02:30:22,920 --> 02:30:25,520 ET CETERA. 3941 02:30:25,520 --> 02:30:27,560 THE IDEA BUILDS ON HYPOTHESIS 3942 02:30:27,560 --> 02:30:30,280 AND MANY DISEASES SHARE 3943 02:30:30,280 --> 02:30:33,400 MECHANISMS OF DISEASE, IN 3944 02:30:33,400 --> 02:30:35,120 PARTICULAR INFLAMMATION, AND BY 3945 02:30:35,120 --> 02:30:37,640 LOOKING AT DATASETS THAT HAVE 3946 02:30:37,640 --> 02:30:39,160 BEEN GENERATED INDEPENDENTLY BY 3947 02:30:39,160 --> 02:30:41,880 EACH OF THE PROGRAMS ONE COULD 3948 02:30:41,880 --> 02:30:42,400 POTENTIALLY IDENTIFY THOSE 3949 02:30:42,400 --> 02:30:45,000 MECHANISMS THAT ARE SHARED AND 3950 02:30:45,000 --> 02:30:47,800 THOSE THAT ARE DISTINCT, AND 3951 02:30:47,800 --> 02:30:51,960 IMPORTANTLY TARGET THEM FOR 3952 02:30:51,960 --> 02:30:53,960 DIAGNOSIS OR TREATMENT. 3953 02:30:53,960 --> 02:30:57,640 SO, AS YOU CAN IMAGINE, THESE 3954 02:30:57,640 --> 02:30:59,840 PROJECTS ARE LARGE, THEY INVOLVE 3955 02:30:59,840 --> 02:31:03,800 FUNDING BY THE NIH AND FUNDING 3956 02:31:03,800 --> 02:31:06,680 BY THE PRIVATE SECTOR, THEY ARE 3957 02:31:06,680 --> 02:31:09,360 MANAGED BY FOUNDATION OF NIH 3958 02:31:09,360 --> 02:31:10,520 RESEARCH, BECAUSE THE PROJECTS 3959 02:31:10,520 --> 02:31:13,680 THEMSELVES ARE LARGE AND THE 3960 02:31:13,680 --> 02:31:17,240 DATASETS ARE VERY LARGE, THE 3961 02:31:17,240 --> 02:31:20,760 CONCEPT, THE PROJECT REQUIRES 3962 02:31:20,760 --> 02:31:23,760 SIGNIFICANT DATA SCIENCE 3963 02:31:23,760 --> 02:31:24,400 INFRASTRUCTURE. 3964 02:31:24,400 --> 02:31:28,840 SO, IN ORDER TO SUPPORT THE 3965 02:31:28,840 --> 02:31:31,800 CONCEPT, WE THOUGHT ABOUT DATA 3966 02:31:31,800 --> 02:31:34,240 SCIENCE ACTIVITY OR AN 3967 02:31:34,240 --> 02:31:37,520 INFRASTRUCTURE THAT WE CALL AIDE 3968 02:31:37,520 --> 02:31:40,480 THAT WOULD CHANGE THE PARADIGM A 3969 02:31:40,480 --> 02:31:42,440 LITTLE BIT HOW WE GO ABOUT 3970 02:31:42,440 --> 02:31:44,000 GETTING THE INFORMATION THAT WE 3971 02:31:44,000 --> 02:31:47,560 NEED FROM THE DIFFERENT DATASETS 3972 02:31:47,560 --> 02:31:50,000 TO SUPPORT THE HYPOTHESIS THAT 3973 02:31:50,000 --> 02:31:51,960 WE MIGHT HAVE SHARED MECHANISMS 3974 02:31:51,960 --> 02:31:53,360 OF DISEASE AMONG THE VERY 3975 02:31:53,360 --> 02:31:55,200 DIFFERENT TYPES OF DISEASES THAT 3976 02:31:55,200 --> 02:31:59,400 WE CAN TARGET FOR TREATMENT. 3977 02:31:59,400 --> 02:32:00,480 SO, CURRENT APPROACH YOU HAVE TO 3978 02:32:00,480 --> 02:32:02,560 FIND THE DATA, IF YOU'RE AN 3979 02:32:02,560 --> 02:32:03,480 INVESTIGATOR, ACCESS DATA FROM 3980 02:32:03,480 --> 02:32:05,440 THE SOURCE, YOU HAVE TO DEVELOP 3981 02:32:05,440 --> 02:32:07,200 YOUR HYPOTHESIS, YOU HAVE TO 3982 02:32:07,200 --> 02:32:09,360 CONDUCT YOUR DATA ANALYSIS. 3983 02:32:09,360 --> 02:32:12,080 AND THEN YOU HAVE TO DO YOUR 3984 02:32:12,080 --> 02:32:13,800 ANALYSIS OF YOUR RESULTS. 3985 02:32:13,800 --> 02:32:15,040 BUT IT REQUIRES INVESTIGATOR TO 3986 02:32:15,040 --> 02:32:17,080 GO OUT AND GET THE DATA. 3987 02:32:17,080 --> 02:32:19,400 EVEN IF THE DATA ARE ANNOTATED 3988 02:32:19,400 --> 02:32:20,800 AND INTEROPERABLE. 3989 02:32:20,800 --> 02:32:24,560 WHAT WE WANTED TO DO WITH AIDE 3990 02:32:24,560 --> 02:32:28,200 WAS EXPLORE POSSIBILITY THAT WE 3991 02:32:28,200 --> 02:32:32,400 COULD CREATE A SYSTEM, DATA 3992 02:32:32,400 --> 02:32:33,080 SYSTEM, THROUGH ALGORITHMS AND 3993 02:32:33,080 --> 02:32:37,040 DATA THEMES THAT WOULD AM LOU 3994 02:32:37,040 --> 02:32:39,000 YOU TO PUT THE HIGH -- ALLOW YOU 3995 02:32:39,000 --> 02:32:41,160 TO PUT THE HYPOTHESIS INTO THE 3996 02:32:41,160 --> 02:32:42,080 SYSTEM, SYSTEM WOULD BE 3997 02:32:42,080 --> 02:32:43,960 PROGRAMMED TO DO QUERIES FOR 3998 02:32:43,960 --> 02:32:46,800 YOU, AND FISH OUT RELEVANT 3999 02:32:46,800 --> 02:32:48,560 DATASETS OR RELEVANT DATA POINTS 4000 02:32:48,560 --> 02:32:50,640 FROM ALL OF VERY DISPARATE 4001 02:32:50,640 --> 02:32:54,000 DATASETS THAT MAY EXIST IN YOUR 4002 02:32:54,000 --> 02:32:54,280 ECOSYSTEM. 4003 02:32:54,280 --> 02:32:56,840 AND IN THE END, ONCE YOU HAVE 4004 02:32:56,840 --> 02:32:59,720 YOUR DATA, IT WOULD ALLOW THE 4005 02:32:59,720 --> 02:33:02,560 SYSTEM TO FIND THE RELEVANT 4006 02:33:02,560 --> 02:33:07,120 CLINICAL DATA TO VALIDATE YOUR 4007 02:33:07,120 --> 02:33:07,440 HYPOTHESIS. 4008 02:33:07,440 --> 02:33:10,560 THIS IS OBVIOUSLY VERY AMBITIOUS 4009 02:33:10,560 --> 02:33:11,920 AND WE'RE AT THE VERY BEGINNING 4010 02:33:11,920 --> 02:33:13,480 OF THE PROCESS, IT WOULD REQUIRE 4011 02:33:13,480 --> 02:33:15,560 MANY ITERATIONS BUT WE DO HAVE 4012 02:33:15,560 --> 02:33:17,720 LEVEL OF COMPLEXITY IN THE AMP 4013 02:33:17,720 --> 02:33:20,280 SYSTEM, IN THE AMP ENVIRONMENT, 4014 02:33:20,280 --> 02:33:21,920 TO REALLY APPROACH THE QUESTION 4015 02:33:21,920 --> 02:33:25,120 OF WHETHER WE CAN CHANGE HOW WE 4016 02:33:25,120 --> 02:33:28,360 LOOK AT DISEASE AND GOING FROM A 4017 02:33:28,360 --> 02:33:30,000 CLASSIFICATION AND DIAGNOSIS OF 4018 02:33:30,000 --> 02:33:33,360 DISEASE PRIMARILY DRIVEN BY 4019 02:33:33,360 --> 02:33:36,800 CLINICAL PRESENTATION NOWADAYS, 4020 02:33:36,800 --> 02:33:40,280 TO A MORE COMPLEX OR TO A 4021 02:33:40,280 --> 02:33:42,600 DIFFERENT APPROACH THAT IS 4022 02:33:42,600 --> 02:33:44,240 DRIVEN BY MOLECULAR SIGNATURES 4023 02:33:44,240 --> 02:33:47,480 AND PATHWAYS OF DISEASE COMBINED 4024 02:33:47,480 --> 02:33:48,080 WITH CLINICAL OUTCOMES. 4025 02:33:48,080 --> 02:33:50,480 SO, THIS IS IN THE WORKS, AND WE 4026 02:33:50,480 --> 02:33:54,080 HOPE THAT AS WE MOVE FORWARD, AS 4027 02:33:54,080 --> 02:33:55,840 I MENTIONED, FNIH IS WORKING 4028 02:33:55,840 --> 02:33:58,120 WITH THE PRIVATE SECTOR TO RAISE 4029 02:33:58,120 --> 02:33:59,960 FUNDING AND WE WITHIN THE NIH 4030 02:33:59,960 --> 02:34:05,240 ARE WORKING WITH YOUR SISTER 4031 02:34:05,240 --> 02:34:07,960 I.C.s TO SEEK INTEREST AND 4032 02:34:07,960 --> 02:34:11,600 POTENTIALLY FUNDING AS WELL TO 4033 02:34:11,600 --> 02:34:14,760 CREATE THIS NEW CONCEPT FOR 4034 02:34:14,760 --> 02:34:15,960 SYSTEMS BIOLOGY OF INFLAMMATION. 4035 02:34:15,960 --> 02:34:17,680 WITH THAT I'LL STOP AND BE HAPPY 4036 02:34:17,680 --> 02:34:21,560 TO ANSWER ANY QUESTIONS. 4037 02:34:21,560 --> 02:34:24,640 >> SO, THANK YOU, SUSANA. 4038 02:34:24,640 --> 02:34:27,280 I FAILED IN INTRODUCING YOU TO 4039 02:34:27,280 --> 02:34:28,840 HIGHLIGHT YOUR IMPORTANT ROLE AS 4040 02:34:28,840 --> 02:34:30,000 ASSOCIATE DIRECTOR FOR STRATEGIC 4041 02:34:30,000 --> 02:34:31,160 INITIATIVES, AND IN THAT ROLE 4042 02:34:31,160 --> 02:34:33,680 YOU CAN ONLY IMAGINE ALL OF THE 4043 02:34:33,680 --> 02:34:35,520 MANY PROJECTS AND INITIATIVES 4044 02:34:35,520 --> 02:34:36,400 THAT SUSANA HAS BEEN DEEPLY 4045 02:34:36,400 --> 02:34:36,960 INVOLVED IN. 4046 02:34:36,960 --> 02:34:38,960 THANK YOU SO MUCH, ALSO FOR THAT 4047 02:34:38,960 --> 02:34:39,160 SUMMARY. 4048 02:34:39,160 --> 02:34:42,400 WE HAVE TIME FOR A COUPLE OF 4049 02:34:42,400 --> 02:34:44,720 QUESTIONS FOR SUSANA? 4050 02:34:44,720 --> 02:34:44,920 ELLEN? 4051 02:34:44,920 --> 02:34:47,000 >> YES, THAT'S REALLY A 4052 02:34:47,000 --> 02:34:48,360 FANTASTIC PRESENTATION, JUST 4053 02:34:48,360 --> 02:34:50,760 VERY, VERY EXCITING APPROACH. 4054 02:34:50,760 --> 02:34:51,920 I WAS INTERESTED, IF YOU COULD 4055 02:34:51,920 --> 02:34:54,400 TELL US MORE ABOUT THIS 4056 02:34:54,400 --> 02:34:55,680 INFLAMMATION PROJECT AND 4057 02:34:55,680 --> 02:34:57,480 DIFFERENT DATASETS, WHERE DO THE 4058 02:34:57,480 --> 02:34:59,080 DATASETS COME FROM? 4059 02:34:59,080 --> 02:35:00,480 HOW WOULD THEY BE INTEGRATED? 4060 02:35:00,480 --> 02:35:02,560 AND AT WHAT POINT WOULD AN 4061 02:35:02,560 --> 02:35:05,280 INVESTIGATOR BE ABLE TO QUERY 4062 02:35:05,280 --> 02:35:08,440 THIS LARGER DATASET FOR A 4063 02:35:08,440 --> 02:35:08,840 SPECIFIC QUESTION? 4064 02:35:08,840 --> 02:35:10,440 >> GREAT QUESTIONS. 4065 02:35:10,440 --> 02:35:12,520 I HOPE BOTH LINDSEY AND BOB WILL 4066 02:35:12,520 --> 02:35:14,000 CHIME IN. 4067 02:35:14,000 --> 02:35:16,640 THE DATASETS FOR MANY OF THE AMP 4068 02:35:16,640 --> 02:35:24,440 PROJECTS, FOR EXAMPLE, THE AMP 4069 02:35:24,440 --> 02:35:29,120 ALZHEIMER'S DISEASE, CHRONIC 4070 02:35:29,120 --> 02:35:30,240 METABOLIC DISORDERS, 4071 02:35:30,240 --> 02:35:31,440 PARKINSON'S, ALREADY EXISTED, 4072 02:35:31,440 --> 02:35:33,880 HOUSED IN DIFFERENT PLATFORMS. 4073 02:35:33,880 --> 02:35:35,280 ALZHEIMER'S IN THE PLATFORM WITH 4074 02:35:35,280 --> 02:35:43,840 SAGE, TWO AT THE TERRA PLATFORM. 4075 02:35:43,840 --> 02:35:45,360 SO, THE DATA ARE ALREADY -- A 4076 02:35:45,360 --> 02:35:48,400 LOT OF THE DATA ARE ALREADY 4077 02:35:48,400 --> 02:35:48,600 THERE. 4078 02:35:48,600 --> 02:35:50,960 THE NATIONAL INSTITUTE OF AGING 4079 02:35:50,960 --> 02:35:53,800 FUNDED A SERIES OF PILOTS TO 4080 02:35:53,800 --> 02:35:56,760 PRODUCE A LITTLE BIT OF A PROOF 4081 02:35:56,760 --> 02:36:00,160 OF CONCEPT THAT IS BASED ON THE 4082 02:36:00,160 --> 02:36:02,120 IDEA THAT -- TO SHOW FEASIBILITY 4083 02:36:02,120 --> 02:36:03,520 OF THE APPROACH. 4084 02:36:03,520 --> 02:36:07,320 CAN WE EXPLORE PATHWAYS OF 4085 02:36:07,320 --> 02:36:08,520 INFLAMMATION, USING DATASETS 4086 02:36:08,520 --> 02:36:11,160 FROM DIFFERENT DISEASES AND CAN 4087 02:36:11,160 --> 02:36:14,680 WE FIND ANY COMMON ELEMENTS. 4088 02:36:14,680 --> 02:36:17,200 AND THE PILOTS ARE DRIVEN BY 4089 02:36:17,200 --> 02:36:17,960 PARTICULAR HYPOTHESIS, SOMEONE 4090 02:36:17,960 --> 02:36:21,160 IS INTERESTED IN IMMUNE 4091 02:36:21,160 --> 02:36:22,680 MECHANISMS, IN GENETIC 4092 02:36:22,680 --> 02:36:23,920 POLYMORPHISM, SOMEONE ELSE 4093 02:36:23,920 --> 02:36:25,760 INTERESTED IN THE METABOLOME. 4094 02:36:25,760 --> 02:36:28,200 SO THEY ARE IN SMALLER SCALE 4095 02:36:28,200 --> 02:36:31,560 LOOKING AT THE DATA PRODUCED BY 4096 02:36:31,560 --> 02:36:35,200 SOME OF THE PROJECTS, AND 4097 02:36:35,200 --> 02:36:36,400 REQUIRES PROCESSING OF DATA, 4098 02:36:36,400 --> 02:36:37,320 REQUIRES APPROACH I MENTIONED 4099 02:36:37,320 --> 02:36:39,040 BEFORE, THEY HAVE TO GO, LOOK 4100 02:36:39,040 --> 02:36:41,000 FOR THE DATA, PROCESS THE DATA, 4101 02:36:41,000 --> 02:36:44,080 DO ANALYSIS, AND SEE IF WHETHER 4102 02:36:44,080 --> 02:36:48,760 THE HYPOTHESIS IS VALID OR NOT. 4103 02:36:48,760 --> 02:36:50,520 THAT, THOSE PILOTS ARE BEING 4104 02:36:50,520 --> 02:36:51,560 CONDUCTED RIGHT NOW, PROBABLY 4105 02:36:51,560 --> 02:36:53,040 DONE WITHIN A YEAR OR SO. 4106 02:36:53,040 --> 02:36:57,720 WHICH IS A TIME FRAME WE'RE 4107 02:36:57,720 --> 02:36:59,600 THINKING ABOUT TO LAUNCH SYSTEMS 4108 02:36:59,600 --> 02:37:00,200 BIOLOGY OF INFLAMMATION. 4109 02:37:00,200 --> 02:37:01,880 A LOT OF DATA ARE AVAILABLE NOW 4110 02:37:01,880 --> 02:37:03,280 BUT, AGAIN, IT WOULD REQUIRE A 4111 02:37:03,280 --> 02:37:05,280 LOT OF WORK BY INVESTIGATORS WHO 4112 02:37:05,280 --> 02:37:07,040 WANTS TO USE THE DATA. 4113 02:37:07,040 --> 02:37:13,800 THAT'S PART OF THE PROBLEM THAT 4114 02:37:13,800 --> 02:37:15,960 WE ARE TRYING TO -- 4115 02:37:15,960 --> 02:37:17,720 >>BOB, DID YOU WANT TO MAKE 4116 02:37:17,720 --> 02:37:20,600 COMMENTS NOW AND THEN MARIA AND 4117 02:37:20,600 --> 02:37:20,800 DAVID? 4118 02:37:20,800 --> 02:37:23,440 >> QUICK THINGS. 4119 02:37:23,440 --> 02:37:25,080 THE SYSTEMS BIOLOGY INFORMATION 4120 02:37:25,080 --> 02:37:27,040 USES THE DIFFERENT DATASETS THAT 4121 02:37:27,040 --> 02:37:30,360 HAVE BEEN GENERATED WITHIN THE 4122 02:37:30,360 --> 02:37:32,120 AMP LARGER PROGRAM BUT SOME OF 4123 02:37:32,120 --> 02:37:33,480 YOU KNOW, ELLEN IN PARTICULAR, 4124 02:37:33,480 --> 02:37:36,480 THE AMP, JUST AMP AIM, THE ONE 4125 02:37:36,480 --> 02:37:41,160 WE'RE INVOLVED IN, AUTOIMMUNE 4126 02:37:41,160 --> 02:37:42,320 DISEASES, SUCCESSOR TO LUPUS, 4127 02:37:42,320 --> 02:37:43,480 TRANSCRIPTOMICS ON HUNDREDS OF 4128 02:37:43,480 --> 02:37:45,080 PATIENTS, ALL THE CLINICAL DATA. 4129 02:37:45,080 --> 02:37:46,680 THESE ARE ALL HUGE DATASETS, BUT 4130 02:37:46,680 --> 02:37:48,600 THEY DON'T TALK TO EACH OTHER. 4131 02:37:48,600 --> 02:37:50,400 BECAUSE THAT'S THE WAY NIH WAS 4132 02:37:50,400 --> 02:37:53,080 BUILT AND STRUCTURED. 4133 02:37:53,080 --> 02:37:54,960 THESE PROJECTS WERE INDEPENDENTS 4134 02:37:54,960 --> 02:37:58,880 OF EACH OVER, A CRYING SHAME 4135 02:37:58,880 --> 02:38:02,640 HOLDING BACK PROCESS . 4136 02:38:02,640 --> 02:38:04,520 SAME TRUE OF AUTOIMMUNE DISEASE, 4137 02:38:04,520 --> 02:38:06,920 THERE'S A LOT OF INFORMATION 4138 02:38:06,920 --> 02:38:08,560 HOUSED IN DIFFERENT INSTITUTES. 4139 02:38:08,560 --> 02:38:12,120 IT'S NOT THAT THEY ARE UNWILLIG 4140 02:38:12,120 --> 02:38:18,080 TO SHARE, IT'S NOT THE CULTURE 4141 02:38:18,080 --> 02:38:19,360 OF NIH. 4142 02:38:19,360 --> 02:38:22,800 IT WOULD SEEM LIKE A LOW-HANGING 4143 02:38:22,800 --> 02:38:25,080 FRUIT, OBVIOUS, AND MAYBE THE 4144 02:38:25,080 --> 02:38:26,200 OFFICE OF AUTOIMMUNE DISEASE 4145 02:38:26,200 --> 02:38:28,360 RESEARCH WITHIN ORWH CAN HELP 4146 02:38:28,360 --> 02:38:29,960 FACILITATE THIS. 4147 02:38:29,960 --> 02:38:31,360 I DO HOPE THERE WILL BE A 4148 02:38:31,360 --> 02:38:33,880 WORKING GROUP THAT WILL BE 4149 02:38:33,880 --> 02:38:35,400 FORMED, THIS TO ME SEEMS LIKE 4150 02:38:35,400 --> 02:38:37,520 THE MOST OBVIOUS THING FOR THE 4151 02:38:37,520 --> 02:38:39,160 GROUP TO DO. 4152 02:38:39,160 --> 02:38:41,640 IN FACT RESPOND TO CONGRESSIONAL 4153 02:38:41,640 --> 02:38:43,640 MANDATE TO WORK TOGETHER. 4154 02:38:43,640 --> 02:38:44,880 >> THE OFFICE OF DATA SCIENCE 4155 02:38:44,880 --> 02:38:46,240 STRATEGY IS EXCITED ABOUT THIS 4156 02:38:46,240 --> 02:38:47,240 PROJECT TOO. 4157 02:38:47,240 --> 02:38:49,760 I THINK MARIA AND THEN DAVID. 4158 02:38:49,760 --> 02:38:52,920 >> YES, VERY EXCITING PROJECT. 4159 02:38:52,920 --> 02:38:54,880 MY QUESTION IS MORE POLICY 4160 02:38:54,880 --> 02:38:57,120 RELATED, THE FINAL AIM OF THE 4161 02:38:57,120 --> 02:39:02,400 THIS TO HAVE A DATASET PUBLIC AT 4162 02:39:02,400 --> 02:39:06,400 LARGE OR TO HAVE JUST FOR 4163 02:39:06,400 --> 02:39:08,800 INVESTIGATORS TO APPLY TO GRANTS 4164 02:39:08,800 --> 02:39:09,840 TO USE RESOURCES? 4165 02:39:09,840 --> 02:39:12,000 >> NO, THE ULTIMATE GOAL TO 4166 02:39:12,000 --> 02:39:16,440 MAKE ALL DATASETS PUBLICLY 4167 02:39:16,440 --> 02:39:16,720 AVAILABLE. 4168 02:39:16,720 --> 02:39:17,680 THERE IS OBVIOUSLY -- WHEN 4169 02:39:17,680 --> 02:39:19,240 YOU'RE WORKING IN PROJECTS LIKE 4170 02:39:19,240 --> 02:39:21,360 THIS, THERE IS OBVIOUSLY A 4171 02:39:21,360 --> 02:39:23,080 PERIOD IN WHICH INVESTIGATORS 4172 02:39:23,080 --> 02:39:26,280 WHO ARE PART OF THE PROJECTS, 4173 02:39:26,280 --> 02:39:27,920 WHO ARE THE INTELLECTUAL DRIVERS 4174 02:39:27,920 --> 02:39:30,680 OF THE PROJECT, HAVE A WORKING 4175 02:39:30,680 --> 02:39:32,800 SPACE, WHEN THEY CAN WORK WITH 4176 02:39:32,800 --> 02:39:34,920 THE DATA. 4177 02:39:34,920 --> 02:39:38,560 BUT THAT TIME FRAME IS LIMITED, 4178 02:39:38,560 --> 02:39:41,160 AFTER A CERTAIN AMOUNT OF TIME 4179 02:39:41,160 --> 02:39:48,160 THE DATA RELEASED TO THE PUBLIC 4180 02:39:48,160 --> 02:39:50,200 SITE, WHETHER PRODUCED OR NOT. 4181 02:39:50,200 --> 02:39:51,320 >> DAVID? 4182 02:39:51,320 --> 02:39:53,000 >> THANK YOU FOR THAT 4183 02:39:53,000 --> 02:39:53,360 PRESENTATION. 4184 02:39:53,360 --> 02:39:54,280 A QUESTION ABOUT AMP. 4185 02:39:54,280 --> 02:39:57,080 I KNOW A LOT OF EFFORT IS PUT IN 4186 02:39:57,080 --> 02:40:02,080 TO LOOK AT MULTIOMICS, THIS IS A 4187 02:40:02,080 --> 02:40:05,000 SCIENTIFIC OR THEMED ON THE 4188 02:40:05,000 --> 02:40:06,240 FOUNDATION FOR NEW MOLECULAR 4189 02:40:06,240 --> 02:40:07,720 TAXONOMY OF DISEASE. 4190 02:40:07,720 --> 02:40:09,120 MY UNDERSTANDING THOSE STUDIES 4191 02:40:09,120 --> 02:40:13,480 ARE QUITE SMALL IN THE SCALE OF 4192 02:40:13,480 --> 02:40:17,280 GENOMIC ANALYSES, SO 50 TO 100 4193 02:40:17,280 --> 02:40:25,400 CASES PER DISEASE PROBABLY DON'T 4194 02:40:25,400 --> 02:40:26,560 REPRESENT HETEROGENEITY OF 4195 02:40:26,560 --> 02:40:27,880 DISEASE, WHERE ALREADY EXISTING 4196 02:40:27,880 --> 02:40:29,640 DATABASES ARE IN THE HUNDREDS OF 4197 02:40:29,640 --> 02:40:30,160 THOUSANDS. 4198 02:40:30,160 --> 02:40:32,680 SO IS THERE AN EFFORT, PARALLEL 4199 02:40:32,680 --> 02:40:34,560 EFFORT OR EXTENSION EFFORT, TO 4200 02:40:34,560 --> 02:40:36,760 USE ALREADY EXISTING DATASETS TO 4201 02:40:36,760 --> 02:40:41,080 LOOK AT GENOMIC, IT WON'T BE 4202 02:40:41,080 --> 02:40:42,320 POSSIBLE POTENTIALLY FOR OTHER 4203 02:40:42,320 --> 02:40:48,920 APPROACHES BUT MIGHT BE A NICE 4204 02:40:48,920 --> 02:40:49,880 WAY TO ON MAGNIFICATION TO 4205 02:40:49,880 --> 02:40:52,080 GENOMIC ANALYSIS OF HUNDREDS OF 4206 02:40:52,080 --> 02:40:52,360 THOUSANDS? 4207 02:40:52,360 --> 02:40:54,360 >> YOU'RE ABSOLUTELY CORRECT. 4208 02:40:54,360 --> 02:41:00,400 IT IS THE -- AMP-RA LUPUS, TO 4209 02:41:00,400 --> 02:41:03,320 SOME EXTENT I THINK THE 4210 02:41:03,320 --> 02:41:04,200 PARKINSON'S PROJECTS HAVE FEWER 4211 02:41:04,200 --> 02:41:09,560 PATIENTS THAN SOME OF THE OTHER 4212 02:41:09,560 --> 02:41:11,760 AMP DATASETS, THE ONE ON CHRONIC 4213 02:41:11,760 --> 02:41:12,880 METABOLIC DISORDER FOR EXAMPLE 4214 02:41:12,880 --> 02:41:19,360 INCLUDES A VERY, VERY LARGE 4215 02:41:19,360 --> 02:41:22,400 INTERNATIONAL DATASET, AND THE 4216 02:41:22,400 --> 02:41:25,320 GENOMICS OF DIABETES WITH 4217 02:41:25,320 --> 02:41:28,640 THOUSANDS OF PATIENTS OR PERSONS 4218 02:41:28,640 --> 02:41:29,240 CONTRIBUTING DATA. 4219 02:41:29,240 --> 02:41:32,680 SO THE SIZE OF THE DIFFERENT 4220 02:41:32,680 --> 02:41:35,800 AMPS, COVERED RANGE. 4221 02:41:35,800 --> 02:41:38,880 SO PROBABLY R.A. ALUMINUM -- 4222 02:41:38,880 --> 02:41:40,800 LUPUS IS ONE OF THE SMALLER IN 4223 02:41:40,800 --> 02:41:50,120 TERMS OF NUMBERS OF PATIENTS, O 4224 02:41:50,120 --> 02:41:52,280 THERE IS AN OPPORTUNITY TO THINK 4225 02:41:52,280 --> 02:41:54,000 ABOUT HOW THE DATASETS CAN 4226 02:41:54,000 --> 02:41:55,760 COMPLEMENT EACH OTHER, IF YOU'RE 4227 02:41:55,760 --> 02:42:01,320 IN THE DISCOVERY PHASE VERSUS 4228 02:42:01,320 --> 02:42:03,920 VALIDATION, ET CETERA. 4229 02:42:03,920 --> 02:42:04,200 >> BOB? 4230 02:42:04,200 --> 02:42:05,480 >> IT'S INTERESTING, RISK 4231 02:42:05,480 --> 02:42:08,880 COMMON METABOLIC DISEASE WAS 4232 02:42:08,880 --> 02:42:10,240 BUILT AS GENETICS REPOSITORY TO 4233 02:42:10,240 --> 02:42:15,320 FED RATE ACROSS GENOMIC DATASETS 4234 02:42:15,320 --> 02:42:16,920 SO ANYBODY COULD FIND ANNOTATED 4235 02:42:16,920 --> 02:42:21,720 GENES AND DRILL DOWN FROM THERE 4236 02:42:21,720 --> 02:42:23,280 AND USE STANDARD TECHNIQUES FOR 4237 02:42:23,280 --> 02:42:25,360 SPECIFIC TARGETS FOR DIFFERENT 4238 02:42:25,360 --> 02:42:27,120 CONDITIONS VERSUS SOMETHING LIKE 4239 02:42:27,120 --> 02:42:30,600 AMP RA LUPUS OR AIM, MUCH MORE 4240 02:42:30,600 --> 02:42:35,800 FOCUSED ON SINGLE CELL 4241 02:42:35,800 --> 02:42:37,520 TRANSCRIPTOMICS BUT THEY ARE 4242 02:42:37,520 --> 02:42:38,040 CONVERGING. 4243 02:42:38,040 --> 02:42:39,720 IN COMMON METABOLIC DISEASE WEB 4244 02:42:39,720 --> 02:42:43,080 PORTAL THERE'S NOW AN AUTOIMMUNE 4245 02:42:43,080 --> 02:42:45,400 DISEASE SECTION WITH THE 4246 02:42:45,400 --> 02:42:47,880 GENETICS OF AUTOIMMUNE DISEASE 4247 02:42:47,880 --> 02:42:50,080 IN THE COMMON METABOLIC DISEASE 4248 02:42:50,080 --> 02:42:51,320 KNOWLEDGE PORTAL BECAUSE IT'S 4249 02:42:51,320 --> 02:42:53,720 MUCH MORE BUILT AROUND ANNOTATED 4250 02:42:53,720 --> 02:42:55,560 GENETICS BUT ANNOTATED GENETICS 4251 02:42:55,560 --> 02:42:58,080 IS NOW GETTING TO EXPRESSION 4252 02:42:58,080 --> 02:43:00,720 WHICH IS ACTUALLY SINGLE CELL 4253 02:43:00,720 --> 02:43:01,360 TRANSCRIPTOMICS. 4254 02:43:01,360 --> 02:43:02,880 SO, YOUR QUESTION IS RIGHT THEY 4255 02:43:02,880 --> 02:43:04,640 ARE DIFFERENT SCALES BUT 4256 02:43:04,640 --> 02:43:06,600 DIFFERENT PURPOSES, AND IT'S 4257 02:43:06,600 --> 02:43:08,040 SOMETHING WE STRUGGLE WITH, 4258 02:43:08,040 --> 02:43:12,560 OKAY, HERE WE AT NIAMS BUT WE 4259 02:43:12,560 --> 02:43:13,840 KNOW THERE'S AN AUTOIMMUNE 4260 02:43:13,840 --> 02:43:17,680 DISEASE PART WITHIN THE COMMON 4261 02:43:17,680 --> 02:43:21,680 METABOLIC DISEASE GENETIC-BASED 4262 02:43:21,680 --> 02:43:21,920 PORTAL. 4263 02:43:21,920 --> 02:43:24,160 >> AND WE WOULD HAVE THE OPTION 4264 02:43:24,160 --> 02:43:27,800 OF BRINGING DATASETS THAT ARE 4265 02:43:27,800 --> 02:43:32,320 NOT DATASETS ALSO THAT BEEN 4266 02:43:32,320 --> 02:43:32,840 CONSIDERED AS WELL. 4267 02:43:32,840 --> 02:43:33,120 >> MARY? 4268 02:43:33,120 --> 02:43:34,480 >>YEAH, THANKS FOR THAT. 4269 02:43:34,480 --> 02:43:37,000 I WANTED TO TAKE A STEP BACK. 4270 02:43:37,000 --> 02:43:39,040 ONE OF MY REFLECTIONS LOOKING AT 4271 02:43:39,040 --> 02:43:41,320 THIS WE HAVE A LOT OF FOCUS ON 4272 02:43:41,320 --> 02:43:43,680 AUTOIMMUNE DISEASE, SO WHERE DO 4273 02:43:43,680 --> 02:43:46,760 WE SEE BIG DATA IN THE OTHER 4274 02:43:46,760 --> 02:43:47,120 AREAS OF NIAMS? 4275 02:43:47,120 --> 02:43:49,360 FOR EXAMPLE, WHAT ABOUT THE 4276 02:43:49,360 --> 02:43:51,680 MUSCULOSKELETAL PORTAL THAT YOU 4277 02:43:51,680 --> 02:43:53,080 MENTIONED? 4278 02:43:53,080 --> 02:43:57,280 THERE WAS A PRESENTATION. 4279 02:43:57,280 --> 02:43:59,320 AGAIN, A LOT OF EXISTING DATA. 4280 02:43:59,320 --> 02:44:01,240 IS THIS VIEWED AS PILOT AND THE 4281 02:44:01,240 --> 02:44:02,760 OTHERS WILL COME ALONG? 4282 02:44:02,760 --> 02:44:06,000 I HAVEN'T HEARD MUCH TALK ABOUT 4283 02:44:06,000 --> 02:44:06,920 OTHER AREAS. 4284 02:44:06,920 --> 02:44:10,960 >> SO IN TERMS OF KNOWLEDGE 4285 02:44:10,960 --> 02:44:11,600 BASES FOR MUSCULOSKELETAL 4286 02:44:11,600 --> 02:44:13,080 DISEASES, I THINK WE WILL BE 4287 02:44:13,080 --> 02:44:18,080 TALKING ABOUT THAT SOME MORE, AS 4288 02:44:18,080 --> 02:44:21,160 TIME, SO HOPEFULLY WE'LL BE ABLE 4289 02:44:21,160 --> 02:44:23,440 TO ADDRESS THAT NEED OF THE 4290 02:44:23,440 --> 02:44:25,880 COMMUNITY WHICH WE REALIZE AND 4291 02:44:25,880 --> 02:44:36,040 HEARD ABOUT IN THE NEXT FEW 4292 02:44:36,040 --> 02:44:36,280 MONTHS. 4293 02:44:36,280 --> 02:44:39,120 >> HIS DATA IS IN THE COMMON 4294 02:44:39,120 --> 02:44:46,560 METABOLIC DISEASE PORTAL, SO, 4295 02:44:46,560 --> 02:44:46,760 YEAH. 4296 02:44:46,760 --> 02:44:50,160 >> SO, THAT'S IN TERMS OF 4297 02:44:50,160 --> 02:44:52,440 KNOWLEDGE, KNOWLEDGE BASE. 4298 02:44:52,440 --> 02:44:55,280 SO THERE ARE GENERALLY 4299 02:44:55,280 --> 02:44:59,360 REPOSITORIES, DATA REPOSITORIES 4300 02:44:59,360 --> 02:45:02,720 LIKE IMPORTANT OTHERS, SKIN, THE 4301 02:45:02,720 --> 02:45:06,480 EXTRACELLULAR MATRIX, ET CETERA, 4302 02:45:06,480 --> 02:45:09,640 THAT WE'RE LOOKING AS WELL. 4303 02:45:09,640 --> 02:45:13,600 SO CERTAINLY IN THE RANGE OF 4304 02:45:13,600 --> 02:45:16,000 REPOSITORIES AND KNOWLEDGE BASES 4305 02:45:16,000 --> 02:45:19,520 IT'S IMPORTANT TO MAKE SURE THAT 4306 02:45:19,520 --> 02:45:23,000 WE CAN PROVIDE A GATEWAY TO OUR 4307 02:45:23,000 --> 02:45:26,480 COMMUNITIES SO THAT THEY CAN 4308 02:45:26,480 --> 02:45:29,080 FIND THE DATA, THE REPOSITORIES, 4309 02:45:29,080 --> 02:45:30,440 THE RESOURCES, TOOLS FOR 4310 02:45:30,440 --> 02:45:32,080 ANALYZING THE DATA, THAT ARE 4311 02:45:32,080 --> 02:45:32,360 NECESSARY. 4312 02:45:32,360 --> 02:45:34,080 SO THE WORKING GROUP IS VERY 4313 02:45:34,080 --> 02:45:35,480 AWARE OF THAT. 4314 02:45:35,480 --> 02:45:38,960 WE HAVE BOTH DR. KEHL AND 4315 02:45:38,960 --> 02:45:40,160 WESTENDORF IN THE WORKING GROUP 4316 02:45:40,160 --> 02:45:43,560 AND THEY HAVE BOTH TALKED ABOUT 4317 02:45:43,560 --> 02:45:49,280 THE NEEDS OF THE MUSCULOSKELETAL 4318 02:45:49,280 --> 02:45:50,640 DISEASE -- THE MUSCULOSKELETAL 4319 02:45:50,640 --> 02:45:51,720 DISEASE RESEARCH COMMUNITIES, 4320 02:45:51,720 --> 02:45:54,680 AND THERE ARE AREAS THAT ARE 4321 02:45:54,680 --> 02:45:55,520 VERY SPECIALIZED, IMAGING FOR 4322 02:45:55,520 --> 02:45:56,840 EXAMPLE, RIGHT? 4323 02:45:56,840 --> 02:46:00,120 WHERE THE NEEDS MIGHT BE 4324 02:46:00,120 --> 02:46:04,080 DIFFERENT, AND IN OTHER DISEASE 4325 02:46:04,080 --> 02:46:07,080 AREAS WHERE DATA NEEDS RELATE TO 4326 02:46:07,080 --> 02:46:07,560 OTHER TYPES OF DATASETS. 4327 02:46:07,560 --> 02:46:10,560 >> I WANT TO ALSO FOR CONTEXT, 4328 02:46:10,560 --> 02:46:13,080 THE WORKING GROUP IS FOCUSED 4329 02:46:13,080 --> 02:46:13,400 BROADLY. 4330 02:46:13,400 --> 02:46:16,360 IT IS NOT FOCUSING SPECIFICALLY 4331 02:46:16,360 --> 02:46:18,120 ON AUTOIMMUNE DISEASE. 4332 02:46:18,120 --> 02:46:21,920 THE SYSTEMS BIOLOGY OF 4333 02:46:21,920 --> 02:46:25,560 INFLAMMATION AND THIS VISION 4334 02:46:25,560 --> 02:46:27,400 WE'RE CALLING AIDE, IT TAKES 4335 02:46:27,400 --> 02:46:30,280 ADVANTAGE OF THE AMP, 4336 02:46:30,280 --> 02:46:31,240 ACCELERATED MEDICINES 4337 02:46:31,240 --> 02:46:32,760 PARTNERSHIP, INFRASTRUCTURE AND 4338 02:46:32,760 --> 02:46:34,600 RESOURCES WHERE A FOCUS ON 4339 02:46:34,600 --> 02:46:35,480 AUTOIMMUNITY WAS A LOGICAL PLACE 4340 02:46:35,480 --> 02:46:37,040 TO START BUT THESE ARE -- YOU 4341 02:46:37,040 --> 02:46:39,120 KNOW, THERE'S THE BROADER EFFORT 4342 02:46:39,120 --> 02:46:41,560 THAT'S BROAD-BASED IN TERMS OF 4343 02:46:41,560 --> 02:46:42,920 NIAMS MISSION AREAS, FOR THE 4344 02:46:42,920 --> 02:46:45,080 WORKING GROUP, AND SYSTEMS 4345 02:46:45,080 --> 02:46:46,240 BIOLOGY OF INFLAMMATION IS MORE 4346 02:46:46,240 --> 02:46:48,080 SPECIFIC NOT BECAUSE THAT'S OUR 4347 02:46:48,080 --> 02:46:49,600 PRIMARY OR SOLE AREA OF INTEREST 4348 02:46:49,600 --> 02:46:51,080 BUT THERE'S AN OPPORTUNITY 4349 02:46:51,080 --> 02:46:51,400 THERE. 4350 02:46:51,400 --> 02:46:55,080 I WANTED TO MAKE THAT 4351 02:46:55,080 --> 02:46:57,080 DISTINCTION TOO. 4352 02:46:57,080 --> 02:46:59,320 BUT MAYBE LET'S MOVE ON AND ONCE 4353 02:46:59,320 --> 02:47:00,520 AGAIN SUSANA WILL BE AROUND FOR 4354 02:47:00,520 --> 02:47:02,440 THE REST OF THE DAY FOR FURTHER 4355 02:47:02,440 --> 02:47:04,640 QUESTIONS ON THAT TOPIC. 4356 02:47:04,640 --> 02:47:05,640 AND DARREN, OVER TO YOU. 4357 02:47:05,640 --> 02:47:06,920 >> THANK YOU VERY MUCH. 4358 02:47:06,920 --> 02:47:10,880 WE'RE GOING TO TURN ON OUR 4359 02:47:10,880 --> 02:47:11,960 CONCEPT CLEARANCE PRESENTATION. 4360 02:47:11,960 --> 02:47:13,880 AND I'D LIKE TO JUST TAKE A FEW 4361 02:47:13,880 --> 02:47:17,640 MOMENTS TO GO OVER THE NIAMS 4362 02:47:17,640 --> 02:47:19,600 PROCESS FOR CONCEPT CLEARANCE. 4363 02:47:19,600 --> 02:47:22,160 SO, AS YOU CAN SEE FROM PUT 4364 02:47:22,160 --> 02:47:27,160 POINTS STAFF CONTINUALLY WORK TO 4365 02:47:27,160 --> 02:47:28,360 IDENTIFY OPPORTUNITIES, PROGRAM 4366 02:47:28,360 --> 02:47:30,320 OFFICERS RECOMMEND CONCEPT WHICH 4367 02:47:30,320 --> 02:47:35,280 DESCRIBE BASIC PURPOSE, SCOPE, 4368 02:47:35,280 --> 02:47:36,240 OBJECTIVES OF INITIATIVES. 4369 02:47:36,240 --> 02:47:39,720 CONCEPT CLEARANCE IS THE PROCESS 4370 02:47:39,720 --> 02:47:45,080 BY WHICH WE RECEIVE PUBLIC INPUT 4371 02:47:45,080 --> 02:47:46,240 AND ADVICE, CONCEPTS WILL BE 4372 02:47:46,240 --> 02:47:48,800 PUBLISHED ON WEBSITE TO INFORM 4373 02:47:48,800 --> 02:47:49,720 RESEARCHERS ABOUT INTEREST IN 4374 02:47:49,720 --> 02:47:51,480 POTENTIAL FUNDING OPPORTUNITIES. 4375 02:47:51,480 --> 02:47:52,960 THESE ARE CONCEPTS, VERY BROAD, 4376 02:47:52,960 --> 02:47:55,520 WE CAN GET ONE OR MORE FUNDING 4377 02:47:55,520 --> 02:47:56,600 OPPORTUNITIES FROM ANY ONE 4378 02:47:56,600 --> 02:47:57,040 CONCEPT. 4379 02:47:57,040 --> 02:47:59,240 SO I'M GOING TO PASS NOW TO 4380 02:47:59,240 --> 02:48:01,560 GAYLE WHO IS THE DIRECTOR OF OUR 4381 02:48:01,560 --> 02:48:03,280 DIVISION OF EXTRAMURAL RESEARCH 4382 02:48:03,280 --> 02:48:05,000 TO LEAD THE DISCUSSION ON THE 4383 02:48:05,000 --> 02:48:07,760 CONCEPTS WE'RE CONSIDERING 4384 02:48:07,760 --> 02:48:09,080 TODAY. 4385 02:48:09,080 --> 02:48:09,760 WE HAVE THREE. 4386 02:48:09,760 --> 02:48:13,120 >> WE HAVE THREE CONCEPTS. 4387 02:48:13,120 --> 02:48:16,120 THE FIRST TWO ARE NEW CONCEPTS, 4388 02:48:16,120 --> 02:48:18,280 CAN WE -- FIRST SLIDE. 4389 02:48:18,280 --> 02:48:20,400 THIS IS ONE THAT SUSANA JUST 4390 02:48:20,400 --> 02:48:22,000 MENTIONED TO YOU. 4391 02:48:22,000 --> 02:48:32,440 AND IT IS THE ACCELERATING 4392 02:48:33,520 --> 02:48:36,240 INTEROPERABLE ECOSYSTEMS 4393 02:48:36,240 --> 02:48:37,800 GENERATED BY DR. SZTEIN AND 4394 02:48:37,800 --> 02:48:41,040 SHARMA, GOALS TO USE THE DATA 4395 02:48:41,040 --> 02:48:43,760 RESOURCES BEING GENERATED BY 4396 02:48:43,760 --> 02:48:47,920 AMP, AIM, AND OTHER NIH DATASETS 4397 02:48:47,920 --> 02:48:50,720 TO ESTABLISH KNOWLEDGE NETWORK 4398 02:48:50,720 --> 02:48:53,080 FOR MOLECULAR TAXONOMY OF 4399 02:48:53,080 --> 02:49:01,360 DISEASE ENABLED BY OPEN SCIENCE 4400 02:49:01,360 --> 02:49:03,600 PRACTICES AND DATA 4401 02:49:03,600 --> 02:49:04,440 INTEROPERABILITY, EACH PATIENT 4402 02:49:04,440 --> 02:49:06,800 IS TREATED ON PATHWAYS CAUSING 4403 02:49:06,800 --> 02:49:07,520 DISEASE AND CLINICAL 4404 02:49:07,520 --> 02:49:09,080 MANIFESTATIONS. 4405 02:49:09,080 --> 02:49:12,800 THIS IS THE FIRST CONCEPT. 4406 02:49:12,800 --> 02:49:15,640 AND THE SECONDS NEW CONCEPT I 4407 02:49:15,640 --> 02:49:16,840 THINK ACTUALLY SUSANA ALSO 4408 02:49:16,840 --> 02:49:21,040 REFERRED TO AT ONE POINT, THE 4409 02:49:21,040 --> 02:49:23,480 EXOSOME AND AUTOIMMUNE DISEASE 4410 02:49:23,480 --> 02:49:27,640 COLLABORATING TEAMS, EXACT, NICE 4411 02:49:27,640 --> 02:49:27,880 ACRONYMS. 4412 02:49:27,880 --> 02:49:30,920 SOME THINGS LEND THEMSELVES TO 4413 02:49:30,920 --> 02:49:34,360 IT, OTHERS DON'T. 4414 02:49:34,360 --> 02:49:40,440 THIS, AGAIN, IS SIMILAR IN 4415 02:49:40,440 --> 02:49:43,040 NATURE TO THE AUTOIMMUNITY 4416 02:49:43,040 --> 02:49:45,920 PROJECTS COMING OUT OF THE 4417 02:49:45,920 --> 02:49:47,600 OFFICE OF AUTOIMMUNITY IN THE 4418 02:49:47,600 --> 02:49:51,840 OFFICE OF RESEARCH ON WOMEN'S 4419 02:49:51,840 --> 02:49:52,720 HEALTH, IT'S DESCRIBED HERE, 4420 02:49:52,720 --> 02:50:00,840 BASED ON THE COMPLEXITY OF HUMAN 4421 02:50:00,840 --> 02:50:04,480 DISEASE AND GENETIC 4422 02:50:04,480 --> 02:50:05,760 SUSCEPTIBILITY AND ENVIRONMENTAL 4423 02:50:05,760 --> 02:50:07,160 EXPOSURES, IMPORTANT AS THE 4424 02:50:07,160 --> 02:50:09,400 SMOKE COMES DOWN FROM CANADA 4425 02:50:09,400 --> 02:50:17,000 TODAY AND SULLIES OUR BEAUTIFUL 4426 02:50:17,000 --> 02:50:20,000 SUNSHINE. 4427 02:50:20,000 --> 02:50:21,000 THESE BIOLOGICAL RESPONSES 4428 02:50:21,000 --> 02:50:24,080 GENERATE IN DISEASE INITIATION 4429 02:50:24,080 --> 02:50:25,720 AND PROGRESSION AND ARE 4430 02:50:25,720 --> 02:50:28,400 SIGNIFICANT GAPS IN OUR 4431 02:50:28,400 --> 02:50:33,480 UNDERSTANDING OF HOW THE 4432 02:50:33,480 --> 02:50:35,400 EXPOSOME AFFECTS HETEROGENEITY 4433 02:50:35,400 --> 02:50:38,120 OF MOLECULAR AND CELLULAR 4434 02:50:38,120 --> 02:50:38,840 PATHWAYS. 4435 02:50:38,840 --> 02:50:42,800 SO, THE SECOND CONCEPT REALLY 4436 02:50:42,800 --> 02:50:47,360 FOCUSES MORE SPECIFICALLY ON 4437 02:50:47,360 --> 02:50:48,800 EXPOSURES AND THAT IS -- WE 4438 02:50:48,800 --> 02:50:51,800 WON'T TALK ABOUT HOW WE WILL 4439 02:50:51,800 --> 02:50:53,720 ADDRESS THIS BUT JUST THIS 4440 02:50:53,720 --> 02:50:55,400 GENERAL CONCEPT RIGHT NOW. 4441 02:50:55,400 --> 02:50:58,560 THE THIRD CONCEPT IS A REISSUE, 4442 02:50:58,560 --> 02:51:01,520 AND THIS IS FOR THE RISK 4443 02:51:01,520 --> 02:51:04,480 INITIATIVE, AGAIN A NICE LITTLE 4444 02:51:04,480 --> 02:51:07,680 ACRONYM, BECAUSE IT'S BASED ON 4445 02:51:07,680 --> 02:51:09,400 RESEARCH INNOVATION, THE RISK IS 4446 02:51:09,400 --> 02:51:11,760 DESIGNED TO CAPTURE AND TEST 4447 02:51:11,760 --> 02:51:15,280 NOVEL AND AUDACIOUS IDEAS IN THE 4448 02:51:15,280 --> 02:51:19,960 EARLY STAGES OF DEVELOPMENT, NO 4449 02:51:19,960 --> 02:51:21,880 PRELIMINARY DATA REQUIRED. 4450 02:51:21,880 --> 02:51:25,400 AND MUCH LESS CONVENTIONAL 4451 02:51:25,400 --> 02:51:29,000 PROPOSALS THAN THE USUAL NIH 4452 02:51:29,000 --> 02:51:29,440 FUNDING MECHANISMS. 4453 02:51:29,440 --> 02:51:32,240 NOW, WE INITIALLY PUT FORTH THIS 4454 02:51:32,240 --> 02:51:34,400 CONCEPT, AND THIS IS THE 4455 02:51:34,400 --> 02:51:37,680 REISSUE, IN 2014, IT WAS HIGHLY 4456 02:51:37,680 --> 02:51:40,240 SUBSCRIBED, VERY IMPORTANT, WE 4457 02:51:40,240 --> 02:51:42,640 WENT THROUGH TWO FUNDING 4458 02:51:42,640 --> 02:51:44,720 OPPORTUNITY ANNOUNCEMENTS, THAT 4459 02:51:44,720 --> 02:51:46,520 WERE PUBLISHED IN 2017, AND 4460 02:51:46,520 --> 02:51:49,760 THERE WAS A PRETTY HIGH SUCCESS 4461 02:51:49,760 --> 02:51:52,560 RATE, 20% OF THE APPLICATIONS 4462 02:51:52,560 --> 02:51:55,200 SUBMITTED ENDED UP BEING FUNDED. 4463 02:51:55,200 --> 02:51:58,360 SO, THE RISK WAS PRESENTED TO 4464 02:51:58,360 --> 02:52:04,160 COUNCIL IN THE LAST COUNCIL 4465 02:52:04,160 --> 02:52:09,680 MEETING BY DR. HUNG TSENG WHO 4466 02:52:09,680 --> 02:52:12,920 WORKED WITH PROGRAM DIRECTORS. 4467 02:52:12,920 --> 02:52:16,120 THESE ARE THE THREE CONCEPTS. 4468 02:52:16,120 --> 02:52:16,520 YOUR TURN, DARREN. 4469 02:52:16,520 --> 02:52:18,160 >> THANK YOU. 4470 02:52:18,160 --> 02:52:20,440 IF WE COULD GO BACK TO THE FIRST 4471 02:52:20,440 --> 02:52:20,600 ONE. 4472 02:52:20,600 --> 02:52:23,320 DO WE HAVE ANY DISCUSSION FROM 4473 02:52:23,320 --> 02:52:26,280 THE COUNCIL MEMBERS ABOUT THIS 4474 02:52:26,280 --> 02:52:26,520 CONCEPT? 4475 02:52:26,520 --> 02:52:29,240 >> COULD YOU JUST CLARIFY FOR 4476 02:52:29,240 --> 02:52:31,320 US, ARE THESE -- WHAT WERE THE 4477 02:52:31,320 --> 02:52:32,960 FUNDING MECHANISM BE ASSOCIATED 4478 02:52:32,960 --> 02:52:38,240 OR DOES IT DEPEND ON EACH ONE? 4479 02:52:38,240 --> 02:52:38,960 >> UNDECIDED, DEPENDING ON EACH 4480 02:52:38,960 --> 02:52:40,640 ONE AND WHAT IS THE BEST 4481 02:52:40,640 --> 02:52:42,040 MECHANISM TO REACH THESE GOALS. 4482 02:52:42,040 --> 02:52:44,680 >> THE OTHER THING IS SOME OF 4483 02:52:44,680 --> 02:52:46,680 THESE COULD BE ROUNDTABLES, 4484 02:52:46,680 --> 02:52:49,520 COULD BE WORKSHOPS, THEY COULD 4485 02:52:49,520 --> 02:52:53,520 BE SOME TYPE OF FUNDING 4486 02:52:53,520 --> 02:52:54,200 OPPORTUNITY ANNOUNCEMENT, COULD 4487 02:52:54,200 --> 02:52:58,560 JUST BE AN AREA OF FOCUS FOR THE 4488 02:52:58,560 --> 02:52:59,280 INSTITUTE. 4489 02:52:59,280 --> 02:53:01,400 SO, THERE ARE CONCEPTS THAT 4490 02:53:01,400 --> 02:53:03,720 WE'VE TRIED TO PUT TOGETHER 4491 02:53:03,720 --> 02:53:07,320 BASED ON WHERE WE SEE NEEDS, AND 4492 02:53:07,320 --> 02:53:08,280 THEY WILL BE MANIFEST IN 4493 02:53:08,280 --> 02:53:09,080 DIFFERENT WAYS. 4494 02:53:09,080 --> 02:53:11,840 AND THOSE WOULD BE PRESENTED TO 4495 02:53:11,840 --> 02:53:13,720 COUNCIL AT A LATER TIME. 4496 02:53:13,720 --> 02:53:16,120 SO, THE LAST TIME WE PRESENTED 4497 02:53:16,120 --> 02:53:18,160 THE RISK WAS IN 2014, AND THEN 4498 02:53:18,160 --> 02:53:19,280 IT DIDN'T GET PUBLISHED BECAUSE 4499 02:53:19,280 --> 02:53:22,960 WE HAD TO WORK THROUGH A LOT OF 4500 02:53:22,960 --> 02:53:26,160 INS AND OUTS OF WHAT WE WOULD DO 4501 02:53:26,160 --> 02:53:28,320 WITH RISK PROPOSAL AND FINALLY 4502 02:53:28,320 --> 02:53:31,000 GOT PUBLISHED AS A FUNDING 4503 02:53:31,000 --> 02:53:32,520 OPPORTUNITY ANNOUNCEMENT IN 4504 02:53:32,520 --> 02:53:32,720 2017. 4505 02:53:32,720 --> 02:53:36,800 BUT OTHER CONCEPTS HAVE BEEN 4506 02:53:36,800 --> 02:53:40,080 WORKSHOPS OR MEETINGS, 4507 02:53:40,080 --> 02:53:40,520 SCIENTIFIC MEETINGS. 4508 02:53:40,520 --> 02:53:41,600 >> GREAT. 4509 02:53:41,600 --> 02:53:43,440 LET ME JUST SAY -- I'M SORRY. 4510 02:53:43,440 --> 02:53:45,440 LET ME JUST SAY I SHOULD HAVE 4511 02:53:45,440 --> 02:53:47,040 MENTIONED EARLIER FOR US TO MOVE 4512 02:53:47,040 --> 02:53:49,120 FORWARD ON ANY OF THE CONCEPTS 4513 02:53:49,120 --> 02:53:50,560 WE NEED AFFIRMATIVE VOTE FROM 4514 02:53:50,560 --> 02:53:51,080 COUNCIL. 4515 02:53:51,080 --> 02:53:52,960 I'M GOING TO CALL FOR THAT VOTE 4516 02:53:52,960 --> 02:53:56,800 AFTER WE DISCUSS EACH OF THESE 4517 02:53:56,800 --> 02:53:57,400 INDIVIDUALLY. 4518 02:53:57,400 --> 02:54:00,040 AGAIN, AS GAYLE SAID, THESE ARE 4519 02:54:00,040 --> 02:54:01,080 BROAD CONCEPTS THAT WILL 4520 02:54:01,080 --> 02:54:02,200 EVENTUALLY TURN INTO SOMETHING 4521 02:54:02,200 --> 02:54:03,920 BUT WE'RE STILL WORKING ON WHAT 4522 02:54:03,920 --> 02:54:05,440 THAT'S GOING TO BE. 4523 02:54:05,440 --> 02:54:06,440 I'M SORRY, GO AHEAD. 4524 02:54:06,440 --> 02:54:07,760 >> YES, JUST SO I UNDERSTAND A 4525 02:54:07,760 --> 02:54:09,600 LITTLE BETTER THIS IS A CONCEPT 4526 02:54:09,600 --> 02:54:15,200 BUT HOW DOES IT GET TO BUDGET, 4527 02:54:15,200 --> 02:54:18,240 IS THIS SOMETHING THAT YOU THEN 4528 02:54:18,240 --> 02:54:20,640 TAKE AND TRY TO GET FUNDS THAT 4529 02:54:20,640 --> 02:54:22,280 INCREASE YOUR BUDGET OR IT TAKES 4530 02:54:22,280 --> 02:54:24,800 AWAY FROM SOMETHING THAT'S 4531 02:54:24,800 --> 02:54:26,400 ALREADY IN BUDGET TO PROCEED 4532 02:54:26,400 --> 02:54:27,120 WITH THESE PARTICULAR IDEAS. 4533 02:54:27,120 --> 02:54:28,000 >> EXACTLY. 4534 02:54:28,000 --> 02:54:30,400 IF IT DOES COST MONEY, OTHER 4535 02:54:30,400 --> 02:54:32,040 THAN JUST SOMETHING LIKE A 4536 02:54:32,040 --> 02:54:35,320 WORKSHOP WHICH WOULD BE A VERY 4537 02:54:35,320 --> 02:54:37,720 LIMITED TIME, ONE-TIME BUDGET 4538 02:54:37,720 --> 02:54:44,080 THING, THEN WE WOULD BE LOOKING 4539 02:54:44,080 --> 02:54:47,200 FOR PARTNERS, AS WAS MENTIONED, 4540 02:54:47,200 --> 02:54:48,880 FOUNDATION FOR NIH, OTHER 4541 02:54:48,880 --> 02:54:49,560 INSTITUTES AND CENTERS WOULD 4542 02:54:49,560 --> 02:54:51,040 PARTNER WITH US ON THESE. 4543 02:54:51,040 --> 02:54:55,600 >> AGAIN, JUST TO BE CLEAR, IT 4544 02:54:55,600 --> 02:54:57,400 DOESN'T TAKE AWAY FROM REGULAR 4545 02:54:57,400 --> 02:54:57,640 FUNDING. 4546 02:54:57,640 --> 02:54:58,720 >> NO, WOULD NOT TAKE AWAY OR 4547 02:54:58,720 --> 02:55:01,680 HAVE AN IMPACT ON THE PAYLINE. 4548 02:55:01,680 --> 02:55:03,040 >> TO BE CLEAR IT'S POSSIBLE 4549 02:55:03,040 --> 02:55:04,880 YOU COULD END UP WITH SOMETHING 4550 02:55:04,880 --> 02:55:06,160 WITH A SET-ASIDE BUT THIS DOES 4551 02:55:06,160 --> 02:55:08,840 NOT GUARANTEE IT WOULD BE A 4552 02:55:08,840 --> 02:55:09,120 SET-ASIDE. 4553 02:55:09,120 --> 02:55:10,680 >> FOR SURE, ABSOLUTELY. 4554 02:55:10,680 --> 02:55:13,880 AND I MEAN THESE -- MOST OF 4555 02:55:13,880 --> 02:55:15,320 THESE ARE VERY MODEST, TO TELL 4556 02:55:15,320 --> 02:55:19,200 YOU THE TRUTH. 4557 02:55:19,200 --> 02:55:19,880 WE'RE RELATIVELY CONSERVATIVE. 4558 02:55:19,880 --> 02:55:22,880 >> STUART, YOUR HAND IS UP. 4559 02:55:22,880 --> 02:55:24,280 >> YES. 4560 02:55:24,280 --> 02:55:26,240 QUICK QUESTION, ON THE SECOND 4561 02:55:26,240 --> 02:55:28,200 INITIATIVES, MAYBE IF WE COULD 4562 02:55:28,200 --> 02:55:29,400 HAVE THAT SLIDE UP. 4563 02:55:29,400 --> 02:55:30,920 >> ACTUALLY CAN WE WAIT. 4564 02:55:30,920 --> 02:55:33,480 LET ME GO THROUGH THIS ONE, IF 4565 02:55:33,480 --> 02:55:34,680 WE HAVE DISCUSSION POINTS WE'LL 4566 02:55:34,680 --> 02:55:36,920 VOTE ON THIS AND GO IT THE NEXT 4567 02:55:36,920 --> 02:55:38,720 ONE AND MOVE TO YOUR QUESTION. 4568 02:55:38,720 --> 02:55:40,080 IS THAT OKAY? 4569 02:55:40,080 --> 02:55:46,440 >> THAT'S PERFECTLY OKAY. 4570 02:55:46,440 --> 02:55:46,720 >> OKAY. 4571 02:55:46,720 --> 02:55:48,000 >> WE'RE VOTING BUT I'M NOT 4572 02:55:48,000 --> 02:55:48,880 SURE WHAT WE'RE VOTING ON. 4573 02:55:48,880 --> 02:55:53,600 I DON'T KNOW THAT WE'RE 4574 02:55:53,600 --> 02:55:54,640 ALLOCATING MONEY. 4575 02:55:54,640 --> 02:55:54,880 >> NO. 4576 02:55:54,880 --> 02:55:57,320 >> JUST IT'S A GOOD IDEA. 4577 02:55:57,320 --> 02:55:59,520 >> IT'S A FORMALITY FOR US TO 4578 02:55:59,520 --> 02:56:01,080 DEVELOP A CONCEPT IN ANY WAY, WE 4579 02:56:01,080 --> 02:56:03,360 HAVE TO PRESENT IT TO COUNCIL 4580 02:56:03,360 --> 02:56:06,920 AND COUNCIL HAS TO ENDORSE THAT 4581 02:56:06,920 --> 02:56:10,200 AS MERITORIOUS, RELEVANT, ET 4582 02:56:10,200 --> 02:56:10,600 CETERA. 4583 02:56:10,600 --> 02:56:12,520 BY NO MEANS BY ENDORSING THIS 4584 02:56:12,520 --> 02:56:13,680 ARE YOU SAYING YOU APPROVE FOR 4585 02:56:13,680 --> 02:56:15,280 MONEY TO BE MOVED FROM THIS AREA 4586 02:56:15,280 --> 02:56:16,800 TO THAT AREA OR YOU'RE NOT 4587 02:56:16,800 --> 02:56:18,640 SAYING THIS IS MORE IMPORTANT 4588 02:56:18,640 --> 02:56:20,360 THAN SOMETHING ELSE. 4589 02:56:20,360 --> 02:56:23,600 AND MANY CONCEPTS WON'T GO 4590 02:56:23,600 --> 02:56:24,160 ANYWHERE. 4591 02:56:24,160 --> 02:56:28,080 BUT WE MUST, AS WE GENERATE 4592 02:56:28,080 --> 02:56:33,760 IDEAS, THAT MIGHT TURN INTO A 4593 02:56:33,760 --> 02:56:35,840 WORKSHOP, ROUNDTABLE, RFA, WE'RE 4594 02:56:35,840 --> 02:56:38,680 REQUIRED TO ENGAGE YOU IN A VERY 4595 02:56:38,680 --> 02:56:40,440 BRIEF PRESENTATION BECAUSE IT'S 4596 02:56:40,440 --> 02:56:42,840 JUST A CONCEPT. 4597 02:56:42,840 --> 02:56:46,480 AND TO HEAR FROM YOU, QUESTIONS 4598 02:56:46,480 --> 02:56:47,440 YOU HAVE, ET CETERA. 4599 02:56:47,440 --> 02:56:50,000 >> YEAH, I WOULD ENCOURAGE 4600 02:56:50,000 --> 02:56:51,640 COUNCIL MEMBERS, IF THEY HAVE 4601 02:56:51,640 --> 02:56:55,440 SOME INPUT FOR ONE OF THESE, TO 4602 02:56:55,440 --> 02:57:01,400 BE IN CONTACT WITH MYSELF OR DR. 4603 02:57:01,400 --> 02:57:02,120 SZTEIN OR BOTH. 4604 02:57:02,120 --> 02:57:05,120 >> OR BRING IT UP NOW FOR 4605 02:57:05,120 --> 02:57:05,520 GENERAL QUESTIONS. 4606 02:57:05,520 --> 02:57:06,920 >> THERE'S SO MUCH BIG DATA 4607 02:57:06,920 --> 02:57:08,560 THAT'S AVAILABLE, I KNOW THIS IS 4608 02:57:08,560 --> 02:57:10,720 CRAZY TO SUGGEST, BUT IN PHARMA 4609 02:57:10,720 --> 02:57:12,000 WHERE THEY HAVE REALLY PROFILED 4610 02:57:12,000 --> 02:57:16,320 A LOT OF THESE PATIENTS, THIS IS 4611 02:57:16,320 --> 02:57:16,880 AN OPPORTUNITY FOR 4612 02:57:16,880 --> 02:57:17,400 PUBLIC/PRIVATE PARTNERSHIP 4613 02:57:17,400 --> 02:57:19,080 FELLOWSHIP TRY TONE COURAGE MORE 4614 02:57:19,080 --> 02:57:22,000 DATA BE ADDED TO THIS 4615 02:57:22,000 --> 02:57:24,320 PARTICULARLY THAT SITS BEHIND 4616 02:57:24,320 --> 02:57:30,120 WALLS IN PHARMA. 4617 02:57:30,120 --> 02:57:31,320 >> FNIH, THAT'S THE ROLE THEY 4618 02:57:31,320 --> 02:57:31,520 PLAY. 4619 02:57:31,520 --> 02:57:34,160 >>THIS IS RIGHT FOR THAT. 4620 02:57:34,160 --> 02:57:36,840 THEY WILL BENEFIT BUT MANY MORE 4621 02:57:36,840 --> 02:57:37,680 PEOPLE CAN BENEFIT. 4622 02:57:37,680 --> 02:57:39,120 >> A SIMILAR THOUGHT. 4623 02:57:39,120 --> 02:57:42,440 I'VE RAISED THIS TO THIS GROUP 4624 02:57:42,440 --> 02:57:45,080 BEFORE BUT JUST FOR THE HOPEFUL 4625 02:57:45,080 --> 02:57:47,400 BENEFIT OF COUNCIL I THINK IT'S 4626 02:57:47,400 --> 02:57:51,120 FAIRLY ASPIRATIONAL AND I'M NOT 4627 02:57:51,120 --> 02:57:52,760 A TRAINED SCIENTIST, BUT I HAVE 4628 02:57:52,760 --> 02:57:55,280 ENCOURAGED AS WE TALKED ABOUT 4629 02:57:55,280 --> 02:57:58,680 THIS THAT WE ALSO THINK ABOUT 4630 02:57:58,680 --> 02:58:00,800 NOT CREATING SILOS BETWEEN REAL 4631 02:58:00,800 --> 02:58:02,120 WORLD EVIDENCE GENERATED FROM 4632 02:58:02,120 --> 02:58:04,200 PATIENTS AND PATIENT GROUPS AND 4633 02:58:04,200 --> 02:58:06,080 THIS IS PARTICULARLY IMPORTANT 4634 02:58:06,080 --> 02:58:07,840 IN RARE COMMUNITIES, SO RARE 4635 02:58:07,840 --> 02:58:11,080 AUTOIMMUNE DISEASES OR RARE 4636 02:58:11,080 --> 02:58:12,080 SUBTYPES OF AUTOIMMUNE DISEASES, 4637 02:58:12,080 --> 02:58:13,400 WHEN PATIENTS ARE GETTING 4638 02:58:13,400 --> 02:58:16,160 TOGETHER AND POOLING DATA AND 4639 02:58:16,160 --> 02:58:19,960 FINDING TRENDS AND THEMES IN 4640 02:58:19,960 --> 02:58:20,880 PRESENTATION OR WEIRD THINGS 4641 02:58:20,880 --> 02:58:22,800 THAT HAPPENED AMONG THE COHORT 4642 02:58:22,800 --> 02:58:24,920 OF PATIENTS, IT SEEMS LIKE THOSE 4643 02:58:24,920 --> 02:58:27,080 WILL BE REALLY IMPORTANT 4644 02:58:27,080 --> 02:58:29,600 OPPORTUNITIES TO CROSS-WALK TO 4645 02:58:29,600 --> 02:58:30,560 MASSIVE DATASETS. 4646 02:58:30,560 --> 02:58:32,240 JUST DRAWING A BIG ENOUGH -- 4647 02:58:32,240 --> 02:58:35,640 PUTTING A BIG ENOUGH TENT OVER 4648 02:58:35,640 --> 02:58:41,200 THIS THAT WE THINK ABOUT 4649 02:58:41,200 --> 02:58:43,040 PATIENT -- RIGOROUSLY COLLECTED 4650 02:58:43,040 --> 02:58:43,440 PATIENT DATA. 4651 02:58:43,440 --> 02:58:51,120 I WANTED TO SAY IT OUT LOUD. 4652 02:58:51,120 --> 02:58:51,680 >> THANK YOU. 4653 02:58:51,680 --> 02:58:54,440 >> I'M GOING TOE MOVE THAT WE 4654 02:58:54,440 --> 02:58:57,400 APPROVE THIS CONCEPT FOR FUTURE 4655 02:58:57,400 --> 02:58:57,720 DEVELOPMENT. 4656 02:58:57,720 --> 02:59:00,280 DO I HAVE A SECOND? 4657 02:59:00,280 --> 02:59:00,720 >> SECOND. 4658 02:59:00,720 --> 02:59:03,080 >> THANK YOU. 4659 02:59:03,080 --> 02:59:04,960 ALL THOSE WHO ARE OPPOSED PLEASE 4660 02:59:04,960 --> 02:59:08,000 RAISE YOUR HAND OR SAY AYE AND 4661 02:59:08,000 --> 02:59:12,120 STUART I'LL ASSUME YOUR HAND 4662 02:59:12,120 --> 02:59:13,920 RAISED IS NOT OPPOSED. 4663 02:59:13,920 --> 02:59:16,960 GIVEN THAT, I WILL SAY THIS HAS 4664 02:59:16,960 --> 02:59:18,640 BEEN APPROVED UNANIMOUSLY, TO 4665 02:59:18,640 --> 02:59:19,480 MOVE FORWARD FOR FURTHER 4666 02:59:19,480 --> 02:59:20,120 DEVELOPMENT. 4667 02:59:20,120 --> 02:59:25,080 LET'S GO TO THE NEXT CONCEPT. 4668 02:59:25,080 --> 02:59:27,000 STUART, ASK YOUR QUESTION. 4669 02:59:27,000 --> 02:59:29,360 >> SO I NOTICED THE WORD 4670 02:59:29,360 --> 02:59:33,720 "AUTOIMMUNE" AND I WAS WONDERING 4671 02:59:33,720 --> 02:59:37,160 WHY IT'S RESTRICTED TO 4672 02:59:37,160 --> 02:59:42,920 AUTOIMMUNE AND NOT GENERALIZED 4673 02:59:42,920 --> 02:59:43,360 IMMUNE DISEASES. 4674 02:59:43,360 --> 02:59:44,800 >> THAT'S A GOOD QUESTION. 4675 02:59:44,800 --> 02:59:47,200 WHO IS THE BEST TO ANSWER THAT? 4676 02:59:47,200 --> 02:59:49,080 >> I'LL TURN THIS TO SOMEONE 4677 02:59:49,080 --> 02:59:49,280 ELSE. 4678 02:59:49,280 --> 02:59:53,040 >> I'LL START BY SAYING THAT I 4679 02:59:53,040 --> 02:59:55,400 DON'T KNOW IF WOULD YOU RECALL, 4680 02:59:55,400 --> 02:59:58,280 I WOULDN'T EXPECT YOU TO, BUT WE 4681 02:59:58,280 --> 03:00:01,000 SEIZED THE OPPORTUNITY OF THE 4682 03:00:01,000 --> 03:00:04,640 NEW OFFICE OF AUTOIMMUNE DISEASE 4683 03:00:04,640 --> 03:00:07,200 RESEARCH TO LAUNCH THIS AS 4684 03:00:07,200 --> 03:00:08,720 INITIALLY AS AN R21 OPPORTUNITY. 4685 03:00:08,720 --> 03:00:12,560 NOW, I THINK WHETHER YOU SAY 4686 03:00:12,560 --> 03:00:13,120 AUTOIMMUNE OR AUTOIMMUNE 4687 03:00:13,120 --> 03:00:15,320 MEDIATED, YOU KNOW, THAT'S A 4688 03:00:15,320 --> 03:00:16,200 SPECTRUM AND THERE'S BEEN 4689 03:00:16,200 --> 03:00:17,600 DISCUSSION WITH THE OFFICE OF 4690 03:00:17,600 --> 03:00:19,800 RESEARCH ON WOMEN'S HEALTH ABOUT 4691 03:00:19,800 --> 03:00:22,440 EXACTLY WHAT IS THE SCOPE OF THE 4692 03:00:22,440 --> 03:00:26,360 BROAD OFFICE OF AUTOIMMUNE 4693 03:00:26,360 --> 03:00:27,680 DISEASE RESEARCH. 4694 03:00:27,680 --> 03:00:29,240 SO GOOD QUESTION, YEAH, FOR US 4695 03:00:29,240 --> 03:00:33,520 TO THINK ABOUT AGAIN AND TO 4696 03:00:33,520 --> 03:00:36,240 CIRCLE BACK TO ORWH WHO IS THE 4697 03:00:36,240 --> 03:00:38,320 LEAD ON THIS, BY VIRTUE OF THE 4698 03:00:38,320 --> 03:00:39,960 RESOURCES THAT THEY RECEIVE FROM 4699 03:00:39,960 --> 03:00:41,360 CONGRESS TO SUPPORT RESEARCH IN 4700 03:00:41,360 --> 03:00:44,120 THIS AREA. 4701 03:00:44,120 --> 03:00:44,760 BUT GOOD POINT, STUART. 4702 03:00:44,760 --> 03:00:48,720 >> I THINK IT COULD BE 4703 03:00:48,720 --> 03:00:54,000 MODULATED JUST BY SAYING 4704 03:00:54,000 --> 03:00:54,520 "IMMUNE-RELATED DISEASES." 4705 03:00:54,520 --> 03:00:56,360 >> EXCELLENT POINT. 4706 03:00:56,360 --> 03:00:57,840 IT'S A SPECTRUM, YEAH. 4707 03:00:57,840 --> 03:00:58,080 >> SURE. 4708 03:00:58,080 --> 03:00:59,640 >> REALLY INTERESTING POINT. 4709 03:00:59,640 --> 03:01:03,680 THANK YOU. 4710 03:01:03,680 --> 03:01:04,120 THE WORDS MATTER. 4711 03:01:04,120 --> 03:01:08,760 >> IF THERE ARE NO OTHER 4712 03:01:08,760 --> 03:01:11,920 COMMENTS THEN I MOVE -- I'D LIKE 4713 03:01:11,920 --> 03:01:13,680 A MOTION TO APPROVE FOR FURTHER 4714 03:01:13,680 --> 03:01:14,080 DEVELOPMENT. 4715 03:01:14,080 --> 03:01:16,120 DO I HAVE A SECOND? 4716 03:01:16,120 --> 03:01:19,360 >> ARE WE CHANGING ACCORDING TO 4717 03:01:19,360 --> 03:01:20,760 THE COMMENT FROM STUART? 4718 03:01:20,760 --> 03:01:21,160 >> GOOD QUESTION. 4719 03:01:21,160 --> 03:01:22,960 >> I WANT TO MAKE SURE I KNOW 4720 03:01:22,960 --> 03:01:24,200 WHAT WE'RE VOTING ON, THIS OR 4721 03:01:24,200 --> 03:01:28,240 THE TITLE WOULD BE THE EXPOSOME 4722 03:01:28,240 --> 03:01:30,320 IN IMMUNE-MEDIATED DISEASES OR 4723 03:01:30,320 --> 03:01:31,520 DOES IT MATTER? 4724 03:01:31,520 --> 03:01:32,520 OUT OF MY AREA. 4725 03:01:32,520 --> 03:01:36,240 >> IT DOES MATTER. 4726 03:01:36,240 --> 03:01:38,240 IS I THINK TAKING INTO ACCOUNT, 4727 03:01:38,240 --> 03:01:39,720 I'M NOT AN EXPERT SO IT'S 4728 03:01:39,720 --> 03:01:43,040 DIFFICULT TO DISCUSS THE SCIENCE 4729 03:01:43,040 --> 03:01:43,320 PER SE. 4730 03:01:43,320 --> 03:01:45,640 YOU THINK THIS IS AN IMPORTANT 4731 03:01:45,640 --> 03:01:47,080 THING FOR THE INSTITUTE IT'S 4732 03:01:47,080 --> 03:01:49,520 BETTER TO COME BACK WITH A 4733 03:01:49,520 --> 03:01:50,680 DIFFERENT CONCEPT FOR MORE BROAD 4734 03:01:50,680 --> 03:01:52,080 IMMUNE DISEASES OR DO YOU FEEL 4735 03:01:52,080 --> 03:01:53,680 THAT THIS WOULD COVER IT? 4736 03:01:53,680 --> 03:01:57,120 >> THIS DOES COME OUT OF 4737 03:01:57,120 --> 03:01:57,800 SOMETHING SPECIFIC. 4738 03:01:57,800 --> 03:01:59,440 LINDSEY ALLUDED TO IT IN OPENING 4739 03:01:59,440 --> 03:02:01,320 REMARKS, WHAT'S ON THE STREET 4740 03:02:01,320 --> 03:02:05,560 NOW IS EXACT PLAN, TO PLAN 4741 03:02:05,560 --> 03:02:05,840 SOMETHING. 4742 03:02:05,840 --> 03:02:08,440 I DO THINK IT IS IN CONJUNCTION 4743 03:02:08,440 --> 03:02:09,640 WITH THE ORWH AND WE DO EXPECT 4744 03:02:09,640 --> 03:02:11,600 THEM TO BE A MAJOR SOURCE OF 4745 03:02:11,600 --> 03:02:17,720 FUNDING, AND IT'S IN 4746 03:02:17,720 --> 03:02:18,280 COLLABORATION WITH NIEHS, 4747 03:02:18,280 --> 03:02:19,320 NATIONAL INSTITUTE OF 4748 03:02:19,320 --> 03:02:20,880 ENVIRONMENTAL HEALTH SCIENCE, 4749 03:02:20,880 --> 03:02:22,640 SPECIFIC CONNECTION TO 4750 03:02:22,640 --> 03:02:23,320 AUTOIMMUNE DISEASE. 4751 03:02:23,320 --> 03:02:27,360 FOR SOMETHING CALLED EXACT, IT 4752 03:02:27,360 --> 03:02:28,120 IS INDEED AUTOIMMUNE BECAUSE -- 4753 03:02:28,120 --> 03:02:30,200 AND IT IS TIED TO A COUPLE OTHER 4754 03:02:30,200 --> 03:02:34,560 THINGS GOING ON NOW WHICH DO 4755 03:02:34,560 --> 03:02:36,440 LIMIT ITS SCOPE TO THAT. 4756 03:02:36,440 --> 03:02:37,760 MY PERSONAL THING IS WHAT WE'RE 4757 03:02:37,760 --> 03:02:39,400 DOING HERE IS CLEARING THIS 4758 03:02:39,400 --> 03:02:42,480 CONCEPT SO WE CAN MOVE FORWARD 4759 03:02:42,480 --> 03:02:44,080 CAN DEVELOPING WHAT EXACT 4760 03:02:44,080 --> 03:02:44,840 ACTUALLY LOOKS LIKE. 4761 03:02:44,840 --> 03:02:47,880 AND BY EXACT I ACTUALLY MEAN 4762 03:02:47,880 --> 03:02:49,000 AUTOIMMUNE BECAUSE THE OTHER 4763 03:02:49,000 --> 03:02:50,800 PEOPLE INVOLVED. 4764 03:02:50,800 --> 03:02:52,600 BUT THE POINT IS CORRECT. 4765 03:02:52,600 --> 03:02:55,320 MY VOTE WOULD BE IF WE WANT TO 4766 03:02:55,320 --> 03:02:56,440 DEVELOP SOMETHING BROADER WE 4767 03:02:56,440 --> 03:03:01,360 COME BACK, BUT I DON'T FEEL 4768 03:03:01,360 --> 03:03:01,840 STRONGLY ABOUT IT. 4769 03:03:01,840 --> 03:03:06,320 >> SO THEN TO ANSWER YOUR 4770 03:03:06,320 --> 03:03:08,200 QUESTION -- I'M SORRY, SUSANA. 4771 03:03:08,200 --> 03:03:10,120 >> SO, I AGREE WITH THE COMMENT 4772 03:03:10,120 --> 03:03:13,640 THAT BOB JUST MADE. 4773 03:03:13,640 --> 03:03:18,240 THIS WAS BASED IN PART WITH AN 4774 03:03:18,240 --> 03:03:20,480 OPPORTUNITY IT'S BEING CREATED 4775 03:03:20,480 --> 03:03:23,920 THROUGH THE OFFICE OF AUTOIMMUNE 4776 03:03:23,920 --> 03:03:26,880 DISEASES RESEARCH, AND A NEED 4777 03:03:26,880 --> 03:03:28,320 IDENTIFIED BY NATIONAL ACADEMIES 4778 03:03:28,320 --> 03:03:32,160 REPORT TO EXPLORE THE ROLE OF 4779 03:03:32,160 --> 03:03:34,880 ENVIRONMENTAL EXPOSURES IN 4780 03:03:34,880 --> 03:03:36,160 DEVELOPMENT OF AUTOIMMUNE 4781 03:03:36,160 --> 03:03:37,320 DISEASES. 4782 03:03:37,320 --> 03:03:42,200 THE LIST OF AUTOIMMUNE DISEASES 4783 03:03:42,200 --> 03:03:44,640 IN THE NASEM REPORT INCLUDES 4784 03:03:44,640 --> 03:03:46,880 300, VERY BROAD INDEED. 4785 03:03:46,880 --> 03:03:48,760 THAT'S THE GENESIS OF THIS 4786 03:03:48,760 --> 03:03:49,760 CONCEPT. 4787 03:03:49,760 --> 03:03:52,080 THERE ARE MULTIPLE INSTITUTES 4788 03:03:52,080 --> 03:03:54,880 INVOLVED LIKE LINDSEY MENTIONED, 4789 03:03:54,880 --> 03:03:58,880 AND IT IS DOING -- WHAT WE'RE 4790 03:03:58,880 --> 03:04:02,560 DOING TODAY, TO DIFFERENT 4791 03:04:02,560 --> 03:04:03,920 DEGREES, I THINK THIS IS GOING 4792 03:04:03,920 --> 03:04:07,160 TO GET A LOT OF INPUT FROM MANY 4793 03:04:07,160 --> 03:04:08,600 DIFFERENT GROUPS. 4794 03:04:08,600 --> 03:04:11,760 BUT THE INITIAL FOCUS AND 4795 03:04:11,760 --> 03:04:12,400 IMPETUS WAS AROUND AUTOIMMUNE 4796 03:04:12,400 --> 03:04:12,640 DISEASE. 4797 03:04:12,640 --> 03:04:14,400 >> I GUESS THAT ANSWERS YOUR 4798 03:04:14,400 --> 03:04:14,960 QUESTION. 4799 03:04:14,960 --> 03:04:20,640 BUT WE DO APPRECIATE THE 4800 03:04:20,640 --> 03:04:25,120 FEEDBACK, FROM ALL OF YOU AND 4801 03:04:25,120 --> 03:04:26,440 STUART, FOR COMMENTS GOING 4802 03:04:26,440 --> 03:04:27,160 FORWARD. 4803 03:04:27,160 --> 03:04:29,920 >> ONE MORE POINT ABOUT THIS. 4804 03:04:29,920 --> 03:04:31,560 I DIDN'T DESCRIBE IN DETAIL BUT 4805 03:04:31,560 --> 03:04:33,960 SOME OF YOU MAY POSSIBLY HAVE 4806 03:04:33,960 --> 03:04:36,800 RECALLED THAT IN THAT SLIDE I 4807 03:04:36,800 --> 03:04:40,640 SHOWED OF THE EXACT PLAN THERE 4808 03:04:40,640 --> 03:04:43,480 WAS A PYRAMID THAT TALKS ABOUT 4809 03:04:43,480 --> 03:04:46,800 EXPANSION TO OTHER DISEASE 4810 03:04:46,800 --> 03:04:47,520 CONDITIONS, CERTAINLY IMMUNE 4811 03:04:47,520 --> 03:04:49,120 RELATED, IMMUNE MEDIATED, BUT 4812 03:04:49,120 --> 03:04:49,840 OTHER DISEASES. 4813 03:04:49,840 --> 03:04:53,440 THIS IS AN OPPORTUNITY FOCUSING 4814 03:04:53,440 --> 03:04:54,760 RELATIVELY NARROWLY TO TRY TO 4815 03:04:54,760 --> 03:04:56,200 FIGURE OUT HOW TO DEFINE THE 4816 03:04:56,200 --> 03:04:57,480 EXPOSOME IN DISEASE WITH THE 4817 03:04:57,480 --> 03:05:00,120 IDEA THAT WHAT WE LEARN HERE CAN 4818 03:05:00,120 --> 03:05:01,560 BE EASILY EXPANDED AND 4819 03:05:01,560 --> 03:05:03,680 EXTRAPOLATED TO A BROADER AND 4820 03:05:03,680 --> 03:05:05,800 BROADER SET OF CONDITIONS. 4821 03:05:05,800 --> 03:05:07,920 SO ANYWAY, FOR WHAT THAT'S 4822 03:05:07,920 --> 03:05:08,120 WORTH. 4823 03:05:08,120 --> 03:05:09,400 >> THANK YOU. 4824 03:05:09,400 --> 03:05:13,360 SO I THINK IT WAS SECONDED, THE 4825 03:05:13,360 --> 03:05:16,760 MOTION TO APPROVE FOR FURTHER 4826 03:05:16,760 --> 03:05:17,200 DEVELOPMENT. 4827 03:05:17,200 --> 03:05:18,200 IS ANYBODY DISAGREEING, DOES 4828 03:05:18,200 --> 03:05:21,440 ANYBODY VOTE NO? 4829 03:05:21,440 --> 03:05:21,640 OKAY. 4830 03:05:21,640 --> 03:05:23,560 SEEING NONE, THIS WAS 4831 03:05:23,560 --> 03:05:24,040 UNANIMOUSLY APPROVED. 4832 03:05:24,040 --> 03:05:27,240 LET'S GO TO NUMBER THREE. 4833 03:05:27,240 --> 03:05:30,040 SO DO WE HAVE ANY QUESTIONS 4834 03:05:30,040 --> 03:05:32,440 ABOUT THIS RE-ISSUE OF THE 4835 03:05:32,440 --> 03:05:33,440 RESEARCH INNOVATIONS FOR 4836 03:05:33,440 --> 03:05:35,680 SCIENTIFIC KNOWLEDGE INITIATIVE? 4837 03:05:35,680 --> 03:05:36,720 YES, GO AHEAD. 4838 03:05:36,720 --> 03:05:40,600 >> WILL THIS BE SIMILAR TO THE 4839 03:05:40,600 --> 03:05:44,720 FIRST ITERATION OR WILL THERE BE 4840 03:05:44,720 --> 03:05:46,640 DIFFERENCES? 4841 03:05:46,640 --> 03:05:49,000 >> VERY MINOR BUT VERY SIMILAR. 4842 03:05:49,000 --> 03:05:50,600 >> WE DID AN EVALUATION AND 4843 03:05:50,600 --> 03:05:53,800 CAME UP WITH MODIFICATIONS THAT 4844 03:05:53,800 --> 03:05:56,520 COULD BE MADE TO ENABLE A LITTLE 4845 03:05:56,520 --> 03:06:00,360 BIT MORE EASE OF REVIEW, TO BE 4846 03:06:00,360 --> 03:06:02,840 MORE INCLUSIVE OF PROPOSALS THAT 4847 03:06:02,840 --> 03:06:03,520 CAME IN. 4848 03:06:03,520 --> 03:06:07,000 IT'S A TWO PHASE, YOU COME IN 4849 03:06:07,000 --> 03:06:11,840 WITH A ONE-PAGER TO BE MORE 4850 03:06:11,840 --> 03:06:14,560 INCLUESIVE OF THE ONE-PAGEERS. 4851 03:06:14,560 --> 03:06:16,880 >>THERE WAS A PRESENTATION BY 4852 03:06:16,880 --> 03:06:18,680 HUNG TSENG AT THE LAST MEETING, 4853 03:06:18,680 --> 03:06:20,360 BECAUSE THIS WAS GOING TO COME 4854 03:06:20,360 --> 03:06:22,240 UP AS A CONCEPT WE PUT THAT 4855 03:06:22,240 --> 03:06:24,320 PRESENTATION IN THERE. 4856 03:06:24,320 --> 03:06:26,480 FOR THOSE THAT DIDN'T HEAR IT IT 4857 03:06:26,480 --> 03:06:27,720 GOES INTO OBSERVATIONS AND 4858 03:06:27,720 --> 03:06:28,120 LESSONS LEARNED. 4859 03:06:28,120 --> 03:06:31,200 >> HOW WE'LL BE MODIFYING FOR 4860 03:06:31,200 --> 03:06:31,560 THE REISSUE. 4861 03:06:31,560 --> 03:06:36,000 IN THIS CASE THIS DOES ACTUALLY 4862 03:06:36,000 --> 03:06:37,640 TAKE INSTITUTE MONEY BUT WE FEEL 4863 03:06:37,640 --> 03:06:41,080 LIKE IT'S A VERY GOOD USE OF IT 4864 03:06:41,080 --> 03:06:43,560 BECAUSE IT DOES ENCOURAGE 4865 03:06:43,560 --> 03:06:45,720 INNOVATION TO SUCH A HIGH LEVEL, 4866 03:06:45,720 --> 03:06:51,360 HIGH DEGREE, TO MUCH MORE THAN 4867 03:06:51,360 --> 03:06:52,240 THE R21 WOULD. 4868 03:06:52,240 --> 03:06:52,560 >> STAR? 4869 03:06:52,560 --> 03:06:55,560 >> I MISSED THE PRESENTATION IN 4870 03:06:55,560 --> 03:06:57,120 THE COUNCIL BOOK. 4871 03:06:57,120 --> 03:06:59,480 CAN SOMEONE GIVE AN EXAMPLE OF 4872 03:06:59,480 --> 03:07:06,480 LIKE AN AUDACIOUS IDEA THAT HAS 4873 03:07:06,480 --> 03:07:06,840 BEEN PROPOSED? 4874 03:07:06,840 --> 03:07:10,160 >> IS ALEXA HERE? 4875 03:07:10,160 --> 03:07:10,880 >> NO, NOT HERE. 4876 03:07:10,880 --> 03:07:13,120 >> HE'S NOT HERE. 4877 03:07:13,120 --> 03:07:14,760 TED OR FAYE COULD POSSIBLY SPEAK 4878 03:07:14,760 --> 03:07:15,680 TO THIS. 4879 03:07:15,680 --> 03:07:17,400 I COULDN'T HEAR YOUR QUESTION. 4880 03:07:17,400 --> 03:07:17,880 I'M SORRY. 4881 03:07:17,880 --> 03:07:20,480 >> THE QUESTION WAS WHAT WAS AN 4882 03:07:20,480 --> 03:07:21,560 AUDACIOUS IDEA, WHAT DID WE GET 4883 03:07:21,560 --> 03:07:25,880 OUT OF THE FIRST ROUND OF THE 4884 03:07:25,880 --> 03:07:30,480 RISKS, BIG RISKY IDEAS. 4885 03:07:30,480 --> 03:07:32,560 >> FUNDED APPLICATIONS. 4886 03:07:32,560 --> 03:07:37,920 >> THE ONE THING, SUMMARIZE THE 4887 03:07:37,920 --> 03:07:41,280 PRESENTATION, YOU COULD SEE THE 4888 03:07:41,280 --> 03:07:43,400 OUTCOME CORRELATED BETTER WITH 4889 03:07:43,400 --> 03:07:45,080 INNOVATION UNDER THIS PROGRAM 4890 03:07:45,080 --> 03:07:47,120 COMPARED TO APPROACH UNDER THE 4891 03:07:47,120 --> 03:07:47,800 CSR ONES. 4892 03:07:47,800 --> 03:07:50,360 SO, AT LEAST AT THE REVIEW 4893 03:07:50,360 --> 03:07:52,560 LEVEL, THE LEVEL OF INNOVATION 4894 03:07:52,560 --> 03:07:53,880 WAS MORE STRONGLY CONSIDERED. 4895 03:07:53,880 --> 03:07:57,080 THAT DOESN'T ANSWER YOUR 4896 03:07:57,080 --> 03:07:57,360 QUESTION. 4897 03:07:57,360 --> 03:07:58,520 >> AT THE LAST COUNCIL MEETING 4898 03:07:58,520 --> 03:08:00,480 WE TALKED ABOUT HOPING TO GET 4899 03:08:00,480 --> 03:08:02,000 MORE INFORMATION ON OUTCOMES, 4900 03:08:02,000 --> 03:08:04,440 PERHAPS TOO SOON TO GET THAT. 4901 03:08:04,440 --> 03:08:06,000 >> YES, IT'S A LITTLE SOON. 4902 03:08:06,000 --> 03:08:06,960 >> AS I RECALL. 4903 03:08:06,960 --> 03:08:08,000 THAT'S JUST SOMETHING FOR US TO 4904 03:08:08,000 --> 03:08:09,880 GET IN THE FUTURE WHEN IT'S 4905 03:08:09,880 --> 03:08:11,520 AVAILABLE TO START TO LOOK AT 4906 03:08:11,520 --> 03:08:12,760 WHAT THOSE OUTCOMES ARE AND 4907 03:08:12,760 --> 03:08:14,200 AGAIN IN THIS PARTICULAR CASE 4908 03:08:14,200 --> 03:08:15,760 SOME OF THE OUTCOMES MAY NOT 4909 03:08:15,760 --> 03:08:18,200 NECESSARILY BE IN THE FORM OF 4910 03:08:18,200 --> 03:08:19,440 PUBLICATIONS BUT COULD BE IN THE 4911 03:08:19,440 --> 03:08:20,520 FORM OF PATENT APPLICATIONS OR 4912 03:08:20,520 --> 03:08:22,720 ALL SORTS OF OTHER THINGS. 4913 03:08:22,720 --> 03:08:25,120 SO, I THINK WE DIDN'T HAVE THAT 4914 03:08:25,120 --> 03:08:27,440 INFORMATION YET, IF I RECALL. 4915 03:08:27,440 --> 03:08:30,560 >> FAYE JUST APPROACHED THE 4916 03:08:30,560 --> 03:08:39,560 MICROPHONE TO HAVE SOME 4917 03:08:39,560 --> 03:08:42,280 COMMENTS. 4918 03:08:42,280 --> 03:08:42,600 THANKS, FAYE. 4919 03:08:42,600 --> 03:08:43,560 >> OLDER FUNDED WITH GRANTS, 4920 03:08:43,560 --> 03:08:46,840 YOU CAN FUND ON NIH REPORTER, 4921 03:08:46,840 --> 03:08:49,400 NOW WHEN THEY ARE TRANSITION, 4922 03:08:49,400 --> 03:08:51,960 WHEN THEY ARE AWARDED THERE ARE 4923 03:08:51,960 --> 03:08:56,200 61 APPLICATIONS SO IF YOU SEARCH 4924 03:08:56,200 --> 03:09:00,200 FOR NIAMS R61 OR, AND SOME HAVE 4925 03:09:00,200 --> 03:09:02,840 TRANSITIONED TO R33, THAT'S A 4926 03:09:02,840 --> 03:09:06,800 SECOND PHASE TRANSITION, SO 4927 03:09:06,800 --> 03:09:11,400 EITHER R61 OR R33, SO IF YOU'RE 4928 03:09:11,400 --> 03:09:17,240 INTERESTED IN ANY SPECIFIC, YOU 4929 03:09:17,240 --> 03:09:19,360 KNOW, GRANT I THINK THE 4930 03:09:19,360 --> 03:09:20,720 SPECIFICS, WE CAN TALK ABOUT. 4931 03:09:20,720 --> 03:09:24,720 THE OTHER -- I'M SORRY? 4932 03:09:24,720 --> 03:09:27,000 ABOUT THE OUTCOMES, HUNG 4933 03:09:27,000 --> 03:09:30,080 ACTUALLY, WHEN HE REPORTED AT 4934 03:09:30,080 --> 03:09:33,040 THE LAST COUNCIL, LOOKING AT THE 4935 03:09:33,040 --> 03:09:35,960 PUBLICATIONS, HE ACTUALLY LOOKED 4936 03:09:35,960 --> 03:09:39,920 AT THE RCR, DIFFERENT CITATION, 4937 03:09:39,920 --> 03:09:41,000 RCR NUMBERS. 4938 03:09:41,000 --> 03:09:45,720 SO COMPARED TO THE PARENT R21 4939 03:09:45,720 --> 03:09:48,880 PUBLICATIONS, HIS DATA ACTUALLY 4940 03:09:48,880 --> 03:09:53,040 SHOWED THE RISK PAPERS, THEY 4941 03:09:53,040 --> 03:09:54,200 HAVE BETTER RCR OUTCOMES. 4942 03:09:54,200 --> 03:10:02,360 >> HIGHER LEVELS OF INNOVATION. 4943 03:10:02,360 --> 03:10:02,680 >> CORRECT. 4944 03:10:02,680 --> 03:10:03,080 >> DEFINITELY. 4945 03:10:03,080 --> 03:10:03,480 >>THANK YOU. 4946 03:10:03,480 --> 03:10:06,240 TED WILL ADD A COUPLE POINTS. 4947 03:10:06,240 --> 03:10:09,000 >> WE HAVE LIMITED DATA 4948 03:10:09,000 --> 03:10:12,040 ANALYSIS, SO BASED ON CURRENT 4949 03:10:12,040 --> 03:10:13,840 ROUND OF TOTALLY 32 AWARD FUNDED 4950 03:10:13,840 --> 03:10:16,880 AND FROM THE PUBLICATION WE GET 4951 03:10:16,880 --> 03:10:19,960 READOUT REVIEWS AND, YOU KNOW, 4952 03:10:19,960 --> 03:10:22,280 SOME CROSS-REFERENCE, BUT WE PUT 4953 03:10:22,280 --> 03:10:25,480 OUT 48 PUBLICATIONS FROM RISK 4954 03:10:25,480 --> 03:10:32,480 COMPARED TO 309 PUBLICATIONS. 4955 03:10:32,480 --> 03:10:35,000 WE USED THE CITATION RATIO, 4956 03:10:35,000 --> 03:10:38,560 RECENTLY DEVELOPED BY NIH, AT 4957 03:10:38,560 --> 03:10:42,720 THE MATRIX TO EVALUATE IMPACT, 4958 03:10:42,720 --> 03:10:48,640 NOT ONLY -- IT'S BASED ON A 4959 03:10:48,640 --> 03:10:50,840 FIELD, FIELD FORMALIZED MATRIX, 4960 03:10:50,840 --> 03:10:54,880 SO ONE WILL BE MEDIAN IMPACT. 4961 03:10:54,880 --> 03:10:59,360 SO R21, THE NUMBER IS LIKE 1.55, 4962 03:10:59,360 --> 03:11:01,120 AND RISK IS 2.3. 4963 03:11:01,120 --> 03:11:02,320 SO IT'S SIGNIFICANT DIFFERENCE. 4964 03:11:02,320 --> 03:11:06,280 ALSO IN TERM OF AVERAGE NUMBER, 4965 03:11:06,280 --> 03:11:12,000 TO NUMBER OF CITATION COMPARERS 4966 03:11:12,000 --> 03:11:15,320 R21 16 VERSUS 10. 4967 03:11:15,320 --> 03:11:17,120 PRIMARY ANALYSIS, OVERALL 4968 03:11:17,120 --> 03:11:18,640 PERFORMANCE IS SUPERIOR THAN 4969 03:11:18,640 --> 03:11:22,680 R21, IN ADDITION TO WHAT WAS 4970 03:11:22,680 --> 03:11:23,640 SAID ABOUT RISK. 4971 03:11:23,640 --> 03:11:26,720 >> THE WHOLE POINT IS LIKE YOU 4972 03:11:26,720 --> 03:11:28,440 JUST SAID PRELIMINARY DATA, 4973 03:11:28,440 --> 03:11:30,240 SOMEONE WANTS TO SEE LONGEVITY 4974 03:11:30,240 --> 03:11:31,760 AND LOOK FORWARD TO HEARING 4975 03:11:31,760 --> 03:11:31,960 MORE. 4976 03:11:31,960 --> 03:11:32,840 >> THANK YOU. 4977 03:11:32,840 --> 03:11:35,680 >> ANOTHER EXCELLENT POINT HERE 4978 03:11:35,680 --> 03:11:38,360 IS THE ORIGINAL PROPOSAL, THE 4979 03:11:38,360 --> 03:11:41,840 ONE-PAGER, CANNOT MAKE ANY 4980 03:11:41,840 --> 03:11:44,560 REFERENCE TO YOUR INSTITUTION, 4981 03:11:44,560 --> 03:11:48,720 YOUR MENTOR, ANY BACKGROUND 4982 03:11:48,720 --> 03:11:49,000 WHATSOEVER. 4983 03:11:49,000 --> 03:11:50,280 SO THE POSSIBILITY OF BIAS BASED 4984 03:11:50,280 --> 03:11:52,120 ON WHERE YOU COME FROM OR WHO 4985 03:11:52,120 --> 03:11:57,240 YOU TRAINED WITH IS VERY 4986 03:11:57,240 --> 03:11:58,600 LIMITED, WE'RE LOOKING AT USUAL 4987 03:11:58,600 --> 03:12:01,440 IDEAS AND ABILITY TO DO THIS. 4988 03:12:01,440 --> 03:12:07,440 >> NIAMS WAS AN INNOVATOR, NIH 4989 03:12:07,440 --> 03:12:11,280 ADOPTED THAT AND OTHER FUNDING 4990 03:12:11,280 --> 03:12:11,560 MECHANISMS. 4991 03:12:11,560 --> 03:12:13,120 >> ANDREW OR STUART, DO YOU 4992 03:12:13,120 --> 03:12:17,360 HAVE ANY COMMENTS? 4993 03:12:17,360 --> 03:12:19,000 >> NO COMMENTS. 4994 03:12:19,000 --> 03:12:19,320 >> NOTHING. 4995 03:12:19,320 --> 03:12:20,520 >> THANK YOU. 4996 03:12:20,520 --> 03:12:23,080 NO OTHER DISCUSSION, I MOVE WE 4997 03:12:23,080 --> 03:12:24,960 APPROVE THIS CONCEPT FOR FURTHER 4998 03:12:24,960 --> 03:12:25,360 DEVELOPMENT. 4999 03:12:25,360 --> 03:12:29,000 DO I HAVE A SECOND? 5000 03:12:29,000 --> 03:12:29,240 SECOND? 5001 03:12:29,240 --> 03:12:29,880 THANK YOU. 5002 03:12:29,880 --> 03:12:32,360 ALL THOSE OPPOSED TO MOVING THIS 5003 03:12:32,360 --> 03:12:33,760 FORWARD SAY AYE OR RAISE YOUR 5004 03:12:33,760 --> 03:12:37,440 HAND. 5005 03:12:37,440 --> 03:12:40,240 SEEING AND HEARING NONE, THIS 5006 03:12:40,240 --> 03:12:41,160 WAS APPROVED UNANIMOUSLY BY 5007 03:12:41,160 --> 03:12:42,640 COUNCIL TO MOVE FORWARD. 5008 03:12:42,640 --> 03:12:44,080 THANK YOU VERY MUCH. 5009 03:12:44,080 --> 03:12:44,840 >> AND THANKS, EVERYBODY. 5010 03:12:44,840 --> 03:12:48,240 IF YOU HAVE COMMENTS YOU WANT TO 5011 03:12:48,240 --> 03:12:49,080 SHARE, YOU'RE WELCOME TO SEND 5012 03:12:49,080 --> 03:12:51,000 THEM TO ME TO DISTRIBUTE TO 5013 03:12:51,000 --> 03:12:53,160 APPROPRIATE FOLKS FOR THESE 5014 03:12:53,160 --> 03:12:53,440 CONCEPTS. 5015 03:12:53,440 --> 03:12:57,560 THANK YOU. 5016 03:12:57,560 --> 03:12:59,720 >> SO, THE OPEN SESSION OF 5017 03:12:59,720 --> 03:13:02,920 COUNCIL IS SUPPOSED TO END AT 5018 03:13:02,920 --> 03:13:04,080 1:00. 5019 03:13:04,080 --> 03:13:06,640 THAT GIVES US SIX MINUTES FOR 5020 03:13:06,640 --> 03:13:08,000 SOME ADDITIONAL QUESTIONS ON ANY 5021 03:13:08,000 --> 03:13:09,080 TOPIC THAT YOU'VE HEARD THIS 5022 03:13:09,080 --> 03:13:11,440 MORNING OR ANY OTHER TOPIC UNDER 5023 03:13:11,440 --> 03:13:13,480 THE SUN, AS LONG AS IT RELATED 5024 03:13:13,480 --> 03:13:16,280 TO NIAMS OR NIH. 5025 03:13:16,280 --> 03:13:17,280 BUT REMINDER FOR COUNCIL MEMBERS 5026 03:13:17,280 --> 03:13:21,680 OF COURSE WE'LL HAVE A CLOSED 5027 03:13:21,680 --> 03:13:23,440 SESSION OF COUNCIL STARTING AOF 5028 03:13:23,440 --> 03:13:26,040 I BELIEVE AT 2:00, WE SET ASIDE 5029 03:13:26,040 --> 03:13:28,440 TIME FOR ADDITIONAL DISCUSSION 5030 03:13:28,440 --> 03:13:29,760 AS WELL. 5031 03:13:29,760 --> 03:13:33,920 SO, IF THERE ARE SOME RELATED TO 5032 03:13:33,920 --> 03:13:35,760 CONCEPTS OR PRESENTATIONS YOU 5033 03:13:35,760 --> 03:13:38,160 HEARD OR ANYTHING ELSE, I ALWAYS 5034 03:13:38,160 --> 03:13:39,480 WELCOME NEW TOPICS FOR US TO 5035 03:13:39,480 --> 03:13:41,680 START THINKING ABOUT THAT WE 5036 03:13:41,680 --> 03:13:43,560 COULD DEVELOP AS A PRESENTATION 5037 03:13:43,560 --> 03:13:45,840 AND FORMAL SESSION AS PART OF 5038 03:13:45,840 --> 03:13:47,160 COUNCIL OR OTHER QUESTIONS 5039 03:13:47,160 --> 03:13:51,320 RELATED TO THINGS THAT CAME UP 5040 03:13:51,320 --> 03:13:51,520 TODAY. 5041 03:13:51,520 --> 03:13:52,880 PLEASE FEEL FREE TO GET THOSE 5042 03:13:52,880 --> 03:13:55,360 OUT THERE NOW OR YOU CAN 5043 03:13:55,360 --> 03:13:56,520 CONTINUE THINKING ABOUT THEM AND 5044 03:13:56,520 --> 03:14:03,120 WE CAN DISCUSS THEM LATER. 5045 03:14:03,120 --> 03:14:04,920 >> STAR E-MAILED ME SOME THINGS 5046 03:14:04,920 --> 03:14:05,960 SHE WANTED TO DISCUSS. 5047 03:14:05,960 --> 03:14:08,240 DID YOU WANT TO BRING ANY OF 5048 03:14:08,240 --> 03:14:08,840 THOSE UP? 5049 03:14:08,840 --> 03:14:11,000 >> I THINK WE TALKED A LITTLE 5050 03:14:11,000 --> 03:14:13,520 BIT ABOUT THIS EARLIER AS 5051 03:14:13,520 --> 03:14:19,960 RELATED TO COMMUNITY ENGAGED 5052 03:14:19,960 --> 03:14:21,720 RESEARCH AND THINKING ALSO ABOUT 5053 03:14:21,720 --> 03:14:27,040 MORE PARTNERSHIPS WITH COMMUNITY 5054 03:14:27,040 --> 03:14:29,080 SCIENTISTS AND BASIC SCIENTISTS. 5055 03:14:29,080 --> 03:14:31,280 I DON'T HAVE AN INITIAL CONCEPT, 5056 03:14:31,280 --> 03:14:34,320 JUST WONDERING HOW NIAMS CAN 5057 03:14:34,320 --> 03:14:36,520 EXPAND IN THAT AREA. 5058 03:14:36,520 --> 03:14:37,960 >> SO, EXPAND IN TERMS OF THE 5059 03:14:37,960 --> 03:14:42,760 NATURE OF THE PARTNERSHIPS THAT 5060 03:14:42,760 --> 03:14:43,320 WE FORGE? 5061 03:14:43,320 --> 03:14:45,200 >> OR JUST MAYBE MORE EMPHASIS 5062 03:14:45,200 --> 03:14:48,800 JUST ON HOW WE CAN INTEGRATE 5063 03:14:48,800 --> 03:14:51,240 MORE COMMUNITY ENGAGED RESEARCH 5064 03:14:51,240 --> 03:14:52,800 INTO THE PORTFOLIO. 5065 03:14:52,800 --> 03:14:54,360 >> YEAH, SO THIS TOPIC IS 5066 03:14:54,360 --> 03:14:55,960 OBVIOUSLY ONE WE SHOULD SET 5067 03:14:55,960 --> 03:15:00,280 ASIDE SOME TIME AT A FUTURE 5068 03:15:00,280 --> 03:15:00,640 COUNCIL MEETING. 5069 03:15:00,640 --> 03:15:02,200 SUSANA BROUGHT THIS UP TODAY, 5070 03:15:02,200 --> 03:15:05,320 IT'S COME UP, ANN MADE COMMENTS 5071 03:15:05,320 --> 03:15:05,960 ALONG THESE LINES. 5072 03:15:05,960 --> 03:15:08,160 SO THANK YOU FOR RAISING THAT. 5073 03:15:08,160 --> 03:15:11,000 AND WE'LL PUT OUR HEADS TOGETHER 5074 03:15:11,000 --> 03:15:13,120 ABOUT A COUPLE PRESENTERS THAT 5075 03:15:13,120 --> 03:15:18,360 WOULD MAKE FOR AN INFORMATIVE 5076 03:15:18,360 --> 03:15:19,000 AND KIND OF THOUGHT-PROVOKING 5077 03:15:19,000 --> 03:15:19,360 DISCUSSION. 5078 03:15:19,360 --> 03:15:20,840 I WANT TO MAKE SURE I UNDERSTAND 5079 03:15:20,840 --> 03:15:22,840 BETTER WHAT THE OPPORTUNITIES 5080 03:15:22,840 --> 03:15:25,720 ARE OUT THERE AND WHAT WE CAN BE 5081 03:15:25,720 --> 03:15:26,880 DOING TO PURSUE THOSE. 5082 03:15:26,880 --> 03:15:28,080 AND SUPPORT THOSE. 5083 03:15:28,080 --> 03:15:29,440 SO I APPRECIATE YOUR BRINGING 5084 03:15:29,440 --> 03:15:31,920 THAT UP AND OTHERS WHO 5085 03:15:31,920 --> 03:15:34,320 HIGHLIGHTED THAT TOPIC AS WELL. 5086 03:15:34,320 --> 03:15:35,280 THIS CAME UP HEAVILY IN THE 5087 03:15:35,280 --> 03:15:37,920 SECOND OF THE RECENT BRIEFINGS I 5088 03:15:37,920 --> 03:15:39,480 PARTICIPATED IN TOO, IT'S A 5089 03:15:39,480 --> 03:15:40,480 REALLY IMPORTANT TOPIC. 5090 03:15:40,480 --> 03:15:43,880 THANK YOU. 5091 03:15:43,880 --> 03:15:44,040 ANN? 5092 03:15:44,040 --> 03:15:45,600 >> I REALLY APPRECIATED THE 5093 03:15:45,600 --> 03:15:52,600 DISCUSSION AND HEADS UP, AND BOB 5094 03:15:52,600 --> 03:15:53,600 MENTIONED BOLD ASPIRATIONS FROM 5095 03:15:53,600 --> 03:15:55,120 THE LAST ONE. 5096 03:15:55,120 --> 03:15:58,000 WHAT WERE SOME OF THOSE, DO YOU 5097 03:15:58,000 --> 03:15:58,240 RECALL? 5098 03:15:58,240 --> 03:16:00,240 >>I ASKED BOB THE OTHER DAY, 5099 03:16:00,240 --> 03:16:04,240 HOW DID WE DO ON THAT FRONTS? 5100 03:16:04,240 --> 03:16:04,560 NOT BAD. 5101 03:16:04,560 --> 03:16:08,200 >> ONE WAS A GENE THERAPY. 5102 03:16:08,200 --> 03:16:10,080 WAS THAT SKIN? 5103 03:16:10,080 --> 03:16:10,760 >> EPIDERMAL EXPOSOMES? 5104 03:16:10,760 --> 03:16:12,400 >> NOT SO SPECIFIC. 5105 03:16:12,400 --> 03:16:15,160 I'M NOT SURE ABOUT MUSCLE. 5106 03:16:15,160 --> 03:16:17,800 THERE'S THIS GENE THERAPY NOW 5107 03:16:17,800 --> 03:16:26,120 FOR SKIN. 5108 03:16:26,120 --> 03:16:28,520 >> [OFF MICROPHONE]. 5109 03:16:28,520 --> 03:16:31,840 >> YEAH, WHAT WAS IT THOUGH? 5110 03:16:31,840 --> 03:16:35,560 A THERAPY? 5111 03:16:35,560 --> 03:16:38,280 I DON'T REMEMBER. 5112 03:16:38,280 --> 03:16:40,160 >> SOMEONE WAS PREPARED. 5113 03:16:40,160 --> 03:16:40,520 >> THANK YOU. 5114 03:16:40,520 --> 03:16:42,360 >> I PUT THEM ON SEVERAL SLIDES 5115 03:16:42,360 --> 03:16:44,880 BECAUSE WE HAD SEVERAL. 5116 03:16:44,880 --> 03:16:49,800 ONE WAS GENE THERAPY FOR 5117 03:16:49,800 --> 03:16:52,320 MUSCULAR DYSTROPHY OR EB, 5118 03:16:52,320 --> 03:16:58,920 BIOMARKERS TO GUIDE THERAPY FOR 5119 03:16:58,920 --> 03:17:00,200 R.A., NON-SURGICAL TREATMENTS, 5120 03:17:00,200 --> 03:17:03,240 REGENERATIVE MEDICINE FOR O.A., 5121 03:17:03,240 --> 03:17:12,240 AND PREVENTION FOR AUTOIMMUNE 5122 03:17:12,240 --> 03:17:12,680 DISEASES. 5123 03:17:12,680 --> 03:17:13,320 FINALLY HEAL NON-ADDICTIVE 5124 03:17:13,320 --> 03:17:16,640 THERAPIES FOR CHRONIC LOW BACK 5125 03:17:16,640 --> 03:17:20,240 PAIN, REDUCING DISPARITIES, 5126 03:17:20,240 --> 03:17:22,080 USING -- REDUCES HEALTH 5127 03:17:22,080 --> 03:17:23,880 DISPARITIES RELATED TO 5128 03:17:23,880 --> 03:17:24,600 OSTEOARTHRITIS, THE LAST RELATES 5129 03:17:24,600 --> 03:17:25,440 TO OSTEOPOROSIS. 5130 03:17:25,440 --> 03:17:30,080 THAT'S WHAT WE HAD LAST TIME. 5131 03:17:30,080 --> 03:17:31,440 >> I THINK IT'S VERY FAIR TO 5132 03:17:31,440 --> 03:17:33,720 SAY FOR EVERY ONE OF THESE, THE 5133 03:17:33,720 --> 03:17:35,000 INSTITUTE HAS DONE SOMETHING TO 5134 03:17:35,000 --> 03:17:36,320 TRY TO MAKE PROGRESS. 5135 03:17:36,320 --> 03:17:38,640 MOST OF THESE ARE BOLD. 5136 03:17:38,640 --> 03:17:39,280 BY DEFINITION PROBABLY UNLIKELY 5137 03:17:39,280 --> 03:17:41,560 FOR US TO BE ABLE TO DO ON OUR 5138 03:17:41,560 --> 03:17:43,320 OWN BUT I THINK ALL OF THESE 5139 03:17:43,320 --> 03:17:47,480 HAVE BEEN ADVANCED TO SOME 5140 03:17:47,480 --> 03:17:51,320 EXTENT, ROUNDTABLES, WORKSHOPS. 5141 03:17:51,320 --> 03:17:53,720 LEVERAGING "HEAL." 5142 03:17:53,720 --> 03:17:55,840 I'VE FORGOTTEN A COUPLE ON 5143 03:17:55,840 --> 03:17:56,760 PREVIOUS SLIDES. 5144 03:17:56,760 --> 03:17:57,840 STEPHANIE REMINDED US. 5145 03:17:57,840 --> 03:18:01,000 GO BACK TO THE TOPIC AND BRIEFLY 5146 03:18:01,000 --> 03:18:01,160 -- 5147 03:18:01,160 --> 03:18:03,320 >>IT'S NOT EVEN 2025 YET. 5148 03:18:03,320 --> 03:18:03,760 >> RIGHT. 5149 03:18:03,760 --> 03:18:05,400 >> WE'RE ONLY HALFWAY THERE. 5150 03:18:05,400 --> 03:18:07,440 THERE WE GO. 5151 03:18:07,440 --> 03:18:10,360 SO, YOU KNOW, WE'RE NOW THE LEAD 5152 03:18:10,360 --> 03:18:12,440 INSTITUTE FOR REGENERATIVE 5153 03:18:12,440 --> 03:18:15,800 MEDICINE INNOVATION PROGRAM, SO 5154 03:18:15,800 --> 03:18:18,440 MUSCULAR DYSTROPHY AND EB IS A 5155 03:18:18,440 --> 03:18:19,640 SCORE. 5156 03:18:19,640 --> 03:18:20,320 BIOMARKERS FOR RHEUMATOID 5157 03:18:20,320 --> 03:18:22,800 ARTHRITIS, YOU KNOW, THAT 5158 03:18:22,800 --> 03:18:23,280 REMAINS A CHALLENGE. 5159 03:18:23,280 --> 03:18:26,000 I THINK WE'RE DOING A LOT IN 5160 03:18:26,000 --> 03:18:33,120 RHEUMATOID ARTHRITIS TO GET US 5161 03:18:33,120 --> 03:18:33,600 THERE EVENTUALLY. 5162 03:18:33,600 --> 03:18:36,800 >> AND IT WAS PUBLISHED TO 5163 03:18:36,800 --> 03:18:40,440 PREDICT OUTCOME OF R.A. BASED ON 5164 03:18:40,440 --> 03:18:40,640 BIAS. 5165 03:18:40,640 --> 03:18:44,400 >> WE HAVE AN EXPERT HERE. 5166 03:18:44,400 --> 03:18:48,560 >> VERY LIMITED SET OF 5167 03:18:48,560 --> 03:18:49,320 PATIENTS, LIMITED CHOICE OF 5168 03:18:49,320 --> 03:18:51,640 THERAPIES BUT IT WAS VERY 5169 03:18:51,640 --> 03:18:53,080 ENCOURAGING, I HAVE TO SAY. 5170 03:18:53,080 --> 03:18:53,920 AND VERY EXCITING. 5171 03:18:53,920 --> 03:18:57,080 I KNOW HE'S GOT MORE DATA COMING 5172 03:18:57,080 --> 03:18:59,600 TO SUPPORT THAT. 5173 03:18:59,600 --> 03:19:01,040 >>WE SKIPPED ONE. 5174 03:19:01,040 --> 03:19:01,560 OOPS. 5175 03:19:01,560 --> 03:19:04,760 MAYBE THESE ARE ON AUTOADVANCE. 5176 03:19:04,760 --> 03:19:08,960 WE HAVE THIS REALLY EXCITING 5177 03:19:08,960 --> 03:19:13,080 BACPAC PROGRAM, THE BACK PAIN 5178 03:19:13,080 --> 03:19:14,600 CONSORTIUM THAT'S PART OF 5179 03:19:14,600 --> 03:19:17,000 "HEAL," VERY HIGH PROFILE THAT 5180 03:19:17,000 --> 03:19:19,920 HAS AN IMPRESSIVE SET OF ENGAGED 5181 03:19:19,920 --> 03:19:22,640 INVESTIGATORS AND THAT EFFORT IS 5182 03:19:22,640 --> 03:19:24,840 NOW LEVERAGING NEW "HEAL"-FUNDED 5183 03:19:24,840 --> 03:19:26,920 EFFORTS SUCH AS RE-JOIN WHICH 5184 03:19:26,920 --> 03:19:30,240 WE'RE DEEPLY INVOLVED IN AND 5185 03:19:30,240 --> 03:19:32,120 MYOFASCIAL PAIN EFFORT THAT 5186 03:19:32,120 --> 03:19:35,080 NCCIH IS LEADING WITH OUR 5187 03:19:35,080 --> 03:19:38,680 SUPPORT, ET CETERA. 5188 03:19:38,680 --> 03:19:40,800 DISPARITIES, WE HAD THE -- I'VE 5189 03:19:40,800 --> 03:19:43,280 FORGOTTEN WHETHER IT WAS A 5190 03:19:43,280 --> 03:19:48,200 ROUNDTABLE OR WORKSHOP, HEALTH 5191 03:19:48,200 --> 03:19:49,280 DISPARITIES IN OSTEOARTHRITIS, 5192 03:19:49,280 --> 03:19:50,320 HELD WITH OTHER INSTITUTES AND 5193 03:19:50,320 --> 03:19:51,960 WE NEED TO CIRCLE BACK AND 5194 03:19:51,960 --> 03:19:54,200 FIGURE OUT WHAT OUR NEXT STEPS 5195 03:19:54,200 --> 03:19:55,320 ARE IN FOLLOW-UP TO THAT. 5196 03:19:55,320 --> 03:20:01,000 WHAT ARE THE OTHER ONES? 5197 03:20:01,000 --> 03:20:03,760 OSTEOPOROSIS, MARY, WE'VE TALKED 5198 03:20:03,760 --> 03:20:04,520 ABOUT THIS. 5199 03:20:04,520 --> 03:20:05,520 NIAMS CAN SAY THEY HAVE BEEN 5200 03:20:05,520 --> 03:20:07,480 PLAYING A ROLE FOR THE PAST 5201 03:20:07,480 --> 03:20:10,600 DECADE IN TRYING TO ADVANCE OUR 5202 03:20:10,600 --> 03:20:14,480 KNOWLEDGE OF, YOU KNOW, HOW TO 5203 03:20:14,480 --> 03:20:15,440 FACILITATE IDENTIFICATION OF 5204 03:20:15,440 --> 03:20:17,840 THERAPIES, HOW TO GET THEM 5205 03:20:17,840 --> 03:20:18,520 IMPLEMENTED INTO PRACTICE, ET 5206 03:20:18,520 --> 03:20:19,960 CETERA, ET CETERA. 5207 03:20:19,960 --> 03:20:22,720 SOME OF YOU, I DON'T KNOW, MARY, 5208 03:20:22,720 --> 03:20:26,280 IF YOU WANT TO SPEAK TO EFFORTS. 5209 03:20:26,280 --> 03:20:26,840 THERE'S FNIH BIOMARKERS 5210 03:20:26,840 --> 03:20:27,840 CONSORTIUM EFFORT GAYLE IS 5211 03:20:27,840 --> 03:20:29,080 INVOLVED IN. 5212 03:20:29,080 --> 03:20:30,360 MARY, YOU'VE BEEN INVOLVED ON 5213 03:20:30,360 --> 03:20:32,320 SOME FRONTS. 5214 03:20:32,320 --> 03:20:33,760 WE JUST INVESTED MONEY TO MAKE 5215 03:20:33,760 --> 03:20:36,880 SURE THAT SOME OF THE POPULATION 5216 03:20:36,880 --> 03:20:38,960 OPINION BASED DATA COLLECTION 5217 03:20:38,960 --> 03:20:40,880 EFFORTS, CHRISTY NIX TO SPEAK TO 5218 03:20:40,880 --> 03:20:43,320 THAT, TO HELP US UNDERSTAND 5219 03:20:43,320 --> 03:20:44,960 WHAT'S GOING ON RELATED TO 5220 03:20:44,960 --> 03:20:48,560 OSTEOPOROSIS AND USE OF 5221 03:20:48,560 --> 03:20:50,320 MEDICATIONS WILL EXIST, SO YOU 5222 03:20:50,320 --> 03:20:52,600 ALL KNOW -- ANYTHING ELSE YOU 5223 03:20:52,600 --> 03:20:58,320 WANT TO CHIME IN, IN TERMS OF 5224 03:20:58,320 --> 03:21:01,240 PROGRESS? 5225 03:21:01,240 --> 03:21:01,800 >> [OFF MICROPHONE]. 5226 03:21:01,800 --> 03:21:04,040 >> MAY I MAKE A COMMENT? 5227 03:21:04,040 --> 03:21:05,280 >> YES, STUART. 5228 03:21:05,280 --> 03:21:10,480 GO AHEAD AND CHRISTY WILL FOLLOW 5229 03:21:10,480 --> 03:21:10,640 YOU. 5230 03:21:10,640 --> 03:21:15,040 >> I CAN ACQUIESCE TO CHRISTY. 5231 03:21:15,040 --> 03:21:15,720 I DON'T MIND. 5232 03:21:15,720 --> 03:21:21,120 >> I WAS JUST GOING TO SAY THE 5233 03:21:21,120 --> 03:21:22,520 NHANES PROJECT IS BEING 5234 03:21:22,520 --> 03:21:23,440 REVAMPED, WE'RE INVESTING OUR 5235 03:21:23,440 --> 03:21:25,000 MONEY BUT NOT SURE AT THE 5236 03:21:25,000 --> 03:21:27,400 CURRENT MOMENT WHETHER OR NOT WE 5237 03:21:27,400 --> 03:21:30,400 WERE GOING TO HAVE DEXA INCLUDED 5238 03:21:30,400 --> 03:21:31,600 IN THE STUDY. 5239 03:21:31,600 --> 03:21:33,600 SO WE ARE WORKING ON THAT, AND 5240 03:21:33,600 --> 03:21:35,760 HOPEFULLY WE'LL HAVE MORE DATA 5241 03:21:35,760 --> 03:21:35,960 SOON. 5242 03:21:35,960 --> 03:21:37,600 >> SO, THESE ARE SUPPOSED TO BE 5243 03:21:37,600 --> 03:21:37,800 BOLD. 5244 03:21:37,800 --> 03:21:39,480 THE IDEA IS NOT THAT WE'RE GOING 5245 03:21:39,480 --> 03:21:41,520 TO ACHIEVE ALL OF THESE. 5246 03:21:41,520 --> 03:21:45,920 AS SOMEONE POINTED OUT IT'S ONLY 5247 03:21:45,920 --> 03:21:46,320 2023. 5248 03:21:46,320 --> 03:21:49,800 BUT IMPORTANTLY, WE PLAN TO HAVE 5249 03:21:49,800 --> 03:21:50,520 MORE FORMAL STEWARDSHIP 5250 03:21:50,520 --> 03:21:52,160 ACTIVITIES WITH THIS NEXT PLAN 5251 03:21:52,160 --> 03:21:56,440 SO THAT WE'RE FOLLOWING AND 5252 03:21:56,440 --> 03:21:58,200 TRACKING, YOU KNOW, FOLLOWING 5253 03:21:58,200 --> 03:22:00,000 THROUGH ON THE COMMITMENTS WE 5254 03:22:00,000 --> 03:22:01,760 MAKE, THE VALUES AND PRIORITIES 5255 03:22:01,760 --> 03:22:03,000 THAT WE ESTABLISH, AND WE THINK 5256 03:22:03,000 --> 03:22:04,840 IT SHOULD PLAY AN IMPORTANT ROLE 5257 03:22:04,840 --> 03:22:12,000 IN FUNDING DECISIONS AS WELL. 5258 03:22:12,000 --> 03:22:14,400 5259 03:22:14,400 --> 03:22:15,600 STUART, YES, PLEASE. 5260 03:22:15,600 --> 03:22:16,480 >> QUICK COMMENT. 5261 03:22:16,480 --> 03:22:18,360 WHEN I WAS LOOKING AT WHAT'S 5262 03:22:18,360 --> 03:22:21,080 BEING FUNDED IN THE INSTITUTE OF 5263 03:22:21,080 --> 03:22:24,880 AGING, I NOTICED THAT IT'S 5264 03:22:24,880 --> 03:22:28,280 PRIMARILY RELATED TO DEMENTIA, 5265 03:22:28,280 --> 03:22:29,280 PARKINSONISM, NEUROLOGICAL 5266 03:22:29,280 --> 03:22:30,840 DISORDERS. 5267 03:22:30,840 --> 03:22:34,000 AND I THINK ONE OF THE POTENTIAL 5268 03:22:34,000 --> 03:22:38,280 BOLD ASPIRATIONS WE SHOULD BE 5269 03:22:38,280 --> 03:22:41,800 ENCOMPASSING IS TO LOOK AT AGING 5270 03:22:41,800 --> 03:22:43,640 AND MUSCULOSKELETAL TISSUES. 5271 03:22:43,640 --> 03:22:47,240 AND THIS REALLY LOOKS AT 5272 03:22:47,240 --> 03:22:48,960 EVERYTHING FROM OSTEOPOROSIS TO 5273 03:22:48,960 --> 03:22:50,760 FRACTURES IN THE ELDERLY, TO THE 5274 03:22:50,760 --> 03:22:53,760 INCREASING INCIDENCE OF BACK 5275 03:22:53,760 --> 03:22:55,360 PAIN AND OTHER IMMUNE AND 5276 03:22:55,360 --> 03:22:57,440 AUTOIMMUNE DISEASES THAT SEEM TO 5277 03:22:57,440 --> 03:23:04,800 BE INCREASING IN THE ELDERLY. 5278 03:23:04,800 --> 03:23:07,200 >> THAT'S AN EXCELLENT POINT. 5279 03:23:07,200 --> 03:23:09,440 I RECALL A MEETING EIGHT OR NINE 5280 03:23:09,440 --> 03:23:11,960 MONTHS AGO WITH THE PREVIOUS 5281 03:23:11,960 --> 03:23:12,880 DIRECTOR OF AIDS RESEARCH 5282 03:23:12,880 --> 03:23:13,840 INTERESTED IN AGING MUSCLE, 5283 03:23:13,840 --> 03:23:15,560 THERE'S A CONNECTION TO OUR 5284 03:23:15,560 --> 03:23:16,920 INSTITUTE THERE. 5285 03:23:16,920 --> 03:23:19,080 YES, YOU KNOW, STUART, PART OF 5286 03:23:19,080 --> 03:23:21,080 THE REASON FOR THAT EMPHASIS IN 5287 03:23:21,080 --> 03:23:23,480 NIA, THEY HAVE BEEN FORTUNATE 5288 03:23:23,480 --> 03:23:25,480 RECIPIENT OF TARGETED FUNDING 5289 03:23:25,480 --> 03:23:28,120 FROM CONGRESS FOR SPECIFIC 5290 03:23:28,120 --> 03:23:28,520 AREAS. 5291 03:23:28,520 --> 03:23:33,160 SO THAT EXPLAINS THE OF PERHAPS 5292 03:23:33,160 --> 03:23:34,880 ASYMMETRY IN THEIR PORTFOLIO, 5293 03:23:34,880 --> 03:23:36,200 BUT EXCELLENT POINT. 5294 03:23:36,200 --> 03:23:37,600 MAYBE THAT'S ANOTHER POTENTIAL 5295 03:23:37,600 --> 03:23:45,840 CONCEPT FOR A ROUNDTABLE OR 5296 03:23:45,840 --> 03:23:46,120 SOMETHING. 5297 03:23:46,120 --> 03:23:53,640 >> TO PUT NIAMS ON THE MAP WITH 5298 03:23:53,640 --> 03:23:54,480 CONGRESS, MUSCULOSKELETAL HEALTH 5299 03:23:54,480 --> 03:23:56,320 IS HEAVILY FUNDED IN OTHER PARTS 5300 03:23:56,320 --> 03:23:58,400 OF THE WORLD, IT WOULD BE GREAT 5301 03:23:58,400 --> 03:24:00,920 IF NIAMS GOT SOME OF THAT. 5302 03:24:00,920 --> 03:24:03,760 >> HOPING SKIN DISEASE TOO. 5303 03:24:03,760 --> 03:24:06,160 I WAS SAYING ONE COULD ADD SKIN 5304 03:24:06,160 --> 03:24:07,520 DISEASES TOO. 5305 03:24:07,520 --> 03:24:11,360 IT'S NOT JUST MUSCULOSKELETAL. 5306 03:24:11,360 --> 03:24:17,040 ALL ASPECTS OF OUR INSTITUTE ARE 5307 03:24:17,040 --> 03:24:17,320 AFFECTED. 5308 03:24:17,320 --> 03:24:17,640 >> YEAH. 5309 03:24:17,640 --> 03:24:19,520 ONE OF THE HIGH LEVEL CHALLENGES 5310 03:24:19,520 --> 03:24:22,400 WE FACE IS THAT FOR THE MOST 5311 03:24:22,400 --> 03:24:23,960 MART, THE DISEASES AND 5312 03:24:23,960 --> 03:24:26,200 CONDITIONS THAT FALL WITHIN OUR 5313 03:24:26,200 --> 03:24:28,480 MISSION AREAS DON'T IMMEDIATELY 5314 03:24:28,480 --> 03:24:31,480 KILL YOU, AND CAN BE HARD TO 5315 03:24:31,480 --> 03:24:33,400 ATTRACT THE SENSE OF URGENCY AND 5316 03:24:33,400 --> 03:24:33,680 ATTENTION. 5317 03:24:33,680 --> 03:24:34,880 AS A MEMBER OF CONGRESS SAID 5318 03:24:34,880 --> 03:24:36,840 RECENTLY WE HAVE TO CHANGE THE 5319 03:24:36,840 --> 03:24:38,280 MINDSET SO PEOPLE DON'T THINK, 5320 03:24:38,280 --> 03:24:39,440 FOR EXAMPLE, ARTHRITIS IS JUST 5321 03:24:39,440 --> 03:24:43,520 AN INEVITABLE PART OF THE AGING 5322 03:24:43,520 --> 03:24:44,280 PROCESS. 5323 03:24:44,280 --> 03:24:45,600 LET'S TURN THINKING AROUND, AND 5324 03:24:45,600 --> 03:24:48,120 BOLDLY SAY THIS IS SOMETHING 5325 03:24:48,120 --> 03:24:49,640 THAT WE CAN PREVENT, REVERSE, 5326 03:24:49,640 --> 03:24:51,040 CORRECT, ET CETERA. 5327 03:24:51,040 --> 03:24:54,120 SO I HOPE THAT GETS BACK TO THIS 5328 03:24:54,120 --> 03:24:56,120 BOLD ASPIRATION CONCEPT. 5329 03:24:56,120 --> 03:24:59,800 IF WE CAN INSPIRE THE COMMUNITY 5330 03:24:59,800 --> 03:25:01,560 AND MEMBERS OF CONGRESS AND 5331 03:25:01,560 --> 03:25:03,200 FUNDERS THAT THAT'S POSSIBLE, 5332 03:25:03,200 --> 03:25:05,520 MAYBE WE CAN MAKE SOME REAL 5333 03:25:05,520 --> 03:25:08,840 PROGRESS ON THAT FRONT. 5334 03:25:08,840 --> 03:25:09,560 STEPHANIE, PLEASE, YEAH. 5335 03:25:09,560 --> 03:25:11,760 >> SO, I MENTIONED WE HAD ONE 5336 03:25:11,760 --> 03:25:13,600 REQUEST FOR INFORMATION, WE 5337 03:25:13,600 --> 03:25:16,040 ASKED FOR BOLD ASPIRATION, AND I 5338 03:25:16,040 --> 03:25:18,800 HAVE TO SAY WE GOT A LOT OF 5339 03:25:18,800 --> 03:25:21,600 CROSS-CUTTING THEMES, MOD AS -- 5340 03:25:21,600 --> 03:25:25,560 NOT AS MUCH ON BOLD ASPIRATIONS. 5341 03:25:25,560 --> 03:25:27,280 WE'LL HAVE THEM FOR SURE BUT 5342 03:25:27,280 --> 03:25:28,800 WOULD LOVE MORE INPUT IN THAT 5343 03:25:28,800 --> 03:25:29,000 VEIN. 5344 03:25:29,000 --> 03:25:30,240 >> SOME OF THE INSTITUTES HAVE 5345 03:25:30,240 --> 03:25:32,400 WHAT I THINK THEY CALL A VISION 5346 03:25:32,400 --> 03:25:35,480 STATEMENT, THAT BASICALLY IS A 5347 03:25:35,480 --> 03:25:37,880 BOLD ASPIRATION, THAT CATCHINGS 5348 03:25:37,880 --> 03:25:39,560 THE ATTENTION AND, YOU KNOW, 5349 03:25:39,560 --> 03:25:40,880 IT'S TOUGH WITH NIAMS, WITH SUCH 5350 03:25:40,880 --> 03:25:44,360 A BROAD SET OF MISSION AREAS, 5351 03:25:44,360 --> 03:25:45,800 BUT I WOULD KIND OF CHALLENGE 5352 03:25:45,800 --> 03:25:48,440 YOU ALL TO THINK ABOUT SOME 5353 03:25:48,440 --> 03:25:50,080 CATCHY PHRASES, THAT EITHER 5354 03:25:50,080 --> 03:25:51,040 REPRESENT BOLD ASPIRATIONS OR 5355 03:25:51,040 --> 03:25:55,240 MAYBE EVEN A THEME OR SOMETHING 5356 03:25:55,240 --> 03:25:57,080 THAT IS BROAD ENOUGH THAT WE 5357 03:25:57,080 --> 03:25:58,200 COULD CONNECT DIRECTLY TO NIAMS 5358 03:25:58,200 --> 03:25:59,920 AS A STATEMENT OF WHERE WE'RE 5359 03:25:59,920 --> 03:26:03,720 TRYING TO GO, AS AN INSTITUTE 5360 03:26:03,720 --> 03:26:05,680 WOULD BE REALLY USEFUL. 5361 03:26:05,680 --> 03:26:09,000 ANY OTHER -- I'M CUTTING INTO 5362 03:26:09,000 --> 03:26:11,160 THE LUNCH HOUR. 5363 03:26:11,160 --> 03:26:11,840 STUART, WAS THAT YOU? 5364 03:26:11,840 --> 03:26:13,520 >> THAT WAS ME. 5365 03:26:13,520 --> 03:26:13,960 >> MARY, SORRY. 5366 03:26:13,960 --> 03:26:17,200 >> ONE COMMENT ABOUT A BOLD 5367 03:26:17,200 --> 03:26:18,960 ASPIRATION FOR OUR INSTITUTE, 5368 03:26:18,960 --> 03:26:20,520 WHICH IS THE ABILITY OF PEOPLE 5369 03:26:20,520 --> 03:26:23,640 TO MOVE AND BE ACTIVE, WHICH IS 5370 03:26:23,640 --> 03:26:25,640 DOMINATED BY THE MUSCULOSKELETAL 5371 03:26:25,640 --> 03:26:28,680 SYSTEM, INFLUENCES SO MANY 5372 03:26:28,680 --> 03:26:29,240 DISEASES, CARDIOVASCULAR 5373 03:26:29,240 --> 03:26:31,240 DISEASE, OBESITY, DIABETES. 5374 03:26:31,240 --> 03:26:33,440 SO WE ARE NOT NECESSARILY 5375 03:26:33,440 --> 03:26:36,240 SECONDARY AND OFF OVER HERE. 5376 03:26:36,240 --> 03:26:38,680 WE SHOULD BE FUNDAMENTAL TO 5377 03:26:38,680 --> 03:26:39,760 PREVENTION OF THESE OTHER 5378 03:26:39,760 --> 03:26:41,400 CHRONIC DISEASES. 5379 03:26:41,400 --> 03:26:44,120 IF WE CAN REFRAME THE NARRATIVE 5380 03:26:44,120 --> 03:26:46,400 OF OUR INSTITUTE AROUND THAT, 5381 03:26:46,400 --> 03:26:48,200 MAYBE WE'LL GET MORE MONEY OR 5382 03:26:48,200 --> 03:26:51,120 MAYBE WOULD HAVE SOME MORE 5383 03:26:51,120 --> 03:26:51,880 CROSS-CUTTING ASPIRATIONS, BUT I 5384 03:26:51,880 --> 03:26:54,960 THINK WE HAVE TO WORK REALLY 5385 03:26:54,960 --> 03:26:57,360 HARD TO SAY HOW FUNDAMENTAL 5386 03:26:57,360 --> 03:26:58,960 BEING ACTIVE AND MOBILE IS GOING 5387 03:26:58,960 --> 03:27:01,680 TO PREVENT THESE OTHER DISEASES. 5388 03:27:01,680 --> 03:27:05,400 >> WE'RE THE CORE, NOT THE 5389 03:27:05,400 --> 03:27:05,680 EXTREMITIES. 5390 03:27:05,680 --> 03:27:06,000 >>EXACTLY. 5391 03:27:06,000 --> 03:27:08,760 >> WE'RE NOT THE PERIPHERY. 5392 03:27:08,760 --> 03:27:09,160 >> EXACTLY. 5393 03:27:09,160 --> 03:27:10,320 >> WE'VE BEEN HAVING 5394 03:27:10,320 --> 03:27:14,680 CONVERSATIONS ABOUT VISION 5395 03:27:14,680 --> 03:27:15,200 STATEMENTS AND THEMES. 5396 03:27:15,200 --> 03:27:17,200 I THINK WE'LL HAVE A SESSION 5397 03:27:17,200 --> 03:27:18,640 ABOUT THE NEXT COUNCIL MEETING 5398 03:27:18,640 --> 03:27:20,320 ABOUT OUR VALUES. 5399 03:27:20,320 --> 03:27:22,920 MAYBE WE CAN EXPAND TO INCLUDE 5400 03:27:22,920 --> 03:27:24,640 THIS SORT OF THING. 5401 03:27:24,640 --> 03:27:26,960 RICK HAD TO STEP OUT. 5402 03:27:26,960 --> 03:27:27,440 OKAY. 5403 03:27:27,440 --> 03:27:29,680 I HOPE THERE ARE PLANS FOR YOU 5404 03:27:29,680 --> 03:27:31,120 ALL TO GET LUNCH. 5405 03:27:31,120 --> 03:27:34,040 DID SOMEONE THINK ABOUT THAT? 5406 03:27:34,040 --> 03:27:34,520 >> YES. 5407 03:27:34,520 --> 03:27:38,440 I WAS GOING TO WAIT UNTIL WE 5408 03:27:38,440 --> 03:27:39,240 ENDED THE OPEN SESSION. 5409 03:27:39,240 --> 03:27:40,840 >> DO I USE THE GAVEL? 5410 03:27:40,840 --> 03:27:47,920 >> I MUST GAVEL IT CLOSED. 5411 03:27:47,920 --> 03:27:48,360 >> THANK YOU. 5412 03:27:48,360 --> 00:00:00,000 [APPLAUSE]